data_2gto_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gto _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 120.346 0.117 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.647 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.1 pp -60.62 -25.82 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.162 0.506 . . . . 0.0 112.143 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 94.9 mttt -72.46 -24.49 61.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.291 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -97.78 -46.73 5.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.073 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.7 tttt -66.52 -53.42 35.14 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.87 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 80.0 m-85 -98.46 -8.86 26.02 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.44 0.638 . . . . 0.0 109.375 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.6 ttmt 60.84 75.48 0.41 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.161 1.384 . . . . 0.0 112.534 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.751 HD22 HG12 ' A' ' 25' ' ' ILE . 8.3 mp -117.58 17.01 14.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.256 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -56.21 104.94 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.395 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.55 -160.17 20.07 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.35 117.68 0.64 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.209 2.606 . . . . 0.0 112.583 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.757 HD13 HG12 ' A' ' 55' ' ' ILE . 2.6 pp -117.01 143.82 26.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 120.666 0.27 . . . . 0.0 111.616 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -120.17 155.22 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.82 137.59 22.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 121.484 0.659 . . . . 0.0 112.19 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG22 ' CD2' ' A' ' 29' ' ' HIS . 46.4 mm -91.46 -41.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.982 ' HB2' HD12 ' A' ' 54' ' ' ILE . 73.7 m-70 -152.84 177.86 10.28 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.12 117.41 29.99 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.62 168.24 9.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.17 107.77 3.5 Favored 'General case' 0 C--N 1.255 -3.526 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 176.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.837 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -64.03 132.69 51.33 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.511 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.8 t -116.73 148.14 41.38 Favored 'General case' 0 CA--C 1.44 -3.257 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.3 m 70.29 178.56 0.25 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.273 163.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.13 112.78 15.43 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.823 HG22 ' CE1' ' A' ' 46' ' ' PHE . 9.3 m -110.4 156.79 11.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.682 -174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 17.2 ttmm -49.44 -66.46 0.39 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.926 0.766 . . . . 0.0 110.843 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.11 42.75 98.64 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.148 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.16 -158.6 0.83 Allowed Glycine 0 CA--C 1.54 1.595 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -65.09 -31.38 72.56 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.556 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 29.3 p-10 -93.08 -17.83 23.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.376 -0.529 . . . . 0.0 109.897 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' OE1' ' HG2' ' A' ' 38' ' ' LYS . 42.9 mt-10 -92.64 170.55 9.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.426 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -83.56 138.8 33.23 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -86.01 59.04 5.4 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 121.999 0.904 . . . . 0.0 109.004 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.862 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -95.82 -174.89 3.26 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.587 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 56.3 mtpt -143.86 -173.1 3.89 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.565 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.22 114.99 18.6 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 126.17 1.788 . . . . 0.0 108.95 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.91 10.44 57.58 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 10.1 mm-40 -79.32 123.9 27.9 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 111.208 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -87.23 97.08 10.57 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.171 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.787 HD13 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -109.94 159.39 9.62 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.256 0 CA-C-N 111.554 -2.567 . . . . 0.0 112.207 176.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.87 140.2 53.14 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.982 HD12 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -104.98 127.3 59.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.219 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.757 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -101.65 -21.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.335 -173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.5 ttm180 -136.15 126.42 26.5 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.561 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.79 98.45 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.779 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.881 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mmtm -131.37 157.4 43.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 30.2 m0 -99.72 162.5 12.97 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 123.731 0.644 . . . . 0.0 110.494 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -99.7 114.39 27.47 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.774 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.698 ' HA3' HD13 ' A' ' 77' ' ' ILE . . . -120.85 175.55 16.07 Favored Glycine 0 N--CA 1.423 -2.175 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' SER . 40.2 ptt180 -151.69 141.09 21.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.515 ' HA ' HG23 ' A' ' 52' ' ' ILE . 16.9 p -81.26 164.07 22.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.59 -8.28 53.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.409 1.1 . . . . 0.0 109.237 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -87.02 -4.64 59.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.339 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.44 32.29 19.79 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.858 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 9.1 m -118.11 124.08 47.16 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.647 ' HB2' HG22 ' A' ' 15' ' ' ILE . 8.0 m-85 -101.6 140.31 36.06 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.39 162.8 36.11 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 119.157 -1.497 . . . . 0.0 113.218 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.558 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 28.3 m-85 -71.87 149.43 45.19 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.203 0.525 . . . . 0.0 110.107 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.862 HG12 ' HE2' ' A' ' 46' ' ' PHE . 74.7 mt -131.99 129.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.605 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' HE3' ' A' ' 64' ' ' LYS . 98.8 mttt -66.58 136.97 56.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 166.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -69.12 -8.75 48.35 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 122.337 1.065 . . . . 0.0 111.447 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 78' ' ' LYS . 7.3 t -97.31 -16.18 20.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.652 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.41 59.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.837 HG13 ' HA ' ' A' ' 33' ' ' ALA . 33.9 m -133.16 159.78 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 CA-C-O 121.365 0.602 . . . . 0.0 112.273 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 34.1 mt-10 -97.5 102.24 13.95 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.553 HG12 HG21 ' A' ' 82' ' ' VAL . 29.2 mm -88.36 120.36 37.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.684 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 121.352 0.596 . . . . 0.0 111.22 179.813 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.439 -1.005 0 CA-C-O 120.967 0.413 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.3 pp -61.08 -25.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' N ' HD12 ' A' ' 15' ' ' ILE . 15.4 ttmm -76.5 -32.17 58.15 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.616 0.722 . . . . 0.0 109.525 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -97.03 -39.95 9.09 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.407 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.6 ttpt -66.09 -43.68 86.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.817 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 26.9 m-85 -97.68 3.17 50.32 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.533 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 53.92 74.44 0.33 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.977 0.894 . . . . 0.0 109.841 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD13 ' NH2' ' A' ' 56' ' ' ARG . 6.8 tp -107.75 13.48 26.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.485 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.33 109.78 0.66 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.49 0.662 . . . . 0.0 111.858 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.72 171.89 12.35 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.93 110.4 1.09 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.449 2.1 . . . . 0.0 111.673 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -89.29 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -126.91 139.21 53.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.58 0.705 . . . . 0.0 110.723 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 53' ' ' GLU . 41.4 t -68.76 116.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.701 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.657 HG22 ' HD2' ' A' ' 29' ' ' HIS . 46.4 mm -84.46 -44.8 17.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.343 0.592 . . . . 0.0 109.927 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.657 ' HD2' HG22 ' A' ' 28' ' ' ILE . 38.7 m-70 -153.72 171.24 19.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.701 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.2 mp -102.61 129.64 49.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 170.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.54 166.22 10.56 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 18.9 pttp -150.14 101.9 3.04 Favored 'General case' 0 C--N 1.255 -3.535 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.84 133.06 50.17 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.456 -2.156 . . . . 0.0 110.685 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -119.37 152.3 37.03 Favored 'General case' 0 CA--C 1.445 -3.068 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.0 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.1 m 70.91 169.47 0.32 Allowed 'General case' 0 N--CA 1.397 -3.11 0 O-C-N 125.771 1.919 . . . . 0.0 111.745 162.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -69.72 101.91 1.78 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.497 0.665 . . . . 0.0 109.988 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.817 HG22 ' CE1' ' A' ' 46' ' ' PHE . 12.3 m -97.18 156.52 3.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.21 -59.05 5.18 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.19 43.72 95.25 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.361 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.48 -172.04 0.51 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -51.78 -53.21 42.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.37 -2.04 58.07 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.92 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -92.27 169.04 10.91 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.657 HD12 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -80.06 139.55 36.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.392 0.615 . . . . 0.0 109.944 -177.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -81.07 40.3 0.54 Allowed 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.652 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.893 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -82.43 -177.83 6.82 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.487 0.661 . . . . 0.0 111.895 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -142.63 -172.89 3.73 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.643 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 8.9 tt0 -84.32 114.89 22.19 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.1 1.36 . . . . 0.0 109.123 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.49 3.02 56.5 Favored Glycine 0 C--N 1.29 -1.985 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -75.27 122.42 23.68 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.783 0.802 . . . . 0.0 111.699 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.61 97.21 9.57 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.876 HD13 HG13 ' A' ' 82' ' ' VAL . 27.7 pt -104.66 158.37 5.54 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.595 0 CA-C-N 111.79 -2.459 . . . . 0.0 111.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.8 mt-10 -121.09 131.73 54.44 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.075 -1.016 . . . . 0.0 109.018 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -92.73 133.37 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.05 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -120.66 11.52 6.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.942 -176.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 44.8 ttm180 -152.34 125.68 8.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.004 176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 28' ' ' ILE . 47.3 mm -111.5 98.01 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.404 -2.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.057 -167.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.496 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.634 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.2 mmtp -134.4 154.32 51.43 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -98.35 157.17 16.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -101.08 111.49 23.71 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.874 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.717 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.8 179.69 18.87 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.506 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 39.0 ptt180 -152.15 144.28 23.88 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.697 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.9 p -81.85 169.35 16.96 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.64 36.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.564 1.173 . . . . 0.0 107.877 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -89.32 -4.92 57.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.418 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.34 33.06 32.93 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.46 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -124.07 121.64 35.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.1 m-85 -89.03 153.68 20.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -173.08 156.36 24.48 Favored Glycine 0 C--N 1.318 -0.446 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.637 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 39.9 m-85 -74.96 139.5 43.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 112.411 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.893 HG12 ' HE2' ' A' ' 46' ' ' PHE . 63.0 mt -121.24 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.633 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 94.7 mttt -73.41 135.91 44.26 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.7 p -65.21 -9.93 27.47 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -98.13 -14.12 20.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.788 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -80.78 -13.45 58.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.386 0.613 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.876 HG13 HD13 ' A' ' 52' ' ' ILE . 31.2 m -129.7 156.16 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.841 0.829 . . . . 0.0 112.01 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.49 100.71 11.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 82' ' ' VAL . 22.5 mm -88.84 108.25 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.918 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 121.237 0.541 . . . . 0.0 112.236 177.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 120.509 0.195 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.792 HG23 ' HB2' ' A' ' 74' ' ' TYR . 2.8 pp -69.56 -26.57 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.704 ' HB3' HG23 ' A' ' 22' ' ' THR . 90.1 mttt -71.43 -16.13 62.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.246 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -94.06 -56.95 2.68 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.7 -44.19 81.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.133 1.373 . . . . 0.0 112.106 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.5 -3.33 22.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.726 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 56.29 78.62 0.2 Allowed 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.326 1.06 . . . . 0.0 110.967 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 66' ' ' LEU . 88.2 mt -126.01 16.42 7.92 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.398 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.704 HG23 ' HB3' ' A' ' 16' ' ' LYS . 4.6 p -72.9 98.84 2.55 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.75 -159.63 28.23 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -89.16 103.84 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.874 2.383 . . . . 0.0 112.393 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.459 HG21 HD23 ' A' ' 21' ' ' LEU . 2.7 pp -109.12 142.21 22.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 120.859 0.362 . . . . 0.0 110.732 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -127.23 148.47 50.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 53' ' ' GLU . 11.3 p -75.62 145.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mm -98.7 -39.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.261 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.658 ' HB2' HD13 ' A' ' 54' ' ' ILE . 43.7 m-70 -156.45 171.73 19.75 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 109.938 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.23 127.49 44.2 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.648 ' HB3' HD13 ' A' ' 84' ' ' ILE . . . -107.18 167.88 9.6 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.4 102.37 2.9 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -67.72 137.04 55.19 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 113.204 -1.816 . . . . 0.0 111.205 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.8 t -123.16 149.81 44.11 Favored 'General case' 0 CA--C 1.439 -3.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.926 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.6 m 72.64 162.87 0.26 Allowed 'General case' 0 N--CA 1.396 -3.163 0 O-C-N 126.129 2.143 . . . . 0.0 111.868 162.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.93 103.33 1.45 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 109.356 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.751 HG21 ' CE1' ' A' ' 46' ' ' PHE . 24.1 m -102.33 156.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.751 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -48.3 -54.15 14.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.668 1.23 . . . . 0.0 109.165 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.9 43.02 60.8 Favored Glycine 0 C--N 1.346 1.114 0 O-C-N 123.859 0.724 . . . . 0.0 114.69 175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.31 -168.51 0.39 Allowed Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.756 1.063 . . . . 0.0 115.756 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -55.7 -49.24 73.54 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 113.426 -174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.14 -10.72 54.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.556 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -92.09 163.92 13.79 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.517 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.641 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -82.57 131.89 35.2 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 m -86.04 71.38 10.59 Favored 'General case' 0 C--N 1.255 -3.538 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.531 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.778 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -99.07 179.03 4.74 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.812 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mtpm? -134.49 -173.05 3.17 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -87.88 113.95 24.03 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 124.549 1.139 . . . . 0.0 108.665 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.08 -3.09 44.26 Favored Glycine 0 C--N 1.284 -2.332 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.8 mm-40 -66.93 123.96 21.65 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.763 0.792 . . . . 0.0 111.415 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -94.01 96.78 9.9 Favored 'General case' 0 N--CA 1.409 -2.483 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.927 HD11 HG11 ' A' ' 82' ' ' VAL . 32.7 pt -110.57 158.28 10.99 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.169 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.372 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.75 ' HB3' HG22 ' A' ' 27' ' ' VAL . 48.1 mt-10 -121.27 136.84 54.91 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.658 HD13 ' HB2' ' A' ' 29' ' ' HIS 0.268 0.2 OUTLIER -97.81 124.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.224 175.173 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.561 HD11 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.09 -16.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.647 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -144.29 122.07 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.373 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.98 101.56 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.281 -2.399 0 CA-C-O 121.568 0.699 . . . . 0.0 112.231 -173.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.549 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.451 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 42.5 mmtm -133.27 138.31 46.4 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.424 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.2 m0 -87.57 159.8 18.45 Favored 'General case' 0 C--N 1.279 -2.485 0 O-C-N 123.725 0.641 . . . . 0.0 109.968 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -97.12 112.14 24.06 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.812 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.26 174.21 15.13 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 73' ' ' SER . 36.1 ptt180 -152.2 139.91 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 52' ' ' ILE . 63.6 p -78.73 177.13 8.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -16.89 61.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 110.27 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -87.86 -19.96 26.68 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.12 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 29.6 5.4 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.033 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.9 m -98.91 115.45 28.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.792 ' HB2' HG23 ' A' ' 15' ' ' ILE . 10.6 m-85 -91.77 139.06 31.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 122.714 0.406 . . . . 0.0 110.717 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.12 158.86 31.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.857 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.451 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.2 m-85 -73.97 135.15 43.17 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.917 0.865 . . . . 0.0 111.285 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.812 HD11 ' HA3' ' A' ' 67' ' ' GLY . 67.5 mt -116.42 128.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.697 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 77' ' ' ILE . 54.8 mttm -65.14 137.14 57.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.0 p -68.7 -7.16 30.94 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.128 0.966 . . . . 0.0 111.469 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -104.16 -13.15 16.33 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.153 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' A' ' 37' ' ' VAL . . . -81.4 -13.08 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.291 0.567 . . . . 0.0 109.736 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.927 HG11 HD11 ' A' ' 52' ' ' ILE . 35.3 m -131.99 154.56 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.368 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.574 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 55.1 mm-40 -103.54 113.13 26.41 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 172.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 31' ' ' ALA . 25.5 mm -81.13 141.74 14.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.793 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.478 -1.802 0 CA-C-O 123.094 1.426 . . . . 0.0 112.443 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.489 HG23 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -61.82 -25.46 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.774 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 92.1 mttt -75.64 -25.86 57.22 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.882 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.24 -38.8 13.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -63.01 -50.88 68.96 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.253 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -103.1 -5.91 22.79 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.44 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 37.7 mtmm 55.35 81.1 0.12 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.556 0.742 . . . . 0.0 110.078 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 21' ' ' LEU . 10.9 tp -83.93 -45.5 13.11 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.13 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 21' ' ' LEU . 25.1 p 46.83 96.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.49 178.83 38.25 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.21 136.53 24.57 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.856 2.371 . . . . 0.0 110.535 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.816 HD11 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -124.68 160.51 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -128.63 148.22 50.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' GLU . 7.1 p -74.7 145.72 10.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.614 0.245 . . . . 0.0 110.812 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -97.99 -44.78 12.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.129 0.49 . . . . 0.0 111.013 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.932 ' HB2' HD11 ' A' ' 54' ' ' ILE . 7.3 m-70 -139.29 162.89 33.89 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.35 122.19 42.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.923 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.743 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.38 164.43 11.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.679 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 51.3 pttt -151.43 105.21 3.15 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.758 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -72.17 125.73 28.04 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.417 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.7 t -112.14 148.76 33.3 Favored 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.791 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.7 m 74.32 167.74 0.3 Allowed 'General case' 0 N--CA 1.405 -2.713 0 O-C-N 126.032 2.083 . . . . 0.0 111.422 162.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.41 102.56 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.758 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.1 m -96.16 156.64 3.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.902 -175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -49.81 -53.92 22.38 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.96 43.3 96.92 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.557 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.57 179.2 0.02 OUTLIER Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.324 1.29 . . . . 0.0 116.324 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -61.47 -34.42 75.42 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -86.26 -16.15 38.53 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.114 0.483 . . . . 0.0 111.207 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' A' ' 78' ' ' LYS . 45.0 mt-10 -92.66 170.4 9.75 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.781 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 1.1 tt -79.07 140.92 37.77 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.921 0.867 . . . . 0.0 110.338 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 m -81.12 47.07 0.97 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.58 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.001 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -87.44 175.58 7.9 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.445 0.641 . . . . 0.0 111.879 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 58.4 mtpt -133.78 -172.76 3.06 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.394 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.69 124.79 29.89 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 125.398 1.479 . . . . 0.0 107.821 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.03 4.93 66.48 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 13.6 mm-40 -74.26 121.87 21.97 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 122.163 0.983 . . . . 0.0 112.283 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -85.51 96.18 9.53 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.812 HD11 HG12 ' A' ' 82' ' ' VAL . 40.0 pt -111.41 158.41 11.9 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.538 0 CA-C-N 112.836 -1.983 . . . . 0.0 112.071 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.743 ' HB3' HG23 ' A' ' 27' ' ' VAL . 51.3 mt-10 -125.43 134.05 52.25 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.932 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.21 127.72 54.18 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.291 175.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.816 HG12 HD11 ' A' ' 25' ' ' ILE . 2.7 mp -97.87 -34.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.165 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.7 ttm180 -116.12 110.01 18.27 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.455 -174.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.41 98.56 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.288 -2.09 0 CA-C-O 121.598 0.713 . . . . 0.0 112.75 -172.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.861 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.57 157.38 28.5 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -102.06 142.15 33.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.77 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -86.25 108.93 18.6 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.59 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -115.18 177.03 17.07 Favored Glycine 0 N--CA 1.415 -2.764 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.411 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 29.6 ptt180 -151.93 142.89 23.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.279 1.032 . . . . 0.0 108.311 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.608 ' HA ' HG22 ' A' ' 52' ' ' ILE . 19.2 p -79.71 173.24 12.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.92 0.866 . . . . 0.0 109.135 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.49 -7.87 59.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.981 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.78 31.82 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.501 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.2 m -103.18 113.38 26.81 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 15' ' ' ILE . 10.7 m-85 -89.52 147.7 23.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.583 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.88 161.09 34.76 Favored Glycine 0 C--N 1.298 -1.537 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.81 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.11 161.73 29.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 1.001 HG12 ' HE2' ' A' ' 46' ' ' PHE . 83.9 mt -142.44 126.65 15.67 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 77' ' ' ILE . 61.0 mttp -64.5 132.53 50.19 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 167.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.3 p -66.29 -8.51 25.47 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 118.927 0.785 . . . . 0.0 112.575 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 t -98.85 -14.49 19.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.581 0.752 . . . . 0.0 110.282 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 37' ' ' VAL . . . -76.06 -19.78 58.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 108.909 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.812 HG12 HD11 ' A' ' 52' ' ' ILE . 34.1 m -125.79 166.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.788 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 29.0 mt-10 -125.44 112.22 16.02 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 29' ' ' HIS . 1.7 mp -88.92 123.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 120.922 0.391 . . . . 0.0 110.135 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 . . . . . 0 CA--C 1.476 -1.872 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.233 176.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.95 -29.78 47.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.389 0.614 . . . . 0.0 111.063 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.23 -27.63 66.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.666 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.14 -46.24 8.21 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.734 0.778 . . . . 0.0 109.231 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.05 -44.65 83.95 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 112.379 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -109.35 -8.6 15.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.66 75.22 0.35 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 111.286 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.13 17.81 19.23 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.072 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -68.35 84.7 0.26 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.239 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.83 41.69 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.39 105.47 0.89 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.978 2.452 . . . . 0.0 113.012 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.34 161.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 27' ' ' VAL . 18.4 mm-40 -133.83 -81.48 0.46 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.613 ' HA ' HG22 ' A' ' 55' ' ' ILE . 1.4 m 178.74 152.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 C-N-CA 128.906 2.882 . . . . 0.0 105.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.515 HG21 ' HD2' ' A' ' 29' ' ' HIS . 38.3 mm -99.31 -44.91 12.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' HD2' HG21 ' A' ' 28' ' ' ILE . 70.5 m-70 -160.74 -176.93 5.83 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 52' ' ' ILE . . . -104.08 169.58 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 21.7 pttm -152.3 107.05 3.21 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.735 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -63.0 135.82 57.49 Favored 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.049 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -112.05 172.86 6.66 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m 58.39 175.87 0.06 Allowed 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 125.101 1.501 . . . . 0.0 114.39 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.49 95.43 9.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.88 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.832 HG23 ' HE1' ' A' ' 46' ' ' PHE . 27.7 m -89.98 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.36 -40.85 75.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.535 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.08 43.18 62.37 Favored Glycine 0 C--N 1.355 1.592 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.892 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -53.14 -173.71 0.05 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 116.879 1.512 . . . . 0.0 116.879 -173.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -63.2 -36.78 84.78 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -100.81 2.21 40.91 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.632 0.729 . . . . 0.0 109.789 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.4 mt-10 -95.68 179.42 5.13 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -94.7 135.73 35.83 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -85.83 76.19 9.93 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.131 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.864 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.37 174.11 6.43 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.997 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 30.3 mmtp -140.79 -175.51 4.32 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.829 0.823 . . . . 0.0 111.497 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -65.09 108.21 1.77 Allowed 'General case' 0 C--N 1.272 -2.791 0 C-N-CA 127.856 2.463 . . . . 0.0 109.886 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.75 5.25 41.99 Favored Glycine 0 C--N 1.294 -1.8 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.5 mm-40 -80.03 116.69 20.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.031 0.92 . . . . 0.0 112.729 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -85.55 96.99 9.81 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.882 HD13 HG11 ' A' ' 82' ' ' VAL . 27.8 pt -110.87 158.66 11.25 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.244 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.045 175.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -118.57 134.25 55.24 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.579 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -96.09 136.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.184 173.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -119.56 3.68 6.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.188 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.574 ' HD3' HG21 ' A' ' 58' ' ' THR . 58.2 ttt180 -150.27 141.15 22.83 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.749 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.4 mm -109.02 96.97 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.574 HG21 ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.217 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.784 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.194 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.5 mmtp -129.29 148.88 51.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.516 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 35.0 m0 -94.64 160.81 14.46 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.682 0.614 . . . . 0.0 109.848 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.58 109.65 21.5 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.705 0.764 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.75 ' HA3' HD13 ' A' ' 77' ' ' ILE . . . -114.08 175.92 16.67 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.1 ptt180 -152.77 146.39 25.05 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.814 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.6 p -73.15 178.59 4.32 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 117.941 0.337 . . . . 0.0 110.847 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -34.22 73.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.123 0.487 . . . . 0.0 110.533 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -82.16 -0.4 44.76 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.172 0.51 . . . . 0.0 111.599 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.34 27.27 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 114.528 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.0 m -91.46 112.55 24.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.563 1.182 . . . . 0.0 107.813 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 79.2 m-85 -82.48 145.18 29.95 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.128 -172.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.83 27.95 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.163 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.443 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 7.7 m-85 -71.45 142.68 50.23 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.87 0.843 . . . . 0.0 112.302 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.864 HG12 ' HE2' ' A' ' 46' ' ' PHE . 61.3 mt -126.59 129.28 71.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.565 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 77' ' ' ILE . 92.3 mttt -65.93 140.95 58.37 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.4 p -69.06 -9.16 51.18 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.0 112.056 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -103.93 -8.67 19.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.519 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -81.79 -11.04 59.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.882 HG11 HD13 ' A' ' 52' ' ' ILE . 27.1 m -133.1 158.27 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.015 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 38.0 mt-10 -104.5 112.94 26.19 Favored 'General case' 0 N--CA 1.394 -3.234 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 31' ' ' ALA . 21.1 mm -94.75 135.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.73 0 C-N-CA 124.038 0.935 . . . . 0.0 109.68 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 CA--C 1.498 -1.048 0 CA-C-O 121.493 0.663 . . . . 0.0 109.948 178.104 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.6 pp -57.49 -28.04 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HB3' HG22 ' A' ' 22' ' ' THR . 43.3 mtmt -79.68 -23.9 42.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -89.37 -41.22 12.25 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 87.3 tttt -60.56 -48.4 81.94 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 112.089 -175.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -100.56 -6.02 25.98 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 59.94 74.39 0.45 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 122.869 1.319 . . . . 0.0 108.059 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 12.5 tp -125.26 14.53 8.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.913 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -69.42 90.51 0.53 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.487 0.66 . . . . 0.0 112.035 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.78 -177.04 45.5 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.95 123.57 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.711 2.274 . . . . 0.0 112.024 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.6 pp -109.33 147.08 14.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 120.872 0.368 . . . . 0.0 111.827 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -127.79 138.1 52.62 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' HA ' HG23 ' A' ' 55' ' ' ILE . 21.9 t -74.08 112.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG23 ' CD2' ' A' ' 29' ' ' HIS . 38.7 mm -83.67 -44.66 18.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.759 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.799 ' HB2' HD11 ' A' ' 54' ' ' ILE . 54.6 m-70 -150.49 167.42 27.22 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.66 117.94 31.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.58 165.06 11.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 42.7 pttt -150.22 102.54 3.09 Favored 'General case' 0 C--N 1.255 -3.514 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.833 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -65.38 125.96 26.76 Favored 'General case' 0 C--N 1.271 -2.806 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.699 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.2 t -109.69 148.08 32.01 Favored 'General case' 0 CA--C 1.432 -3.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.2 m 68.1 -179.14 0.22 Allowed 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 125.99 2.057 . . . . 0.0 110.344 164.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.6 113.53 14.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.84 HG23 ' CE1' ' A' ' 46' ' ' PHE . 5.5 m -106.74 156.37 7.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.225 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 15.0 ptpt -50.72 -66.93 0.3 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.353 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . 61.84 43.32 99.37 Favored Glycine 0 C--O 1.246 0.881 0 C-N-CA 119.754 -1.212 . . . . 0.0 112.542 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -61.41 -150.83 0.02 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 116.729 1.451 . . . . 0.0 116.729 -173.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -73.45 -38.22 65.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -171.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -103.28 -0.42 30.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.991 0.901 . . . . 0.0 109.455 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 68.9 mt-10 -99.37 163.53 12.49 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -79.23 128.36 33.2 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -86.26 67.56 9.98 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-O 122.542 1.163 . . . . 0.0 108.948 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.84 ' CE1' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -98.25 -167.18 1.47 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.521 177.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.823 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 54.8 tttp -147.92 -173.59 4.34 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.823 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 8.7 tt0 -79.0 105.6 10.45 Favored 'General case' 1 C--N 1.243 -4.027 0 C-N-CA 127.112 2.165 . . . . 0.0 109.302 -176.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 8.19 48.01 Favored Glycine 0 C--N 1.285 -2.3 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.005 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.4 128.82 36.22 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.516 0.674 . . . . 0.0 110.759 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 97.03 10.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.835 HD13 HG11 ' A' ' 82' ' ' VAL . 22.7 pt -107.27 158.36 7.2 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.093 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.672 176.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.47 128.79 43.62 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -90.98 132.64 35.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.299 177.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.648 HG23 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.11 11.73 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.734 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 33.1 ttt180 -155.08 114.15 3.61 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.076 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 28' ' ' ILE . 46.3 mm -99.12 95.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.293 -1.89 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.559 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 76' ' ' TYR . 46.1 mmtm -131.57 162.95 29.13 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.415 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 38.8 m0 -102.0 153.54 19.79 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -98.93 112.52 24.6 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 77' ' ' ILE . . . -109.52 177.48 20.07 Favored Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 114.293 -1.322 . . . . 0.0 110.572 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.2 ptm180 -151.32 141.26 22.01 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.51 ' HA ' HG22 ' A' ' 52' ' ' ILE . 64.9 p -79.43 167.85 20.27 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.27 64.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.799 0.809 . . . . 0.0 109.869 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -84.47 -22.37 30.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.073 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.53 19.4 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.091 -1.052 . . . . 0.0 114.314 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.5 m -94.31 110.37 22.13 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 15' ' ' ILE . 38.5 m-85 -87.49 138.43 31.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.64 155.87 27.12 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.355 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.3 m-85 -69.35 143.79 53.65 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.713 0.768 . . . . 0.0 110.7 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.798 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.9 mt -124.53 132.89 70.69 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.687 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 77' ' ' ILE . 52.1 mtmt -73.57 132.34 42.71 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.6 p -63.73 -10.25 18.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.593 0.711 . . . . 0.0 112.857 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -99.98 -16.05 18.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.651 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -14.17 59.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.835 HG11 HD13 ' A' ' 52' ' ' ILE . 33.2 m -131.39 156.21 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.689 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 9.3 mm-40 -106.36 106.22 16.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.555 HD13 ' HB1' ' A' ' 31' ' ' ALA . 23.4 mm -83.62 115.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.538 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 CA--C 1.494 -1.175 0 CA-C-O 121.52 0.676 . . . . 0.0 110.95 179.039 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 120.756 0.312 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.779 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.6 pp -65.86 -24.49 34.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.974 0.416 . . . . 0.0 111.83 -176.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 46.1 mtmt -68.8 -24.37 64.39 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.189 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -97.88 -43.97 6.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.629 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.0 tttt -62.69 -57.25 11.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' HD2' ' HB ' ' A' ' 15' ' ' ILE . 66.6 m-85 -97.59 -13.01 21.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.364 0.602 . . . . 0.0 109.726 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 53.0 mttp 62.39 77.59 0.32 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.185 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.522 HD13 HD12 ' A' ' 15' ' ' ILE . 73.9 mt -121.1 16.85 11.62 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.602 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -61.61 131.47 50.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.474 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.02 -177.18 18.05 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.34 115.01 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.36 2.04 . . . . 0.0 111.577 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.552 HD11 HG12 ' A' ' 55' ' ' ILE . 2.7 pp -109.98 145.31 16.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.764 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.03 130.06 55.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.308 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 53' ' ' GLU . 14.5 p -71.9 144.44 13.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 123.253 0.346 . . . . 0.0 110.41 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.429 HG23 ' CD2' ' A' ' 29' ' ' HIS . 45.4 mm -95.98 -44.71 13.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.694 ' HB2' HD13 ' A' ' 54' ' ' ILE . 74.6 m-70 -154.17 179.99 8.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 123.658 0.783 . . . . 0.0 109.065 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.57 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 5.7 mp -108.07 136.52 47.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 52' ' ' ILE . . . -108.58 176.03 5.26 Favored 'General case' 0 C--N 1.263 -3.174 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -150.57 102.58 3.04 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.62 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -67.93 122.71 18.76 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.47 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 38.3 t -117.25 152.75 34.19 Favored 'General case' 0 CA--C 1.444 -3.1 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.147 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 m 70.78 177.64 0.27 Allowed 'General case' 0 N--CA 1.404 -2.725 0 O-C-N 125.818 1.949 . . . . 0.0 110.583 162.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.16 100.44 6.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.615 1.198 . . . . 0.0 110.541 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 1.019 HG23 ' HE1' ' A' ' 46' ' ' PHE . 11.3 m -87.74 156.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.946 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -61.7 -52.7 63.21 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.66 43.14 99.41 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.345 -0.931 . . . . 0.0 114.763 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.39 -179.33 1.03 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -63.61 -27.95 69.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 29.5 p-10 -90.3 -13.95 34.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 45.7 mt-10 -92.33 159.82 15.41 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.462 -177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.657 HD11 ' HD2' ' A' ' 46' ' ' PHE . 1.4 tt -70.79 137.51 49.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.631 0.729 . . . . 0.0 109.844 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.403 ' N ' HD21 ' A' ' 44' ' ' LEU . 15.1 m -82.96 43.81 0.88 Allowed 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.436 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.019 ' HE1' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -84.93 -161.05 0.53 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.273 178.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.906 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 74.1 tttt -145.54 -171.57 3.7 Favored 'General case' 0 N--CA 1.389 -3.525 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.906 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 7.7 tt0 -75.73 -8.83 57.79 Favored 'General case' 0 C--N 1.254 -3.568 0 C-N-CA 128.746 2.818 . . . . 0.0 114.337 -168.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.47 19.9 1.69 Allowed Glycine 0 C--N 1.27 -3.094 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 18.6 mm-40 -80.56 129.78 34.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -96.88 97.57 9.39 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.889 HD12 HG11 ' A' ' 82' ' ' VAL . 36.6 pt -105.55 159.73 5.7 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.883 -2.417 . . . . 0.0 112.55 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.897 ' HB3' HG23 ' A' ' 27' ' ' VAL . 40.7 mt-10 -120.05 136.0 54.73 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.694 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.4 128.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.866 0.841 . . . . 0.0 112.072 177.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.552 HG12 HD11 ' A' ' 25' ' ' ILE . 2.5 mp -100.59 -35.03 4.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.209 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 1.006 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.1 ttm180 -114.84 121.36 43.0 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.715 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.9 mm -99.09 98.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.083 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.174 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 44.9 mmtm -133.74 155.2 50.2 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.438 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.4 m0 -100.75 153.16 19.68 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.516 0.51 . . . . 0.0 110.171 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -95.03 116.37 28.61 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.753 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -119.04 178.62 16.66 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.765 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 36.3 ptt180 -151.91 147.33 26.46 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.719 ' HA ' HG21 ' A' ' 52' ' ' ILE . 67.0 p -80.05 179.02 7.83 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 118.198 0.454 . . . . 0.0 109.811 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -15.87 61.89 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -80.82 -25.89 37.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.38 9.36 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.348 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 8.0 p -94.1 111.55 23.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.779 ' HB2' HG22 ' A' ' 15' ' ' ILE . 53.7 m-85 -83.13 148.98 27.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -171.62 160.74 32.78 Favored Glycine 0 C--N 1.318 -0.446 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.19 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.546 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 m-85 -76.21 143.21 41.18 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-O 121.67 0.748 . . . . 0.0 111.522 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.799 HG12 ' HE2' ' A' ' 46' ' ' PHE . 44.2 mt -125.39 139.15 52.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.061 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 77' ' ' ILE . 55.7 mttm -74.1 136.47 42.98 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 168.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.6 p -64.56 -13.32 52.3 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.537 0.685 . . . . 0.0 112.143 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -97.27 -16.24 20.43 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.541 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.45 -17.65 59.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.889 HG11 HD12 ' A' ' 52' ' ' ILE . 27.5 m -130.58 153.17 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.75 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -102.85 100.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 31' ' ' ALA . 22.0 mm -70.57 133.14 32.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.098 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.004 0.907 . . . . 0.0 111.692 -178.697 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.479 0.18 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.51 -31.44 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.696 ' HB3' HG21 ' A' ' 22' ' ' THR . 54.1 mttp -72.27 -22.78 61.17 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.596 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -94.11 -40.21 10.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.7 ttpt -65.32 -42.1 93.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.779 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.2 m-85 -111.82 1.54 16.64 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.234 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 34.9 ttmt 53.37 72.22 0.45 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.928 1.347 . . . . 0.0 110.336 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD21 ' HG ' ' A' ' 66' ' ' LEU . 94.9 mt -112.5 16.47 19.81 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.984 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.696 HG21 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -71.93 94.4 1.45 Allowed 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.301 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.96 170.53 25.7 Favored Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.18 128.23 11.97 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.908 2.405 . . . . 0.0 111.452 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.26 159.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -136.71 144.1 43.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.627 HG21 ' HB3' ' A' ' 53' ' ' GLU . 8.0 p -71.43 137.4 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.515 HG13 HG12 ' A' ' 57' ' ' ILE . 40.0 mm -98.87 -37.79 6.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.195 0.521 . . . . 0.0 109.872 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.606 ' HB2' HD12 ' A' ' 54' ' ' ILE . 53.6 m-70 -153.65 164.16 38.76 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.26 132.28 49.65 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.43 171.89 7.11 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.796 0.808 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 14.3 ptpt -151.64 102.72 2.89 Favored 'General case' 0 C--N 1.26 -3.297 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.818 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.81 112.77 3.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -96.95 150.73 20.43 Favored 'General case' 0 CA--C 1.431 -3.599 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.655 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.4 m 67.91 -179.32 0.22 Allowed 'General case' 0 N--CA 1.402 -2.845 0 O-C-N 125.635 1.835 . . . . 0.0 110.782 163.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -79.72 105.29 10.9 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 46' ' ' PHE . 16.9 m -87.76 156.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.896 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -52.58 -58.58 6.32 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.41 41.79 99.74 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.818 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.82 178.29 0.3 Allowed Glycine 0 CA--C 1.526 0.723 0 O-C-N 123.914 0.42 . . . . 0.0 113.528 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -64.42 -32.85 74.65 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 122.104 -0.645 . . . . 0.0 111.547 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -88.08 -7.81 56.43 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.048 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 47.7 mt-10 -92.14 171.96 8.74 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.53 ' HG ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -73.23 148.63 43.51 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.416 ' H ' HD21 ' A' ' 44' ' ' LEU . 17.8 m -89.89 38.45 0.92 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.749 1.261 . . . . 0.0 108.536 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.769 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -85.17 163.45 18.71 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.12 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 28.1 mmtp -133.65 -173.35 3.21 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.882 0.849 . . . . 0.0 111.997 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.7 119.48 10.64 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 126.528 1.931 . . . . 0.0 109.978 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.18 19.07 40.41 Favored Glycine 0 C--N 1.292 -1.901 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.545 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.769 ' HG2' ' HB2' ' A' ' 46' ' ' PHE . 6.6 tp10 -78.64 137.53 37.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.155 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.56 96.68 8.47 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.795 HD12 HG13 ' A' ' 82' ' ' VAL . 22.5 pt -111.86 158.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 112.691 -2.05 . . . . 0.0 113.578 173.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.627 ' HB3' HG21 ' A' ' 27' ' ' VAL . 3.8 mp0 -128.18 137.75 52.19 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 29' ' ' HIS 0.288 0.2 OUTLIER -102.21 124.77 56.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.866 176.213 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.599 HD11 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -107.95 -4.08 10.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.838 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.1 ttm180 -138.97 114.56 9.83 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.96 0.409 . . . . 0.0 110.81 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.515 HG12 HG13 ' A' ' 28' ' ' ILE . 51.1 mm -94.72 98.49 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.489 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 26.7 mmtp -134.93 158.3 44.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.003 0.43 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 17.6 m0 -109.41 162.23 14.55 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -104.04 112.48 25.49 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.561 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.11 177.6 18.24 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.164 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.0 ptm180 -150.02 145.88 26.67 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.438 HG21 HG23 ' A' ' 52' ' ' ILE . 43.9 p -84.75 171.83 11.99 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.42 -23.92 67.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.351 0.596 . . . . 0.0 110.05 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -75.89 -14.93 60.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.106 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.68 28.49 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.285 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.1 m -92.95 109.01 20.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 26.2 m-85 -84.12 140.28 31.89 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.206 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.53 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -165.74 156.22 28.02 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.624 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 12.5 m-85 -68.96 150.18 48.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.603 0.716 . . . . 0.0 111.102 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.614 HD11 ' HA3' ' A' ' 67' ' ' GLY . 70.3 mt -134.77 128.68 50.82 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 77' ' ' ILE . 91.5 mttt -68.21 143.05 55.48 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 168.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 p -68.96 -16.02 63.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.158 0.98 . . . . 0.0 111.546 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.4 t -89.79 -15.94 31.29 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.723 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -17.18 56.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.469 0.652 . . . . 0.0 110.472 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.818 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.3 m -129.63 156.88 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.805 0 CA-C-O 121.464 0.649 . . . . 0.0 112.509 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -98.29 100.65 11.96 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 31' ' ' ALA . 26.2 mm -82.63 109.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.75 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 122.048 0.928 . . . . 0.0 112.409 178.901 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.471 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 2.5 pp -56.33 -25.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.37 -35.18 68.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.482 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.86 -32.52 15.29 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.902 0.858 . . . . 0.0 109.323 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -66.82 -45.71 77.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.37 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -108.02 -3.36 18.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 2.9 mptp? 60.89 75.2 0.42 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.181 0.991 . . . . 0.0 110.006 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 15' ' ' ILE . 8.8 tp -89.76 -24.53 21.48 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.904 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.252 77.3 p 64.79 -69.12 0.1 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.845 1.658 . . . . 0.0 112.473 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.39 -107.97 0.21 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.49 145.51 71.06 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.441 2.094 . . . . 0.0 109.942 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.694 ' HB ' HG23 ' A' ' 55' ' ' ILE . 1.4 pp -138.66 -48.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.621 ' H ' HD12 ' A' ' 25' ' ' ILE . 31.1 mm-40 71.01 123.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.834 1.302 . . . . 0.0 114.129 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.19 140.5 18.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 112.548 -2.115 . . . . 0.0 111.156 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.95 -44.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.831 0.348 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.939 ' HB2' HD11 ' A' ' 54' ' ' ILE . 92.0 m-70 -142.83 177.08 8.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.54 119.25 38.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.453 0.644 . . . . 0.0 111.386 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 52' ' ' ILE . . . -105.53 167.01 10.03 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.802 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 17.2 pttp -153.14 102.78 2.66 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.803 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -59.36 139.61 56.87 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.136 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.9 t -127.61 155.18 44.27 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.6 m 69.45 175.9 0.28 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 125.889 1.993 . . . . 0.0 111.456 162.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.79 113.25 16.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.788 HG22 ' CE1' ' A' ' 46' ' ' PHE . 17.4 m -112.16 155.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.79 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.66 -46.8 83.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.311 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.58 43.01 45.35 Favored Glycine 0 C--N 1.359 1.813 0 O-C-N 123.896 0.747 . . . . 0.0 113.738 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.28 -153.04 0.04 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 116.255 1.262 . . . . 0.0 116.255 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.27 -51.34 25.01 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.95 -6.8 59.49 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.283 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.48 172.73 8.19 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -83.0 141.67 31.91 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -81.62 45.17 0.86 Allowed 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.456 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.862 ' HE2' HG12 ' A' ' 77' ' ' ILE . 1.2 p90 -86.05 179.19 7.02 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.833 0.825 . . . . 0.0 112.021 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.76 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 28.1 mtpp -132.92 -172.06 2.83 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.995 -172.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -76.6 -12.02 59.95 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 126.881 2.073 . . . . 0.0 113.677 -168.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.7 19.59 2.39 Favored Glycine 0 C--N 1.268 -3.208 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.76 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 9.6 mm-40 -77.12 125.46 29.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.86 0.838 . . . . 0.0 113.182 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.38 97.75 9.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.883 HD12 HG12 ' A' ' 82' ' ' VAL . 36.0 pt -112.64 159.1 12.8 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.047 0 CA-C-N 112.511 -2.131 . . . . 0.0 112.62 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.33 139.15 53.52 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.939 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -103.02 134.97 42.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.318 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.694 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -105.73 -24.45 4.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.415 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.762 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 9.3 ttt85 -127.38 122.94 34.98 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.382 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mm -104.6 96.75 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.976 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.463 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 CA-C-O 120.898 0.165 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.1 mmtp -133.28 156.38 47.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 32.5 m0 -93.11 162.35 14.06 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.712 0.633 . . . . 0.0 109.973 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -103.62 115.02 29.73 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.217 0.532 . . . . 0.0 110.327 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.48 -179.16 16.61 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.279 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 36.1 ptt180 -151.78 144.7 24.46 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.743 ' HA ' HG23 ' A' ' 52' ' ' ILE . 21.1 p -78.31 170.44 16.63 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.63 -14.67 59.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.214 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.66 0.03 57.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.217 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.83 68.35 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 m -97.83 113.2 24.94 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 23.0 m-85 -82.47 151.64 26.44 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.801 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.94 159.02 30.94 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.644 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.472 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.7 m-85 -71.63 147.97 47.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.623 0.725 . . . . 0.0 111.606 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.862 HG12 ' HE2' ' A' ' 46' ' ' PHE . 69.3 mt -133.0 133.27 58.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.761 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 77' ' ' ILE . 98.2 mttt -69.43 135.37 50.15 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 167.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.5 p -66.23 -8.11 22.51 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.628 0.728 . . . . 0.0 111.885 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -106.2 -6.96 18.12 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 124.064 0.946 . . . . 0.0 109.731 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -85.99 -14.13 45.5 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.883 HG12 HD12 ' A' ' 52' ' ' ILE . 33.4 m -129.1 152.89 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.138 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.153 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 37.0 mt-10 -94.65 100.46 12.4 Favored 'General case' 0 N--CA 1.397 -3.11 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 27.3 mm -90.77 106.03 17.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 CA--C 1.471 -2.069 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.883 -174.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.438 -1.075 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 2.6 pp -54.88 -31.87 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -73.94 -24.53 59.66 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -96.94 -28.06 14.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 31.5 tttp -61.33 -52.28 65.32 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.257 1.423 . . . . 0.0 110.478 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 42.4 m-85 -99.03 -5.88 29.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.101 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 61.16 76.04 0.39 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.717 1.246 . . . . 0.0 108.304 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 ' HG ' HG23 ' A' ' 25' ' ' ILE . 10.4 tp -116.36 16.09 15.75 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.212 -172.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -75.92 122.79 24.68 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.109 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.52 168.53 18.54 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 121.61 8.84 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.789 2.992 . . . . 0.0 112.196 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.842 HG13 ' H ' ' A' ' 26' ' ' GLN . 18.2 pt -106.37 -76.82 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.842 ' H ' HG13 ' A' ' 25' ' ' ILE 0.258 23.8 mt-30 72.41 141.12 0.06 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.186 1.394 . . . . 0.0 114.316 -177.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 53' ' ' GLU . 60.6 t -81.4 137.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.218 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.494 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.12 -42.3 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.924 ' HB2' HD11 ' A' ' 54' ' ' ILE . 84.8 m-70 -142.46 178.89 7.29 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 45.2 tp -115.27 125.66 53.57 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.63 171.49 7.3 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.64 0.734 . . . . 0.0 109.95 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 61.4 pttt -151.08 107.53 3.48 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -70.15 130.97 43.5 Favored 'General case' 0 C--N 1.255 -3.531 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.589 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.05 166.42 12.02 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 6.3 m 63.73 164.94 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 125.219 1.574 . . . . 0.0 114.444 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.98 111.18 5.49 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.836 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.3 m -111.89 156.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.087 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -56.33 -60.8 2.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 43' ' ' GLU . . . 49.6 41.48 34.14 Favored Glycine 0 C--O 1.21 -1.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.809 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.13 -110.26 0.01 OUTLIER Glycine 0 CA--C 1.542 1.724 0 N-CA-C 118.727 2.251 . . . . 0.0 118.727 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.784 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 9.4 mmpt? -98.87 -53.76 3.19 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 122.271 -0.546 . . . . 0.0 111.535 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.551 HD21 ' HD2' ' A' ' 76' ' ' TYR . 2.2 p-10 -95.43 1.96 54.33 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' C ' ' A' ' 39' ' ' GLY . 39.2 mt-10 -92.65 157.52 16.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.678 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.048 0.927 . . . . 0.0 111.269 -173.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.406 ' H ' HD22 ' A' ' 44' ' ' LEU . 31.6 m -84.07 69.75 10.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.671 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.933 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.86 -175.69 2.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.58 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -145.1 -172.66 3.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 124.036 0.835 . . . . 0.0 109.234 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.7 tt0 -85.7 107.44 17.58 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 125.429 1.492 . . . . 0.0 109.576 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.97 29.98 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.93 126.82 34.38 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.625 0.726 . . . . 0.0 111.629 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.93 96.44 10.68 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.883 HD13 HG11 ' A' ' 82' ' ' VAL . 33.3 pt -109.51 158.09 9.65 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.052 0 CA-C-N 112.495 -2.138 . . . . 0.0 112.704 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HB3' HG13 ' A' ' 27' ' ' VAL . 30.3 mt-10 -121.83 134.64 54.89 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -97.33 129.27 47.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.288 175.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 25' ' ' ILE . 2.5 mp -98.99 -40.28 8.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.008 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.692 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.9 ttm180 -121.87 119.7 32.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.758 -174.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.41 98.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.376 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.264 -175.528 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.939 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 33.0 mmtp -123.66 159.93 28.26 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.431 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.5 m0 -95.98 152.04 18.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.6 tm? -93.69 114.03 26.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.672 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -118.32 179.67 17.02 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.31 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 35.1 ptt180 -152.29 139.69 19.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.844 ' HA ' HG22 ' A' ' 52' ' ' ILE . 5.5 p -76.0 171.49 14.35 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 117.948 0.34 . . . . 0.0 110.446 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.45 -16.19 60.35 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -72.56 -17.48 61.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.558 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.11 23.53 22.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 23.6 m -113.43 128.09 56.33 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 41.2 m-85 -89.67 151.85 21.66 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.525 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -174.89 160.29 29.25 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.551 ' HD2' HD21 ' A' ' 42' ' ' ASN . 17.5 m-85 -74.73 146.45 42.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.388 0.613 . . . . 0.0 111.011 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.933 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.0 mt -128.29 129.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.673 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 77' ' ' ILE . 63.0 mttm -69.77 132.43 46.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 165.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.3 p -63.14 -10.75 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.737 0.78 . . . . 0.0 112.595 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 t -93.88 -21.1 19.45 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.897 0.879 . . . . 0.0 109.709 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -76.36 -15.07 60.04 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.974 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 52' ' ' ILE . 34.4 m -127.19 157.81 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 CA-C-O 121.405 0.622 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 32.0 mt-10 -112.73 101.02 9.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.562 HD13 ' HB1' ' A' ' 31' ' ' ALA . 20.0 mm -74.19 132.57 33.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.197 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.391 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.457 HD13 ' HG3' ' A' ' 16' ' ' LYS . 2.6 pp -64.51 -29.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.933 0.397 . . . . 0.0 111.742 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 45.6 mtmt -76.26 -25.58 55.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.637 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -83.86 -38.2 21.47 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.4 tttt -68.09 -49.28 62.21 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.083 1.353 . . . . 0.0 112.406 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.406 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 62.4 m-85 -102.47 -4.6 25.15 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 57.37 75.52 0.37 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.563 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 10.7 tp -127.51 14.47 7.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.988 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -57.57 117.31 4.05 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.676 -172.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.98 169.47 11.67 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.84 120.15 6.86 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 122.218 1.946 . . . . 0.0 110.764 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.811 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.7 pp -104.26 151.44 6.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -143.46 159.28 42.69 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.345 1.058 . . . . 0.0 108.168 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 53' ' ' GLU . 30.8 m -75.2 154.97 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.66 HD13 HG12 ' A' ' 57' ' ' ILE . 36.0 mt -105.05 -32.74 2.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.589 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.929 ' HB2' HD11 ' A' ' 54' ' ' ILE . 82.9 m-70 -152.01 -178.59 6.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 53' ' ' GLU . 30.2 tp -119.28 132.98 55.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 84' ' ' ILE . . . -113.08 170.6 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.607 0.718 . . . . 0.0 110.646 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 46.0 pttt -153.32 102.87 2.64 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.819 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.99 125.52 23.97 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.689 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.8 p -111.26 166.55 11.0 Favored 'General case' 0 CA--C 1.452 -2.808 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m 61.26 174.67 0.11 Allowed 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 125.038 1.461 . . . . 0.0 112.307 167.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.14 102.96 8.75 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.704 HG22 ' CE1' ' A' ' 46' ' ' PHE . 18.7 m -92.01 154.31 3.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.692 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -58.18 -58.95 6.21 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.65 42.09 90.44 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 124.288 0.992 . . . . 0.0 113.696 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.04 -152.57 0.37 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -63.27 -50.13 71.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 4.5 p-10 -82.8 -8.9 59.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.696 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 41.6 mt-10 -91.68 -179.81 5.44 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.571 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 tt -88.51 149.0 23.86 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.419 ' N ' HD22 ' A' ' 44' ' ' LEU . 29.9 t -92.08 90.17 7.26 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.704 ' CE1' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.61 176.91 9.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.892 -174.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -139.65 -174.0 3.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 111.612 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -79.17 105.68 10.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 126.532 1.933 . . . . 0.0 108.81 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.88 12.15 44.27 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.44 157.8 33.58 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -108.26 96.78 6.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.7 -1.136 . . . . 0.0 107.964 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 82' ' ' VAL . 23.1 pt -117.0 159.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.983 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 5.3 pt-20 -133.21 139.23 46.88 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.929 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.25 0.2 OUTLIER -102.34 132.48 48.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.822 179.458 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.37 -31.95 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.919 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.996 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.7 ttm180 -115.76 126.83 54.56 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.713 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 28' ' ' ILE . 51.1 mm -103.3 98.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.733 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.698 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 47.7 mmtm -133.53 155.91 48.74 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 26.1 m0 -108.36 152.49 24.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.35 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.996 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -92.74 110.72 22.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -116.81 176.56 16.32 Favored Glycine 0 N--CA 1.417 -2.63 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.154 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 73' ' ' SER . 23.0 ptt180 -151.76 143.13 23.41 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.527 ' HA ' HG22 ' A' ' 52' ' ' ILE . 4.2 p -77.05 166.15 23.68 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -20.83 66.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -67.33 -26.43 66.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.842 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.83 20.41 11.6 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.509 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 67.1 m -104.41 120.72 41.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 117.875 0.837 . . . . 0.0 108.799 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.435 ' HB3' HD21 ' A' ' 66' ' ' LEU . 5.6 m-85 -92.58 150.0 21.0 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.983 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.64 155.98 27.53 Favored Glycine 0 C--N 1.305 -1.169 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.15 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.557 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 2.0 m-85 -79.19 116.16 19.29 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-O 121.687 0.756 . . . . 0.0 110.015 174.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 78' ' ' LYS . 65.1 mt -100.41 140.2 20.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.761 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.5 mtmt -71.96 139.3 48.6 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.7 p -68.95 -12.69 61.88 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.768 0.794 . . . . 0.0 111.92 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 t -99.42 -12.22 20.44 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.589 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . . . -77.26 -15.89 59.25 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.193 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.1 m -130.39 154.18 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.7 mt-10 -100.84 102.8 13.94 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 31' ' ' ALA . 29.0 mm -79.58 119.2 28.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 . . . . . 0 CA--C 1.477 -1.836 0 CA-C-O 121.779 0.799 . . . . 0.0 110.593 178.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.52 -27.88 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.19 0.519 . . . . 0.0 111.343 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 92.9 mttt -75.04 -18.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.66 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -97.57 -40.52 8.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.92 -49.28 78.32 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.553 1.141 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.41 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.9 m-85 -100.83 -0.51 36.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.642 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.41 74.68 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.059 0.933 . . . . 0.0 108.737 -171.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 8.6 tp -121.57 15.01 11.11 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.557 -173.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -64.75 118.27 8.71 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.56 -164.75 21.66 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -66.17 140.07 57.87 Favored 'Trans proline' 0 CA--C 1.5 -1.222 0 C-N-CA 122.174 1.916 . . . . 0.0 109.406 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.832 HG12 HG21 ' A' ' 55' ' ' ILE 0.359 0.0 OUTLIER -111.74 -66.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.173 -173.035 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.487 ' N ' HD11 ' A' ' 25' ' ' ILE . 34.2 mm-40 70.96 161.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.121 0.962 . . . . 0.0 113.556 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.46 127.95 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.237 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.4 mm -98.87 -45.49 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.208 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.903 ' HB2' HD13 ' A' ' 54' ' ' ILE . 78.1 m-70 -152.36 170.45 20.04 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.92 125.68 48.65 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.997 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 84' ' ' ILE . . . -106.78 175.18 5.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -153.71 106.59 2.9 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 175.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.85 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -65.52 138.02 57.79 Favored 'General case' 0 C--N 1.274 -2.683 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.118 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.1 t -126.62 151.86 47.43 Favored 'General case' 0 CA--C 1.447 -3.004 0 O-C-N 123.211 0.319 . . . . 0.0 110.307 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.1 m 71.22 167.42 0.31 Allowed 'General case' 0 N--CA 1.403 -2.805 0 O-C-N 125.976 2.048 . . . . 0.0 111.903 163.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.35 104.87 4.51 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.008 0.909 . . . . 0.0 110.707 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.78 HG23 ' CE1' ' A' ' 46' ' ' PHE . 19.7 m -107.49 157.4 7.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 124.633 1.173 . . . . 0.0 110.493 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HD3' ' HE3' ' A' ' 78' ' ' LYS . 13.2 ptmm? -59.11 -53.82 54.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 123.609 0.568 . . . . 0.0 111.164 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 46.89 41.75 14.21 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.901 -0.666 . . . . 0.0 114.121 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.35 -111.13 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.034 1.974 . . . . 0.0 118.034 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.7 -53.79 7.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -112.38 3.29 16.87 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.971 0.891 . . . . 0.0 109.472 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.0 mt-10 -91.92 148.42 22.22 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.662 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -69.94 126.96 31.22 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.72 0.771 . . . . 0.0 109.706 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 m -85.26 83.14 8.08 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.836 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.84 -177.44 3.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.222 -178.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.5 mtpt -125.73 -173.99 2.97 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.193 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -73.93 -9.14 58.33 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.187 2.195 . . . . 0.0 113.785 -170.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.28 18.65 2.48 Favored Glycine 1 C--N 1.245 -4.491 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.0 mm-40 -79.75 128.21 33.14 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.744 0.783 . . . . 0.0 111.556 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -89.26 96.95 10.93 Favored 'General case' 0 N--CA 1.404 -2.755 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.88 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.83 HD12 HG12 ' A' ' 82' ' ' VAL . 20.8 pt -113.72 157.96 14.23 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.916 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.946 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -131.88 141.58 49.43 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.903 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.28 147.62 7.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.699 -177.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.832 HG21 HG12 ' A' ' 25' ' ' ILE . 3.6 mp -112.94 -57.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.42 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.908 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 41.9 ttm180 -92.73 125.55 37.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.777 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.38 100.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.054 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.118 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 45.0 mmtm -134.09 166.09 23.56 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.411 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.0 m0 -104.27 146.65 28.49 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.908 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -94.91 115.7 27.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.615 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -113.64 178.68 18.58 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -151.83 138.79 19.04 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.647 ' HA ' HG23 ' A' ' 52' ' ' ILE . 28.8 p -77.87 176.49 9.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.87 -18.12 62.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.927 0.87 . . . . 0.0 109.209 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -78.49 -15.32 58.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.611 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.54 19.44 41.25 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.434 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -98.34 114.18 26.4 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.551 ' HD2' HD12 ' A' ' 66' ' ' LEU . 27.9 m-85 -83.34 150.59 26.02 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.975 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.534 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.53 154.01 22.18 Favored Glycine 0 CA--C 1.5 -0.885 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.41 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 26.8 m-85 -73.85 143.22 45.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.655 0.741 . . . . 0.0 110.959 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.836 HG12 ' HE2' ' A' ' 46' ' ' PHE . 54.0 mt -128.71 136.59 59.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.089 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 77' ' ' ILE . 88.3 mttt -70.2 140.23 52.46 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.4 p -65.3 -6.77 10.71 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -106.23 -12.22 15.79 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.386 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -77.46 -10.85 59.71 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.369 0.604 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 33' ' ' ALA . 27.0 m -134.63 153.51 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.396 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 15.3 mm-40 -96.19 100.53 12.16 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 31' ' ' ALA . 26.8 mm -75.9 131.11 35.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.622 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 CA--C 1.48 -1.731 0 CA-C-O 122.627 1.203 . . . . 0.0 111.1 178.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 . . . . . 0 CA--C 1.508 -0.638 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.62 -26.5 40.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.806 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -71.04 -42.64 69.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.514 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.62 -7.88 59.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.076 0.465 . . . . 0.0 110.923 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -100.32 -49.34 4.29 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.095 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.535 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.1 m-85 -104.54 -12.1 16.65 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 59.97 79.53 0.23 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.999 0.904 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.44 -36.46 22.33 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.624 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 26.4 p 60.41 -47.55 0.1 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.418 2.287 . . . . 0.0 116.704 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.68 -168.83 11.39 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.74 141.55 49.93 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.529 2.153 . . . . 0.0 111.635 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.99 ' HB ' HG22 ' A' ' 55' ' ' ILE . 2.5 pp -118.37 160.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.526 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.491 ' O ' HG11 ' A' ' 27' ' ' VAL . 49.2 mt-30 -110.93 -93.71 0.44 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.189 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 26' ' ' GLN . 0.2 OUTLIER 170.92 149.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.608 2.363 . . . . 0.0 109.491 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.562 HG23 ' CD2' ' A' ' 29' ' ' HIS . 48.6 mm -110.24 -42.39 5.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.796 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.0 m-70 -153.13 176.64 11.69 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.813 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.9 mp -105.62 137.37 43.58 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 171.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.673 ' HB3' HD11 ' A' ' 84' ' ' ILE . . . -112.84 168.79 9.39 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -151.04 103.25 3.03 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.738 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -58.75 132.18 53.11 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.087 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.6 t -115.75 151.32 35.36 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.1 m 68.73 178.46 0.25 Allowed 'General case' 0 N--CA 1.405 -2.709 0 O-C-N 125.67 1.856 . . . . 0.0 110.491 163.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.57 108.04 15.66 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.822 HG23 ' HE1' ' A' ' 46' ' ' PHE . 8.3 m -99.15 155.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.85 -49.91 74.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.178 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' CB ' ' A' ' 43' ' ' GLU . . . 54.09 41.42 69.21 Favored Glycine 0 C--N 1.352 1.426 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.208 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.89 -102.33 0.01 OUTLIER Glycine 0 C--O 1.245 0.825 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -98.34 -53.72 3.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 34.7 p30 -95.38 0.43 53.5 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.142 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 29.7 mt-10 -90.66 151.26 21.34 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -67.06 146.93 53.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.77 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.46 ' H ' HD21 ' A' ' 44' ' ' LEU . 6.6 m -83.71 70.84 10.4 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.872 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -112.32 -179.79 3.77 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.575 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.1 mtpt -136.3 -173.47 3.41 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.59 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -71.16 -12.39 61.46 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 128.545 2.738 . . . . 0.0 114.652 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.96 19.23 2.34 Favored Glycine 0 C--N 1.259 -3.728 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.626 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 6.8 mm-40 -78.68 127.46 32.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.787 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -97.8 96.33 8.15 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.838 HG22 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -107.67 158.32 7.6 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.152 0 CA-C-N 112.086 -2.325 . . . . 0.0 112.427 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.813 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.1 mt-10 -123.08 133.45 54.3 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 120.901 -1.125 . . . . 0.0 109.362 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.796 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -96.69 138.54 21.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.642 177.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.99 HG22 ' HB ' ' A' ' 25' ' ' ILE . 3.6 mp -111.63 -35.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.795 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.683 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.3 ttm180 -108.92 125.86 52.46 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.043 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.38 104.56 16.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.279 -2.464 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 CA-C-O 121.024 0.235 . . . . 0.0 113.15 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.5 mmtm -102.22 145.27 29.66 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -94.11 144.44 25.49 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.881 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -86.51 109.03 18.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.671 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -112.38 177.84 18.71 Favored Glycine 0 N--CA 1.419 -2.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.251 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 28.8 ptt180 -151.64 136.1 16.91 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.838 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.1 p -73.34 169.88 16.2 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 118.032 0.378 . . . . 0.0 110.55 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -6.94 52.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.501 0.667 . . . . 0.0 109.209 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.84 -25.02 17.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.541 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 31.8 2.09 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.388 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 m -113.13 116.69 30.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.507 ' HB3' HD23 ' A' ' 66' ' ' LEU . 88.7 m-85 -82.93 147.35 28.3 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -164.11 157.07 29.25 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.062 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 1.1 m-30 -80.63 127.48 32.51 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.912 0.863 . . . . 0.0 109.222 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.872 HG12 ' HE2' ' A' ' 46' ' ' PHE . 86.8 mt -107.43 133.87 50.87 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.151 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.113 -175.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HE3' ' HB1' ' A' ' 81' ' ' ALA . 48.7 mtmt -71.01 127.44 32.57 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 167.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.0 p -59.41 -18.29 37.76 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -92.08 -20.89 20.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.709 0.804 . . . . 0.0 109.864 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB1' ' HE3' ' A' ' 78' ' ' LYS . . . -75.85 -13.44 60.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.819 HG13 HD12 ' A' ' 52' ' ' ILE . 34.8 m -127.57 154.55 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.41 101.98 12.7 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 31' ' ' ALA . 26.6 mm -78.14 125.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.428 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 CA--C 1.481 -1.699 0 CA-C-O 122.588 1.185 . . . . 0.0 110.707 178.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pp -60.3 -26.97 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.018 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.48 -21.41 45.42 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -97.95 -37.51 9.76 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.522 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.9 ttpt -65.53 -36.47 83.9 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.48 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.7 m-85 -110.46 8.43 23.12 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 56.45 38.82 30.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.933 0.873 . . . . 0.0 110.395 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.1 tp -94.24 17.01 13.47 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.507 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -62.6 122.09 14.95 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.393 0.616 . . . . 0.0 109.371 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.97 162.01 11.05 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.62 134.3 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.364 2.042 . . . . 0.0 112.443 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 55' ' ' ILE . 2.6 pp -125.66 154.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.453 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.2 mm100 -110.14 -84.31 0.56 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.75 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.698 ' HA ' HG21 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -177.62 136.78 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 C-N-CA 127.363 2.265 . . . . 0.0 108.407 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.428 HG22 HG12 ' A' ' 57' ' ' ILE . 46.9 mm -98.05 -42.83 11.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 1.01 ' HB2' HD11 ' A' ' 54' ' ' ILE . 91.4 m-70 -150.74 168.84 23.19 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -104.62 124.85 50.07 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.81 168.89 8.84 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 15.1 ptpt -153.45 103.86 2.7 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.829 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -66.65 139.89 57.89 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.31 -177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 44.0 t -123.12 150.68 42.91 Favored 'General case' 0 CA--C 1.452 -2.797 0 CA-C-O 121.219 0.533 . . . . 0.0 110.36 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.4 m 68.81 -179.95 0.23 Allowed 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.016 163.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.51 103.2 15.66 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.909 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.694 HG23 ' CE1' ' A' ' 46' ' ' PHE . 12.0 m -93.84 155.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.227 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.62 -42.85 75.5 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.284 0.99 . . . . 0.0 110.851 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.0 43.9 31.88 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 115.201 0.841 . . . . 0.0 115.201 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.06 -175.64 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -47.32 -52.29 16.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.457 1.103 . . . . 0.0 113.741 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -88.78 -4.63 58.46 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.367 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.76 166.6 12.68 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -79.48 145.21 33.38 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.485 0.66 . . . . 0.0 109.375 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 m -85.86 41.95 0.94 Allowed 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.297 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.899 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -82.43 176.78 9.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.589 0.709 . . . . 0.0 112.3 -177.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 60.2 mtpt -132.74 -173.86 3.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.0 -173.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 30.6 tt0 -65.59 -15.8 63.08 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 127.121 2.168 . . . . 0.0 115.532 -169.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.47 19.25 2.81 Favored Glycine 0 C--N 1.26 -3.651 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 11.5 mm-40 -77.37 126.47 30.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -89.62 97.34 11.14 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 113.936 -1.484 . . . . 0.0 107.657 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.954 HD13 HG11 ' A' ' 82' ' ' VAL . 24.7 pt -110.4 158.54 10.66 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.343 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.652 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.59 139.38 52.31 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 121.286 -0.884 . . . . 0.0 108.825 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.01 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.61 135.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.889 0.852 . . . . 0.0 110.232 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -118.97 8.47 6.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.741 -177.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.758 ' HG2' HG22 ' A' ' 58' ' ' THR . 28.7 ttm180 -154.97 117.75 4.34 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.511 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 28' ' ' ILE . 51.2 mm -93.28 96.85 6.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.758 HG22 ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.278 -2.54 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.994 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.3 mmtt -133.36 161.66 33.93 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.458 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.5 m0 -101.03 159.18 15.44 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -100.35 115.3 29.66 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.151 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.49 -178.48 16.52 Favored Glycine 0 N--CA 1.419 -2.473 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.88 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 37.0 ptt180 -151.83 144.42 24.23 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.662 ' HA ' HG23 ' A' ' 52' ' ' ILE . 21.8 p -78.85 175.21 10.71 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 118.598 0.635 . . . . 0.0 109.513 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.92 60.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.24 1.019 . . . . 0.0 109.477 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.15 -14.36 41.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.283 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 33.5 14.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.801 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 113.29 26.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 66.1 m-85 -82.89 147.6 28.19 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.776 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.53 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.28 154.28 23.56 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.43 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 27.8 m-85 -73.31 149.35 42.73 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.84 0.828 . . . . 0.0 111.08 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.899 HG12 ' HE2' ' A' ' 46' ' ' PHE . 59.9 mt -130.05 134.07 63.4 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.875 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 77' ' ' ILE . 47.9 mtmt -67.58 139.47 56.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 p -66.92 -12.06 58.26 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.84 0.828 . . . . 0.0 111.742 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -100.88 -18.04 16.56 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.565 1.146 . . . . 0.0 110.178 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.559 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -74.1 -13.89 60.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.758 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.954 HG11 HD13 ' A' ' 52' ' ' ILE . 28.2 m -135.76 161.68 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.83 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 31.1 mm-40 -110.21 113.54 26.3 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.44 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.2 mp -84.79 140.47 15.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 122.009 0.909 . . . . 0.0 112.156 -176.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 120.788 0.327 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.01 -30.46 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.718 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 96.8 mttt -73.75 -29.72 62.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.95 -40.31 16.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.48 -44.52 64.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.116 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -95.12 -5.16 44.8 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.798 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm 59.5 71.92 0.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.6 tp -107.3 16.65 23.76 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.502 -171.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -49.85 132.41 22.41 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.543 0.737 . . . . 0.0 112.418 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.76 -152.77 17.43 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.97 142.87 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 122.931 2.42 . . . . 0.0 112.84 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.407 HD13 ' C ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -115.75 109.61 28.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.182 179.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.26 141.6 39.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.681 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 14.8 m -67.55 152.91 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-O 121.258 0.551 . . . . 0.0 111.356 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG23 HG12 ' A' ' 57' ' ' ILE . 21.0 mm -107.65 -31.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 1.028 ' HB2' HD11 ' A' ' 54' ' ' ILE . 47.8 m-70 -153.98 179.57 8.78 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -117.45 128.96 55.52 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 84' ' ' ILE . . . -113.6 169.73 8.76 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.234 0.54 . . . . 0.0 110.599 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HE2' ' OD2' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -153.7 111.48 3.53 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 174.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.48 138.97 58.44 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.88 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' GLN . 41.7 t -121.1 148.69 43.83 Favored 'General case' 0 CA--C 1.442 -3.178 0 CA-C-O 121.16 0.505 . . . . 0.0 110.081 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.532 ' N ' ' HA ' ' A' ' 48' ' ' GLN . 12.3 m 70.11 176.07 0.28 Allowed 'General case' 0 N--CA 1.401 -2.876 0 O-C-N 126.055 2.097 . . . . 0.0 111.537 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.6 114.37 20.25 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.01 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.809 HG23 ' CE1' ' A' ' 46' ' ' PHE . 13.1 m -115.57 156.48 16.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.671 -174.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -47.31 -61.63 1.81 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.339 1.025 . . . . 0.0 109.328 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.11 43.67 83.48 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.449 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.79 -171.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 27.2 mtpp -54.01 -46.07 71.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -174.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.574 HD21 ' HD2' ' A' ' 76' ' ' TYR . 4.0 p-10 -94.46 -4.87 47.46 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.801 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.77 168.28 10.92 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.661 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -83.2 126.66 32.87 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -85.84 45.89 1.26 Allowed 'General case' 0 C--N 1.256 -3.46 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.974 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.908 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -75.75 179.26 5.55 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.867 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.826 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 54.8 mtpt -122.25 -172.61 2.49 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.233 -174.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.532 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 39.1 tt0 -69.17 -17.71 63.84 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 126.482 1.913 . . . . 0.0 115.45 -166.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.63 19.2 2.03 Favored Glycine 1 C--N 1.249 -4.261 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.826 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.2 mm-40 -70.36 132.82 46.23 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.12 97.33 11.08 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 123.211 1.482 . . . . 0.0 108.616 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.785 HD11 HG13 ' A' ' 82' ' ' VAL . 18.9 pt -110.83 159.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.726 0 CA-C-N 111.363 -2.653 . . . . 0.0 112.367 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.8 130.02 31.27 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.619 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.028 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -91.72 130.04 41.48 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.405 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.545 HD11 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -113.78 6.44 7.8 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.535 -175.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 37.3 ttm180 -154.29 119.5 5.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.027 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 HG23 ' A' ' 28' ' ' ILE . 41.7 mm -87.78 111.26 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 170.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.3 p . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.45 0.643 . . . . 0.0 112.618 -171.491 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.073 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.568 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 30.5 mmtp -110.29 142.43 41.92 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.423 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 34.9 m0 -83.93 152.42 24.51 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 123.623 0.577 . . . . 0.0 110.927 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.8 tm? -93.58 107.77 19.58 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.284 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -111.9 174.26 16.3 Favored Glycine 0 N--CA 1.414 -2.814 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.669 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HG2' HD12 ' A' ' 55' ' ' ILE . 13.4 ptm180 -151.69 146.36 25.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 52' ' ' ILE . 71.3 p -82.0 169.66 16.48 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.8 31.02 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.234 0.54 . . . . 0.0 110.536 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.87 4.31 47.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.331 0.586 . . . . 0.0 109.852 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.84 17.75 59.24 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.526 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -98.73 109.26 22.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 25.8 m-85 -87.87 146.37 25.61 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.197 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.06 158.21 30.65 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.813 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HD2' HD21 ' A' ' 42' ' ' ASN . 27.2 m-85 -74.28 135.35 42.62 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.699 0.761 . . . . 0.0 110.976 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.908 HG12 ' HE2' ' A' ' 46' ' ' PHE . 87.5 mt -114.83 124.44 71.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.338 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.07 128.53 36.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.0 p -60.9 -11.87 9.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.394 0.616 . . . . 0.0 112.656 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 t -92.39 -19.83 21.67 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.674 0.79 . . . . 0.0 110.329 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.636 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -79.43 -10.6 59.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.972 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 33' ' ' ALA . 31.6 m -133.29 160.77 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.298 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -102.21 103.93 14.47 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 31' ' ' ALA . 30.0 mm -84.35 121.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.949 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 63.0 m-20 . . . . . 0 C--N 1.309 -1.168 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.434 -1.251 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -26.56 39.25 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 87.9 mttt -74.03 -22.57 59.52 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.434 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.54 -39.59 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -65.93 -51.03 62.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.004 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -98.87 3.01 47.17 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.92 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm 51.67 76.21 0.18 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.397 1.094 . . . . 0.0 109.912 -173.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.776 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.5 tp -127.51 15.93 7.07 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.783 -173.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -57.62 128.66 38.2 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.251 0.548 . . . . 0.0 110.75 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.07 166.97 12.78 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 111.71 3.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.293 1.995 . . . . 0.0 110.651 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.83 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 pp -98.57 142.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -116.21 142.63 46.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.152 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.875 HG23 ' HB3' ' A' ' 53' ' ' GLU . 14.8 p -71.08 144.65 13.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 HG23 ' CD2' ' A' ' 29' ' ' HIS . 51.2 mm -103.76 -36.03 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.191 0.52 . . . . 0.0 110.757 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.802 ' HB2' HD13 ' A' ' 54' ' ' ILE . 75.1 m-70 -147.94 152.58 37.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.06 119.71 32.01 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.41 174.88 5.68 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.541 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.35 112.66 3.8 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.823 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.69 137.34 56.61 Favored 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.567 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.2 t -127.47 154.22 45.36 Favored 'General case' 0 CA--C 1.444 -3.133 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.777 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.3 m 71.15 175.11 0.29 Allowed 'General case' 0 N--CA 1.4 -2.965 0 O-C-N 125.748 1.905 . . . . 0.0 111.275 163.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.27 110.21 14.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.745 HG23 ' CE1' ' A' ' 46' ' ' PHE . 14.0 m -108.44 155.27 9.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.613 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -56.68 -46.41 81.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.83 43.0 87.15 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.788 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.77 -178.81 0.31 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -29.73 38.13 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -106.76 -6.12 18.0 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.328 0.585 . . . . 0.0 109.945 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.78 164.34 12.79 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.523 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.619 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.8 140.13 38.27 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 t -88.0 43.91 1.15 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.964 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -80.16 -178.98 6.82 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.372 -178.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.9 mtpt -130.53 178.87 6.29 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.069 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.2 -12.77 54.77 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 128.236 2.614 . . . . 0.0 114.241 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.39 18.65 3.45 Favored Glycine 0 C--N 1.266 -3.333 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.1 mm-40 -85.22 127.42 34.29 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 112.679 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 97.22 10.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.954 HD12 HG12 ' A' ' 82' ' ' VAL . 27.6 pt -109.56 157.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.914 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.201 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.875 ' HB3' HG23 ' A' ' 27' ' ' VAL . 43.5 mt-10 -123.71 135.53 53.92 Favored 'General case' 0 C--N 1.281 -2.393 0 O-C-N 121.265 -0.897 . . . . 0.0 109.099 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.25 137.03 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.011 -179.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.83 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.7 mp -104.13 -49.09 9.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.203 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.842 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 40.6 ttm180 -97.56 113.89 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.661 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.57 98.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--N 1.315 -0.92 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.42 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.677 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.4 mmtt -134.28 167.78 20.08 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 42.8 m0 -104.18 140.36 37.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.768 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.4 tm? -87.2 111.93 21.48 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -109.24 -179.64 21.19 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.14 138.88 19.77 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.722 ' HA ' HG21 ' A' ' 52' ' ' ILE . 40.9 p -77.98 171.8 14.46 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -0.18 19.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.603 0.716 . . . . 0.0 109.979 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 1.8 mmp_? -101.11 -14.56 17.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.815 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.8 21.38 9.72 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.112 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -103.12 113.66 27.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 117.324 0.562 . . . . 0.0 109.787 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.485 ' HB3' HD21 ' A' ' 66' ' ' LEU . 47.5 m-85 -86.96 144.79 26.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.854 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -167.73 153.32 22.56 Favored Glycine 0 C--N 1.301 -1.396 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.935 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.526 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 41.4 m-85 -73.04 155.13 40.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.393 0.616 . . . . 0.0 111.324 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.964 HG12 ' HE2' ' A' ' 46' ' ' PHE . 53.1 mt -137.87 136.39 45.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 77' ' ' ILE . 44.0 mtmt -69.16 141.72 54.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 168.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -69.49 -6.82 33.06 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 119.271 0.941 . . . . 0.0 112.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.3 t -96.18 -22.11 17.48 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.069 0.948 . . . . 0.0 109.71 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -73.21 -15.48 61.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.954 HG12 HD12 ' A' ' 52' ' ' ILE . 27.3 m -130.69 152.33 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 121.17 0.51 . . . . 0.0 112.13 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -92.65 100.68 13.14 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 82' ' ' VAL . 27.8 mm -92.22 125.02 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.75 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 . . . . . 0 C--N 1.297 -1.711 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.941 174.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.538 HD11 ' HG3' ' A' ' 16' ' ' LYS . 2.8 pp -55.87 -28.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.314 1.046 . . . . 0.0 111.916 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HG3' HD11 ' A' ' 15' ' ' ILE . 95.9 mttt -72.5 -22.4 61.05 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.97 -45.17 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -59.42 -47.3 85.99 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.149 1.38 . . . . 0.0 111.729 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.45 0.3 19.26 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 56.54 75.24 0.36 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.54 1.162 . . . . 0.0 111.593 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD12 ' CD2' ' A' ' 74' ' ' TYR . 78.8 mt -125.98 16.71 7.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.867 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -72.62 102.46 3.29 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.392 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.63 -155.19 26.37 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -93.32 121.09 0.41 Allowed 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 123.113 2.542 . . . . 0.0 111.65 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 55' ' ' ILE . 2.6 pp -111.79 142.16 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.569 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.466 ' C ' HG21 ' A' ' 55' ' ' ILE . 54.3 mt-30 -132.47 138.38 47.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 m -59.94 134.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.346 0.593 . . . . 0.0 111.953 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.87 -34.7 5.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 1.001 ' HB2' HD13 ' A' ' 54' ' ' ILE . 76.1 m-70 -155.1 173.59 16.38 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.8 139.88 48.05 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.749 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.58 172.01 7.18 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.163 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -152.71 102.64 2.72 Favored 'General case' 0 C--N 1.264 -3.145 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -69.11 137.36 53.39 Favored 'General case' 0 C--N 1.268 -2.978 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.792 -175.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.0 t -124.78 150.08 46.68 Favored 'General case' 0 CA--C 1.436 -3.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.268 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.3 m 72.74 164.7 0.29 Allowed 'General case' 0 N--CA 1.4 -2.958 0 O-C-N 126.234 2.209 . . . . 0.0 111.15 163.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.64 106.76 1.9 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.771 HG22 ' CE1' ' A' ' 46' ' ' PHE . 19.9 m -98.81 157.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.445 -173.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -42.52 -65.89 0.42 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 125.001 1.438 . . . . 0.0 110.331 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.08 43.53 90.18 Favored Glycine 0 C--N 1.321 -0.259 0 C-N-CA 119.85 -1.167 . . . . 0.0 114.264 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -57.46 -173.01 0.27 Allowed Glycine 0 CA--C 1.552 2.405 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -64.62 -37.92 89.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -102.2 1.96 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.649 0.737 . . . . 0.0 109.937 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 47.2 mt-10 -92.53 163.26 13.88 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.714 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -84.73 127.31 34.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -89.93 73.75 7.38 Favored 'General case' 0 C--N 1.253 -3.625 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.851 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -97.73 -176.76 3.56 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.546 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 47.7 mtpt -131.44 -173.18 3.04 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.822 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.06 114.74 24.98 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 125.089 1.356 . . . . 0.0 107.651 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.89 -1.77 51.96 Favored Glycine 0 C--N 1.29 -2.025 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 12.7 mm-40 -72.32 125.18 26.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.548 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.95 96.2 9.96 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-O 123.316 1.532 . . . . 0.0 108.154 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.913 HD13 HG11 ' A' ' 82' ' ' VAL . 23.5 pt -106.59 158.61 6.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.912 -2.404 . . . . 0.0 111.004 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -134.67 130.22 36.01 Favored 'General case' 0 C--N 1.249 -3.785 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.623 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -93.69 136.2 26.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 CA-C-O 122.196 0.998 . . . . 0.0 112.158 -178.381 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.466 HG21 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -118.47 7.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.697 -177.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.867 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.7 ttm180 -149.44 123.84 9.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.182 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 HG21 ' CZ2' ' A' ' 65' ' ' TRP . 51.0 mm -109.35 99.71 9.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.752 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.432 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 46.7 mmtm -133.74 161.01 35.85 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.478 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.1 m0 -102.7 161.05 14.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.867 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -106.3 115.42 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.961 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.714 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -116.44 179.39 17.7 Favored Glycine 0 N--CA 1.416 -2.668 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.972 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 31.3 ptt180 -152.22 144.4 23.9 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.789 ' HA ' HG23 ' A' ' 52' ' ' ILE . 27.5 p -74.55 169.89 16.85 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.06 64.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.628 0.728 . . . . 0.0 109.196 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -78.26 -23.86 47.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.653 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.36 26.96 6.68 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.303 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -108.83 111.74 23.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 1.9 m-85 -87.11 148.09 25.37 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.716 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.84 154.19 22.32 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.008 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 34.6 m-85 -70.44 142.58 51.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.763 0.792 . . . . 0.0 111.626 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.851 HG12 ' HE2' ' A' ' 46' ' ' PHE . 67.2 mt -125.39 136.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.415 -173.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' O ' HG23 ' A' ' 77' ' ' ILE . 89.5 mttt -72.82 135.98 45.31 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 166.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.8 p -65.23 -10.47 32.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.619 0.723 . . . . 0.0 112.031 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -98.7 -17.66 18.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.209 1.004 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.68 -12.77 60.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.584 0.707 . . . . 0.0 109.224 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.913 HG11 HD13 ' A' ' 52' ' ' ILE . 34.9 m -134.97 155.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.511 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -98.87 100.53 11.73 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.603 HD12 ' HB1' ' A' ' 31' ' ' ALA . 26.1 mm -79.72 128.46 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--N 1.31 -1.132 0 CA-C-O 121.993 0.901 . . . . 0.0 110.655 178.449 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -60.71 -29.34 44.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.668 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 98.2 mttt -80.69 -25.67 38.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.878 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -90.5 -42.67 10.71 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.381 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -69.82 -52.73 22.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.433 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.23 -0.46 53.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 54.08 73.41 0.39 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.947 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HG ' HG23 ' A' ' 25' ' ' ILE . 4.5 tp -127.03 16.61 7.3 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.351 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.668 ' HB ' ' HB3' ' A' ' 16' ' ' LYS . 10.3 t -77.39 126.06 30.32 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 119.184 -1.007 . . . . 0.0 110.433 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.76 -155.72 16.2 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.74 137.11 34.75 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.395 2.73 . . . . 0.0 110.486 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.883 ' HB ' HG23 ' A' ' 55' ' ' ILE . 17.0 pt -127.07 -70.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.83 ' H ' HG13 ' A' ' 25' ' ' ILE . 30.4 mt-30 70.39 131.37 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.14 1.776 . . . . 0.0 113.638 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.26 136.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.871 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.442 HG22 ' CD2' ' A' ' 29' ' ' HIS . 47.9 mm -99.83 -43.63 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.976 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.927 ' HB2' HD11 ' A' ' 54' ' ' ILE . 65.2 m-70 -140.24 173.88 11.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.86 124.77 51.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.05 172.49 6.77 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.519 0.676 . . . . 0.0 110.302 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 4.4 ttmp? -151.88 106.46 3.22 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.881 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.44 120.57 13.58 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.24 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 42.2 t -93.32 155.8 17.19 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.2 m 62.5 -174.11 0.15 Allowed 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 125.6 1.812 . . . . 0.0 111.127 163.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -91.21 118.27 30.33 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 166.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.89 HG21 ' HE1' ' A' ' 46' ' ' PHE . 20.9 m -97.41 156.89 3.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.614 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -51.43 -47.81 62.9 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.232 0.957 . . . . 0.0 108.703 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.36 95.68 Favored Glycine 0 N--CA 1.438 -1.201 0 O-C-N 124.157 0.911 . . . . 0.0 113.388 173.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.23 178.59 0.13 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.466 0.946 . . . . 0.0 115.466 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.41 -43.56 44.54 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.843 1.257 . . . . 0.0 113.304 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -94.19 -1.58 53.89 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.573 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.4 167.09 12.21 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.164 0.507 . . . . 0.0 110.961 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -79.75 141.95 35.86 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.103 -177.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' H ' HD21 ' A' ' 44' ' ' LEU . 54.0 p -87.44 84.73 7.13 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.076 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.89 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.15 176.89 6.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.631 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 57.6 mtpt -128.44 -172.81 2.79 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.748 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.2 110.25 17.9 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 125.099 1.359 . . . . 0.0 109.945 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.76 17.4 48.57 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.5 mm-40 -76.33 130.39 38.03 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.626 0.727 . . . . 0.0 110.99 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.98 96.9 10.43 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.521 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.822 HD13 HG13 ' A' ' 82' ' ' VAL . 28.7 pt -113.57 157.74 14.16 Favored 'Isoleucine or valine' 1 C--N 1.235 -4.41 0 CA-C-N 111.834 -2.439 . . . . 0.0 111.053 174.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.19 136.94 53.44 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.58 138.7 23.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.806 178.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.883 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.2 -47.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.569 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 57.0 ttt180 -110.17 121.79 46.1 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.325 -172.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.9 mm -97.72 95.89 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.304 -1.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 175.324 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 45.8 mmtm -121.61 144.33 48.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 35.3 m0 -93.75 162.22 14.01 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.851 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -102.59 117.33 34.44 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.667 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.56 176.79 16.3 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.65 142.57 23.0 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 124.536 1.134 . . . . 0.0 108.814 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 52' ' ' ILE . 31.1 p -77.89 168.36 20.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.37 66.42 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.674 0.273 . . . . 0.0 110.633 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -78.8 -27.04 44.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.8 25.81 3.81 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.14 -1.029 . . . . 0.0 114.188 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.1 m -100.03 113.25 25.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.747 ' HB2' HG22 ' A' ' 15' ' ' ILE . 7.0 m-85 -91.93 144.04 25.88 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.533 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 159.64 32.81 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.191 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.56 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 24.2 m-85 -72.0 151.0 43.52 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.15 0.5 . . . . 0.0 110.119 174.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.682 HG12 ' HE2' ' A' ' 46' ' ' PHE . 60.2 mt -135.18 130.9 51.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.871 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.607 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.2 mtmt -64.48 136.74 57.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -67.53 -13.05 61.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.859 0.838 . . . . 0.0 111.936 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.8 t -96.14 -14.15 23.04 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.287 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -77.27 -20.27 55.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 33' ' ' ALA . 34.3 m -128.96 149.64 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 121.361 0.601 . . . . 0.0 112.369 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.5 pt-20 -96.97 102.37 14.14 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.447 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.578 HD12 ' HB1' ' A' ' 31' ' ' ALA . 25.2 mm -81.72 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.672 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--N 1.317 -0.84 0 CA-C-O 121.174 0.511 . . . . 0.0 110.303 -178.611 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 119.858 -0.115 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.33 -29.53 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.427 0.691 . . . . 0.0 112.65 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.76 -22.32 58.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.048 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -97.07 -42.83 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.911 0.862 . . . . 0.0 108.744 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -62.65 -50.13 72.41 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.809 1.644 . . . . 0.0 110.732 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -102.05 -2.09 30.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.156 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 58.48 76.42 0.34 Allowed 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 124.096 0.872 . . . . 0.0 108.839 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.62 16.36 9.56 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.865 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -82.46 114.4 20.87 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.889 0.852 . . . . 0.0 110.028 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.96 -170.41 24.55 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.14 117.72 4.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.601 2.2 . . . . 0.0 111.928 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.9 pp -132.3 139.32 50.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -131.4 140.29 49.63 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.776 0.431 . . . . 0.0 110.448 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.787 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.0 p -63.4 141.19 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 O-C-N 123.603 0.565 . . . . 0.0 111.138 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.647 HD13 HG12 ' A' ' 57' ' ' ILE . 54.6 mt -103.6 -33.08 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.157 0.503 . . . . 0.0 111.937 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.783 ' HB2' HD11 ' A' ' 54' ' ' ILE . 67.8 m-70 -154.95 167.5 30.11 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.597 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.0 mp -106.69 137.64 44.34 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HB1' HG13 ' A' ' 52' ' ' ILE . . . -111.42 171.92 7.2 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.257 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -151.17 106.66 3.36 Favored 'General case' 0 N--CA 1.397 -3.09 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.789 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -62.86 109.55 1.48 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.461 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.5 t -96.26 150.73 20.22 Favored 'General case' 0 CA--C 1.426 -3.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.573 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.5 m 66.45 -175.84 0.19 Allowed 'General case' 0 N--CA 1.399 -3.005 0 O-C-N 126.078 2.111 . . . . 0.0 109.385 165.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.81 120.63 18.7 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.627 HG23 ' CE1' ' A' ' 46' ' ' PHE . 4.3 m -98.99 154.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -59.38 -69.14 0.22 Allowed 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.813 0.696 . . . . 0.0 109.29 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.98 42.6 84.93 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.242 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.27 -116.51 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -99.61 -52.97 3.32 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.651 -0.911 . . . . 0.0 112.474 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -90.64 2.84 55.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.378 0.609 . . . . 0.0 110.555 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 38.3 mt-10 -90.25 159.16 16.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.145 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -64.8 149.09 50.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 124.05 0.844 . . . . 0.0 110.207 -176.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.411 ' H ' HD21 ' A' ' 44' ' ' LEU . 40.8 m -88.81 80.14 7.25 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.645 ' HD2' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -134.79 167.61 20.56 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.46 -177.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.9 mmtp -143.67 -172.8 3.8 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.736 0.779 . . . . 0.0 111.263 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 35' ' ' CYS . 49.7 tt0 -67.93 120.7 14.64 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 126.492 1.917 . . . . 0.0 109.346 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.17 4.57 68.6 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.034 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 48.5 mm-40 -76.12 126.77 31.62 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.936 0.874 . . . . 0.0 111.355 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -96.12 96.94 9.18 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.848 HG23 ' HA ' ' A' ' 69' ' ' THR . 33.1 pt -107.75 159.7 7.18 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.105 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.164 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.787 ' HB3' HG21 ' A' ' 27' ' ' VAL . 50.4 mt-10 -121.29 139.73 53.01 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.259 0.2 OUTLIER -105.06 132.17 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.94 175.462 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.9 mp -105.42 -34.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.562 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.864 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.8 ttm180 -114.5 119.51 37.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.751 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 28' ' ' ILE . 44.0 mm -101.71 98.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.347 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.504 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.4 mmtm -133.49 160.54 37.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.419 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 40.5 m0 -101.57 141.87 33.79 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.546 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.864 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -88.75 113.64 24.53 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.663 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -115.58 178.32 17.6 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.843 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 73' ' ' SER . 20.7 ptt180 -151.57 135.74 16.7 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 124.261 1.025 . . . . 0.0 108.396 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.848 ' HA ' HG23 ' A' ' 52' ' ' ILE . 10.8 p -72.67 169.17 17.18 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -17.65 62.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.44 -26.52 60.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.99 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.92 12.31 20.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.727 -0.749 . . . . 0.0 114.688 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 21.3 m -91.08 118.93 30.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 118.178 0.989 . . . . 0.0 108.977 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HD2' HD11 ' A' ' 66' ' ' LEU . 61.4 m-85 -84.06 144.11 29.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.223 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.4 156.64 28.67 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.541 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 10.3 m-85 -76.72 134.79 39.1 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.67 0.748 . . . . 0.0 110.018 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.663 HD12 ' HA3' ' A' ' 67' ' ' GLY . 71.6 mt -114.94 138.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.685 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 77' ' ' ILE . 90.5 mttt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 168.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.6 p -64.62 -18.26 64.76 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.762 0.791 . . . . 0.0 111.751 -171.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 -19.63 27.19 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.18 -17.84 59.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.816 HG13 HD11 ' A' ' 52' ' ' ILE . 35.1 m -129.19 151.81 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -98.27 105.78 17.98 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -83.55 123.69 38.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.682 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.258 1.539 0 CA-C-O 122.594 1.187 . . . . 0.0 111.806 -179.163 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.54 0.21 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.13 -26.24 39.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 97.1 mttt -75.27 -18.6 60.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.041 0.448 . . . . 0.0 111.292 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -96.9 -41.13 8.57 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -68.07 -46.89 69.82 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.683 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -108.01 -3.09 19.08 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.389 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 72.9 mmtt 56.69 69.99 0.69 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.068 0.855 . . . . 0.0 110.369 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.66 16.93 15.4 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.392 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -51.99 117.83 3.03 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.801 0.84 . . . . 0.0 112.791 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.1 179.31 15.91 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.557 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 121.71 6.52 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.364 2.709 . . . . 0.0 110.488 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.705 HD11 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -120.44 163.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.966 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -126.07 155.49 41.48 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.842 0.829 . . . . 0.0 111.194 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 53' ' ' GLU . 59.8 t -90.43 107.96 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.272 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.63 -37.56 24.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.875 ' HB2' HD13 ' A' ' 54' ' ' ILE . 69.5 m-70 -150.57 168.47 24.16 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 121.04 0.448 . . . . 0.0 110.416 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 3.8 mm? -101.88 119.73 39.26 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB1' HG13 ' A' ' 52' ' ' ILE . . . -103.91 164.04 11.96 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -152.46 107.28 3.21 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.74 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -60.44 126.27 26.82 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 p -103.1 -11.0 18.4 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -167.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.82 175.02 14.12 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.0 -157.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.36 107.83 5.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.833 HG22 ' HE1' ' A' ' 46' ' ' PHE . 14.7 m -103.96 156.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.691 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -57.91 -48.93 78.45 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.8 42.97 60.15 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.605 1.19 . . . . 0.0 113.634 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.38 -170.44 0.25 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -52.03 -38.81 58.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -100.57 -0.22 38.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.685 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.49 167.23 11.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.98 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -76.08 139.51 41.41 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.933 0.873 . . . . 0.0 111.634 -176.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -82.84 76.03 9.71 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.912 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.833 ' HE1' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.05 -178.99 4.37 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.442 179.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 28.6 mtpp -139.52 -173.09 3.52 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 123.648 0.593 . . . . 0.0 110.041 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -67.87 -13.14 61.91 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 126.464 1.906 . . . . 0.0 115.619 -168.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.5 15.0 4.73 Favored Glycine 0 C--N 1.254 -3.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 21.0 mm-40 -72.65 123.32 23.0 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 122.282 1.039 . . . . 0.0 112.892 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -93.66 96.17 9.65 Favored 'General case' 0 N--CA 1.397 -3.077 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.828 HD13 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -105.11 159.18 5.59 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.08 0 CA-C-N 111.653 -2.521 . . . . 0.0 112.685 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.496 ' HG2' ' CD1' ' A' ' 30' ' ' LEU . 35.3 mt-10 -124.63 132.04 53.44 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.875 HD13 ' HB2' ' A' ' 29' ' ' HIS 0.277 0.2 OUTLIER -100.47 143.81 13.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 117.503 -1.679 . . . . 0.0 112.284 178.147 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.705 HG12 HD11 ' A' ' 25' ' ' ILE . 2.9 mp -111.6 -21.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.613 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.818 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.2 ttm180 -127.73 121.36 30.09 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.813 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mm -112.51 102.91 14.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 103.842 -2.651 . . . . 0.0 103.842 173.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.286 -2.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.614 -170.752 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.856 0 CA-C-O 120.098 -0.279 . . . . 0.0 113.258 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 71.3 mmtt -135.31 -177.91 4.87 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.876 0.846 . . . . 0.0 112.372 -174.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.418 ' HZ3' HG12 ' A' ' 84' ' ' ILE . 20.1 m0 -120.66 162.27 19.97 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 106.638 166.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -105.9 120.7 42.42 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.131 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -124.05 -176.32 14.66 Favored Glycine 0 N--CA 1.422 -2.249 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.206 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 33.5 ptt180 -151.23 146.1 25.84 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.633 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.8 p -85.17 166.78 16.3 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.54 25.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -91.42 -19.88 22.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.749 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.82 36.9 3.33 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.526 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -128.61 137.53 51.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 29.9 m-85 -106.19 152.14 23.85 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.547 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -169.8 152.6 19.82 Favored Glycine 0 CA--C 1.478 -2.251 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.067 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.517 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 9.3 m-85 -74.53 152.8 39.29 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.681 HG12 ' HE2' ' A' ' 46' ' ' PHE . 40.7 mt -136.67 134.71 48.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 77' ' ' ILE . 94.3 mttt -70.7 142.67 51.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -65.34 -12.46 52.17 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.757 0.789 . . . . 0.0 112.738 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.479 HG21 ' HB3' ' A' ' 78' ' ' LYS . 8.2 t -94.86 -15.04 24.02 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -78.9 -19.76 51.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 52' ' ' ILE . 35.1 m -134.1 163.95 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.316 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.27 106.82 14.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.659 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.4 mp -85.02 127.71 39.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.986 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 121.368 0.604 . . . . 0.0 109.997 175.323 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 CA--C 1.506 -0.718 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -81.73 69.34 8.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.16 0.981 . . . . 0.0 110.42 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB3' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -101.56 86.04 2.88 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 175.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.68 -63.38 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -107.0 141.67 37.84 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -111.78 -43.22 3.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 58.05 87.17 0.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.146 1.378 . . . . 0.0 110.914 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -96.51 -59.94 1.72 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -114.55 -153.6 0.53 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -174.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.11 6.32 28.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.23 -42.95 22.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.905 -172.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.588 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -65.62 -23.54 66.84 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -49.47 77.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.74 -46.38 66.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.192 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.647 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.1 pp -60.62 -25.82 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.162 0.506 . . . . 0.0 112.143 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 94.9 mttt -72.46 -24.49 61.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.291 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -97.78 -46.73 5.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.073 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.7 tttt -66.52 -53.42 35.14 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.87 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 80.0 m-85 -98.46 -8.86 26.02 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.44 0.638 . . . . 0.0 109.375 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.6 ttmt 60.84 75.48 0.41 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.161 1.384 . . . . 0.0 112.534 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.751 HD22 HG12 ' A' ' 25' ' ' ILE . 8.3 mp -117.58 17.01 14.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.256 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -56.21 104.94 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.395 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.55 -160.17 20.07 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.35 117.68 0.64 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.209 2.606 . . . . 0.0 112.583 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.757 HD13 HG12 ' A' ' 55' ' ' ILE . 2.6 pp -117.01 143.82 26.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 120.666 0.27 . . . . 0.0 111.616 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -120.17 155.22 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.82 137.59 22.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 121.484 0.659 . . . . 0.0 112.19 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG22 ' CD2' ' A' ' 29' ' ' HIS . 46.4 mm -91.46 -41.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.982 ' HB2' HD12 ' A' ' 54' ' ' ILE . 73.7 m-70 -152.84 177.86 10.28 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 3.4 mm? -116.12 117.41 29.99 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.62 168.24 9.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.17 107.77 3.5 Favored 'General case' 0 C--N 1.255 -3.526 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 176.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.837 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -64.03 132.69 51.33 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.511 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.8 t -116.73 148.14 41.38 Favored 'General case' 0 CA--C 1.44 -3.257 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.3 m 70.29 178.56 0.25 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.273 163.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.13 112.78 15.43 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.823 HG22 ' CE1' ' A' ' 46' ' ' PHE . 9.3 m -110.4 156.79 11.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.682 -174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 17.2 ttmm -49.44 -66.46 0.39 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.926 0.766 . . . . 0.0 110.843 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.11 42.75 98.64 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.148 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.16 -158.6 0.83 Allowed Glycine 0 CA--C 1.54 1.595 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -65.09 -31.38 72.56 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.556 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 29.3 p-10 -93.08 -17.83 23.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.376 -0.529 . . . . 0.0 109.897 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' OE1' ' HG2' ' A' ' 38' ' ' LYS . 42.9 mt-10 -92.64 170.55 9.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.426 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -83.56 138.8 33.23 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -86.01 59.04 5.4 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 121.999 0.904 . . . . 0.0 109.004 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.862 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -95.82 -174.89 3.26 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.587 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 56.3 mtpt -143.86 -173.1 3.89 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.565 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.22 114.99 18.6 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 126.17 1.788 . . . . 0.0 108.95 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.91 10.44 57.58 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 10.1 mm-40 -79.32 123.9 27.9 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 111.208 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -87.23 97.08 10.57 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.171 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.787 HD13 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -109.94 159.39 9.62 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.256 0 CA-C-N 111.554 -2.567 . . . . 0.0 112.207 176.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.87 140.2 53.14 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.982 HD12 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -104.98 127.3 59.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.219 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.757 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -101.65 -21.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.335 -173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.5 ttm180 -136.15 126.42 26.5 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.561 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.79 98.45 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -90.05 141.91 28.22 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.779 -176.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -114.14 8.29 16.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.08 143.82 98.05 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.179 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -38.5 -26.81 0.1 Allowed 'Trans proline' 0 C--N 1.376 1.999 1 C-N-CA 126.533 4.822 . . . . 0.0 116.97 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.4 mm-40 -57.5 -31.57 66.16 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.74 28.09 73.37 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mmtm -131.37 157.4 43.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 30.2 m0 -99.72 162.5 12.97 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 123.731 0.644 . . . . 0.0 110.494 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -99.7 114.39 27.47 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.774 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.698 ' HA3' HD13 ' A' ' 77' ' ' ILE . . . -120.85 175.55 16.07 Favored Glycine 0 N--CA 1.423 -2.175 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' SER . 40.2 ptt180 -151.69 141.09 21.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.515 ' HA ' HG23 ' A' ' 52' ' ' ILE . 16.9 p -81.26 164.07 22.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.59 -8.28 53.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.409 1.1 . . . . 0.0 109.237 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -87.02 -4.64 59.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.339 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.44 32.29 19.79 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.858 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 9.1 m -118.11 124.08 47.16 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.647 ' HB2' HG22 ' A' ' 15' ' ' ILE . 8.0 m-85 -101.6 140.31 36.06 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.39 162.8 36.11 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 119.157 -1.497 . . . . 0.0 113.218 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.558 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 28.3 m-85 -71.87 149.43 45.19 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.203 0.525 . . . . 0.0 110.107 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.862 HG12 ' HE2' ' A' ' 46' ' ' PHE . 74.7 mt -131.99 129.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.605 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' HE3' ' A' ' 64' ' ' LYS . 98.8 mttt -66.58 136.97 56.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 166.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -69.12 -8.75 48.35 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 122.337 1.065 . . . . 0.0 111.447 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 78' ' ' LYS . 7.3 t -97.31 -16.18 20.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.652 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.41 59.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.837 HG13 ' HA ' ' A' ' 33' ' ' ALA . 33.9 m -133.16 159.78 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 CA-C-O 121.365 0.602 . . . . 0.0 112.273 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 34.1 mt-10 -97.5 102.24 13.95 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.553 HG12 HG21 ' A' ' 82' ' ' VAL . 29.2 mm -88.36 120.36 37.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.684 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -123.55 154.51 39.13 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.352 0.596 . . . . 0.0 111.22 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.504 ' HA ' HD21 ' A' ' 89' ' ' LEU . 82.9 t80 -98.06 -26.53 14.58 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.88 -49.97 61.93 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.225 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.554 ' HA ' HD22 ' A' ' 91' ' ' LEU . 15.7 m -60.57 -10.09 4.66 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 29' ' ' HIS . 4.1 mm? -77.19 -28.63 54.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.426 0.631 . . . . 0.0 109.518 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -108.43 -34.84 6.66 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.466 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.554 HD22 ' HA ' ' A' ' 88' ' ' SER . 96.3 mt 64.72 84.56 0.15 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 124.548 1.139 . . . . 0.0 108.26 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 23.66 11.63 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.438 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -68.84 -50.57 48.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.479 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.49 -57.02 3.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt 57.55 72.75 0.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.281 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.414 -178.204 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.577 0.227 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -124.52 -83.47 0.64 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.687 -0.633 . . . . 0.0 110.812 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.07 81.33 1.91 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -132.69 -36.57 1.07 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.507 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 65.08 21.53 12.23 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.528 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -114.24 105.83 13.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.12 110.38 1.36 Allowed 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.655 0.74 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -69.74 -27.95 65.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.192 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.8 4.44 52.84 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.896 0.855 . . . . 0.0 110.157 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -105.97 -4.91 20.03 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -50.49 62.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.287 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.933 ' HA ' HG13 ' A' ' 15' ' ' ILE 0.341 0.0 OUTLIER -78.35 -8.13 58.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.574 -176.816 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.34 -38.14 50.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.87 -57.2 4.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.065 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.933 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.3 pp -61.08 -25.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 15.4 ttmm -76.5 -32.17 58.15 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.616 0.722 . . . . 0.0 109.525 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -97.03 -39.95 9.09 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.407 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.6 ttpt -66.09 -43.68 86.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.817 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 26.9 m-85 -97.68 3.17 50.32 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.533 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 53.92 74.44 0.33 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.977 0.894 . . . . 0.0 109.841 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD13 ' NH2' ' A' ' 56' ' ' ARG . 6.8 tp -107.75 13.48 26.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.485 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.33 109.78 0.66 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.49 0.662 . . . . 0.0 111.858 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.72 171.89 12.35 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.93 110.4 1.09 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.449 2.1 . . . . 0.0 111.673 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -89.29 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -126.91 139.21 53.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.58 0.705 . . . . 0.0 110.723 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 53' ' ' GLU . 41.4 t -68.76 116.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.701 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.657 HG22 ' HD2' ' A' ' 29' ' ' HIS . 46.4 mm -84.46 -44.8 17.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.343 0.592 . . . . 0.0 109.927 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.657 ' HD2' HG22 ' A' ' 28' ' ' ILE . 38.7 m-70 -153.72 171.24 19.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.701 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.2 mp -102.61 129.64 49.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 170.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.54 166.22 10.56 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 18.9 pttp -150.14 101.9 3.04 Favored 'General case' 0 C--N 1.255 -3.535 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.84 133.06 50.17 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.456 -2.156 . . . . 0.0 110.685 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -119.37 152.3 37.03 Favored 'General case' 0 CA--C 1.445 -3.068 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.0 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.1 m 70.91 169.47 0.32 Allowed 'General case' 0 N--CA 1.397 -3.11 0 O-C-N 125.771 1.919 . . . . 0.0 111.745 162.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -69.72 101.91 1.78 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.497 0.665 . . . . 0.0 109.988 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.817 HG22 ' CE1' ' A' ' 46' ' ' PHE . 12.3 m -97.18 156.52 3.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.21 -59.05 5.18 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.19 43.72 95.25 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.361 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.48 -172.04 0.51 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -51.78 -53.21 42.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.37 -2.04 58.07 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.92 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -92.27 169.04 10.91 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.657 HD12 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -80.06 139.55 36.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.392 0.615 . . . . 0.0 109.944 -177.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -81.07 40.3 0.54 Allowed 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.652 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.893 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -82.43 -177.83 6.82 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.487 0.661 . . . . 0.0 111.895 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -142.63 -172.89 3.73 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.643 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 8.9 tt0 -84.32 114.89 22.19 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.1 1.36 . . . . 0.0 109.123 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.49 3.02 56.5 Favored Glycine 0 C--N 1.29 -1.985 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -75.27 122.42 23.68 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.783 0.802 . . . . 0.0 111.699 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.61 97.21 9.57 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.876 HD13 HG13 ' A' ' 82' ' ' VAL . 27.7 pt -104.66 158.37 5.54 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.595 0 CA-C-N 111.79 -2.459 . . . . 0.0 111.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.8 mt-10 -121.09 131.73 54.44 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.075 -1.016 . . . . 0.0 109.018 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -92.73 133.37 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.05 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -120.66 11.52 6.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.942 -176.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 44.8 ttm180 -152.34 125.68 8.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.004 176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 28' ' ' ILE . 47.3 mm -111.5 98.01 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.5 138.73 32.62 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.057 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -115.3 -30.91 6.14 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.458 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -71.77 151.21 93.3 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.722 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -46.74 105.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.617 3.545 . . . . 0.0 115.684 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -162.94 -58.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.05 13.72 60.16 Favored Glycine 0 CA--C 1.474 -2.496 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.007 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.634 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.2 mmtp -134.4 154.32 51.43 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -98.35 157.17 16.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -101.08 111.49 23.71 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.874 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.717 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.8 179.69 18.87 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.506 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 39.0 ptt180 -152.15 144.28 23.88 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.697 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.9 p -81.85 169.35 16.96 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.64 36.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.564 1.173 . . . . 0.0 107.877 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -89.32 -4.92 57.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.418 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.34 33.06 32.93 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.46 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -124.07 121.64 35.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.1 m-85 -89.03 153.68 20.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -173.08 156.36 24.48 Favored Glycine 0 C--N 1.318 -0.446 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.637 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 39.9 m-85 -74.96 139.5 43.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 112.411 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.893 HG12 ' HE2' ' A' ' 46' ' ' PHE . 63.0 mt -121.24 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.633 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 94.7 mttt -73.41 135.91 44.26 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.7 p -65.21 -9.93 27.47 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -98.13 -14.12 20.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.788 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -80.78 -13.45 58.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.386 0.613 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.876 HG13 HD13 ' A' ' 52' ' ' ILE . 31.2 m -129.7 156.16 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.841 0.829 . . . . 0.0 112.01 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.49 100.71 11.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 82' ' ' VAL . 22.5 mm -88.84 108.25 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.918 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -124.67 157.48 35.48 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.237 0.541 . . . . 0.0 112.236 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.539 ' HA ' HD23 ' A' ' 89' ' ' LEU . 45.5 t80 -88.62 -4.31 58.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.1 -32.14 70.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.703 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -77.82 -3.91 43.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.163 0.506 . . . . 0.0 111.173 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 29' ' ' HIS . 3.1 mm? -103.06 -63.59 1.16 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -90.45 119.96 31.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.694 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.9 107.95 13.08 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -71.9 125.97 28.56 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.269 0.557 . . . . 0.0 112.159 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -153.71 178.91 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.637 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.86 -47.77 4.69 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 tt -165.33 -51.59 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.317 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HB2' ' HZ2' ' A' ' 2' ' ' LYS . 5.1 ttmp? -141.76 -50.8 0.41 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -82.57 93.25 7.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.32 160.24 7.59 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -117.67 -44.75 2.72 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.873 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tptt 179.37 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.242 0.68 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -178.27 74.99 0.02 OUTLIER 'General case' 0 C--O 1.248 0.998 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.15 111.65 11.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.523 -176.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 44.7 mt-10 -130.35 -166.91 1.74 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 14' ' ' GLU . 48.1 mmtt -80.89 -12.34 59.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -69.52 0.55 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.627 ' HA ' HG13 ' A' ' 15' ' ' ILE 0.31 0.0 OUTLIER -95.04 -22.14 18.12 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -173.838 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 9' ' ' GLU . 6.0 tt0 -64.3 -39.42 93.89 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.611 0.72 . . . . 0.0 110.259 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 10' ' ' LYS . 5.8 mm-40 -81.33 -33.96 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.495 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.792 HG23 ' HB2' ' A' ' 74' ' ' TYR . 2.8 pp -69.56 -26.57 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.704 ' HB3' HG23 ' A' ' 22' ' ' THR . 90.1 mttt -71.43 -16.13 62.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.246 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -94.06 -56.95 2.68 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.7 -44.19 81.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.133 1.373 . . . . 0.0 112.106 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.5 -3.33 22.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.726 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 56.29 78.62 0.2 Allowed 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.326 1.06 . . . . 0.0 110.967 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 66' ' ' LEU . 88.2 mt -126.01 16.42 7.92 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.398 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.704 HG23 ' HB3' ' A' ' 16' ' ' LYS . 4.6 p -72.9 98.84 2.55 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.75 -159.63 28.23 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -89.16 103.84 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.874 2.383 . . . . 0.0 112.393 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.459 HG21 HD23 ' A' ' 21' ' ' LEU . 2.7 pp -109.12 142.21 22.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 120.859 0.362 . . . . 0.0 110.732 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -127.23 148.47 50.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 53' ' ' GLU . 11.3 p -75.62 145.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mm -98.7 -39.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.261 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.658 ' HB2' HD13 ' A' ' 54' ' ' ILE . 43.7 m-70 -156.45 171.73 19.75 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 109.938 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.23 127.49 44.2 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.648 ' HB3' HD13 ' A' ' 84' ' ' ILE . . . -107.18 167.88 9.6 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HE2' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.4 102.37 2.9 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -67.72 137.04 55.19 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 113.204 -1.816 . . . . 0.0 111.205 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.8 t -123.16 149.81 44.11 Favored 'General case' 0 CA--C 1.439 -3.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.926 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.6 m 72.64 162.87 0.26 Allowed 'General case' 0 N--CA 1.396 -3.163 0 O-C-N 126.129 2.143 . . . . 0.0 111.868 162.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.93 103.33 1.45 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 109.356 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.751 HG21 ' CE1' ' A' ' 46' ' ' PHE . 24.1 m -102.33 156.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.751 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -48.3 -54.15 14.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.668 1.23 . . . . 0.0 109.165 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.9 43.02 60.8 Favored Glycine 0 C--N 1.346 1.114 0 O-C-N 123.859 0.724 . . . . 0.0 114.69 175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.31 -168.51 0.39 Allowed Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.756 1.063 . . . . 0.0 115.756 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -55.7 -49.24 73.54 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 113.426 -174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.14 -10.72 54.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.556 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -92.09 163.92 13.79 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.517 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.641 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -82.57 131.89 35.2 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 m -86.04 71.38 10.59 Favored 'General case' 0 C--N 1.255 -3.538 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.531 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.778 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -99.07 179.03 4.74 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.812 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mtpm? -134.49 -173.05 3.17 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -87.88 113.95 24.03 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 124.549 1.139 . . . . 0.0 108.665 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.08 -3.09 44.26 Favored Glycine 0 C--N 1.284 -2.332 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.8 mm-40 -66.93 123.96 21.65 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.763 0.792 . . . . 0.0 111.415 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -94.01 96.78 9.9 Favored 'General case' 0 N--CA 1.409 -2.483 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.927 HD11 HG11 ' A' ' 82' ' ' VAL . 32.7 pt -110.57 158.28 10.99 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.169 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.372 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.75 ' HB3' HG22 ' A' ' 27' ' ' VAL . 48.1 mt-10 -121.27 136.84 54.91 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.658 HD13 ' HB2' ' A' ' 29' ' ' HIS 0.268 0.2 OUTLIER -97.81 124.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.224 175.173 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.561 HD11 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.09 -16.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.647 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -144.29 122.07 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.373 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.98 101.56 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p -83.34 154.51 24.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-O 121.568 0.699 . . . . 0.0 112.231 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -114.98 8.57 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.686 1.231 . . . . 0.0 108.438 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -69.42 157.65 88.88 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.738 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.39 -17.68 49.41 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.999 2.466 . . . . 0.0 111.62 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.91 -37.33 66.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.832 0.853 . . . . 0.0 110.514 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.08 29.4 66.83 Favored Glycine 0 CA--C 1.489 -1.549 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.27 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.451 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 42.5 mmtm -133.27 138.31 46.4 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.424 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.2 m0 -87.57 159.8 18.45 Favored 'General case' 0 C--N 1.279 -2.485 0 O-C-N 123.725 0.641 . . . . 0.0 109.968 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.631 HD12 HD12 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -97.12 112.14 24.06 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.812 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.26 174.21 15.13 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 73' ' ' SER . 36.1 ptt180 -152.2 139.91 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 52' ' ' ILE . 63.6 p -78.73 177.13 8.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -16.89 61.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 110.27 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -87.86 -19.96 26.68 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.12 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 29.6 5.4 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.033 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.9 m -98.91 115.45 28.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.792 ' HB2' HG23 ' A' ' 15' ' ' ILE . 10.6 m-85 -91.77 139.06 31.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 122.714 0.406 . . . . 0.0 110.717 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.12 158.86 31.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.857 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.451 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.2 m-85 -73.97 135.15 43.17 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.917 0.865 . . . . 0.0 111.285 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.812 HD11 ' HA3' ' A' ' 67' ' ' GLY . 67.5 mt -116.42 128.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.697 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.584 ' O ' HG21 ' A' ' 77' ' ' ILE . 54.8 mttm -65.14 137.14 57.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.0 p -68.7 -7.16 30.94 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.128 0.966 . . . . 0.0 111.469 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -104.16 -13.15 16.33 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.153 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' HB1' HG13 ' A' ' 37' ' ' VAL . . . -81.4 -13.08 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.291 0.567 . . . . 0.0 109.736 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.927 HG11 HD11 ' A' ' 52' ' ' ILE . 35.3 m -131.99 154.56 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.368 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.574 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 55.1 mm-40 -103.54 113.13 26.41 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 172.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 31' ' ' ALA . 25.5 mm -81.13 141.74 14.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.793 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.85 124.74 23.79 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-O 123.094 1.426 . . . . 0.0 112.443 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' HA ' HD23 ' A' ' 89' ' ' LEU . 51.2 m-85 -100.44 4.73 43.98 Favored 'General case' 0 C--N 1.255 -3.507 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.057 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.5 -39.14 89.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.709 1.204 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -68.56 -15.25 63.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.336 0.589 . . . . 0.0 111.857 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 86' ' ' TYR . 2.0 mm? -104.25 -3.75 23.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -91.31 111.4 22.88 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.905 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.03 -73.1 0.66 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -166.76 52.39 0.08 Allowed 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -78.69 -31.52 46.65 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.5 t70 55.2 -96.21 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.963 1.705 . . . . 0.0 110.343 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.0 mt -159.8 160.61 34.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.293 -1.866 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.133 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -101.07 -40.74 7.06 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -159.22 138.6 11.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.684 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 64.59 115.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.15 0.98 . . . . 0.0 112.588 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.37 89.45 3.12 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -139.58 129.01 24.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.41 101.95 7.54 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -98.24 85.46 3.44 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.472 1.13 . . . . 0.0 110.403 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 26.8 tt0 -80.86 138.71 36.2 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.155 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -67.74 6.15 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.31 -20.12 64.72 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.554 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.36 -23.42 63.75 Favored 'General case' 0 C--O 1.208 -1.093 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.56 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -67.6 -33.61 75.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -51.37 24.77 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.0 pp -61.82 -25.46 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.774 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 92.1 mttt -75.64 -25.86 57.22 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.882 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.24 -38.8 13.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -63.01 -50.88 68.96 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.253 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -103.1 -5.91 22.79 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.44 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 37.7 mtmm 55.35 81.1 0.12 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.556 0.742 . . . . 0.0 110.078 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 21' ' ' LEU . 10.9 tp -83.93 -45.5 13.11 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.13 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 21' ' ' LEU . 25.1 p 46.83 96.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.49 178.83 38.25 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.21 136.53 24.57 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.856 2.371 . . . . 0.0 110.535 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.816 HD11 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -124.68 160.51 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -128.63 148.22 50.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 53' ' ' GLU . 7.1 p -74.7 145.72 10.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.614 0.245 . . . . 0.0 110.812 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -97.99 -44.78 12.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.129 0.49 . . . . 0.0 111.013 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.932 ' HB2' HD11 ' A' ' 54' ' ' ILE . 7.3 m-70 -139.29 162.89 33.89 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.35 122.19 42.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.923 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.743 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.38 164.43 11.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.679 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 51.3 pttt -151.43 105.21 3.15 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.758 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -72.17 125.73 28.04 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.417 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.7 t -112.14 148.76 33.3 Favored 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.791 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.7 m 74.32 167.74 0.3 Allowed 'General case' 0 N--CA 1.405 -2.713 0 O-C-N 126.032 2.083 . . . . 0.0 111.422 162.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.41 102.56 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.758 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.1 m -96.16 156.64 3.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.902 -175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -49.81 -53.92 22.38 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.96 43.3 96.92 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.557 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.57 179.2 0.02 OUTLIER Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.324 1.29 . . . . 0.0 116.324 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -61.47 -34.42 75.42 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -86.26 -16.15 38.53 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.114 0.483 . . . . 0.0 111.207 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' A' ' 78' ' ' LYS . 45.0 mt-10 -92.66 170.4 9.75 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.781 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 1.1 tt -79.07 140.92 37.77 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.921 0.867 . . . . 0.0 110.338 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 m -81.12 47.07 0.97 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.58 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.001 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -87.44 175.58 7.9 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.445 0.641 . . . . 0.0 111.879 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 58.4 mtpt -133.78 -172.76 3.06 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.394 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.69 124.79 29.89 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 125.398 1.479 . . . . 0.0 107.821 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.03 4.93 66.48 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 13.6 mm-40 -74.26 121.87 21.97 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 122.163 0.983 . . . . 0.0 112.283 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -85.51 96.18 9.53 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.812 HD11 HG12 ' A' ' 82' ' ' VAL . 40.0 pt -111.41 158.41 11.9 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.538 0 CA-C-N 112.836 -1.983 . . . . 0.0 112.071 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.743 ' HB3' HG23 ' A' ' 27' ' ' VAL . 51.3 mt-10 -125.43 134.05 52.25 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.932 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.21 127.72 54.18 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.291 175.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.816 HG12 HD11 ' A' ' 25' ' ' ILE . 2.7 mp -97.87 -34.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.165 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.7 ttm180 -116.12 110.01 18.27 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.455 -174.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.41 98.56 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -116.08 141.71 47.76 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.598 0.713 . . . . 0.0 112.75 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -93.34 5.25 52.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.664 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 38.7 t30 -58.44 133.05 85.27 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.125 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 60' ' ' ASN . 18.7 Cg_exo -34.2 -28.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.749 1 C-N-CA 126.03 4.487 . . . . 0.0 117.286 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.1 -34.8 70.58 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 110.774 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.75 31.53 73.25 Favored Glycine 0 CA--C 1.5 -0.861 0 CA-C-N 115.758 -0.655 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -119.57 157.38 28.5 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -102.06 142.15 33.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.77 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -86.25 108.93 18.6 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.59 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -115.18 177.03 17.07 Favored Glycine 0 N--CA 1.415 -2.764 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.411 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 29.6 ptt180 -151.93 142.89 23.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.279 1.032 . . . . 0.0 108.311 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.608 ' HA ' HG22 ' A' ' 52' ' ' ILE . 19.2 p -79.71 173.24 12.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.92 0.866 . . . . 0.0 109.135 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.49 -7.87 59.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.981 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.78 31.82 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.501 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.2 m -103.18 113.38 26.81 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 15' ' ' ILE . 10.7 m-85 -89.52 147.7 23.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.583 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.88 161.09 34.76 Favored Glycine 0 C--N 1.298 -1.537 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.81 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -70.11 161.73 29.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 1.001 HG12 ' HE2' ' A' ' 46' ' ' PHE . 83.9 mt -142.44 126.65 15.67 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 77' ' ' ILE . 61.0 mttp -64.5 132.53 50.19 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 167.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.3 p -66.29 -8.51 25.47 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 118.927 0.785 . . . . 0.0 112.575 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 t -98.85 -14.49 19.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.581 0.752 . . . . 0.0 110.282 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 37' ' ' VAL . . . -76.06 -19.78 58.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 108.909 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.812 HG12 HD11 ' A' ' 52' ' ' ILE . 34.1 m -125.79 166.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.788 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 29.0 mt-10 -125.44 112.22 16.02 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 29' ' ' HIS . 1.7 mp -88.92 123.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 120.922 0.391 . . . . 0.0 110.135 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -100.78 140.57 34.87 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.233 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -93.03 -21.68 19.6 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.851 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 34.7 t70 -59.52 -38.79 81.89 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.301 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 49.8 m -64.28 -21.65 66.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.845 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 29' ' ' HIS . 71.5 mt -85.19 -30.34 23.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.851 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 6.4 mtpm? -71.95 -44.12 64.12 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.851 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.419 ' O ' HD11 ' A' ' 91' ' ' LEU . 3.5 tm? -73.54 -22.35 60.11 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.118 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' SER . 6.4 tmtm? -59.19 112.39 1.69 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.598 0.759 . . . . 0.0 109.538 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -148.81 -44.19 0.15 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.67 141.39 52.7 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.395 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.93 91.09 8.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.814 0.816 . . . . 0.0 111.434 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.675 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -137.97 93.53 2.78 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -118.05 -23.72 7.3 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.323 -175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -98.57 108.32 20.99 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -127.44 -28.39 2.79 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.131 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -133.92 23.65 3.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.66 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 33.0 mt-10 -115.43 82.69 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.668 0.747 . . . . 0.0 110.188 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -127.97 108.23 10.51 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.612 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 3.2 mp0 -66.14 114.8 5.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.631 -177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -107.74 -60.82 1.65 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.68 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -80.3 -18.02 50.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.992 0.901 . . . . 0.0 108.774 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 14.2 mp0 -83.14 -7.27 59.65 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.259 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -62.15 -39.45 92.66 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.44 -29.76 30.5 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.789 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.0 pp -65.95 -29.78 47.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.389 0.614 . . . . 0.0 111.063 -172.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 9' ' ' GLU . 67.9 mttm -68.23 -27.63 66.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.666 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.14 -46.24 8.21 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.734 0.778 . . . . 0.0 109.231 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.05 -44.65 83.95 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 112.379 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -109.35 -8.6 15.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.66 75.22 0.35 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 111.286 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.13 17.81 19.23 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.072 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -68.35 84.7 0.26 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.239 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.83 41.69 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.39 105.47 0.89 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.978 2.452 . . . . 0.0 113.012 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.34 161.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 27' ' ' VAL . 18.4 mm-40 -133.83 -81.48 0.46 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.613 ' HA ' HG22 ' A' ' 55' ' ' ILE . 1.4 m 178.74 152.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 C-N-CA 128.906 2.882 . . . . 0.0 105.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.515 HG21 ' HD2' ' A' ' 29' ' ' HIS . 38.3 mm -99.31 -44.91 12.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' HD2' HG21 ' A' ' 28' ' ' ILE . 70.5 m-70 -160.74 -176.93 5.83 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 52' ' ' ILE . . . -104.08 169.58 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 21.7 pttm -152.3 107.05 3.21 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.735 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -63.0 135.82 57.49 Favored 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.049 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -112.05 172.86 6.66 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m 58.39 175.87 0.06 Allowed 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 125.101 1.501 . . . . 0.0 114.39 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.49 95.43 9.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.88 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.832 HG23 ' HE1' ' A' ' 46' ' ' PHE . 27.7 m -89.98 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.36 -40.85 75.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.535 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.08 43.18 62.37 Favored Glycine 0 C--N 1.355 1.592 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.892 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -53.14 -173.71 0.05 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 116.879 1.512 . . . . 0.0 116.879 -173.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -63.2 -36.78 84.78 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -100.81 2.21 40.91 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.632 0.729 . . . . 0.0 109.789 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.4 mt-10 -95.68 179.42 5.13 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -94.7 135.73 35.83 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -85.83 76.19 9.93 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.131 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.864 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.37 174.11 6.43 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.997 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 30.3 mmtp -140.79 -175.51 4.32 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.829 0.823 . . . . 0.0 111.497 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -65.09 108.21 1.77 Allowed 'General case' 0 C--N 1.272 -2.791 0 C-N-CA 127.856 2.463 . . . . 0.0 109.886 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.75 5.25 41.99 Favored Glycine 0 C--N 1.294 -1.8 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.5 mm-40 -80.03 116.69 20.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.031 0.92 . . . . 0.0 112.729 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -85.55 96.99 9.81 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.882 HD13 HG11 ' A' ' 82' ' ' VAL . 27.8 pt -110.87 158.66 11.25 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.244 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.045 175.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -118.57 134.25 55.24 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.579 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -96.09 136.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.184 173.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -119.56 3.68 6.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.188 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.574 ' HD3' HG21 ' A' ' 58' ' ' THR . 58.2 ttt180 -150.27 141.15 22.83 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.749 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.4 mm -109.02 96.97 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.574 HG21 ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -86.68 141.32 29.02 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.784 -178.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -114.22 -2.86 13.27 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.712 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -54.59 150.19 18.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.739 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -36.24 -37.46 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.973 1 C-N-CA 126.021 4.481 . . . . 0.0 116.047 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -52.35 -36.1 52.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 31.55 68.99 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.5 mmtp -129.29 148.88 51.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.516 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 35.0 m0 -94.64 160.81 14.46 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.682 0.614 . . . . 0.0 109.848 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.58 109.65 21.5 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.705 0.764 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.75 ' HA3' HD13 ' A' ' 77' ' ' ILE . . . -114.08 175.92 16.67 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.1 ptt180 -152.77 146.39 25.05 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.814 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.6 p -73.15 178.59 4.32 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 117.941 0.337 . . . . 0.0 110.847 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -34.22 73.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.123 0.487 . . . . 0.0 110.533 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -82.16 -0.4 44.76 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.172 0.51 . . . . 0.0 111.599 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.34 27.27 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 114.528 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.0 m -91.46 112.55 24.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.563 1.182 . . . . 0.0 107.813 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 79.2 m-85 -82.48 145.18 29.95 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.128 -172.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.83 27.95 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.163 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.443 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 7.7 m-85 -71.45 142.68 50.23 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.87 0.843 . . . . 0.0 112.302 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.864 HG12 ' HE2' ' A' ' 46' ' ' PHE . 61.3 mt -126.59 129.28 71.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.565 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 77' ' ' ILE . 92.3 mttt -65.93 140.95 58.37 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.4 p -69.06 -9.16 51.18 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.0 112.056 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -103.93 -8.67 19.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.519 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -81.79 -11.04 59.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.882 HG11 HD13 ' A' ' 52' ' ' ILE . 27.1 m -133.1 158.27 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.015 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 38.0 mt-10 -104.5 112.94 26.19 Favored 'General case' 0 N--CA 1.394 -3.234 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 31' ' ' ALA . 21.1 mm -94.75 135.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.73 0 C-N-CA 124.038 0.935 . . . . 0.0 109.68 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -77.43 153.72 33.32 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.493 0.663 . . . . 0.0 109.948 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -101.75 -22.83 14.31 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.579 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -65.4 -17.79 64.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -64.97 -17.48 64.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 118.179 0.445 . . . . 0.0 111.639 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.7 mt -73.15 -24.87 60.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -99.62 158.93 15.41 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.9 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -136.14 88.12 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -139.75 126.41 20.53 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.736 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -80.82 106.22 12.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -140.26 81.39 1.81 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.999 0.904 . . . . 0.0 109.733 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.3 mt -105.29 -47.92 3.83 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.205 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.2 139.35 50.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.934 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.1 90.62 3.06 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 65.83 170.41 0.22 Allowed 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.202 0.938 . . . . 0.0 109.558 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.92 124.64 28.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -107.79 99.15 8.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -73.99 123.75 24.93 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -139.56 77.11 1.6 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.583 -3.117 . . . . 0.0 102.583 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.646 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 6.4 mm-40 -72.03 139.56 48.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.263 -168.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 72.0 mmtt -80.48 -11.9 59.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.767 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.646 ' HG2' ' HB3' ' A' ' 9' ' ' GLU . 9.6 ptpp? -81.0 -28.03 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.264 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.717 ' HA ' HG13 ' A' ' 15' ' ' ILE . 12.4 pt-20 -77.52 -23.82 50.12 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.818 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 29.7 pt20 -65.25 -29.56 70.36 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -77.77 -55.43 5.34 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.308 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.717 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -57.49 -28.04 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HB3' HG22 ' A' ' 22' ' ' THR . 43.3 mtmt -79.68 -23.9 42.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -89.37 -41.22 12.25 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 87.3 tttt -60.56 -48.4 81.94 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 112.089 -175.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -100.56 -6.02 25.98 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 59.94 74.39 0.45 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 122.869 1.319 . . . . 0.0 108.059 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 12.5 tp -125.26 14.53 8.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.913 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -69.42 90.51 0.53 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.487 0.66 . . . . 0.0 112.035 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.78 -177.04 45.5 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.95 123.57 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.711 2.274 . . . . 0.0 112.024 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.6 pp -109.33 147.08 14.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 120.872 0.368 . . . . 0.0 111.827 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -127.79 138.1 52.62 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' HA ' HG23 ' A' ' 55' ' ' ILE . 21.9 t -74.08 112.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG23 ' CD2' ' A' ' 29' ' ' HIS . 38.7 mm -83.67 -44.66 18.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.759 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.799 ' HB2' HD11 ' A' ' 54' ' ' ILE . 54.6 m-70 -150.49 167.42 27.22 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.66 117.94 31.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.58 165.06 11.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 42.7 pttt -150.22 102.54 3.09 Favored 'General case' 0 C--N 1.255 -3.514 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.833 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -65.38 125.96 26.76 Favored 'General case' 0 C--N 1.271 -2.806 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.699 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.2 t -109.69 148.08 32.01 Favored 'General case' 0 CA--C 1.432 -3.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.2 m 68.1 -179.14 0.22 Allowed 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 125.99 2.057 . . . . 0.0 110.344 164.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.6 113.53 14.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.84 HG23 ' CE1' ' A' ' 46' ' ' PHE . 5.5 m -106.74 156.37 7.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.225 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 15.0 ptpt -50.72 -66.93 0.3 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.353 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . 61.84 43.32 99.37 Favored Glycine 0 C--O 1.246 0.881 0 C-N-CA 119.754 -1.212 . . . . 0.0 112.542 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -61.41 -150.83 0.02 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 116.729 1.451 . . . . 0.0 116.729 -173.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -73.45 -38.22 65.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -171.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -103.28 -0.42 30.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.991 0.901 . . . . 0.0 109.455 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 68.9 mt-10 -99.37 163.53 12.49 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -79.23 128.36 33.2 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -86.26 67.56 9.98 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-O 122.542 1.163 . . . . 0.0 108.948 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.84 ' CE1' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -98.25 -167.18 1.47 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.521 177.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.823 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 54.8 tttp -147.92 -173.59 4.34 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.823 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 8.7 tt0 -79.0 105.6 10.45 Favored 'General case' 1 C--N 1.243 -4.027 0 C-N-CA 127.112 2.165 . . . . 0.0 109.302 -176.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 8.19 48.01 Favored Glycine 0 C--N 1.285 -2.3 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.005 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.4 128.82 36.22 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.516 0.674 . . . . 0.0 110.759 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 97.03 10.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.835 HD13 HG11 ' A' ' 82' ' ' VAL . 22.7 pt -107.27 158.36 7.2 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.093 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.672 176.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.47 128.79 43.62 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -90.98 132.64 35.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.299 177.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.648 HG23 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.11 11.73 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.734 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 33.1 ttt180 -155.08 114.15 3.61 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.076 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 28' ' ' ILE . 46.3 mm -99.12 95.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.91 140.86 36.64 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -110.26 -46.05 3.49 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.086 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 25.6 t-20 -82.06 -58.83 0.45 Allowed Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.963 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 40.0 Cg_exo -60.02 103.63 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.618 2.212 . . . . 0.0 113.164 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.615 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 15.0 tp10 72.2 -24.62 0.19 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.007 1.323 . . . . 0.0 113.029 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.06 54.38 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.1 mmtm -131.57 162.95 29.13 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.415 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 38.8 m0 -102.0 153.54 19.79 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -98.93 112.52 24.6 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.657 ' HA3' HD13 ' A' ' 77' ' ' ILE . . . -109.52 177.48 20.07 Favored Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 114.293 -1.322 . . . . 0.0 110.572 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.2 ptm180 -151.32 141.26 22.01 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.51 ' HA ' HG22 ' A' ' 52' ' ' ILE . 64.9 p -79.43 167.85 20.27 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.27 64.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.799 0.809 . . . . 0.0 109.869 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -84.47 -22.37 30.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.073 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.53 19.4 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.091 -1.052 . . . . 0.0 114.314 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.5 m -94.31 110.37 22.13 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 15' ' ' ILE . 38.5 m-85 -87.49 138.43 31.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.64 155.87 27.12 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.355 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.3 m-85 -69.35 143.79 53.65 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.713 0.768 . . . . 0.0 110.7 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.798 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.9 mt -124.53 132.89 70.69 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.687 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' O ' HG23 ' A' ' 77' ' ' ILE . 52.1 mtmt -73.57 132.34 42.71 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.6 p -63.73 -10.25 18.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.593 0.711 . . . . 0.0 112.857 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -99.98 -16.05 18.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.651 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -14.17 59.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.835 HG11 HD13 ' A' ' 52' ' ' ILE . 33.2 m -131.39 156.21 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.689 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 9.3 mm-40 -106.36 106.22 16.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.555 HD13 ' HB1' ' A' ' 31' ' ' ALA . 23.4 mm -83.62 115.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.538 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -84.24 150.48 25.42 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.52 0.676 . . . . 0.0 110.95 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.03 -6.86 27.74 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.145 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.66 -5.93 40.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.545 1.138 . . . . 0.0 110.964 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 29' ' ' HIS . 23.4 m -61.19 -24.56 66.41 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.15 -45.1 43.07 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.337 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -177.47 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -159.97 158.65 31.05 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -70.69 122.51 19.95 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.74 0.781 . . . . 0.0 112.008 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -146.22 38.45 1.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.961 -1.472 . . . . 0.0 107.696 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.96 -50.97 52.73 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.303 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' N ' ' A' ' 96' ' ' GLU . 5.4 tt -163.63 147.6 10.41 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.477 ' N ' HD21 ' A' ' 95' ' ' LEU . 51.5 mm-40 . . . . . 0 CA--C 1.508 -0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 110.486 -176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.526 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -106.88 -49.99 3.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -95.92 163.96 12.93 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.858 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 37.1 tt0 -140.98 81.0 1.77 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 169.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.27 100.74 5.49 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 80.43 14.98 0.75 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 125.087 1.492 . . . . 0.0 108.635 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 1.8 mp0 -93.14 65.62 3.98 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.246 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -99.58 -6.66 27.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.68 95.39 10.05 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -107.78 -4.49 18.05 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.502 0.668 . . . . 0.0 110.129 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -57.32 -55.48 34.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.931 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.627 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -84.78 -9.79 57.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.118 -175.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.08 -50.03 65.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.779 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.16 -41.02 82.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.779 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.6 pp -65.86 -24.49 34.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.974 0.416 . . . . 0.0 111.83 -176.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 46.1 mtmt -68.8 -24.37 64.39 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.189 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -97.88 -43.97 6.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.629 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.0 tttt -62.69 -57.25 11.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' HD2' ' HB ' ' A' ' 15' ' ' ILE . 66.6 m-85 -97.59 -13.01 21.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.364 0.602 . . . . 0.0 109.726 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 53.0 mttp 62.39 77.59 0.32 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.185 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.522 HD13 HD12 ' A' ' 15' ' ' ILE . 73.9 mt -121.1 16.85 11.62 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.602 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -61.61 131.47 50.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.474 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.02 -177.18 18.05 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.34 115.01 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.36 2.04 . . . . 0.0 111.577 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.552 HD11 HG12 ' A' ' 55' ' ' ILE . 2.7 pp -109.98 145.31 16.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.764 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.03 130.06 55.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.308 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 53' ' ' GLU . 14.5 p -71.9 144.44 13.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 123.253 0.346 . . . . 0.0 110.41 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.429 HG23 ' CD2' ' A' ' 29' ' ' HIS . 45.4 mm -95.98 -44.71 13.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.694 ' HB2' HD13 ' A' ' 54' ' ' ILE . 74.6 m-70 -154.17 179.99 8.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 123.658 0.783 . . . . 0.0 109.065 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.57 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 5.7 mp -108.07 136.52 47.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.59 ' HB1' HG13 ' A' ' 52' ' ' ILE . . . -108.58 176.03 5.26 Favored 'General case' 0 C--N 1.263 -3.174 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -150.57 102.58 3.04 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.62 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -67.93 122.71 18.76 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.47 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 38.3 t -117.25 152.75 34.19 Favored 'General case' 0 CA--C 1.444 -3.1 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.147 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 m 70.78 177.64 0.27 Allowed 'General case' 0 N--CA 1.404 -2.725 0 O-C-N 125.818 1.949 . . . . 0.0 110.583 162.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.16 100.44 6.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.615 1.198 . . . . 0.0 110.541 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 1.019 HG23 ' HE1' ' A' ' 46' ' ' PHE . 11.3 m -87.74 156.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.946 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -61.7 -52.7 63.21 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.66 43.14 99.41 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.345 -0.931 . . . . 0.0 114.763 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.39 -179.33 1.03 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -63.61 -27.95 69.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 29.5 p-10 -90.3 -13.95 34.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 45.7 mt-10 -92.33 159.82 15.41 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.462 -177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.657 HD11 ' HD2' ' A' ' 46' ' ' PHE . 1.4 tt -70.79 137.51 49.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.631 0.729 . . . . 0.0 109.844 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.403 ' N ' HD21 ' A' ' 44' ' ' LEU . 15.1 m -82.96 43.81 0.88 Allowed 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.436 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.019 ' HE1' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -84.93 -161.05 0.53 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.273 178.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.906 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 74.1 tttt -145.54 -171.57 3.7 Favored 'General case' 0 N--CA 1.389 -3.525 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.906 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 7.7 tt0 -75.73 -8.83 57.79 Favored 'General case' 0 C--N 1.254 -3.568 0 C-N-CA 128.746 2.818 . . . . 0.0 114.337 -168.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.47 19.9 1.69 Allowed Glycine 0 C--N 1.27 -3.094 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 18.6 mm-40 -80.56 129.78 34.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -96.88 97.57 9.39 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.889 HD12 HG11 ' A' ' 82' ' ' VAL . 36.6 pt -105.55 159.73 5.7 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.883 -2.417 . . . . 0.0 112.55 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.897 ' HB3' HG23 ' A' ' 27' ' ' VAL . 40.7 mt-10 -120.05 136.0 54.73 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.694 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.4 128.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.866 0.841 . . . . 0.0 112.072 177.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.552 HG12 HD11 ' A' ' 25' ' ' ILE . 2.5 mp -100.59 -35.03 4.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.209 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 1.006 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.1 ttm180 -114.84 121.36 43.0 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.715 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.9 mm -99.09 98.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.27 141.65 34.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -106.45 -16.15 14.62 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -39.58 140.83 0.77 Allowed Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 126.659 1.984 . . . . 0.0 113.06 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -35.6 -25.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.751 1 C-N-CA 126.283 4.655 . . . . 0.0 117.49 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 27.3 mm-40 -59.69 -28.82 67.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.741 0.7 . . . . 0.0 110.22 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.36 29.76 75.52 Favored Glycine 0 CA--C 1.495 -1.174 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.013 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 44.9 mmtm -133.74 155.2 50.2 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.438 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.4 m0 -100.75 153.16 19.68 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.516 0.51 . . . . 0.0 110.171 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -95.03 116.37 28.61 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.753 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -119.04 178.62 16.66 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.765 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 36.3 ptt180 -151.91 147.33 26.46 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.719 ' HA ' HG21 ' A' ' 52' ' ' ILE . 67.0 p -80.05 179.02 7.83 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 118.198 0.454 . . . . 0.0 109.811 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -15.87 61.89 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -80.82 -25.89 37.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.38 9.36 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.348 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 8.0 p -94.1 111.55 23.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.779 ' HB2' HG22 ' A' ' 15' ' ' ILE . 53.7 m-85 -83.13 148.98 27.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -171.62 160.74 32.78 Favored Glycine 0 C--N 1.318 -0.446 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.19 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.546 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 m-85 -76.21 143.21 41.18 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-O 121.67 0.748 . . . . 0.0 111.522 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.799 HG12 ' HE2' ' A' ' 46' ' ' PHE . 44.2 mt -125.39 139.15 52.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.061 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 77' ' ' ILE . 55.7 mttm -74.1 136.47 42.98 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 168.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.6 p -64.56 -13.32 52.3 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.537 0.685 . . . . 0.0 112.143 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -97.27 -16.24 20.43 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.541 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.45 -17.65 59.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.889 HG11 HD12 ' A' ' 52' ' ' ILE . 27.5 m -130.58 153.17 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.75 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -102.85 100.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 31' ' ' ALA . 22.0 mm -70.57 133.14 32.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.098 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.0 149.98 37.49 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.004 0.907 . . . . 0.0 111.692 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -101.84 10.02 40.23 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 114.266 -1.333 . . . . 0.0 107.499 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -100.33 -17.54 17.21 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -162.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -53.83 -22.67 10.2 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.24 -62.91 1.52 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -136.07 135.41 39.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.07 113.57 3.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.525 0.516 . . . . 0.0 110.046 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -149.03 27.52 0.86 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.589 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -60.15 138.99 57.79 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.648 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -109.39 173.92 6.1 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.0 mp 60.58 76.63 0.36 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 122.279 1.038 . . . . 0.0 109.59 -172.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--N 1.286 -2.194 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.751 -175.378 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -105.87 -60.72 1.6 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.809 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp 74.47 -53.13 0.68 Allowed 'General case' 0 C--O 1.253 1.278 0 C-N-CA 125.017 1.327 . . . . 0.0 109.48 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 69.94 8.52 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.04 0.924 . . . . 0.0 108.937 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -127.87 -12.03 5.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.132 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -118.19 -0.28 11.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 45.68 76.16 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.418 1.074 . . . . 0.0 110.993 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 21.5 ptmt -107.99 -175.94 2.92 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.474 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.14 93.96 4.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.697 0.761 . . . . 0.0 111.522 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -106.1 -12.21 15.84 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HB3' ' HZ3' ' A' ' 11' ' ' LYS . 6.3 ttpm? -47.48 -68.21 0.21 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.622 1.969 . . . . 0.0 112.336 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HA ' HG12 ' A' ' 15' ' ' ILE . 3.3 pm0 -79.95 -7.1 58.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.51 -44.51 14.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.812 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -71.68 -38.61 70.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.744 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -59.51 -31.44 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.696 ' HB3' HG21 ' A' ' 22' ' ' THR . 54.1 mttp -72.27 -22.78 61.17 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.596 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -94.11 -40.21 10.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.7 ttpt -65.32 -42.1 93.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.779 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.2 m-85 -111.82 1.54 16.64 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.234 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 34.9 ttmt 53.37 72.22 0.45 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.928 1.347 . . . . 0.0 110.336 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD21 ' HG ' ' A' ' 66' ' ' LEU . 94.9 mt -112.5 16.47 19.81 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.984 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.696 HG21 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -71.93 94.4 1.45 Allowed 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.301 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.96 170.53 25.7 Favored Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.18 128.23 11.97 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.908 2.405 . . . . 0.0 111.452 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.26 159.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -136.71 144.1 43.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.627 HG21 ' HB3' ' A' ' 53' ' ' GLU . 8.0 p -71.43 137.4 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.515 HG13 HG12 ' A' ' 57' ' ' ILE . 40.0 mm -98.87 -37.79 6.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.195 0.521 . . . . 0.0 109.872 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.606 ' HB2' HD12 ' A' ' 54' ' ' ILE . 53.6 m-70 -153.65 164.16 38.76 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.655 HD13 ' HB3' ' A' ' 88' ' ' SER . 9.4 mp -103.26 132.28 49.65 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.43 171.89 7.11 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.796 0.808 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 14.3 ptpt -151.64 102.72 2.89 Favored 'General case' 0 C--N 1.26 -3.297 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.818 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.81 112.77 3.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -96.95 150.73 20.43 Favored 'General case' 0 CA--C 1.431 -3.599 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.655 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.4 m 67.91 -179.32 0.22 Allowed 'General case' 0 N--CA 1.402 -2.845 0 O-C-N 125.635 1.835 . . . . 0.0 110.782 163.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -79.72 105.29 10.9 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.669 HG23 ' CE1' ' A' ' 46' ' ' PHE . 16.9 m -87.76 156.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.896 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -52.58 -58.58 6.32 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.41 41.79 99.74 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.818 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.82 178.29 0.3 Allowed Glycine 0 CA--C 1.526 0.723 0 O-C-N 123.914 0.42 . . . . 0.0 113.528 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -64.42 -32.85 74.65 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 122.104 -0.645 . . . . 0.0 111.547 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -88.08 -7.81 56.43 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.048 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 47.7 mt-10 -92.14 171.96 8.74 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.53 ' HG ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -73.23 148.63 43.51 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.416 ' H ' HD21 ' A' ' 44' ' ' LEU . 17.8 m -89.89 38.45 0.92 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.749 1.261 . . . . 0.0 108.536 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.769 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -85.17 163.45 18.71 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.12 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 28.1 mmtp -133.65 -173.35 3.21 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.882 0.849 . . . . 0.0 111.997 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.7 119.48 10.64 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 126.528 1.931 . . . . 0.0 109.978 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.18 19.07 40.41 Favored Glycine 0 C--N 1.292 -1.901 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.545 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.769 ' HG2' ' HB2' ' A' ' 46' ' ' PHE . 6.6 tp10 -78.64 137.53 37.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.155 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.56 96.68 8.47 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.795 HD12 HG13 ' A' ' 82' ' ' VAL . 22.5 pt -111.86 158.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 112.691 -2.05 . . . . 0.0 113.578 173.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.627 ' HB3' HG21 ' A' ' 27' ' ' VAL . 3.8 mp0 -128.18 137.75 52.19 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 29' ' ' HIS 0.288 0.2 OUTLIER -102.21 124.77 56.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.866 176.213 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.599 HD11 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -107.95 -4.08 10.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.838 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.1 ttm180 -138.97 114.56 9.83 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.96 0.409 . . . . 0.0 110.81 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.515 HG12 HG13 ' A' ' 28' ' ' ILE . 51.1 mm -94.72 98.49 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.05 139.41 31.18 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.6 2.43 14.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 1.5 m-20 -73.62 126.87 89.44 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.312 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 52.0 Cg_exo -55.91 120.11 7.71 Favored 'Trans proline' 0 C--O 1.251 1.147 0 C-N-CA 123.336 2.691 . . . . 0.0 114.533 -176.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.52 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.31 29.11 6.14 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.722 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 26.7 mmtp -134.93 158.3 44.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.003 0.43 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 17.6 m0 -109.41 162.23 14.55 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -104.04 112.48 25.49 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.561 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.11 177.6 18.24 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.164 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.0 ptm180 -150.02 145.88 26.67 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.438 HG21 HG23 ' A' ' 52' ' ' ILE . 43.9 p -84.75 171.83 11.99 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.42 -23.92 67.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.351 0.596 . . . . 0.0 110.05 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -75.89 -14.93 60.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.106 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.68 28.49 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.285 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.1 m -92.95 109.01 20.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 26.2 m-85 -84.12 140.28 31.89 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.206 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.53 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -165.74 156.22 28.02 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.624 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.538 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 12.5 m-85 -68.96 150.18 48.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.603 0.716 . . . . 0.0 111.102 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.614 HD11 ' HA3' ' A' ' 67' ' ' GLY . 70.3 mt -134.77 128.68 50.82 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 77' ' ' ILE . 91.5 mttt -68.21 143.05 55.48 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 168.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 p -68.96 -16.02 63.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.158 0.98 . . . . 0.0 111.546 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.4 t -89.79 -15.94 31.29 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.723 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -17.18 56.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.469 0.652 . . . . 0.0 110.472 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.818 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.3 m -129.63 156.88 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.805 0 CA-C-O 121.464 0.649 . . . . 0.0 112.509 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -98.29 100.65 11.96 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 31' ' ' ALA . 26.2 mm -82.63 109.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.75 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 1.3 m-20 -93.87 154.83 17.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.048 0.928 . . . . 0.0 112.409 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -92.34 -20.98 20.53 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 15.5 t70 -44.26 -32.16 1.2 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.491 2.316 . . . . 0.0 112.751 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.655 ' HB3' HD13 ' A' ' 30' ' ' LEU . 6.7 m -52.17 -43.6 64.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.436 1.094 . . . . 0.0 111.508 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 88' ' ' SER . 1.9 mm? -101.67 -31.23 10.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 64.68 95.63 0.05 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.794 1.638 . . . . 0.0 111.017 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.43 -175.48 3.35 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -86.62 75.09 9.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.53 96.13 3.64 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.899 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.71 111.75 23.15 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.0 mt 77.25 86.23 0.08 Allowed 'General case' 0 C--O 1.244 0.813 0 O-C-N 125.116 1.51 . . . . 0.0 109.139 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -177.359 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.505 -0.753 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 55.86 81.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.966 0.888 . . . . 0.0 113.093 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.24 97.6 8.37 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.957 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.09 126.3 53.04 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.099 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -109.55 116.29 31.5 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -118.0 76.68 1.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.803 0.811 . . . . 0.0 111.305 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.95 29.5 4.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -78.93 101.86 7.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.982 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 56.61 41.35 28.6 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.474 1.108 . . . . 0.0 109.967 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -107.64 7.52 28.62 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.212 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -66.4 -26.93 67.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.202 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.88 -22.97 60.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.562 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.11 -37.36 84.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -71.43 -59.04 2.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.481 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.559 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.5 pp -56.33 -25.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.37 -35.18 68.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.482 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.86 -32.52 15.29 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.902 0.858 . . . . 0.0 109.323 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -66.82 -45.71 77.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.37 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -108.02 -3.36 18.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 2.9 mptp? 60.89 75.2 0.42 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.181 0.991 . . . . 0.0 110.006 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 15' ' ' ILE . 8.8 tp -89.76 -24.53 21.48 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.904 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.252 77.3 p 64.79 -69.12 0.1 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.845 1.658 . . . . 0.0 112.473 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.39 -107.97 0.21 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.49 145.51 71.06 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.441 2.094 . . . . 0.0 109.942 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.694 ' HB ' HG23 ' A' ' 55' ' ' ILE . 1.4 pp -138.66 -48.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.621 ' H ' HD12 ' A' ' 25' ' ' ILE . 31.1 mm-40 71.01 123.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.834 1.302 . . . . 0.0 114.129 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.19 140.5 18.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 112.548 -2.115 . . . . 0.0 111.156 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.95 -44.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.831 0.348 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.939 ' HB2' HD11 ' A' ' 54' ' ' ILE . 92.0 m-70 -142.83 177.08 8.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.53 HD13 HD12 ' A' ' 89' ' ' LEU . 11.1 mp -110.54 119.25 38.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.453 0.644 . . . . 0.0 111.386 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 52' ' ' ILE . . . -105.53 167.01 10.03 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.802 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 17.2 pttp -153.14 102.78 2.66 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.803 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -59.36 139.61 56.87 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.136 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.9 t -127.61 155.18 44.27 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.6 m 69.45 175.9 0.28 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 125.889 1.993 . . . . 0.0 111.456 162.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.79 113.25 16.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.788 HG22 ' CE1' ' A' ' 46' ' ' PHE . 17.4 m -112.16 155.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.79 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.66 -46.8 83.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.311 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.58 43.01 45.35 Favored Glycine 0 C--N 1.359 1.813 0 O-C-N 123.896 0.747 . . . . 0.0 113.738 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.28 -153.04 0.04 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 116.255 1.262 . . . . 0.0 116.255 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.27 -51.34 25.01 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.95 -6.8 59.49 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.283 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.48 172.73 8.19 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -83.0 141.67 31.91 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -81.62 45.17 0.86 Allowed 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.456 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.862 ' HE2' HG12 ' A' ' 77' ' ' ILE . 1.2 p90 -86.05 179.19 7.02 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.833 0.825 . . . . 0.0 112.021 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.76 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 28.1 mtpp -132.92 -172.06 2.83 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.995 -172.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -76.6 -12.02 59.95 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 126.881 2.073 . . . . 0.0 113.677 -168.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.7 19.59 2.39 Favored Glycine 0 C--N 1.268 -3.208 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.76 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 9.6 mm-40 -77.12 125.46 29.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.86 0.838 . . . . 0.0 113.182 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.38 97.75 9.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.883 HD12 HG12 ' A' ' 82' ' ' VAL . 36.0 pt -112.64 159.1 12.8 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.047 0 CA-C-N 112.511 -2.131 . . . . 0.0 112.62 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.33 139.15 53.52 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.939 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -103.02 134.97 42.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.318 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.694 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -105.73 -24.45 4.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.415 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.762 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 9.3 ttt85 -127.38 122.94 34.98 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.382 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mm -104.6 96.75 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.55 140.38 41.09 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.463 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -114.26 -21.89 10.22 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -64.26 148.62 95.64 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.814 1.246 . . . . 0.0 107.977 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.39 47.66 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 124.042 3.161 . . . . 0.0 115.483 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -78.68 -33.12 47.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.08 -19.42 52.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.881 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.1 mmtp -133.28 156.38 47.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 32.5 m0 -93.11 162.35 14.06 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.712 0.633 . . . . 0.0 109.973 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -103.62 115.02 29.73 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.217 0.532 . . . . 0.0 110.327 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.742 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.48 -179.16 16.61 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.279 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 36.1 ptt180 -151.78 144.7 24.46 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.743 ' HA ' HG23 ' A' ' 52' ' ' ILE . 21.1 p -78.31 170.44 16.63 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.63 -14.67 59.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.214 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.66 0.03 57.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.217 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.83 68.35 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 m -97.83 113.2 24.94 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 23.0 m-85 -82.47 151.64 26.44 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.801 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.94 159.02 30.94 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.644 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.472 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.7 m-85 -71.63 147.97 47.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.623 0.725 . . . . 0.0 111.606 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.862 HG12 ' HE2' ' A' ' 46' ' ' PHE . 69.3 mt -133.0 133.27 58.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.761 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 77' ' ' ILE . 98.2 mttt -69.43 135.37 50.15 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 167.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.5 p -66.23 -8.11 22.51 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.628 0.728 . . . . 0.0 111.885 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -106.2 -6.96 18.12 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 124.064 0.946 . . . . 0.0 109.731 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -85.99 -14.13 45.5 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.883 HG12 HD12 ' A' ' 52' ' ' ILE . 33.4 m -129.1 152.89 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.138 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.153 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 37.0 mt-10 -94.65 100.46 12.4 Favored 'General case' 0 N--CA 1.397 -3.11 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 27.3 mm -90.77 106.03 17.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.1 134.42 54.23 Favored 'General case' 0 CA--C 1.471 -2.069 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.883 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -74.26 -28.57 61.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -50.17 -36.46 30.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 111.151 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -65.68 -18.73 65.54 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.279 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 HD12 HD13 ' A' ' 30' ' ' LEU . 3.6 mm? -103.93 -48.32 3.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 39.1 ttmt -158.55 150.89 21.74 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 87.7 mt -61.67 141.76 57.62 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.048 0.451 . . . . 0.0 111.025 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.86 123.74 19.71 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.736 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt 69.91 20.86 6.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.062 0.945 . . . . 0.0 110.159 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 27.9 t70 -77.38 140.39 39.92 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.88 140.21 29.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.036 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 124.025 0.93 . . . . 0.0 111.527 -179.044 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.236 0.357 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 1.4 mptm? -99.86 111.35 23.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.779 0.799 . . . . 0.0 111.265 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -113.33 16.26 19.04 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.298 175.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.37 -69.2 0.3 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.16 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -125.25 -68.85 0.82 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttm 49.22 68.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 111.849 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -80.17 -26.33 39.35 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.515 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 59.27 72.09 0.55 Allowed 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.837 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 173.96 -62.79 0.01 OUTLIER 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.76 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -61.19 -42.97 99.53 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.458 -173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 15' ' ' ILE . 12.9 mptt -65.37 -47.62 75.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' HA ' HG12 ' A' ' 15' ' ' ILE . 26.8 mp0 -77.49 -11.97 59.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -81.85 -23.33 36.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -89.94 -33.49 16.39 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.758 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -54.88 -31.87 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -73.94 -24.53 59.66 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -96.94 -28.06 14.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 31.5 tttp -61.33 -52.28 65.32 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.257 1.423 . . . . 0.0 110.478 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 42.4 m-85 -99.03 -5.88 29.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.101 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 61.16 76.04 0.39 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.717 1.246 . . . . 0.0 108.304 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.489 ' HG ' HG23 ' A' ' 25' ' ' ILE . 10.4 tp -116.36 16.09 15.75 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.212 -172.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -75.92 122.79 24.68 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.109 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.52 168.53 18.54 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 121.61 8.84 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.789 2.992 . . . . 0.0 112.196 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.842 HG13 ' H ' ' A' ' 26' ' ' GLN . 18.2 pt -106.37 -76.82 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.842 ' H ' HG13 ' A' ' 25' ' ' ILE 0.258 23.8 mt-30 72.41 141.12 0.06 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.186 1.394 . . . . 0.0 114.316 -177.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 53' ' ' GLU . 60.6 t -81.4 137.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.218 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.494 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.12 -42.3 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.924 ' HB2' HD11 ' A' ' 54' ' ' ILE . 84.8 m-70 -142.46 178.89 7.29 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 88' ' ' SER . 45.2 tp -115.27 125.66 53.57 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.63 171.49 7.3 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.64 0.734 . . . . 0.0 109.95 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 61.4 pttt -151.08 107.53 3.48 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -70.15 130.97 43.5 Favored 'General case' 0 C--N 1.255 -3.531 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.589 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.05 166.42 12.02 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 6.3 m 63.73 164.94 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 125.219 1.574 . . . . 0.0 114.444 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.98 111.18 5.49 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.836 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.3 m -111.89 156.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.087 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -56.33 -60.8 2.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 43' ' ' GLU . . . 49.6 41.48 34.14 Favored Glycine 0 C--O 1.21 -1.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.809 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.13 -110.26 0.01 OUTLIER Glycine 0 CA--C 1.542 1.724 0 N-CA-C 118.727 2.251 . . . . 0.0 118.727 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.784 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 9.4 mmpt? -98.87 -53.76 3.19 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 122.271 -0.546 . . . . 0.0 111.535 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.551 HD21 ' HD2' ' A' ' 76' ' ' TYR . 2.2 p-10 -95.43 1.96 54.33 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' C ' ' A' ' 39' ' ' GLY . 39.2 mt-10 -92.65 157.52 16.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.678 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.048 0.927 . . . . 0.0 111.269 -173.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HB3' ' HD3' ' A' ' 2' ' ' LYS . 31.6 m -84.07 69.75 10.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.671 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.933 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.86 -175.69 2.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.58 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -145.1 -172.66 3.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 124.036 0.835 . . . . 0.0 109.234 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.7 tt0 -85.7 107.44 17.58 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 125.429 1.492 . . . . 0.0 109.576 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.97 29.98 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.93 126.82 34.38 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.625 0.726 . . . . 0.0 111.629 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.93 96.44 10.68 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.883 HD13 HG11 ' A' ' 82' ' ' VAL . 33.3 pt -109.51 158.09 9.65 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.052 0 CA-C-N 112.495 -2.138 . . . . 0.0 112.704 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HB3' HG13 ' A' ' 27' ' ' VAL . 30.3 mt-10 -121.83 134.64 54.89 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -97.33 129.27 47.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.288 175.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 25' ' ' ILE . 2.5 mp -98.99 -40.28 8.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.008 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.692 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.9 ttm180 -121.87 119.7 32.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.758 -174.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.41 98.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 t -125.34 146.11 49.72 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.264 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -114.02 9.32 17.32 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.43 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.684 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 5.0 m-20 -61.41 170.79 1.54 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.259 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.684 ' HD2' ' HB3' ' A' ' 60' ' ' ASN . 51.8 Cg_exo -19.68 -52.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.86 1 C-N-CA 126.95 5.1 . . . . 0.0 117.874 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 11.9 mm-40 -64.35 -36.81 85.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.77 31.74 73.4 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 33.0 mmtp -123.66 159.93 28.26 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.431 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.5 m0 -95.98 152.04 18.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.6 tm? -93.69 114.03 26.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.672 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -118.32 179.67 17.02 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.31 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 35.1 ptt180 -152.29 139.69 19.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.844 ' HA ' HG22 ' A' ' 52' ' ' ILE . 5.5 p -76.0 171.49 14.35 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 117.948 0.34 . . . . 0.0 110.446 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.45 -16.19 60.35 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -72.56 -17.48 61.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.558 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.11 23.53 22.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 23.6 m -113.43 128.09 56.33 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 41.2 m-85 -89.67 151.85 21.66 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.525 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -174.89 160.29 29.25 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.551 ' HD2' HD21 ' A' ' 42' ' ' ASN . 17.5 m-85 -74.73 146.45 42.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.388 0.613 . . . . 0.0 111.011 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.933 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.0 mt -128.29 129.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.673 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 77' ' ' ILE . 63.0 mttm -69.77 132.43 46.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 165.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.3 p -63.14 -10.75 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.737 0.78 . . . . 0.0 112.595 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 t -93.88 -21.1 19.45 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.897 0.879 . . . . 0.0 109.709 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -76.36 -15.07 60.04 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.974 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 52' ' ' ILE . 34.4 m -127.19 157.81 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 CA-C-O 121.405 0.622 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 32.0 mt-10 -112.73 101.02 9.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.562 HD13 ' HB1' ' A' ' 31' ' ' ALA . 20.0 mm -74.19 132.57 33.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.197 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -109.74 146.78 34.36 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -99.81 -37.91 8.87 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.002 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.78 -33.58 75.48 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.167 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.768 ' HB3' HD23 ' A' ' 30' ' ' LEU . 38.9 m -72.05 1.62 7.06 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 29' ' ' HIS . 4.2 mm? -81.79 -3.72 54.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.111 0.958 . . . . 0.0 109.78 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -111.8 154.02 25.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.65 83.97 3.3 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -167.06 130.6 1.85 Allowed 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -160.4 112.02 1.93 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 133.13 54.88 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -65.18 131.12 45.71 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.259 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 C--N 1.304 -1.387 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.22 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -87.77 130.11 34.95 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -115.86 72.77 0.82 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 59.29 27.06 16.02 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.134 0.968 . . . . 0.0 108.791 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 58.37 85.38 0.09 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.439 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -14.3 60.06 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.206 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.24 130.81 44.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -94.81 -10.53 31.15 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.573 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 69.07 99.12 0.06 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.39 1.076 . . . . 0.0 112.701 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.5 -25.08 67.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.032 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -61.1 -43.29 99.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.232 0.539 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.564 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 9.5 pt-20 -84.52 -26.85 27.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.02 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.18 -42.15 94.41 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.175 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.3 -41.87 66.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -64.51 -29.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.933 0.397 . . . . 0.0 111.742 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 45.6 mtmt -76.26 -25.58 55.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.637 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -83.86 -38.2 21.47 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.4 tttt -68.09 -49.28 62.21 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.083 1.353 . . . . 0.0 112.406 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.406 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 62.4 m-85 -102.47 -4.6 25.15 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 57.37 75.52 0.37 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.563 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 10.7 tp -127.51 14.47 7.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.988 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -57.57 117.31 4.05 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.676 -172.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.98 169.47 11.67 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.84 120.15 6.86 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 122.218 1.946 . . . . 0.0 110.764 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.811 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.7 pp -104.26 151.44 6.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -143.46 159.28 42.69 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.345 1.058 . . . . 0.0 108.168 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 53' ' ' GLU . 30.8 m -75.2 154.97 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.66 HD13 HG12 ' A' ' 57' ' ' ILE . 36.0 mt -105.05 -32.74 2.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.589 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.929 ' HB2' HD11 ' A' ' 54' ' ' ILE . 82.9 m-70 -152.01 -178.59 6.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 53' ' ' GLU . 30.2 tp -119.28 132.98 55.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 84' ' ' ILE . . . -113.08 170.6 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.607 0.718 . . . . 0.0 110.646 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 46.0 pttt -153.32 102.87 2.64 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.819 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.99 125.52 23.97 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.689 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.8 p -111.26 166.55 11.0 Favored 'General case' 0 CA--C 1.452 -2.808 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.4 m 61.26 174.67 0.11 Allowed 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 125.038 1.461 . . . . 0.0 112.307 167.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.14 102.96 8.75 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.704 HG22 ' CE1' ' A' ' 46' ' ' PHE . 18.7 m -92.01 154.31 3.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.692 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -58.18 -58.95 6.21 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.65 42.09 90.44 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 124.288 0.992 . . . . 0.0 113.696 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.04 -152.57 0.37 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -63.27 -50.13 71.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 4.5 p-10 -82.8 -8.9 59.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.696 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 41.6 mt-10 -91.68 -179.81 5.44 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.571 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 1.4 tt -88.51 149.0 23.86 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.419 ' N ' HD22 ' A' ' 44' ' ' LEU . 29.9 t -92.08 90.17 7.26 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.704 ' CE1' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.61 176.91 9.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.892 -174.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -139.65 -174.0 3.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 111.612 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -79.17 105.68 10.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 126.532 1.933 . . . . 0.0 108.81 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.88 12.15 44.27 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.44 157.8 33.58 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -108.26 96.78 6.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.7 -1.136 . . . . 0.0 107.964 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 82' ' ' VAL . 23.1 pt -117.0 159.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.983 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 5.3 pt-20 -133.21 139.23 46.88 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.929 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.25 0.2 OUTLIER -102.34 132.48 48.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.822 179.458 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.37 -31.95 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.919 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.996 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.7 ttm180 -115.76 126.83 54.56 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.713 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 28' ' ' ILE . 51.1 mm -103.3 98.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.69 141.7 31.17 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.733 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -110.12 -13.86 14.3 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -43.09 142.2 1.58 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.27 1.828 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -43.34 -20.15 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.971 1 C-N-CA 125.784 4.323 . . . . 0.0 116.173 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 11.3 tp10 -55.92 -36.08 67.31 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.75 31.62 76.29 Favored Glycine 0 CA--C 1.487 -1.698 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.958 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 47.7 mmtm -133.53 155.91 48.74 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 26.1 m0 -108.36 152.49 24.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.35 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.996 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -92.74 110.72 22.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -116.81 176.56 16.32 Favored Glycine 0 N--CA 1.417 -2.63 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.154 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 73' ' ' SER . 23.0 ptt180 -151.76 143.13 23.41 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.527 ' HA ' HG22 ' A' ' 52' ' ' ILE . 4.2 p -77.05 166.15 23.68 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -20.83 66.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -67.33 -26.43 66.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.842 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.83 20.41 11.6 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.509 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 67.1 m -104.41 120.72 41.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 117.875 0.837 . . . . 0.0 108.799 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.435 ' HB3' HD21 ' A' ' 66' ' ' LEU . 5.6 m-85 -92.58 150.0 21.0 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.983 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.64 155.98 27.53 Favored Glycine 0 C--N 1.305 -1.169 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.15 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.557 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 2.0 m-85 -79.19 116.16 19.29 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-O 121.687 0.756 . . . . 0.0 110.015 174.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 78' ' ' LYS . 65.1 mt -100.41 140.2 20.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.761 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.5 mtmt -71.96 139.3 48.6 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.7 p -68.95 -12.69 61.88 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.768 0.794 . . . . 0.0 111.92 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 t -99.42 -12.22 20.44 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.589 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . . . -77.26 -15.89 59.25 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.193 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.1 m -130.39 154.18 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.7 mt-10 -100.84 102.8 13.94 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 31' ' ' ALA . 29.0 mm -79.58 119.2 28.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -97.06 140.99 30.75 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.779 0.799 . . . . 0.0 110.593 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -98.31 -34.52 10.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.265 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -69.66 -8.43 47.57 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.01 -3.81 27.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.642 0.734 . . . . 0.0 109.157 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -106.81 -70.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.058 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.652 HD22 ' HG ' ' A' ' 95' ' ' LEU . 93.6 mt 51.96 89.37 0.03 OUTLIER 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 113.08 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -114.17 -61.51 1.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -149.02 74.07 1.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' H ' HD12 ' A' ' 95' ' ' LEU . 8.9 p-10 -172.13 27.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.259 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.652 ' HG ' HD22 ' A' ' 91' ' ' LEU . 5.2 mp -94.23 88.44 5.59 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.169 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 174.427 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.242 0.705 0 CA-C-O 121.572 0.701 . . . . 0.0 112.413 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -115.15 -43.34 3.09 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -147.11 25.51 1.12 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 1' ' ' GLU . 1.8 mp0 -101.02 -147.14 0.35 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.844 -173.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' ' 4' ' ' GLU . 52.1 tt0 72.41 34.64 1.28 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 123.981 1.848 . . . . 0.0 107.182 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.5 154.9 39.71 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.571 -2.104 . . . . 0.0 107.323 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB3' ' HG2' ' A' ' 9' ' ' GLU . 2.4 mp0 -54.76 147.27 15.18 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.436 0.636 . . . . 0.0 110.748 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.57 14.44 28.41 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 7' ' ' GLU . 16.9 mm-40 -74.25 95.22 2.6 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.826 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -108.03 -33.87 7.06 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.673 0.749 . . . . 0.0 109.2 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.75 -23.83 67.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -81.2 -16.58 52.39 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.495 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -80.95 -34.82 32.95 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -46.27 89.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.146 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.52 -27.88 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.19 0.519 . . . . 0.0 111.343 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 92.9 mttt -75.04 -18.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.66 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -97.57 -40.52 8.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.92 -49.28 78.32 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.553 1.141 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.41 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.9 m-85 -100.83 -0.51 36.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.642 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.41 74.68 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.059 0.933 . . . . 0.0 108.737 -171.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 8.6 tp -121.57 15.01 11.11 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.557 -173.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -64.75 118.27 8.71 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.56 -164.75 21.66 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -66.17 140.07 57.87 Favored 'Trans proline' 0 CA--C 1.5 -1.222 0 C-N-CA 122.174 1.916 . . . . 0.0 109.406 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.832 HG12 HG21 ' A' ' 55' ' ' ILE 0.359 0.0 OUTLIER -111.74 -66.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.173 -173.035 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.487 ' N ' HD11 ' A' ' 25' ' ' ILE . 34.2 mm-40 70.96 161.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.121 0.962 . . . . 0.0 113.556 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.46 127.95 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.237 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.4 mm -98.87 -45.49 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.208 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.903 ' HB2' HD13 ' A' ' 54' ' ' ILE . 78.1 m-70 -152.36 170.45 20.04 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.92 125.68 48.65 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.997 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 84' ' ' ILE . . . -106.78 175.18 5.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -153.71 106.59 2.9 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 175.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.85 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -65.52 138.02 57.79 Favored 'General case' 0 C--N 1.274 -2.683 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.118 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.1 t -126.62 151.86 47.43 Favored 'General case' 0 CA--C 1.447 -3.004 0 O-C-N 123.211 0.319 . . . . 0.0 110.307 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.1 m 71.22 167.42 0.31 Allowed 'General case' 0 N--CA 1.403 -2.805 0 O-C-N 125.976 2.048 . . . . 0.0 111.903 163.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.35 104.87 4.51 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.008 0.909 . . . . 0.0 110.707 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.78 HG23 ' CE1' ' A' ' 46' ' ' PHE . 19.7 m -107.49 157.4 7.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 124.633 1.173 . . . . 0.0 110.493 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HD3' ' HE3' ' A' ' 78' ' ' LYS . 13.2 ptmm? -59.11 -53.82 54.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 123.609 0.568 . . . . 0.0 111.164 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 46.89 41.75 14.21 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.901 -0.666 . . . . 0.0 114.121 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.35 -111.13 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.034 1.974 . . . . 0.0 118.034 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.7 -53.79 7.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -112.38 3.29 16.87 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.971 0.891 . . . . 0.0 109.472 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.0 mt-10 -91.92 148.42 22.22 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.662 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -69.94 126.96 31.22 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.72 0.771 . . . . 0.0 109.706 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 m -85.26 83.14 8.08 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.836 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.84 -177.44 3.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.222 -178.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.5 mtpt -125.73 -173.99 2.97 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.193 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -73.93 -9.14 58.33 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.187 2.195 . . . . 0.0 113.785 -170.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.28 18.65 2.48 Favored Glycine 1 C--N 1.245 -4.491 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.0 mm-40 -79.75 128.21 33.14 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.744 0.783 . . . . 0.0 111.556 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -89.26 96.95 10.93 Favored 'General case' 0 N--CA 1.404 -2.755 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.88 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.83 HD12 HG12 ' A' ' 82' ' ' VAL . 20.8 pt -113.72 157.96 14.23 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.916 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.946 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -131.88 141.58 49.43 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.903 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.28 147.62 7.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.699 -177.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.832 HG21 HG12 ' A' ' 25' ' ' ILE . 3.6 mp -112.94 -57.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.42 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.908 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 41.9 ttm180 -92.73 125.55 37.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.777 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.38 100.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.595 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 1.3 p -136.15 148.35 48.15 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 8.6 m-20 -114.04 -38.47 4.17 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.646 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.683 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 52.9 t30 -77.76 -63.07 0.49 Allowed Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.746 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 52.8 Cg_exo -59.14 103.76 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.296 1.997 . . . . 0.0 112.216 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 69.97 -12.45 0.48 Allowed 'General case' 0 C--O 1.251 1.135 0 C-N-CA 125.081 1.352 . . . . 0.0 113.733 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 59' ' ' ASP . . . 66.49 31.03 77.56 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -175.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 45.0 mmtm -134.09 166.09 23.56 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.411 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.0 m0 -104.27 146.65 28.49 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.908 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -94.91 115.7 27.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.615 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -113.64 178.68 18.58 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -151.83 138.79 19.04 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.647 ' HA ' HG23 ' A' ' 52' ' ' ILE . 28.8 p -77.87 176.49 9.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.87 -18.12 62.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.927 0.87 . . . . 0.0 109.209 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -78.49 -15.32 58.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.611 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.54 19.44 41.25 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.434 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -98.34 114.18 26.4 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.551 ' HD2' HD12 ' A' ' 66' ' ' LEU . 27.9 m-85 -83.34 150.59 26.02 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.975 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.534 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.53 154.01 22.18 Favored Glycine 0 CA--C 1.5 -0.885 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.41 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 26.8 m-85 -73.85 143.22 45.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.655 0.741 . . . . 0.0 110.959 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.836 HG12 ' HE2' ' A' ' 46' ' ' PHE . 54.0 mt -128.71 136.59 59.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.089 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 77' ' ' ILE . 88.3 mttt -70.2 140.23 52.46 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.4 p -65.3 -6.77 10.71 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -106.23 -12.22 15.79 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.386 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -77.46 -10.85 59.71 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.369 0.604 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 33' ' ' ALA . 27.0 m -134.63 153.51 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.396 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 15.3 mm-40 -96.19 100.53 12.16 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 31' ' ' ALA . 26.8 mm -75.9 131.11 35.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.622 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.15 114.85 20.96 Favored 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 122.627 1.203 . . . . 0.0 111.1 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.454 ' HA ' HD23 ' A' ' 89' ' ' LEU . 85.7 m-85 -100.84 -20.03 15.69 Favored 'General case' 1 C--N 1.242 -4.072 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.422 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 48.5 m-20 -64.98 -44.88 87.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.075 -173.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -73.87 -5.56 41.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 112.007 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 86' ' ' TYR . 3.5 mm? -78.02 -20.13 53.08 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.602 -0.686 . . . . 0.0 110.527 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -125.14 80.96 1.92 Allowed 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.4 mt 70.37 -76.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.204 1.401 . . . . 0.0 111.467 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 33.2 ttmt -171.19 -43.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.523 0.329 . . . . 0.0 110.923 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 55.3 mttp 62.44 91.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -84.47 -12.84 53.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.8 tp -168.17 -48.32 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.442 1.897 . . . . 0.0 106.398 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.182 177.85 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp 71.87 21.69 4.1 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.087 1.755 . . . . 0.0 110.769 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -127.96 13.31 6.78 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -87.05 116.55 25.19 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.958 -1.473 . . . . 0.0 108.597 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -62.73 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -90.89 125.17 35.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.837 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE1' ' HG3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -70.54 169.19 14.71 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.56 1.144 . . . . 0.0 109.235 -178.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 8' ' ' LYS 0.314 1.0 OUTLIER -77.15 101.69 6.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.622 1.201 . . . . 0.0 114.136 -176.778 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -89.86 -34.39 16.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.855 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -37.97 79.19 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.56 -175.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -53.85 -50.31 66.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.296 0.997 . . . . 0.0 110.297 176.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.554 ' O ' HG13 ' A' ' 15' ' ' ILE . 9.8 pt-20 -78.31 -25.43 46.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.959 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -64.82 -40.81 95.8 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -63.98 -46.75 83.22 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.421 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.3 pp -64.62 -26.5 40.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.806 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -71.04 -42.64 69.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.514 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.62 -7.88 59.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.076 0.465 . . . . 0.0 110.923 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -100.32 -49.34 4.29 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.095 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.535 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.1 m-85 -104.54 -12.1 16.65 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 59.97 79.53 0.23 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.999 0.904 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.44 -36.46 22.33 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.624 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 26.4 p 60.41 -47.55 0.1 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.418 2.287 . . . . 0.0 116.704 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.68 -168.83 11.39 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.74 141.55 49.93 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.529 2.153 . . . . 0.0 111.635 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.99 ' HB ' HG22 ' A' ' 55' ' ' ILE . 2.5 pp -118.37 160.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.526 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.491 ' O ' HG11 ' A' ' 27' ' ' VAL . 49.2 mt-30 -110.93 -93.71 0.44 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.189 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 26' ' ' GLN . 0.2 OUTLIER 170.92 149.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.608 2.363 . . . . 0.0 109.491 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.562 HG23 ' CD2' ' A' ' 29' ' ' HIS . 48.6 mm -110.24 -42.39 5.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.823 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 76.0 m-70 -153.13 176.64 11.69 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.813 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.9 mp -105.62 137.37 43.58 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 171.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.673 ' HB3' HD11 ' A' ' 84' ' ' ILE . . . -112.84 168.79 9.39 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -151.04 103.25 3.03 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.738 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -58.75 132.18 53.11 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.087 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.6 t -115.75 151.32 35.36 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.1 m 68.73 178.46 0.25 Allowed 'General case' 0 N--CA 1.405 -2.709 0 O-C-N 125.67 1.856 . . . . 0.0 110.491 163.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.57 108.04 15.66 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.822 HG23 ' HE1' ' A' ' 46' ' ' PHE . 8.3 m -99.15 155.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.85 -49.91 74.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.178 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' CB ' ' A' ' 43' ' ' GLU . . . 54.09 41.42 69.21 Favored Glycine 0 C--N 1.352 1.426 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.208 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.89 -102.33 0.01 OUTLIER Glycine 0 C--O 1.245 0.825 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -98.34 -53.72 3.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 34.7 p30 -95.38 0.43 53.5 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.142 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 29.7 mt-10 -90.66 151.26 21.34 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -67.06 146.93 53.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.77 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.46 ' H ' HD21 ' A' ' 44' ' ' LEU . 6.6 m -83.71 70.84 10.4 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.872 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -112.32 -179.79 3.77 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.575 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.1 mtpt -136.3 -173.47 3.41 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.59 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -71.16 -12.39 61.46 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 128.545 2.738 . . . . 0.0 114.652 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.96 19.23 2.34 Favored Glycine 0 C--N 1.259 -3.728 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.626 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 6.8 mm-40 -78.68 127.46 32.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.787 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -97.8 96.33 8.15 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.838 HG22 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -107.67 158.32 7.6 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.152 0 CA-C-N 112.086 -2.325 . . . . 0.0 112.427 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.813 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.1 mt-10 -123.08 133.45 54.3 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 120.901 -1.125 . . . . 0.0 109.362 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.796 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -96.69 138.54 21.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.642 177.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.99 HG22 ' HB ' ' A' ' 25' ' ' ILE . 3.6 mp -111.63 -35.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.795 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.683 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.3 ttm180 -108.92 125.86 52.46 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.043 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.38 104.56 16.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 141.62 37.75 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.18 -25.68 9.19 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.497 -1.228 . . . . 0.0 107.911 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -51.15 145.18 13.43 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.932 1.293 . . . . 0.0 110.682 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 93.5 Cg_exo -21.91 136.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.461 1 C-N-CA 126.629 4.886 . . . . 0.0 115.199 177.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 47.7 mm-40 87.52 -35.6 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 112.271 -172.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.6 32.17 83.32 Favored Glycine 0 CA--C 1.496 -1.145 0 O-C-N 123.601 0.563 . . . . 0.0 113.15 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.5 mmtm -102.22 145.27 29.66 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -94.11 144.44 25.49 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.881 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -86.51 109.03 18.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.671 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -112.38 177.84 18.71 Favored Glycine 0 N--CA 1.419 -2.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.251 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 28.8 ptt180 -151.64 136.1 16.91 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.838 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.1 p -73.34 169.88 16.2 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 118.032 0.378 . . . . 0.0 110.55 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -6.94 52.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.501 0.667 . . . . 0.0 109.209 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.84 -25.02 17.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.541 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 31.8 2.09 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.388 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 m -113.13 116.69 30.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.507 ' HB3' HD23 ' A' ' 66' ' ' LEU . 88.7 m-85 -82.93 147.35 28.3 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -164.11 157.07 29.25 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.062 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 1.1 m-30 -80.63 127.48 32.51 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.912 0.863 . . . . 0.0 109.222 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.872 HG12 ' HE2' ' A' ' 46' ' ' PHE . 86.8 mt -107.43 133.87 50.87 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.151 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.113 -175.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.634 ' HE3' ' HB1' ' A' ' 81' ' ' ALA . 48.7 mtmt -71.01 127.44 32.57 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 167.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.0 p -59.41 -18.29 37.76 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -92.08 -20.89 20.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.709 0.804 . . . . 0.0 109.864 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB1' ' HE3' ' A' ' 78' ' ' LYS . . . -75.85 -13.44 60.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.819 HG13 HD12 ' A' ' 52' ' ' ILE . 34.8 m -127.57 154.55 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.41 101.98 12.7 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 31' ' ' ALA . 26.6 mm -78.14 125.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.428 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.69 121.34 30.97 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.588 1.185 . . . . 0.0 110.707 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.65 -31.73 11.43 Favored 'General case' 0 C--N 1.248 -3.817 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.085 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.26 -50.23 73.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -81.66 -18.6 44.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.193 0.52 . . . . 0.0 110.528 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.823 ' HG ' ' HA ' ' A' ' 29' ' ' HIS . 3.8 mm? -88.48 -23.55 23.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 90' ' ' LYS . 34.6 mmtp 74.12 -32.35 0.23 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.419 1.488 . . . . 0.0 114.253 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.58 107.86 2.66 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 122.591 0.356 . . . . 0.0 110.195 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -158.27 119.45 3.47 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.186 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -121.96 122.11 38.61 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -121.3 102.92 8.6 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 mp 63.12 93.13 0.06 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.056 0.942 . . . . 0.0 110.341 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.495 -175.775 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -120.27 70.49 0.88 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.71 0.767 . . . . 0.0 109.347 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -107.9 -55.05 2.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.73 -37.33 6.76 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 56.83 64.99 1.5 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.433 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -100.16 -26.29 13.99 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.436 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.06 92.61 2.65 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.309 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -124.98 162.47 24.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.96 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.683 ' HA ' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mp0 -73.24 -20.59 60.81 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.87 -31.15 68.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.837 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 42.5 tptt -80.15 -43.62 21.3 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.735 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 9' ' ' GLU . 6.6 pt-20 -68.82 -18.85 64.23 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 120.932 0.396 . . . . 0.0 110.439 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.97 -30.97 72.0 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.49 -59.29 3.08 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.738 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.5 pp -60.3 -26.97 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.018 -175.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.48 -21.41 45.42 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -97.95 -37.51 9.76 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.522 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.9 ttpt -65.53 -36.47 83.9 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.48 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.7 m-85 -110.46 8.43 23.12 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 56.45 38.82 30.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.933 0.873 . . . . 0.0 110.395 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 21' ' ' LEU . 7.1 tp -94.24 17.01 13.47 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.507 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -62.6 122.09 14.95 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.393 0.616 . . . . 0.0 109.371 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.97 162.01 11.05 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.62 134.3 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.364 2.042 . . . . 0.0 112.443 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 55' ' ' ILE . 2.6 pp -125.66 154.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.453 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.2 mm100 -110.14 -84.31 0.56 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.75 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.698 ' HA ' HG21 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -177.62 136.78 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 C-N-CA 127.363 2.265 . . . . 0.0 108.407 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.428 HG22 HG12 ' A' ' 57' ' ' ILE . 46.9 mm -98.05 -42.83 11.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 1.01 ' HB2' HD11 ' A' ' 54' ' ' ILE . 91.4 m-70 -150.74 168.84 23.19 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -104.62 124.85 50.07 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.81 168.89 8.84 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 15.1 ptpt -153.45 103.86 2.7 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.829 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -66.65 139.89 57.89 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.31 -177.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 44.0 t -123.12 150.68 42.91 Favored 'General case' 0 CA--C 1.452 -2.797 0 CA-C-O 121.219 0.533 . . . . 0.0 110.36 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.4 m 68.81 -179.95 0.23 Allowed 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.016 163.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.51 103.2 15.66 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.909 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.694 HG23 ' CE1' ' A' ' 46' ' ' PHE . 12.0 m -93.84 155.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.227 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.62 -42.85 75.5 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.284 0.99 . . . . 0.0 110.851 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.0 43.9 31.88 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 115.201 0.841 . . . . 0.0 115.201 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.06 -175.64 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -47.32 -52.29 16.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.457 1.103 . . . . 0.0 113.741 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -88.78 -4.63 58.46 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.367 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.76 166.6 12.68 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -79.48 145.21 33.38 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.485 0.66 . . . . 0.0 109.375 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 m -85.86 41.95 0.94 Allowed 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.297 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.899 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -82.43 176.78 9.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.589 0.709 . . . . 0.0 112.3 -177.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 60.2 mtpt -132.74 -173.86 3.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.0 -173.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 30.6 tt0 -65.59 -15.8 63.08 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 127.121 2.168 . . . . 0.0 115.532 -169.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.47 19.25 2.81 Favored Glycine 0 C--N 1.26 -3.651 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 11.5 mm-40 -77.37 126.47 30.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -89.62 97.34 11.14 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 113.936 -1.484 . . . . 0.0 107.657 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.954 HD13 HG11 ' A' ' 82' ' ' VAL . 24.7 pt -110.4 158.54 10.66 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.343 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.652 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.59 139.38 52.31 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 121.286 -0.884 . . . . 0.0 108.825 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.01 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.61 135.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.889 0.852 . . . . 0.0 110.232 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -118.97 8.47 6.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.741 -177.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.758 ' HG2' HG22 ' A' ' 58' ' ' THR . 28.7 ttm180 -154.97 117.75 4.34 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.511 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 28' ' ' ILE . 51.2 mm -93.28 96.85 6.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.758 HG22 ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -94.69 139.48 31.17 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.994 -175.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -115.4 8.82 15.41 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 58' ' ' THR . 14.3 m120 -57.62 162.59 4.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.977 1.711 . . . . 0.0 111.318 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.23 12.41 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 124.04 3.16 . . . . 0.0 114.667 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -84.1 -37.0 22.57 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.44 19.9 75.6 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.514 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.3 mmtt -133.36 161.66 33.93 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.458 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.5 m0 -101.03 159.18 15.44 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -100.35 115.3 29.66 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.151 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.49 -178.48 16.52 Favored Glycine 0 N--CA 1.419 -2.473 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.88 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 37.0 ptt180 -151.83 144.42 24.23 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.662 ' HA ' HG23 ' A' ' 52' ' ' ILE . 21.8 p -78.85 175.21 10.71 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 118.598 0.635 . . . . 0.0 109.513 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.92 60.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.24 1.019 . . . . 0.0 109.477 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.15 -14.36 41.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.283 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 33.5 14.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.801 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 113.29 26.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 66.1 m-85 -82.89 147.6 28.19 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.776 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.53 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.28 154.28 23.56 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.43 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 27.8 m-85 -73.31 149.35 42.73 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.84 0.828 . . . . 0.0 111.08 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.899 HG12 ' HE2' ' A' ' 46' ' ' PHE . 59.9 mt -130.05 134.07 63.4 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.875 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' O ' HG21 ' A' ' 77' ' ' ILE . 47.9 mtmt -67.58 139.47 56.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 p -66.92 -12.06 58.26 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.84 0.828 . . . . 0.0 111.742 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 t -100.88 -18.04 16.56 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.565 1.146 . . . . 0.0 110.178 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.559 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -74.1 -13.89 60.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.758 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.954 HG11 HD13 ' A' ' 52' ' ' ILE . 28.2 m -135.76 161.68 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.83 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 31.1 mm-40 -110.21 113.54 26.3 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.44 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.2 mp -84.79 140.47 15.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' CG ' ' HG ' ' A' ' 88' ' ' SER . 3.9 p-10 -78.19 154.68 30.9 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 122.009 0.909 . . . . 0.0 112.156 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -98.83 -19.65 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.772 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.03 -39.07 74.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.437 1.095 . . . . 0.0 111.915 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.452 ' HG ' ' CG ' ' A' ' 85' ' ' ASP . 2.2 p -54.81 -27.16 39.79 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.084 0.954 . . . . 0.0 112.535 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 ' CE1' ' A' ' 29' ' ' HIS . 27.9 mt -93.48 -63.94 1.15 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -104.98 99.26 8.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.54 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.49 100.03 6.71 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -125.74 136.81 53.59 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.699 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.54 113.7 20.45 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.894 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -91.61 113.52 25.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.86 97.08 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.26 1.607 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.32 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.661 ' HD2' ' HB2' ' A' ' 6' ' ' LYS . 13.5 tppt? -145.33 49.45 1.25 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -82.38 2.69 31.21 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.735 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -85.24 -3.47 58.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 6.2 tp60 64.96 95.07 0.05 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.514 1.926 . . . . 0.0 112.979 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 65.7 mttm -152.64 174.05 14.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -87.02 -91.12 0.11 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -159.51 92.71 1.07 Allowed 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 125.119 1.368 . . . . 0.0 107.591 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 38.5 mt-10 -85.72 16.9 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.813 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -56.55 -34.85 67.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.09 -54.86 5.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.448 0.642 . . . . 0.0 109.429 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.634 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 14.9 pt-20 -68.47 -28.12 66.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -171.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.438 ' HG3' ' HB3' ' A' ' 9' ' ' GLU . 94.1 mt-30 -60.21 -32.81 71.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.422 0.556 . . . . 0.0 111.865 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.26 -46.65 11.6 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.634 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.2 pp -61.01 -30.46 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.718 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 96.8 mttt -73.75 -29.72 62.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.95 -40.31 16.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.48 -44.52 64.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.116 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -95.12 -5.16 44.8 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.798 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm 59.5 71.92 0.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.6 tp -107.3 16.65 23.76 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.502 -171.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -49.85 132.41 22.41 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.543 0.737 . . . . 0.0 112.418 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.76 -152.77 17.43 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.97 142.87 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 122.931 2.42 . . . . 0.0 112.84 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.407 HD13 ' C ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -115.75 109.61 28.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.182 179.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.26 141.6 39.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.681 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 14.8 m -67.55 152.91 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-O 121.258 0.551 . . . . 0.0 111.356 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG23 HG12 ' A' ' 57' ' ' ILE . 21.0 mm -107.65 -31.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 1.028 ' HB2' HD11 ' A' ' 54' ' ' ILE . 47.8 m-70 -153.98 179.57 8.78 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -117.45 128.96 55.52 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 84' ' ' ILE . . . -113.6 169.73 8.76 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.234 0.54 . . . . 0.0 110.599 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' HE2' ' OD2' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -153.7 111.48 3.53 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 174.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.48 138.97 58.44 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.88 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' GLN . 41.7 t -121.1 148.69 43.83 Favored 'General case' 0 CA--C 1.442 -3.178 0 CA-C-O 121.16 0.505 . . . . 0.0 110.081 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' N ' ' HA ' ' A' ' 48' ' ' GLN . 12.3 m 70.11 176.07 0.28 Allowed 'General case' 0 N--CA 1.401 -2.876 0 O-C-N 126.055 2.097 . . . . 0.0 111.537 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.6 114.37 20.25 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.01 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.809 HG23 ' CE1' ' A' ' 46' ' ' PHE . 13.1 m -115.57 156.48 16.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.671 -174.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -47.31 -61.63 1.81 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.339 1.025 . . . . 0.0 109.328 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.11 43.67 83.48 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.449 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.79 -171.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 27.2 mtpp -54.01 -46.07 71.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -174.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.574 HD21 ' HD2' ' A' ' 76' ' ' TYR . 4.0 p-10 -94.46 -4.87 47.46 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.801 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.77 168.28 10.92 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.661 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -83.2 126.66 32.87 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -85.84 45.89 1.26 Allowed 'General case' 0 C--N 1.256 -3.46 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.974 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.908 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -75.75 179.26 5.55 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.867 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.826 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 54.8 mtpt -122.25 -172.61 2.49 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.233 -174.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.532 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 39.1 tt0 -69.17 -17.71 63.84 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 126.482 1.913 . . . . 0.0 115.45 -166.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.63 19.2 2.03 Favored Glycine 1 C--N 1.249 -4.261 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.826 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.2 mm-40 -70.36 132.82 46.23 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.12 97.33 11.08 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 123.211 1.482 . . . . 0.0 108.616 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.785 HD11 HG13 ' A' ' 82' ' ' VAL . 18.9 pt -110.83 159.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.726 0 CA-C-N 111.363 -2.653 . . . . 0.0 112.367 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.8 130.02 31.27 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.619 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.028 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -91.72 130.04 41.48 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.405 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.545 HD11 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -113.78 6.44 7.8 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.535 -175.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 37.3 ttm180 -154.29 119.5 5.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.027 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 HG23 ' A' ' 28' ' ' ILE . 41.7 mm -87.78 111.26 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 170.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.3 p -91.43 146.18 24.01 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.45 0.643 . . . . 0.0 112.618 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.22 0.98 19.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -53.75 145.97 28.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 111.874 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.16 -30.69 15.03 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.657 3.571 . . . . 0.0 115.247 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.708 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 12.9 mm-40 -59.82 -37.8 80.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.83 79.06 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -175.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.708 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 30.5 mmtp -110.29 142.43 41.92 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.423 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 34.9 m0 -83.93 152.42 24.51 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 123.623 0.577 . . . . 0.0 110.927 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.8 tm? -93.58 107.77 19.58 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.284 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -111.9 174.26 16.3 Favored Glycine 0 N--CA 1.414 -2.814 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.669 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HG2' HD12 ' A' ' 55' ' ' ILE . 13.4 ptm180 -151.69 146.36 25.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 52' ' ' ILE . 71.3 p -82.0 169.66 16.48 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.8 31.02 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.234 0.54 . . . . 0.0 110.536 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.87 4.31 47.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.331 0.586 . . . . 0.0 109.852 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.84 17.75 59.24 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.526 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -98.73 109.26 22.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 25.8 m-85 -87.87 146.37 25.61 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.197 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.06 158.21 30.65 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.813 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' HD2' HD21 ' A' ' 42' ' ' ASN . 27.2 m-85 -74.28 135.35 42.62 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.699 0.761 . . . . 0.0 110.976 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.908 HG12 ' HE2' ' A' ' 46' ' ' PHE . 87.5 mt -114.83 124.44 71.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.338 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.07 128.53 36.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.0 p -60.9 -11.87 9.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.394 0.616 . . . . 0.0 112.656 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 t -92.39 -19.83 21.67 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.674 0.79 . . . . 0.0 110.329 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.636 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -79.43 -10.6 59.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.972 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 33' ' ' ALA . 31.6 m -133.29 160.77 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.298 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -102.21 103.93 14.47 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 31' ' ' ALA . 30.0 mm -84.35 121.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.949 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 63.0 m-20 -88.48 149.32 23.72 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.624 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 80.5 m-85 -99.52 0.9 43.32 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.725 0.774 . . . . 0.0 109.693 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.42 -29.45 61.59 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.561 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.8 t -63.42 -24.12 67.7 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.169 0.293 . . . . 0.0 110.89 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.37 -29.31 10.82 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.624 ' HE3' ' HB2' ' A' ' 86' ' ' TYR . 97.9 mttt -61.39 -53.65 53.87 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.39 0.614 . . . . 0.0 109.386 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.8 tp -124.8 86.95 2.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -78.74 163.14 25.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.274 -171.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -134.74 -82.83 0.43 Allowed 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 46.38 38.51 5.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.195 1.398 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.1 tp -145.53 145.09 30.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.344 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -83.02 -43.44 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -89.96 86.0 6.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.138 0.971 . . . . 0.0 111.169 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -84.52 -37.16 21.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.54 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.13 86.82 4.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.601 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.741 ' H ' ' HD3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.65 116.24 26.76 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.779 177.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.21 164.16 11.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -173.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 9' ' ' GLU . 7.1 tmtm? -87.92 142.61 27.67 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HB2' ' CG ' ' A' ' 12' ' ' GLU . 11.8 pt-20 -72.85 46.13 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 51.6 mtpt -62.8 -35.96 81.57 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 111.545 -177.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -67.04 -41.72 86.06 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 120.99 0.424 . . . . 0.0 109.956 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.754 ' HA ' HG13 ' A' ' 15' ' ' ILE . 11.4 pt-20 -79.91 -27.03 39.99 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 54.1 mt-30 -59.24 -39.6 83.29 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.233 1.016 . . . . 0.0 108.532 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -72.61 -46.88 52.0 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.486 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -65.66 -26.56 39.25 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 87.9 mttt -74.03 -22.57 59.52 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.434 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.54 -39.59 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -65.93 -51.03 62.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.004 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -98.87 3.01 47.17 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.92 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm 51.67 76.21 0.18 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.397 1.094 . . . . 0.0 109.912 -173.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.776 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.5 tp -127.51 15.93 7.07 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.783 -173.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -57.62 128.66 38.2 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.251 0.548 . . . . 0.0 110.75 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.07 166.97 12.78 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 111.71 3.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.293 1.995 . . . . 0.0 110.651 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.83 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 pp -98.57 142.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -116.21 142.63 46.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.152 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.875 HG23 ' HB3' ' A' ' 53' ' ' GLU . 14.8 p -71.08 144.65 13.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 HG23 ' CD2' ' A' ' 29' ' ' HIS . 51.2 mm -103.76 -36.03 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.191 0.52 . . . . 0.0 110.757 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.802 ' HB2' HD13 ' A' ' 54' ' ' ILE . 75.1 m-70 -147.94 152.58 37.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.06 119.71 32.01 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.41 174.88 5.68 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.541 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.35 112.66 3.8 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.823 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -66.69 137.34 56.61 Favored 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.567 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.2 t -127.47 154.22 45.36 Favored 'General case' 0 CA--C 1.444 -3.133 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.777 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.3 m 71.15 175.11 0.29 Allowed 'General case' 0 N--CA 1.4 -2.965 0 O-C-N 125.748 1.905 . . . . 0.0 111.275 163.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.27 110.21 14.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.745 HG23 ' CE1' ' A' ' 46' ' ' PHE . 14.0 m -108.44 155.27 9.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.613 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -56.68 -46.41 81.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.83 43.0 87.15 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.788 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.77 -178.81 0.31 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -29.73 38.13 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -106.76 -6.12 18.0 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.328 0.585 . . . . 0.0 109.945 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.78 164.34 12.79 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.523 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.619 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.8 140.13 38.27 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 t -88.0 43.91 1.15 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.964 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -80.16 -178.98 6.82 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.372 -178.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.9 mtpt -130.53 178.87 6.29 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.069 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.2 -12.77 54.77 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 128.236 2.614 . . . . 0.0 114.241 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.39 18.65 3.45 Favored Glycine 0 C--N 1.266 -3.333 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.1 mm-40 -85.22 127.42 34.29 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 112.679 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 97.22 10.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.954 HD12 HG12 ' A' ' 82' ' ' VAL . 27.6 pt -109.56 157.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.914 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.201 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.875 ' HB3' HG23 ' A' ' 27' ' ' VAL . 43.5 mt-10 -123.71 135.53 53.92 Favored 'General case' 0 C--N 1.281 -2.393 0 O-C-N 121.265 -0.897 . . . . 0.0 109.099 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.25 137.03 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.011 -179.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.83 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.7 mp -104.13 -49.09 9.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.203 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.842 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 40.6 ttm180 -97.56 113.89 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.661 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.57 98.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.851 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 20.7 p -134.76 141.64 46.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.54 -29.08 6.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.655 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -73.38 -62.84 1.11 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.116 -0.945 . . . . 0.0 112.865 -175.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.851 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.4 Cg_exo -56.6 -78.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.242 1.961 . . . . 0.0 114.37 -173.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' H ' ' HB2' ' A' ' 61' ' ' PRO . 25.9 mm-40 -98.86 -10.01 23.49 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.014 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 22.66 76.68 Favored Glycine 0 CA--C 1.503 -0.677 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.4 mmtt -134.28 167.78 20.08 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 42.8 m0 -104.18 140.36 37.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.768 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.4 tm? -87.2 111.93 21.48 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -109.24 -179.64 21.19 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.14 138.88 19.77 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.722 ' HA ' HG21 ' A' ' 52' ' ' ILE . 40.9 p -77.98 171.8 14.46 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -0.18 19.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.603 0.716 . . . . 0.0 109.979 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 1.8 mmp_? -101.11 -14.56 17.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.815 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.8 21.38 9.72 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.112 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -103.12 113.66 27.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 117.324 0.562 . . . . 0.0 109.787 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.485 ' HB3' HD21 ' A' ' 66' ' ' LEU . 47.5 m-85 -86.96 144.79 26.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.854 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -167.73 153.32 22.56 Favored Glycine 0 C--N 1.301 -1.396 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.935 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.526 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 41.4 m-85 -73.04 155.13 40.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.393 0.616 . . . . 0.0 111.324 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.964 HG12 ' HE2' ' A' ' 46' ' ' PHE . 53.1 mt -137.87 136.39 45.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' O ' HG23 ' A' ' 77' ' ' ILE . 44.0 mtmt -69.16 141.72 54.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 168.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -69.49 -6.82 33.06 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 119.271 0.941 . . . . 0.0 112.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.3 t -96.18 -22.11 17.48 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.069 0.948 . . . . 0.0 109.71 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -73.21 -15.48 61.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.954 HG12 HD12 ' A' ' 52' ' ' ILE . 27.3 m -130.69 152.33 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 121.17 0.51 . . . . 0.0 112.13 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -92.65 100.68 13.14 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 82' ' ' VAL . 27.8 mm -92.22 125.02 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.75 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -102.84 140.31 37.28 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.941 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' HA ' ' CE1' ' A' ' 29' ' ' HIS . 75.4 m-85 -79.6 -23.76 42.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -51.11 -20.15 1.37 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.379 1.472 . . . . 0.0 114.552 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -62.32 -60.09 4.06 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 117.779 0.263 . . . . 0.0 111.125 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.481 HD11 HG22 ' A' ' 28' ' ' ILE . 45.8 mt -105.99 -21.18 13.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -100.84 94.22 5.94 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.7 113.47 19.71 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.61 -173.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -98.27 -33.23 11.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.17 101.63 11.1 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.311 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.77 102.08 14.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.4 tp -116.06 91.55 3.63 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.313 -0.98 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -115.89 -43.1 3.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' HG3' ' HG3' ' A' ' 5' ' ' GLN . 19.8 ptpt -125.0 20.22 8.31 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.111 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 75.1 -65.81 0.32 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.52 1.128 . . . . 0.0 112.383 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.683 ' HG3' ' HG3' ' A' ' 3' ' ' LYS . 90.3 mt-30 62.78 -59.77 0.14 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -116.04 12.56 15.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.69 82.09 8.58 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.518 0.675 . . . . 0.0 110.031 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.8 126.59 31.17 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.89 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.23 167.93 19.69 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.148 0.499 . . . . 0.0 110.941 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -80.6 6.8 11.57 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' HG21 ' A' ' 15' ' ' ILE . 67.1 mttm -74.18 -29.79 61.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HA ' HG12 ' A' ' 15' ' ' ILE 0.383 0.0 OUTLIER -69.74 -19.79 63.53 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 -170.893 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -94.36 -12.27 28.28 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.654 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.49 -44.56 12.61 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.538 HD11 ' HG3' ' A' ' 16' ' ' LYS . 2.8 pp -55.87 -28.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.314 1.046 . . . . 0.0 111.916 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HG3' HD11 ' A' ' 15' ' ' ILE . 95.9 mttt -72.5 -22.4 61.05 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.97 -45.17 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -59.42 -47.3 85.99 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.149 1.38 . . . . 0.0 111.729 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.45 0.3 19.26 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 56.54 75.24 0.36 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.54 1.162 . . . . 0.0 111.593 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD12 ' CD2' ' A' ' 74' ' ' TYR . 78.8 mt -125.98 16.71 7.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.867 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -72.62 102.46 3.29 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.392 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.63 -155.19 26.37 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -93.32 121.09 0.41 Allowed 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 123.113 2.542 . . . . 0.0 111.65 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 55' ' ' ILE . 2.6 pp -111.79 142.16 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.569 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.466 ' C ' HG21 ' A' ' 55' ' ' ILE . 54.3 mt-30 -132.47 138.38 47.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 m -59.94 134.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.346 0.593 . . . . 0.0 111.953 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.87 -34.7 5.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 1.001 ' HB2' HD13 ' A' ' 54' ' ' ILE . 76.1 m-70 -155.1 173.59 16.38 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.8 139.88 48.05 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.749 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.58 172.01 7.18 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.163 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -152.71 102.64 2.72 Favored 'General case' 0 C--N 1.264 -3.145 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -69.11 137.36 53.39 Favored 'General case' 0 C--N 1.268 -2.978 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.792 -175.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.0 t -124.78 150.08 46.68 Favored 'General case' 0 CA--C 1.436 -3.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.268 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.3 m 72.74 164.7 0.29 Allowed 'General case' 0 N--CA 1.4 -2.958 0 O-C-N 126.234 2.209 . . . . 0.0 111.15 163.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.64 106.76 1.9 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.771 HG22 ' CE1' ' A' ' 46' ' ' PHE . 19.9 m -98.81 157.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.445 -173.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -42.52 -65.89 0.42 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 125.001 1.438 . . . . 0.0 110.331 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.08 43.53 90.18 Favored Glycine 0 C--N 1.321 -0.259 0 C-N-CA 119.85 -1.167 . . . . 0.0 114.264 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -57.46 -173.01 0.27 Allowed Glycine 0 CA--C 1.552 2.405 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -64.62 -37.92 89.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -102.2 1.96 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.649 0.737 . . . . 0.0 109.937 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 47.2 mt-10 -92.53 163.26 13.88 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.714 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -84.73 127.31 34.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -89.93 73.75 7.38 Favored 'General case' 0 C--N 1.253 -3.625 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.851 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -97.73 -176.76 3.56 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.546 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 47.7 mtpt -131.44 -173.18 3.04 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.822 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.06 114.74 24.98 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 125.089 1.356 . . . . 0.0 107.651 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.89 -1.77 51.96 Favored Glycine 0 C--N 1.29 -2.025 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 12.7 mm-40 -72.32 125.18 26.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.548 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.95 96.2 9.96 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-O 123.316 1.532 . . . . 0.0 108.154 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.913 HD13 HG11 ' A' ' 82' ' ' VAL . 23.5 pt -106.59 158.61 6.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.912 -2.404 . . . . 0.0 111.004 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -134.67 130.22 36.01 Favored 'General case' 0 C--N 1.249 -3.785 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.623 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -93.69 136.2 26.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 CA-C-O 122.196 0.998 . . . . 0.0 112.158 -178.381 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.466 HG21 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -118.47 7.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.697 -177.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.867 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.7 ttm180 -149.44 123.84 9.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.182 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 HG21 ' CZ2' ' A' ' 65' ' ' TRP . 51.0 mm -109.35 99.71 9.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.6 p -128.15 140.41 51.94 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -108.92 -14.29 14.59 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -46.59 136.03 7.56 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 125.67 1.588 . . . . 0.0 110.209 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -26.1 94.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.481 1 C-N-CA 125.929 4.419 . . . . 0.0 114.81 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 173.58 -51.61 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.64 21.06 67.25 Favored Glycine 0 CA--C 1.491 -1.432 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.162 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 46.7 mmtm -133.74 161.01 35.85 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.478 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.1 m0 -102.7 161.05 14.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.867 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -106.3 115.42 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.961 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.714 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -116.44 179.39 17.7 Favored Glycine 0 N--CA 1.416 -2.668 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.972 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 31.3 ptt180 -152.22 144.4 23.9 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.789 ' HA ' HG23 ' A' ' 52' ' ' ILE . 27.5 p -74.55 169.89 16.85 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.06 64.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.628 0.728 . . . . 0.0 109.196 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -78.26 -23.86 47.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.653 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.36 26.96 6.68 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.303 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -108.83 111.74 23.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 1.9 m-85 -87.11 148.09 25.37 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.716 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.84 154.19 22.32 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.008 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 34.6 m-85 -70.44 142.58 51.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.763 0.792 . . . . 0.0 111.626 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.851 HG12 ' HE2' ' A' ' 46' ' ' PHE . 67.2 mt -125.39 136.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.415 -173.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' O ' HG23 ' A' ' 77' ' ' ILE . 89.5 mttt -72.82 135.98 45.31 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 166.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.8 p -65.23 -10.47 32.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.619 0.723 . . . . 0.0 112.031 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -98.7 -17.66 18.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.209 1.004 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.68 -12.77 60.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.584 0.707 . . . . 0.0 109.224 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.913 HG11 HD13 ' A' ' 52' ' ' ILE . 34.9 m -134.97 155.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.511 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -98.87 100.53 11.73 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.603 HD12 ' HB1' ' A' ' 31' ' ' ALA . 26.1 mm -79.72 128.46 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -110.21 148.82 31.1 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.993 0.901 . . . . 0.0 110.655 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.737 ' HD1' ' HE1' ' A' ' 29' ' ' HIS . 51.9 t80 -99.06 -27.45 13.83 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.908 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -50.02 -45.62 52.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.307 1.843 . . . . 0.0 114.124 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m -67.68 -14.9 63.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.649 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.856 HD22 ' HA ' ' A' ' 29' ' ' HIS . 2.1 mm? -104.36 -64.22 1.13 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -142.25 174.8 10.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.92 152.75 36.92 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.07 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -101.15 -0.99 35.08 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.79 0.805 . . . . 0.0 109.402 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.0 141.9 58.62 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.911 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.71 135.31 51.12 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.53 -75.75 0.45 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.939 0.4 . . . . 0.0 110.807 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--N 1.308 -1.221 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -85.13 93.24 8.59 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.379 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.29 -41.47 5.53 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.51 111.8 13.65 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.672 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -110.71 84.17 1.88 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.857 0.837 . . . . 0.0 109.817 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -102.12 -61.74 1.35 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 40.33 72.01 0.17 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.793 1.637 . . . . 0.0 111.264 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HZ2' ' HB2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -164.79 107.71 0.87 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.047 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 65.0 mm-40 -90.95 144.98 25.11 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.762 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -92.6 -3.63 54.69 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.636 0.731 . . . . 0.0 109.77 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 mmtm -61.5 -38.32 86.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.658 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.735 ' HA ' HG13 ' A' ' 15' ' ' ILE . 10.4 pt-20 -63.79 -30.73 71.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -40.88 90.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -72.97 -54.82 7.64 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.879 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -60.71 -29.34 44.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.668 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 98.2 mttt -80.69 -25.67 38.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.878 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -90.5 -42.67 10.71 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.381 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -69.82 -52.73 22.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.433 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.23 -0.46 53.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 54.08 73.41 0.39 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.947 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HG ' HG23 ' A' ' 25' ' ' ILE . 4.5 tp -127.03 16.61 7.3 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.351 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.668 ' HB ' ' HB3' ' A' ' 16' ' ' LYS . 10.3 t -77.39 126.06 30.32 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 119.184 -1.007 . . . . 0.0 110.433 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.76 -155.72 16.2 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.74 137.11 34.75 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.395 2.73 . . . . 0.0 110.486 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.883 ' HB ' HG23 ' A' ' 55' ' ' ILE . 17.0 pt -127.07 -70.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.83 ' H ' HG13 ' A' ' 25' ' ' ILE . 30.4 mt-30 70.39 131.37 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.14 1.776 . . . . 0.0 113.638 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.26 136.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.871 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.442 HG22 ' CD2' ' A' ' 29' ' ' HIS . 47.9 mm -99.83 -43.63 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.976 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.927 ' HB2' HD11 ' A' ' 54' ' ' ILE . 65.2 m-70 -140.24 173.88 11.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.86 124.77 51.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.05 172.49 6.77 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.519 0.676 . . . . 0.0 110.302 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 4.4 ttmp? -151.88 106.46 3.22 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.881 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.44 120.57 13.58 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.24 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 42.2 t -93.32 155.8 17.19 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.2 m 62.5 -174.11 0.15 Allowed 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 125.6 1.812 . . . . 0.0 111.127 163.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -91.21 118.27 30.33 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 166.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.89 HG21 ' HE1' ' A' ' 46' ' ' PHE . 20.9 m -97.41 156.89 3.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.614 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -51.43 -47.81 62.9 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.232 0.957 . . . . 0.0 108.703 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.36 95.68 Favored Glycine 0 N--CA 1.438 -1.201 0 O-C-N 124.157 0.911 . . . . 0.0 113.388 173.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.23 178.59 0.13 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.466 0.946 . . . . 0.0 115.466 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.41 -43.56 44.54 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.843 1.257 . . . . 0.0 113.304 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -94.19 -1.58 53.89 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.573 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.4 167.09 12.21 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.164 0.507 . . . . 0.0 110.961 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -79.75 141.95 35.86 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.103 -177.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' H ' HD21 ' A' ' 44' ' ' LEU . 54.0 p -87.44 84.73 7.13 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.076 175.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.89 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.15 176.89 6.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.631 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 57.6 mtpt -128.44 -172.81 2.79 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.748 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.2 110.25 17.9 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 125.099 1.359 . . . . 0.0 109.945 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.76 17.4 48.57 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.5 mm-40 -76.33 130.39 38.03 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.626 0.727 . . . . 0.0 110.99 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.98 96.9 10.43 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.521 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.822 HD13 HG13 ' A' ' 82' ' ' VAL . 28.7 pt -113.57 157.74 14.16 Favored 'Isoleucine or valine' 1 C--N 1.235 -4.41 0 CA-C-N 111.834 -2.439 . . . . 0.0 111.053 174.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.19 136.94 53.44 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.58 138.7 23.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.806 178.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.883 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.2 -47.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.569 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 57.0 ttt180 -110.17 121.79 46.1 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.325 -172.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.9 mm -97.72 95.89 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 t -137.15 148.92 46.94 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.19 -0.26 21.08 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.22 -52.99 69.29 Favored Pre-proline 0 C--O 1.212 -0.916 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.61 65.82 6.57 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.087 1.858 . . . . 0.0 111.733 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 56.18 38.64 30.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.945 1.298 . . . . 0.0 112.674 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.7 34.19 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 114.96 -1.018 . . . . 0.0 115.498 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 45.8 mmtm -121.61 144.33 48.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 35.3 m0 -93.75 162.22 14.01 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.851 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -102.59 117.33 34.44 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.667 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.56 176.79 16.3 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.65 142.57 23.0 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 124.536 1.134 . . . . 0.0 108.814 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 52' ' ' ILE . 31.1 p -77.89 168.36 20.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.37 66.42 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.674 0.273 . . . . 0.0 110.633 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -78.8 -27.04 44.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.8 25.81 3.81 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.14 -1.029 . . . . 0.0 114.188 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.1 m -100.03 113.25 25.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.747 ' HB2' HG22 ' A' ' 15' ' ' ILE . 7.0 m-85 -91.93 144.04 25.88 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.533 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 159.64 32.81 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.191 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.56 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 24.2 m-85 -72.0 151.0 43.52 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.15 0.5 . . . . 0.0 110.119 174.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.682 HG12 ' HE2' ' A' ' 46' ' ' PHE . 60.2 mt -135.18 130.9 51.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.871 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.607 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.2 mtmt -64.48 136.74 57.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -67.53 -13.05 61.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.859 0.838 . . . . 0.0 111.936 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.8 t -96.14 -14.15 23.04 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.287 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 37' ' ' VAL . . . -77.27 -20.27 55.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 33' ' ' ALA . 34.3 m -128.96 149.64 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 121.361 0.601 . . . . 0.0 112.369 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.5 pt-20 -96.97 102.37 14.14 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.447 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.578 HD12 ' HB1' ' A' ' 31' ' ' ALA . 25.2 mm -81.72 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.672 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.4 ' CG ' ' HG ' ' A' ' 88' ' ' SER . 1.1 p-10 -85.58 154.31 21.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.174 0.511 . . . . 0.0 110.303 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -99.67 -27.13 13.82 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.534 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.06 -29.7 45.13 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.4 ' HG ' ' CG ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -50.82 -35.07 30.37 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 123.903 0.881 . . . . 0.0 112.678 175.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.7 mt -81.19 -38.57 26.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.151 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp 66.94 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.712 1.205 . . . . 0.0 111.475 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.802 HD21 HD13 ' A' ' 95' ' ' LEU . 61.8 tp 69.37 109.8 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.66 0.784 . . . . 0.0 110.624 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -94.26 25.92 3.59 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -146.33 140.21 26.26 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -84.0 132.38 34.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.802 HD13 HD21 ' A' ' 91' ' ' LEU . 10.2 mp -111.28 -37.42 5.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.731 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -105.84 -50.1 3.26 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.11 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 65.52 -177.67 0.18 Allowed 'General case' 0 C--O 1.242 0.689 0 O-C-N 124.263 0.977 . . . . 0.0 109.536 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -81.67 131.76 35.28 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.66 -36.4 84.16 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 48.5 mtpt -103.65 94.0 5.22 Favored 'General case' 0 C--O 1.255 1.39 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.503 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.8 85.64 6.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -160.57 88.86 0.8 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.6 tp10 -109.73 137.05 48.09 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.014 -176.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.42 -11.43 59.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.18 0.514 . . . . 0.0 111.285 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 68.6 mttm -59.4 -43.3 92.99 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.92 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' A' ' 15' ' ' ILE 0.264 0.0 OUTLIER -71.47 -9.93 58.96 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.613 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -85.66 -47.62 9.64 Favored 'General case' 0 C--O 1.251 1.183 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.19 -45.07 86.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.006 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -56.33 -29.53 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.427 0.691 . . . . 0.0 112.65 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.76 -22.32 58.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.048 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -97.07 -42.83 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.911 0.862 . . . . 0.0 108.744 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -62.65 -50.13 72.41 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.809 1.644 . . . . 0.0 110.732 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -102.05 -2.09 30.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.156 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 58.48 76.42 0.34 Allowed 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 124.096 0.872 . . . . 0.0 108.839 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.62 16.36 9.56 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.865 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -82.46 114.4 20.87 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.889 0.852 . . . . 0.0 110.028 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.96 -170.41 24.55 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.14 117.72 4.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.601 2.2 . . . . 0.0 111.928 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.9 pp -132.3 139.32 50.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -131.4 140.29 49.63 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.776 0.431 . . . . 0.0 110.448 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.787 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.0 p -63.4 141.19 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 O-C-N 123.603 0.565 . . . . 0.0 111.138 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.647 HD13 HG12 ' A' ' 57' ' ' ILE . 54.6 mt -103.6 -33.08 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.157 0.503 . . . . 0.0 111.937 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.783 ' HB2' HD11 ' A' ' 54' ' ' ILE . 67.8 m-70 -154.95 167.5 30.11 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.597 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.0 mp -106.69 137.64 44.34 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HB1' HG13 ' A' ' 52' ' ' ILE . . . -111.42 171.92 7.2 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.257 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -151.17 106.66 3.36 Favored 'General case' 0 N--CA 1.397 -3.09 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.789 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -62.86 109.55 1.48 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.461 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.5 t -96.26 150.73 20.22 Favored 'General case' 0 CA--C 1.426 -3.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.573 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.5 m 66.45 -175.84 0.19 Allowed 'General case' 0 N--CA 1.399 -3.005 0 O-C-N 126.078 2.111 . . . . 0.0 109.385 165.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.81 120.63 18.7 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.627 HG23 ' CE1' ' A' ' 46' ' ' PHE . 4.3 m -98.99 154.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -59.38 -69.14 0.22 Allowed 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.813 0.696 . . . . 0.0 109.29 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.98 42.6 84.93 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.242 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.27 -116.51 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -99.61 -52.97 3.32 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.651 -0.911 . . . . 0.0 112.474 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -90.64 2.84 55.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.378 0.609 . . . . 0.0 110.555 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 38.3 mt-10 -90.25 159.16 16.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.145 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -64.8 149.09 50.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 124.05 0.844 . . . . 0.0 110.207 -176.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.411 ' H ' HD21 ' A' ' 44' ' ' LEU . 40.8 m -88.81 80.14 7.25 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.645 ' HD2' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -134.79 167.61 20.56 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.46 -177.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.9 mmtp -143.67 -172.8 3.8 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.736 0.779 . . . . 0.0 111.263 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 35' ' ' CYS . 49.7 tt0 -67.93 120.7 14.64 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 126.492 1.917 . . . . 0.0 109.346 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.17 4.57 68.6 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.034 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 48.5 mm-40 -76.12 126.77 31.62 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.936 0.874 . . . . 0.0 111.355 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -96.12 96.94 9.18 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.848 HG23 ' HA ' ' A' ' 69' ' ' THR . 33.1 pt -107.75 159.7 7.18 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.105 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.164 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.787 ' HB3' HG21 ' A' ' 27' ' ' VAL . 50.4 mt-10 -121.29 139.73 53.01 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.259 0.2 OUTLIER -105.06 132.17 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.94 175.462 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 25' ' ' ILE . 2.9 mp -105.42 -34.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.562 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.864 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.8 ttm180 -114.5 119.51 37.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.751 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 28' ' ' ILE . 44.0 mm -101.71 98.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 3.0 p -136.83 141.71 42.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -115.25 -30.64 6.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.998 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.458 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 86.5 m-20 -66.2 -55.16 21.82 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 31.5 Cg_exo -58.54 -80.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.796 1.664 . . . . 0.0 113.647 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.416 ' H ' ' HB2' ' A' ' 61' ' ' PRO . 37.2 mm-40 -116.79 6.66 13.23 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.797 0.332 . . . . 0.0 111.25 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.89 31.2 78.9 Favored Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.132 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.4 mmtm -133.49 160.54 37.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.419 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 40.5 m0 -101.57 141.87 33.79 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.546 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.864 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -88.75 113.64 24.53 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.663 ' HA3' HD12 ' A' ' 77' ' ' ILE . . . -115.58 178.32 17.6 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.843 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 73' ' ' SER . 20.7 ptt180 -151.57 135.74 16.7 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 124.261 1.025 . . . . 0.0 108.396 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.848 ' HA ' HG23 ' A' ' 52' ' ' ILE . 10.8 p -72.67 169.17 17.18 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -17.65 62.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.44 -26.52 60.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.99 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.92 12.31 20.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.727 -0.749 . . . . 0.0 114.688 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 21.3 m -91.08 118.93 30.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 118.178 0.989 . . . . 0.0 108.977 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HD2' HD11 ' A' ' 66' ' ' LEU . 61.4 m-85 -84.06 144.11 29.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.223 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.4 156.64 28.67 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.541 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 10.3 m-85 -76.72 134.79 39.1 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.67 0.748 . . . . 0.0 110.018 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.663 HD12 ' HA3' ' A' ' 67' ' ' GLY . 71.6 mt -114.94 138.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.685 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 77' ' ' ILE . 90.5 mttt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 168.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.6 p -64.62 -18.26 64.76 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.762 0.791 . . . . 0.0 111.751 -171.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 -19.63 27.19 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.18 -17.84 59.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.816 HG13 HD11 ' A' ' 52' ' ' ILE . 35.1 m -129.19 151.81 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -98.27 105.78 17.98 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -83.55 123.69 38.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.682 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 145.43 24.72 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.594 1.187 . . . . 0.0 111.806 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.771 ' HB3' HD11 ' A' ' 91' ' ' LEU . 84.5 m-85 -99.6 -13.02 19.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.291 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.53 -47.93 72.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.935 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -69.35 -14.71 63.07 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 29' ' ' HIS . 3.0 mm? -102.07 -17.61 15.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.0 mttp 53.7 80.49 0.11 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.557 -1.201 . . . . 0.0 114.099 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.771 HD11 ' HB3' ' A' ' 86' ' ' TYR . 6.5 mp -89.06 87.29 7.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 37.5 mtmt -91.6 -55.03 3.64 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.499 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -174.75 115.03 0.17 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.59 78.68 2.39 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -178.3 102.8 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 C--O 1.259 1.566 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.87 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.666 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -86.99 -60.48 1.97 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -136.82 -50.02 0.65 Allowed 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -100.9 172.76 6.84 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.62 -47.09 8.18 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.732 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 59.16 23.84 12.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.785 0.802 . . . . 0.0 111.147 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.47 25.0 1.54 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -80.02 128.36 33.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.3 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.5 tp10 -136.09 157.06 47.73 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 38.4 mtmt -92.44 1.85 57.0 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.845 0.831 . . . . 0.0 109.683 -176.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 25.2 ttmm -80.05 -12.95 59.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.95 -172.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.589 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.37 -19.57 63.83 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.389 -177.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.505 ' O ' ' HE2' ' A' ' 17' ' ' LYS . 43.6 tt0 -54.92 -44.3 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.6 0.714 . . . . 0.0 109.476 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -80.97 -43.88 19.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.408 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.2 pp -65.13 -26.24 39.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 97.1 mttt -75.27 -18.6 60.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.041 0.448 . . . . 0.0 111.292 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 13' ' ' GLN . 53.0 mtmt -96.9 -41.13 8.57 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -68.07 -46.89 69.82 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.683 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -108.01 -3.09 19.08 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.389 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 72.9 mmtt 56.69 69.99 0.69 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.068 0.855 . . . . 0.0 110.369 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.66 16.93 15.4 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.392 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -51.99 117.83 3.03 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.801 0.84 . . . . 0.0 112.791 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.1 179.31 15.91 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.557 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 121.71 6.52 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.364 2.709 . . . . 0.0 110.488 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.705 HD11 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -120.44 163.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.966 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -126.07 155.49 41.48 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.842 0.829 . . . . 0.0 111.194 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 53' ' ' GLU . 59.8 t -90.43 107.96 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.272 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.63 -37.56 24.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.875 ' HB2' HD13 ' A' ' 54' ' ' ILE . 69.5 m-70 -150.57 168.47 24.16 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 121.04 0.448 . . . . 0.0 110.416 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 3.8 mm? -101.88 119.73 39.26 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.646 ' HB1' HG13 ' A' ' 52' ' ' ILE . . . -103.91 164.04 11.96 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -152.46 107.28 3.21 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.74 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -60.44 126.27 26.82 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 p -103.1 -11.0 18.4 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -167.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.82 175.02 14.12 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.0 -157.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.36 107.83 5.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.833 HG22 ' HE1' ' A' ' 46' ' ' PHE . 14.7 m -103.96 156.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.691 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -57.91 -48.93 78.45 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.8 42.97 60.15 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.605 1.19 . . . . 0.0 113.634 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.38 -170.44 0.25 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -52.03 -38.81 58.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -100.57 -0.22 38.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.685 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.49 167.23 11.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.98 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -76.08 139.51 41.41 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.933 0.873 . . . . 0.0 111.634 -176.239 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -82.84 76.03 9.71 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.912 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.833 ' HE1' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.05 -178.99 4.37 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.442 179.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 28.6 mtpp -139.52 -173.09 3.52 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 123.648 0.593 . . . . 0.0 110.041 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -67.87 -13.14 61.91 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 126.464 1.906 . . . . 0.0 115.619 -168.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.5 15.0 4.73 Favored Glycine 0 C--N 1.254 -3.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 21.0 mm-40 -72.65 123.32 23.0 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 122.282 1.039 . . . . 0.0 112.892 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -93.66 96.17 9.65 Favored 'General case' 0 N--CA 1.397 -3.077 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.828 HD13 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -105.11 159.18 5.59 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.08 0 CA-C-N 111.653 -2.521 . . . . 0.0 112.685 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.496 ' HG2' ' CD1' ' A' ' 30' ' ' LEU . 35.3 mt-10 -124.63 132.04 53.44 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.875 HD13 ' HB2' ' A' ' 29' ' ' HIS 0.277 0.2 OUTLIER -100.47 143.81 13.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 117.503 -1.679 . . . . 0.0 112.284 178.147 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG12 HD11 ' A' ' 25' ' ' ILE . 2.9 mp -111.6 -21.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.613 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.818 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.2 ttm180 -127.73 121.36 30.09 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.813 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.1 mm -112.51 102.91 14.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 103.842 -2.651 . . . . 0.0 103.842 173.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t -128.08 157.47 40.63 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.614 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -108.93 0.56 20.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.53 121.91 56.56 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.74 83.88 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.185 2.59 . . . . 0.0 114.955 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.28 -16.74 5.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.8 9.55 74.32 Favored Glycine 0 CA--C 1.5 -0.856 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.258 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 71.3 mmtt -135.31 -177.91 4.87 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.876 0.846 . . . . 0.0 112.372 -174.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.418 ' HZ3' HG12 ' A' ' 84' ' ' ILE . 20.1 m0 -120.66 162.27 19.97 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 106.638 166.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -105.9 120.7 42.42 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.131 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -124.05 -176.32 14.66 Favored Glycine 0 N--CA 1.422 -2.249 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.206 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 33.5 ptt180 -151.23 146.1 25.84 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.633 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.8 p -85.17 166.78 16.3 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.54 25.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -91.42 -19.88 22.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.749 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.82 36.9 3.33 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.526 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -128.61 137.53 51.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 29.9 m-85 -106.19 152.14 23.85 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.547 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -169.8 152.6 19.82 Favored Glycine 0 CA--C 1.478 -2.251 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.067 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.517 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 9.3 m-85 -74.53 152.8 39.29 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.681 HG12 ' HE2' ' A' ' 46' ' ' PHE . 40.7 mt -136.67 134.71 48.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 77' ' ' ILE . 94.3 mttt -70.7 142.67 51.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -65.34 -12.46 52.17 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.757 0.789 . . . . 0.0 112.738 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.479 HG21 ' HB3' ' A' ' 78' ' ' LYS . 8.2 t -94.86 -15.04 24.02 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -78.9 -19.76 51.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 52' ' ' ILE . 35.1 m -134.1 163.95 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.316 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.27 106.82 14.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.659 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.4 mp -85.02 127.71 39.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.986 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -119.98 154.21 34.85 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.368 0.604 . . . . 0.0 109.997 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.564 ' HA ' HD23 ' A' ' 89' ' ' LEU . 85.3 t80 -98.66 -24.56 15.02 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.989 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.19 -45.04 72.07 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -72.79 -1.46 16.67 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.871 HD22 ' HA ' ' A' ' 29' ' ' HIS . 4.3 mm? -76.48 -21.16 56.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 122.064 -0.397 . . . . 0.0 110.65 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -110.67 133.84 52.97 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -78.01 112.17 14.65 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.598 ' HE2' HD22 ' A' ' 95' ' ' LEU . 60.9 tttm -112.98 90.93 3.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.659 0.742 . . . . 0.0 110.883 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.52 -39.74 3.13 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -112.52 139.47 48.08 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.598 HD22 ' HE2' ' A' ' 92' ' ' LYS . 39.5 tp -137.46 -74.95 0.41 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.615 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 N--CA 1.427 -1.611 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 120.346 0.117 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.1 pp -60.62 -25.82 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.162 0.506 . . . . 0.0 112.143 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 94.9 mttt -72.46 -24.49 61.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.291 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -97.78 -46.73 5.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.073 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.7 tttt -66.52 -53.42 35.14 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.87 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 80.0 m-85 -98.46 -8.86 26.02 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.44 0.638 . . . . 0.0 109.375 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.6 ttmt 60.84 75.48 0.41 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.161 1.384 . . . . 0.0 112.534 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 25' ' ' ILE . 8.3 mp -117.58 17.01 14.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.256 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -56.21 104.94 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.395 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.55 -160.17 20.07 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.35 117.68 0.64 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.209 2.606 . . . . 0.0 112.583 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.773 HD13 HG12 ' A' ' 55' ' ' ILE . 2.6 pp -117.01 143.82 26.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 120.666 0.27 . . . . 0.0 111.616 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -120.17 155.22 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.82 137.59 22.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 121.484 0.659 . . . . 0.0 112.19 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.505 HG22 ' CD2' ' A' ' 29' ' ' HIS . 46.4 mm -91.46 -41.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 1.02 ' HB2' HD11 ' A' ' 54' ' ' ILE . 73.7 m-70 -152.84 177.86 10.28 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.12 117.41 29.99 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.62 168.24 9.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.17 107.77 3.5 Favored 'General case' 0 C--N 1.255 -3.526 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 176.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.837 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.03 132.69 51.33 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.511 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.8 t -116.73 148.14 41.38 Favored 'General case' 0 CA--C 1.44 -3.257 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.3 m 70.29 178.56 0.25 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.273 163.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.13 112.78 15.43 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.834 HG21 ' CE1' ' A' ' 46' ' ' PHE . 9.3 m -110.4 156.79 11.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.682 -174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 17.2 ttmm -49.44 -66.46 0.39 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.926 0.766 . . . . 0.0 110.843 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.11 42.75 98.64 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.148 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.16 -158.6 0.83 Allowed Glycine 0 CA--C 1.54 1.595 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -65.09 -31.38 72.56 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 29.3 p-10 -93.08 -17.83 23.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.376 -0.529 . . . . 0.0 109.897 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' OE1' ' HG2' ' A' ' 38' ' ' LYS . 42.9 mt-10 -92.64 170.55 9.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.426 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -83.56 138.8 33.23 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -86.01 59.04 5.4 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 121.999 0.904 . . . . 0.0 109.004 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.866 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -95.82 -174.89 3.26 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.587 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 56.3 mtpt -143.86 -173.1 3.89 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.565 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.22 114.99 18.6 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 126.17 1.788 . . . . 0.0 108.95 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.91 10.44 57.58 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 10.1 mm-40 -79.32 123.9 27.9 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 111.208 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -87.23 97.08 10.57 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.171 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.822 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -109.94 159.39 9.62 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.256 0 CA-C-N 111.554 -2.567 . . . . 0.0 112.207 176.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.87 140.2 53.14 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.02 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -104.98 127.3 59.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.219 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -101.65 -21.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.335 -173.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.5 ttm180 -136.15 126.42 26.5 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.561 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.79 98.45 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.779 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.881 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mmtm -131.37 157.4 43.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.2 m0 -99.72 162.5 12.97 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 123.731 0.644 . . . . 0.0 110.494 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -99.7 114.39 27.47 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.774 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.85 175.55 16.07 Favored Glycine 0 N--CA 1.423 -2.175 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.2 ptt180 -151.69 141.09 21.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 52' ' ' ILE . 16.9 p -81.26 164.07 22.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.59 -8.28 53.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.409 1.1 . . . . 0.0 109.237 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -87.02 -4.64 59.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.339 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.44 32.29 19.79 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.858 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 9.1 m -118.11 124.08 47.16 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.651 ' HB2' HG21 ' A' ' 15' ' ' ILE . 8.0 m-85 -101.6 140.31 36.06 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.39 162.8 36.11 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 119.157 -1.497 . . . . 0.0 113.218 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.565 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 28.3 m-85 -71.87 149.43 45.19 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.203 0.525 . . . . 0.0 110.107 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 46' ' ' PHE . 74.7 mt -131.99 129.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.605 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG2' ' HE3' ' A' ' 64' ' ' LYS . 98.8 mttt -66.58 136.97 56.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 166.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -69.12 -8.75 48.35 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 122.337 1.065 . . . . 0.0 111.447 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.3 t -97.31 -16.18 20.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.652 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.41 59.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 33' ' ' ALA . 33.9 m -133.16 159.78 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 CA-C-O 121.365 0.602 . . . . 0.0 112.273 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 34.1 mt-10 -97.5 102.24 13.95 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 82' ' ' VAL . 29.2 mm -88.36 120.36 37.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.684 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 121.352 0.596 . . . . 0.0 111.22 179.813 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.439 -1.005 0 CA-C-O 120.967 0.413 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.3 pp -61.08 -25.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' N ' HD12 ' A' ' 15' ' ' ILE . 15.4 ttmm -76.5 -32.17 58.15 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.616 0.722 . . . . 0.0 109.525 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -97.03 -39.95 9.09 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.407 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.6 ttpt -66.09 -43.68 86.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.817 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 26.9 m-85 -97.68 3.17 50.32 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.533 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 53.92 74.44 0.33 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.977 0.894 . . . . 0.0 109.841 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' NH2' ' A' ' 56' ' ' ARG . 6.8 tp -107.75 13.48 26.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.485 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.33 109.78 0.66 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.49 0.662 . . . . 0.0 111.858 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.72 171.89 12.35 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.93 110.4 1.09 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.449 2.1 . . . . 0.0 111.673 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -89.29 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -126.91 139.21 53.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.58 0.705 . . . . 0.0 110.723 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 53' ' ' GLU . 41.4 t -68.76 116.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.701 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.675 HG22 ' HD2' ' A' ' 29' ' ' HIS . 46.4 mm -84.46 -44.8 17.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.343 0.592 . . . . 0.0 109.927 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.675 ' HD2' HG22 ' A' ' 28' ' ' ILE . 38.7 m-70 -153.72 171.24 19.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.2 mp -102.61 129.64 49.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 170.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.54 166.22 10.56 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 18.9 pttp -150.14 101.9 3.04 Favored 'General case' 0 C--N 1.255 -3.535 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.84 133.06 50.17 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.456 -2.156 . . . . 0.0 110.685 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -119.37 152.3 37.03 Favored 'General case' 0 CA--C 1.445 -3.068 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.0 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.1 m 70.91 169.47 0.32 Allowed 'General case' 0 N--CA 1.397 -3.11 0 O-C-N 125.771 1.919 . . . . 0.0 111.745 162.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -69.72 101.91 1.78 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.497 0.665 . . . . 0.0 109.988 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.829 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.3 m -97.18 156.52 3.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.21 -59.05 5.18 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.19 43.72 95.25 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.361 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.48 -172.04 0.51 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -51.78 -53.21 42.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.37 -2.04 58.07 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.92 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -92.27 169.04 10.91 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.665 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -80.06 139.55 36.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.392 0.615 . . . . 0.0 109.944 -177.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -81.07 40.3 0.54 Allowed 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.652 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.91 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -82.43 -177.83 6.82 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.487 0.661 . . . . 0.0 111.895 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -142.63 -172.89 3.73 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.643 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 8.9 tt0 -84.32 114.89 22.19 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.1 1.36 . . . . 0.0 109.123 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.49 3.02 56.5 Favored Glycine 0 C--N 1.29 -1.985 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -75.27 122.42 23.68 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.783 0.802 . . . . 0.0 111.699 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.61 97.21 9.57 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -104.66 158.37 5.54 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.595 0 CA-C-N 111.79 -2.459 . . . . 0.0 111.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.8 mt-10 -121.09 131.73 54.44 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.075 -1.016 . . . . 0.0 109.018 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -92.73 133.37 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.05 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -120.66 11.52 6.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.942 -176.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.835 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 44.8 ttm180 -152.34 125.68 8.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.004 176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 28' ' ' ILE . 47.3 mm -111.5 98.01 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.404 -2.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.057 -167.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.496 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.633 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.2 mmtp -134.4 154.32 51.43 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 33.3 m0 -98.35 157.17 16.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.835 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -101.08 111.49 23.71 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.874 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.8 179.69 18.87 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.506 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 39.0 ptt180 -152.15 144.28 23.88 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.9 p -81.85 169.35 16.96 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.64 36.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.564 1.173 . . . . 0.0 107.877 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -89.32 -4.92 57.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.418 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.34 33.06 32.93 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.46 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -124.07 121.64 35.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.1 m-85 -89.03 153.68 20.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -173.08 156.36 24.48 Favored Glycine 0 C--N 1.318 -0.446 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.637 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 39.9 m-85 -74.96 139.5 43.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 112.411 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.91 HG12 ' HE2' ' A' ' 46' ' ' PHE . 63.0 mt -121.24 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.633 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.633 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 94.7 mttt -73.41 135.91 44.26 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.7 p -65.21 -9.93 27.47 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -98.13 -14.12 20.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.788 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -80.78 -13.45 58.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.386 0.613 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 31.2 m -129.7 156.16 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.841 0.829 . . . . 0.0 112.01 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.49 100.71 11.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 82' ' ' VAL . 22.5 mm -88.84 108.25 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.918 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 121.237 0.541 . . . . 0.0 112.236 177.06 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 120.509 0.195 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.8 pp -69.56 -26.57 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.717 ' HB3' HG23 ' A' ' 22' ' ' THR . 90.1 mttt -71.43 -16.13 62.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.246 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -94.06 -56.95 2.68 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.7 -44.19 81.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.133 1.373 . . . . 0.0 112.106 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.5 -3.33 22.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.726 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 56.29 78.62 0.2 Allowed 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.326 1.06 . . . . 0.0 110.967 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 66' ' ' LEU . 88.2 mt -126.01 16.42 7.92 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.398 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 16' ' ' LYS . 4.6 p -72.9 98.84 2.55 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.75 -159.63 28.23 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -89.16 103.84 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.874 2.383 . . . . 0.0 112.393 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 21' ' ' LEU . 2.7 pp -109.12 142.21 22.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 120.859 0.362 . . . . 0.0 110.732 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -127.23 148.47 50.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.3 p -75.62 145.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.411 HG13 HG12 ' A' ' 57' ' ' ILE . 37.4 mm -98.7 -39.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.261 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.673 ' HB2' HD11 ' A' ' 54' ' ' ILE . 43.7 m-70 -156.45 171.73 19.75 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 109.938 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.23 127.49 44.2 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.615 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -107.18 167.88 9.6 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.594 ' HE2' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.4 102.37 2.9 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.72 137.04 55.19 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 113.204 -1.816 . . . . 0.0 111.205 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.8 t -123.16 149.81 44.11 Favored 'General case' 0 CA--C 1.439 -3.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.926 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.6 m 72.64 162.87 0.26 Allowed 'General case' 0 N--CA 1.396 -3.163 0 O-C-N 126.129 2.143 . . . . 0.0 111.868 162.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.93 103.33 1.45 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 109.356 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 46' ' ' PHE . 24.1 m -102.33 156.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.751 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -48.3 -54.15 14.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.668 1.23 . . . . 0.0 109.165 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.9 43.02 60.8 Favored Glycine 0 C--N 1.346 1.114 0 O-C-N 123.859 0.724 . . . . 0.0 114.69 175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.31 -168.51 0.39 Allowed Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.756 1.063 . . . . 0.0 115.756 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -55.7 -49.24 73.54 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 113.426 -174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.14 -10.72 54.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.556 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -92.09 163.92 13.79 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.517 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -82.57 131.89 35.2 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 m -86.04 71.38 10.59 Favored 'General case' 0 C--N 1.255 -3.538 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.531 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.798 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -99.07 179.03 4.74 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.812 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.611 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mtpm? -134.49 -173.05 3.17 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -87.88 113.95 24.03 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 124.549 1.139 . . . . 0.0 108.665 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.08 -3.09 44.26 Favored Glycine 0 C--N 1.284 -2.332 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.8 mm-40 -66.93 123.96 21.65 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.763 0.792 . . . . 0.0 111.415 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -94.01 96.78 9.9 Favored 'General case' 0 N--CA 1.409 -2.483 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.951 HD11 HG11 ' A' ' 82' ' ' VAL . 32.7 pt -110.57 158.28 10.99 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.169 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.372 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.76 ' HB3' HG21 ' A' ' 27' ' ' VAL . 48.1 mt-10 -121.27 136.84 54.91 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.268 0.2 OUTLIER -97.81 124.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.224 175.173 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.09 -16.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.647 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -144.29 122.07 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.373 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' ILE . 44.3 mm -88.98 101.56 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.281 -2.399 0 CA-C-O 121.568 0.699 . . . . 0.0 112.231 -173.344 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.549 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 42.5 mmtm -133.27 138.31 46.4 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.452 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.2 m0 -87.57 159.8 18.45 Favored 'General case' 0 C--N 1.279 -2.485 0 O-C-N 123.725 0.641 . . . . 0.0 109.968 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -97.12 112.14 24.06 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.815 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.26 174.21 15.13 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' SER . 36.1 ptt180 -152.2 139.91 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.627 ' HA ' HG22 ' A' ' 52' ' ' ILE . 63.6 p -78.73 177.13 8.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -16.89 61.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 110.27 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -87.86 -19.96 26.68 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.12 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 29.6 5.4 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.033 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.9 m -98.91 115.45 28.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.6 m-85 -91.77 139.06 31.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 122.714 0.406 . . . . 0.0 110.717 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.12 158.86 31.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.857 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.448 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.2 m-85 -73.97 135.15 43.17 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.917 0.865 . . . . 0.0 111.285 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.815 HD11 ' HA3' ' A' ' 67' ' ' GLY . 67.5 mt -116.42 128.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.697 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 77' ' ' ILE . 54.8 mttm -65.14 137.14 57.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.0 p -68.7 -7.16 30.94 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.128 0.966 . . . . 0.0 111.469 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -104.16 -13.15 16.33 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.153 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.4 -13.08 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.291 0.567 . . . . 0.0 109.736 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.951 HG11 HD11 ' A' ' 52' ' ' ILE . 35.3 m -131.99 154.56 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.368 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 55.1 mm-40 -103.54 113.13 26.41 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 172.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.5 mm -81.13 141.74 14.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.793 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.478 -1.802 0 CA-C-O 123.094 1.426 . . . . 0.0 112.443 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -61.82 -25.46 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.774 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 92.1 mttt -75.64 -25.86 57.22 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.882 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.24 -38.8 13.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -63.01 -50.88 68.96 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.253 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -103.1 -5.91 22.79 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.44 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 37.7 mtmm 55.35 81.1 0.12 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.556 0.742 . . . . 0.0 110.078 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 21' ' ' LEU . 10.9 tp -83.93 -45.5 13.11 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.13 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 p 46.83 96.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.49 178.83 38.25 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.21 136.53 24.57 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.856 2.371 . . . . 0.0 110.535 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.848 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -124.68 160.51 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -128.63 148.22 50.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 53' ' ' GLU . 7.1 p -74.7 145.72 10.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.614 0.245 . . . . 0.0 110.812 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -97.99 -44.78 12.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.129 0.49 . . . . 0.0 111.013 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.978 ' HB2' HD11 ' A' ' 54' ' ' ILE . 7.3 m-70 -139.29 162.89 33.89 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.35 122.19 42.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.923 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.38 164.43 11.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.679 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 51.3 pttt -151.43 105.21 3.15 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -72.17 125.73 28.04 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.417 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.7 t -112.14 148.76 33.3 Favored 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.791 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.7 m 74.32 167.74 0.3 Allowed 'General case' 0 N--CA 1.405 -2.713 0 O-C-N 126.032 2.083 . . . . 0.0 111.422 162.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.41 102.56 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.758 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.1 m -96.16 156.64 3.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.902 -175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -49.81 -53.92 22.38 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.96 43.3 96.92 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.557 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.57 179.2 0.02 OUTLIER Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.324 1.29 . . . . 0.0 116.324 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -61.47 -34.42 75.42 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -86.26 -16.15 38.53 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.114 0.483 . . . . 0.0 111.207 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 78' ' ' LYS . 45.0 mt-10 -92.66 170.4 9.75 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.781 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.659 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 1.1 tt -79.07 140.92 37.77 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.921 0.867 . . . . 0.0 110.338 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 m -81.12 47.07 0.97 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.58 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.945 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -87.44 175.58 7.9 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.445 0.641 . . . . 0.0 111.879 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.4 mtpt -133.78 -172.76 3.06 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.394 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 47.6 tt0 -81.69 124.79 29.89 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 125.398 1.479 . . . . 0.0 107.821 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.03 4.93 66.48 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.6 mm-40 -74.26 121.87 21.97 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 122.163 0.983 . . . . 0.0 112.283 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -85.51 96.18 9.53 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 82' ' ' VAL . 40.0 pt -111.41 158.41 11.9 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.538 0 CA-C-N 112.836 -1.983 . . . . 0.0 112.071 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 27' ' ' VAL . 51.3 mt-10 -125.43 134.05 52.25 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.21 127.72 54.18 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.291 175.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.848 HG12 HD13 ' A' ' 25' ' ' ILE . 2.7 mp -97.87 -34.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.165 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.7 ttm180 -116.12 110.01 18.27 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.455 -174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.41 98.56 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.288 -2.09 0 CA-C-O 121.598 0.713 . . . . 0.0 112.75 -172.168 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.861 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 69.6 mmtt -119.57 157.38 28.5 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -102.06 142.15 33.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -86.25 108.93 18.6 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -115.18 177.03 17.07 Favored Glycine 0 N--CA 1.415 -2.764 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.411 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 29.6 ptt180 -151.93 142.89 23.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.279 1.032 . . . . 0.0 108.311 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 52' ' ' ILE . 19.2 p -79.71 173.24 12.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.92 0.866 . . . . 0.0 109.135 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.49 -7.87 59.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.981 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.78 31.82 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.501 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.2 m -103.18 113.38 26.81 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.7 m-85 -89.52 147.7 23.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.583 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.88 161.09 34.76 Favored Glycine 0 C--N 1.298 -1.537 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.81 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.2 m-85 -70.11 161.73 29.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.945 HG12 ' HE2' ' A' ' 46' ' ' PHE . 83.9 mt -142.44 126.65 15.67 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' O ' HG22 ' A' ' 77' ' ' ILE . 61.0 mttp -64.5 132.53 50.19 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 167.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.3 p -66.29 -8.51 25.47 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 118.927 0.785 . . . . 0.0 112.575 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 t -98.85 -14.49 19.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.581 0.752 . . . . 0.0 110.282 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.06 -19.78 58.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 108.909 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 52' ' ' ILE . 34.1 m -125.79 166.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.788 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 29.0 mt-10 -125.44 112.22 16.02 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' HIS . 1.7 mp -88.92 123.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 120.922 0.391 . . . . 0.0 110.135 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 . . . . . 0 CA--C 1.476 -1.872 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.233 176.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.95 -29.78 47.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.389 0.614 . . . . 0.0 111.063 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.23 -27.63 66.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.666 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.14 -46.24 8.21 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.734 0.778 . . . . 0.0 109.231 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.05 -44.65 83.95 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 112.379 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -109.35 -8.6 15.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.66 75.22 0.35 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 111.286 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.13 17.81 19.23 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.072 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -68.35 84.7 0.26 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.239 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.83 41.69 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.39 105.47 0.89 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.978 2.452 . . . . 0.0 113.012 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.34 161.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 27' ' ' VAL . 18.4 mm-40 -133.83 -81.48 0.46 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.66 ' HA ' HG22 ' A' ' 55' ' ' ILE . 1.4 m 178.74 152.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 C-N-CA 128.906 2.882 . . . . 0.0 105.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 29' ' ' HIS . 38.3 mm -99.31 -44.91 12.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' HD2' HG22 ' A' ' 28' ' ' ILE . 70.5 m-70 -160.74 -176.93 5.83 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.08 169.58 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 21.7 pttm -152.3 107.05 3.21 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.0 135.82 57.49 Favored 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.049 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -112.05 172.86 6.66 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m 58.39 175.87 0.06 Allowed 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 125.101 1.501 . . . . 0.0 114.39 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.49 95.43 9.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.88 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.841 HG21 ' HE1' ' A' ' 46' ' ' PHE . 27.7 m -89.98 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.36 -40.85 75.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.535 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.08 43.18 62.37 Favored Glycine 0 C--N 1.355 1.592 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.892 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -53.14 -173.71 0.05 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 116.879 1.512 . . . . 0.0 116.879 -173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -63.2 -36.78 84.78 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -100.81 2.21 40.91 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.632 0.729 . . . . 0.0 109.789 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.4 mt-10 -95.68 179.42 5.13 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.68 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -94.7 135.73 35.83 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -85.83 76.19 9.93 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.131 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.869 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.37 174.11 6.43 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.997 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 30.3 mmtp -140.79 -175.51 4.32 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.829 0.823 . . . . 0.0 111.497 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.09 108.21 1.77 Allowed 'General case' 0 C--N 1.272 -2.791 0 C-N-CA 127.856 2.463 . . . . 0.0 109.886 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.75 5.25 41.99 Favored Glycine 0 C--N 1.294 -1.8 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.5 mm-40 -80.03 116.69 20.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.031 0.92 . . . . 0.0 112.729 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.55 96.99 9.81 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.895 HD11 HG11 ' A' ' 82' ' ' VAL . 27.8 pt -110.87 158.66 11.25 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.244 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.045 175.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -118.57 134.25 55.24 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.607 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -96.09 136.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.184 173.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -119.56 3.68 6.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.188 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 58' ' ' THR . 58.2 ttt180 -150.27 141.15 22.83 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.749 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 28' ' ' ILE . 44.4 mm -109.02 96.97 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.217 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.784 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.194 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.5 mmtp -129.29 148.88 51.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 35.0 m0 -94.64 160.81 14.46 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.682 0.614 . . . . 0.0 109.848 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.58 109.65 21.5 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.705 0.764 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -114.08 175.92 16.67 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.1 ptt180 -152.77 146.39 25.05 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.819 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.6 p -73.15 178.59 4.32 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 117.941 0.337 . . . . 0.0 110.847 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -34.22 73.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.123 0.487 . . . . 0.0 110.533 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 71' ' ' ARG . 39.2 mtm-85 -82.16 -0.4 44.76 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.172 0.51 . . . . 0.0 111.599 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.34 27.27 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 114.528 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.0 m -91.46 112.55 24.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.563 1.182 . . . . 0.0 107.813 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 79.2 m-85 -82.48 145.18 29.95 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.128 -172.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.83 27.95 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.163 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 7.7 m-85 -71.45 142.68 50.23 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.87 0.843 . . . . 0.0 112.302 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.869 HG12 ' HE2' ' A' ' 46' ' ' PHE . 61.3 mt -126.59 129.28 71.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.565 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 77' ' ' ILE . 92.3 mttt -65.93 140.95 58.37 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.4 p -69.06 -9.16 51.18 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.0 112.056 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -103.93 -8.67 19.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.519 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.628 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.79 -11.04 59.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 52' ' ' ILE . 27.1 m -133.1 158.27 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.015 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 38.0 mt-10 -104.5 112.94 26.19 Favored 'General case' 0 N--CA 1.394 -3.234 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 31' ' ' ALA . 21.1 mm -94.75 135.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.73 0 C-N-CA 124.038 0.935 . . . . 0.0 109.68 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 CA--C 1.498 -1.048 0 CA-C-O 121.493 0.663 . . . . 0.0 109.948 178.104 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.6 pp -57.49 -28.04 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 22' ' ' THR . 43.3 mtmt -79.68 -23.9 42.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -89.37 -41.22 12.25 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 87.3 tttt -60.56 -48.4 81.94 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 112.089 -175.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -100.56 -6.02 25.98 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 59.94 74.39 0.45 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 122.869 1.319 . . . . 0.0 108.059 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 12.5 tp -125.26 14.53 8.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.913 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -69.42 90.51 0.53 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.487 0.66 . . . . 0.0 112.035 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.78 -177.04 45.5 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.95 123.57 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.711 2.274 . . . . 0.0 112.024 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.628 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.6 pp -109.33 147.08 14.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 120.872 0.368 . . . . 0.0 111.827 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -127.79 138.1 52.62 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.645 ' HA ' HG22 ' A' ' 55' ' ' ILE . 21.9 t -74.08 112.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.556 HG22 ' CD2' ' A' ' 29' ' ' HIS . 38.7 mm -83.67 -44.66 18.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.759 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 54' ' ' ILE . 54.6 m-70 -150.49 167.42 27.22 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.66 117.94 31.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.58 165.06 11.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 42.7 pttt -150.22 102.54 3.09 Favored 'General case' 0 C--N 1.255 -3.514 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.82 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.38 125.96 26.76 Favored 'General case' 0 C--N 1.271 -2.806 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.699 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.2 t -109.69 148.08 32.01 Favored 'General case' 0 CA--C 1.432 -3.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.2 m 68.1 -179.14 0.22 Allowed 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 125.99 2.057 . . . . 0.0 110.344 164.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.6 113.53 14.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 46' ' ' PHE . 5.5 m -106.74 156.37 7.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.225 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 15.0 ptpt -50.72 -66.93 0.3 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.353 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . 61.84 43.32 99.37 Favored Glycine 0 C--O 1.246 0.881 0 C-N-CA 119.754 -1.212 . . . . 0.0 112.542 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -61.41 -150.83 0.02 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 116.729 1.451 . . . . 0.0 116.729 -173.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -73.45 -38.22 65.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -171.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -103.28 -0.42 30.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.991 0.901 . . . . 0.0 109.455 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 68.9 mt-10 -99.37 163.53 12.49 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.643 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -79.23 128.36 33.2 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -86.26 67.56 9.98 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-O 122.542 1.163 . . . . 0.0 108.948 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -98.25 -167.18 1.47 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.521 177.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 54.8 tttp -147.92 -173.59 4.34 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.758 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 54.3 tt0 -79.0 105.6 10.45 Favored 'General case' 1 C--N 1.243 -4.027 0 C-N-CA 127.112 2.165 . . . . 0.0 109.302 -176.187 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 8.19 48.01 Favored Glycine 0 C--N 1.285 -2.3 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.005 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.4 128.82 36.22 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.516 0.674 . . . . 0.0 110.759 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.73 97.03 10.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 22.7 pt -107.27 158.36 7.2 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.093 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.672 176.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.47 128.79 43.62 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -90.98 132.64 35.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.299 177.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.11 11.73 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 33.1 ttt180 -155.08 114.15 3.61 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.076 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 28' ' ' ILE . 46.3 mm -99.12 95.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.293 -1.89 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.559 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 76' ' ' TYR . 46.1 mmtm -131.57 162.95 29.13 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 38.8 m0 -102.0 153.54 19.79 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -98.93 112.52 24.6 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.682 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -109.52 177.48 20.07 Favored Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 114.293 -1.322 . . . . 0.0 110.572 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.2 ptm180 -151.32 141.26 22.01 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 52' ' ' ILE . 64.9 p -79.43 167.85 20.27 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.27 64.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.799 0.809 . . . . 0.0 109.869 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -84.47 -22.37 30.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.073 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.53 19.4 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.091 -1.052 . . . . 0.0 114.314 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.5 m -94.31 110.37 22.13 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.446 ' HB2' HG21 ' A' ' 15' ' ' ILE . 38.5 m-85 -87.49 138.43 31.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.64 155.87 27.12 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.355 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.3 m-85 -69.35 143.79 53.65 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.713 0.768 . . . . 0.0 110.7 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.787 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.9 mt -124.53 132.89 70.69 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.687 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 mtmt -73.57 132.34 42.71 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.6 p -63.73 -10.25 18.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.593 0.711 . . . . 0.0 112.857 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -99.98 -16.05 18.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.651 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -14.17 59.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 52' ' ' ILE . 33.2 m -131.39 156.21 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.689 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 9.3 mm-40 -106.36 106.22 16.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 31' ' ' ALA . 23.4 mm -83.62 115.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.538 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 CA--C 1.494 -1.175 0 CA-C-O 121.52 0.676 . . . . 0.0 110.95 179.039 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 120.756 0.312 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.6 pp -65.86 -24.49 34.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.974 0.416 . . . . 0.0 111.83 -176.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 46.1 mtmt -68.8 -24.37 64.39 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.189 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -97.88 -43.97 6.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.629 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.0 tttt -62.69 -57.25 11.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' HD2' ' HB ' ' A' ' 15' ' ' ILE . 66.6 m-85 -97.59 -13.01 21.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.364 0.602 . . . . 0.0 109.726 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 53.0 mttp 62.39 77.59 0.32 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.185 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 15' ' ' ILE . 73.9 mt -121.1 16.85 11.62 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.602 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -61.61 131.47 50.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.474 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.02 -177.18 18.05 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.34 115.01 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.36 2.04 . . . . 0.0 111.577 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 55' ' ' ILE . 2.7 pp -109.98 145.31 16.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.764 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.03 130.06 55.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.308 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.914 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.5 p -71.9 144.44 13.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 123.253 0.346 . . . . 0.0 110.41 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.44 HG22 ' CD2' ' A' ' 29' ' ' HIS . 45.4 mm -95.98 -44.71 13.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.709 ' HB2' HD11 ' A' ' 54' ' ' ILE . 74.6 m-70 -154.17 179.99 8.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 123.658 0.783 . . . . 0.0 109.065 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 5.7 mp -108.07 136.52 47.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -108.58 176.03 5.26 Favored 'General case' 0 C--N 1.263 -3.174 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 14.8 ptmm? -150.57 102.58 3.04 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.93 122.71 18.76 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.47 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 38.3 t -117.25 152.75 34.19 Favored 'General case' 0 CA--C 1.444 -3.1 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.147 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 m 70.78 177.64 0.27 Allowed 'General case' 0 N--CA 1.404 -2.725 0 O-C-N 125.818 1.949 . . . . 0.0 110.583 162.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.16 100.44 6.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.615 1.198 . . . . 0.0 110.541 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.02 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.3 m -87.74 156.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.946 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -61.7 -52.7 63.21 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.66 43.14 99.41 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.345 -0.931 . . . . 0.0 114.763 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.39 -179.33 1.03 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -63.61 -27.95 69.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 29.5 p-10 -90.3 -13.95 34.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 45.7 mt-10 -92.33 159.82 15.41 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.462 -177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' HD2' ' A' ' 46' ' ' PHE . 1.4 tt -70.79 137.51 49.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.631 0.729 . . . . 0.0 109.844 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 44' ' ' LEU . 15.1 m -82.96 43.81 0.88 Allowed 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.436 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.02 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -84.93 -161.05 0.53 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.273 178.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.882 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 74.1 tttt -145.54 -171.57 3.7 Favored 'General case' 0 N--CA 1.389 -3.525 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.882 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 7.7 tt0 -75.73 -8.83 57.79 Favored 'General case' 0 C--N 1.254 -3.568 0 C-N-CA 128.746 2.818 . . . . 0.0 114.337 -168.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.47 19.9 1.69 Allowed Glycine 0 C--N 1.27 -3.094 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 18.6 mm-40 -80.56 129.78 34.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -96.88 97.57 9.39 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.912 HD11 HG11 ' A' ' 82' ' ' VAL . 36.6 pt -105.55 159.73 5.7 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.883 -2.417 . . . . 0.0 112.55 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.914 ' HB3' HG21 ' A' ' 27' ' ' VAL . 40.7 mt-10 -120.05 136.0 54.73 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.4 128.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.866 0.841 . . . . 0.0 112.072 177.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -100.59 -35.03 4.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.209 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.02 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.1 ttm180 -114.84 121.36 43.0 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.715 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.9 mm -99.09 98.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.083 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.174 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 44.9 mmtm -133.74 155.2 50.2 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.4 m0 -100.75 153.16 19.68 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.516 0.51 . . . . 0.0 110.171 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -95.03 116.37 28.61 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.756 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.04 178.62 16.66 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.765 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 36.3 ptt180 -151.91 147.33 26.46 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.735 ' HA ' HG22 ' A' ' 52' ' ' ILE . 67.0 p -80.05 179.02 7.83 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 118.198 0.454 . . . . 0.0 109.811 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -15.87 61.89 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -80.82 -25.89 37.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.38 9.36 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.348 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 8.0 p -94.1 111.55 23.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.794 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 m-85 -83.13 148.98 27.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -171.62 160.74 32.78 Favored Glycine 0 C--N 1.318 -0.446 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.19 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 m-85 -76.21 143.21 41.18 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-O 121.67 0.748 . . . . 0.0 111.522 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.756 HD11 ' HA3' ' A' ' 67' ' ' GLY . 44.2 mt -125.39 139.15 52.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.061 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 77' ' ' ILE . 55.7 mttm -74.1 136.47 42.98 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 168.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.6 p -64.56 -13.32 52.3 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.537 0.685 . . . . 0.0 112.143 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -97.27 -16.24 20.43 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.541 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.45 -17.65 59.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 52' ' ' ILE . 27.5 m -130.58 153.17 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.75 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 49.0 mm-40 -102.85 100.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 31' ' ' ALA . 22.0 mm -70.57 133.14 32.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.098 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.004 0.907 . . . . 0.0 111.692 -178.697 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.479 0.18 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.51 -31.44 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.722 ' HB3' HG23 ' A' ' 22' ' ' THR . 54.1 mttp -72.27 -22.78 61.17 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.596 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -94.11 -40.21 10.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.573 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.7 ttpt -65.32 -42.1 93.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.779 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.2 m-85 -111.82 1.54 16.64 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.234 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 34.9 ttmt 53.37 72.22 0.45 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.928 1.347 . . . . 0.0 110.336 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.61 HD21 ' HG ' ' A' ' 66' ' ' LEU . 94.9 mt -112.5 16.47 19.81 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.984 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -71.93 94.4 1.45 Allowed 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.301 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.96 170.53 25.7 Favored Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.18 128.23 11.97 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.908 2.405 . . . . 0.0 111.452 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.26 159.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -136.71 144.1 43.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 53' ' ' GLU . 8.0 p -71.43 137.4 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 57' ' ' ILE . 40.0 mm -98.87 -37.79 6.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.195 0.521 . . . . 0.0 109.872 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.599 ' HB2' HD11 ' A' ' 54' ' ' ILE . 53.6 m-70 -153.65 164.16 38.76 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.26 132.28 49.65 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.43 171.89 7.11 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.796 0.808 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 14.3 ptpt -151.64 102.72 2.89 Favored 'General case' 0 C--N 1.26 -3.297 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.81 112.77 3.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -96.95 150.73 20.43 Favored 'General case' 0 CA--C 1.431 -3.599 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.655 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.4 m 67.91 -179.32 0.22 Allowed 'General case' 0 N--CA 1.402 -2.845 0 O-C-N 125.635 1.835 . . . . 0.0 110.782 163.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -79.72 105.29 10.9 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 46' ' ' PHE . 16.9 m -87.76 156.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.896 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -52.58 -58.58 6.32 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.41 41.79 99.74 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.818 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.82 178.29 0.3 Allowed Glycine 0 CA--C 1.526 0.723 0 O-C-N 123.914 0.42 . . . . 0.0 113.528 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -64.42 -32.85 74.65 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 122.104 -0.645 . . . . 0.0 111.547 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -88.08 -7.81 56.43 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.048 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 47.7 mt-10 -92.14 171.96 8.74 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HG ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -73.23 148.63 43.51 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.417 ' H ' HD23 ' A' ' 44' ' ' LEU . 17.8 m -89.89 38.45 0.92 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.749 1.261 . . . . 0.0 108.536 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.813 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -85.17 163.45 18.71 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.12 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.627 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 28.1 mmtp -133.65 -173.35 3.21 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.882 0.849 . . . . 0.0 111.997 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 56.6 tt0 -64.7 119.48 10.64 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 126.528 1.931 . . . . 0.0 109.978 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.18 19.07 40.41 Favored Glycine 0 C--N 1.292 -1.901 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.545 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.813 ' HG2' ' HB2' ' A' ' 46' ' ' PHE . 6.6 tp10 -78.64 137.53 37.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.155 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.56 96.68 8.47 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.842 HD11 HG11 ' A' ' 82' ' ' VAL . 22.5 pt -111.86 158.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 112.691 -2.05 . . . . 0.0 113.578 173.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HB3' HG21 ' A' ' 27' ' ' VAL . 3.8 mp0 -128.18 137.75 52.19 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 67' ' ' GLY 0.288 0.2 OUTLIER -102.21 124.77 56.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.866 176.213 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -107.95 -4.08 10.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.838 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.832 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.1 ttm180 -138.97 114.56 9.83 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.96 0.409 . . . . 0.0 110.81 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 HG13 ' A' ' 28' ' ' ILE . 51.1 mm -94.72 98.49 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.489 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 26.7 mmtp -134.93 158.3 44.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.003 0.43 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 17.6 m0 -109.41 162.23 14.55 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -104.04 112.48 25.49 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.561 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.11 177.6 18.24 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.164 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 7.0 ptm180 -150.02 145.88 26.67 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 52' ' ' ILE . 43.9 p -84.75 171.83 11.99 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.42 -23.92 67.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.351 0.596 . . . . 0.0 110.05 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -75.89 -14.93 60.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.106 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.68 28.49 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.285 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.1 m -92.95 109.01 20.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 26.2 m-85 -84.12 140.28 31.89 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.206 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -165.74 156.22 28.02 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.624 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.596 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 12.5 m-85 -68.96 150.18 48.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.603 0.716 . . . . 0.0 111.102 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 67' ' ' GLY . 70.3 mt -134.77 128.68 50.82 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 77' ' ' ILE . 91.5 mttt -68.21 143.05 55.48 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 168.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 p -68.96 -16.02 63.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.158 0.98 . . . . 0.0 111.546 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 80' ' ' THR . 5.4 t -89.79 -15.94 31.29 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.723 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -17.18 56.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.469 0.652 . . . . 0.0 110.472 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -129.63 156.88 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.805 0 CA-C-O 121.464 0.649 . . . . 0.0 112.509 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -98.29 100.65 11.96 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.2 mm -82.63 109.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.75 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 122.048 0.928 . . . . 0.0 112.409 178.901 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 2.5 pp -56.33 -25.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.37 -35.18 68.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.482 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.86 -32.52 15.29 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.902 0.858 . . . . 0.0 109.323 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -66.82 -45.71 77.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.37 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 65.1 m-85 -108.02 -3.36 18.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 2.9 mptp? 60.89 75.2 0.42 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.181 0.991 . . . . 0.0 110.006 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 15' ' ' ILE . 8.8 tp -89.76 -24.53 21.48 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.904 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.252 77.3 p 64.79 -69.12 0.1 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.845 1.658 . . . . 0.0 112.473 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.39 -107.97 0.21 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.49 145.51 71.06 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.441 2.094 . . . . 0.0 109.942 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.4 pp -138.66 -48.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.624 ' H ' HD12 ' A' ' 25' ' ' ILE . 31.1 mm-40 71.01 123.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.834 1.302 . . . . 0.0 114.129 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.19 140.5 18.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 112.548 -2.115 . . . . 0.0 111.156 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.95 -44.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.831 0.348 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.951 ' HB2' HD11 ' A' ' 54' ' ' ILE . 92.0 m-70 -142.83 177.08 8.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.54 119.25 38.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.453 0.644 . . . . 0.0 111.386 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.53 167.01 10.03 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.802 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 17.2 pttp -153.14 102.78 2.66 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.813 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.36 139.61 56.87 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.136 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.9 t -127.61 155.18 44.27 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.6 m 69.45 175.9 0.28 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 125.889 1.993 . . . . 0.0 111.456 162.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.79 113.25 16.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.796 HG21 ' CE1' ' A' ' 46' ' ' PHE . 17.4 m -112.16 155.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.79 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.66 -46.8 83.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.311 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.58 43.01 45.35 Favored Glycine 0 C--N 1.359 1.813 0 O-C-N 123.896 0.747 . . . . 0.0 113.738 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.28 -153.04 0.04 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 116.255 1.262 . . . . 0.0 116.255 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.27 -51.34 25.01 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.95 -6.8 59.49 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.283 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.48 172.73 8.19 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -83.0 141.67 31.91 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -81.62 45.17 0.86 Allowed 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.456 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.888 ' HE2' HG12 ' A' ' 77' ' ' ILE . 1.2 p90 -86.05 179.19 7.02 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.833 0.825 . . . . 0.0 112.021 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.788 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 28.1 mtpp -132.92 -172.06 2.83 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.995 -172.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 24.6 tt0 -76.6 -12.02 59.95 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 126.881 2.073 . . . . 0.0 113.677 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.7 19.59 2.39 Favored Glycine 0 C--N 1.268 -3.208 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 9.6 mm-40 -77.12 125.46 29.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.86 0.838 . . . . 0.0 113.182 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.38 97.75 9.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 82' ' ' VAL . 36.0 pt -112.64 159.1 12.8 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.047 0 CA-C-N 112.511 -2.131 . . . . 0.0 112.62 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.33 139.15 53.52 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -103.02 134.97 42.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.318 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -105.73 -24.45 4.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.415 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 9.3 ttt85 -127.38 122.94 34.98 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.382 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mm -104.6 96.75 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.976 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.463 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 CA-C-O 120.898 0.165 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.1 mmtp -133.28 156.38 47.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 32.5 m0 -93.11 162.35 14.06 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.712 0.633 . . . . 0.0 109.973 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -103.62 115.02 29.73 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.217 0.532 . . . . 0.0 110.327 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.728 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.48 -179.16 16.61 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.279 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 36.1 ptt180 -151.78 144.7 24.46 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.1 p -78.31 170.44 16.63 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.63 -14.67 59.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.214 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.66 0.03 57.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.217 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.83 68.35 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 m -97.83 113.2 24.94 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 23.0 m-85 -82.47 151.64 26.44 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.801 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -170.94 159.02 30.94 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.644 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.7 m-85 -71.63 147.97 47.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.623 0.725 . . . . 0.0 111.606 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.888 HG12 ' HE2' ' A' ' 46' ' ' PHE . 69.3 mt -133.0 133.27 58.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.761 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 77' ' ' ILE . 98.2 mttt -69.43 135.37 50.15 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 167.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.5 p -66.23 -8.11 22.51 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.628 0.728 . . . . 0.0 111.885 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -106.2 -6.96 18.12 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 124.064 0.946 . . . . 0.0 109.731 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -85.99 -14.13 45.5 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 52' ' ' ILE . 33.4 m -129.1 152.89 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.138 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.153 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.657 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 37.0 mt-10 -94.65 100.46 12.4 Favored 'General case' 0 N--CA 1.397 -3.11 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 27.3 mm -90.77 106.03 17.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 CA--C 1.471 -2.069 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.883 -174.8 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.438 -1.075 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 2.6 pp -54.88 -31.87 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -73.94 -24.53 59.66 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -96.94 -28.06 14.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 31.5 tttp -61.33 -52.28 65.32 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.257 1.423 . . . . 0.0 110.478 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 42.4 m-85 -99.03 -5.88 29.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.101 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 61.16 76.04 0.39 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.717 1.246 . . . . 0.0 108.304 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 25' ' ' ILE . 10.4 tp -116.36 16.09 15.75 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.212 -172.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -75.92 122.79 24.68 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.109 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.52 168.53 18.54 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 121.61 8.84 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.789 2.992 . . . . 0.0 112.196 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.854 HG13 ' H ' ' A' ' 26' ' ' GLN . 18.2 pt -106.37 -76.82 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.854 ' H ' HG13 ' A' ' 25' ' ' ILE 0.258 23.8 mt-30 72.41 141.12 0.06 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.186 1.394 . . . . 0.0 114.316 -177.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 53' ' ' GLU . 60.6 t -81.4 137.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.218 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.494 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.12 -42.3 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.92 ' HB2' HD11 ' A' ' 54' ' ' ILE . 84.8 m-70 -142.46 178.89 7.29 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 45.2 tp -115.27 125.66 53.57 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.63 171.49 7.3 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.64 0.734 . . . . 0.0 109.95 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 61.4 pttt -151.08 107.53 3.48 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -70.15 130.97 43.5 Favored 'General case' 0 C--N 1.255 -3.531 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.589 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.05 166.42 12.02 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 6.3 m 63.73 164.94 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 125.219 1.574 . . . . 0.0 114.444 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.98 111.18 5.49 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.833 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.3 m -111.89 156.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.087 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -56.33 -60.8 2.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 43' ' ' GLU . . . 49.6 41.48 34.14 Favored Glycine 0 C--O 1.21 -1.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.809 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.13 -110.26 0.01 OUTLIER Glycine 0 CA--C 1.542 1.724 0 N-CA-C 118.727 2.251 . . . . 0.0 118.727 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 9.4 mmpt? -98.87 -53.76 3.19 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 122.271 -0.546 . . . . 0.0 111.535 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -95.43 1.96 54.33 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' C ' ' A' ' 39' ' ' GLY . 39.2 mt-10 -92.65 157.52 16.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.684 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.048 0.927 . . . . 0.0 111.269 -173.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.6 m -84.07 69.75 10.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.671 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.925 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.86 -175.69 2.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.58 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -145.1 -172.66 3.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 124.036 0.835 . . . . 0.0 109.234 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.7 tt0 -85.7 107.44 17.58 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 125.429 1.492 . . . . 0.0 109.576 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.97 29.98 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.93 126.82 34.38 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.625 0.726 . . . . 0.0 111.629 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.93 96.44 10.68 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 33.3 pt -109.51 158.09 9.65 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.052 0 CA-C-N 112.495 -2.138 . . . . 0.0 112.704 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB3' HG11 ' A' ' 27' ' ' VAL . 30.3 mt-10 -121.83 134.64 54.89 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -97.33 129.27 47.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.288 175.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.665 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.5 mp -98.99 -40.28 8.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.008 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.9 ttm180 -121.87 119.7 32.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.758 -174.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.41 98.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.376 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.264 -175.528 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.939 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 33.0 mmtp -123.66 159.93 28.26 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.453 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.5 m0 -95.98 152.04 18.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.6 tm? -93.69 114.03 26.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -118.32 179.67 17.02 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.31 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 35.1 ptt180 -152.29 139.69 19.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.87 ' HA ' HG22 ' A' ' 52' ' ' ILE . 5.5 p -76.0 171.49 14.35 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 117.948 0.34 . . . . 0.0 110.446 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.45 -16.19 60.35 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -72.56 -17.48 61.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.558 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.11 23.53 22.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 23.6 m -113.43 128.09 56.33 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 41.2 m-85 -89.67 151.85 21.66 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.525 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -174.89 160.29 29.25 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 17.5 m-85 -74.73 146.45 42.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.388 0.613 . . . . 0.0 111.011 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.925 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.0 mt -128.29 129.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.673 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' O ' HG22 ' A' ' 77' ' ' ILE . 63.0 mttm -69.77 132.43 46.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 165.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.3 p -63.14 -10.75 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.737 0.78 . . . . 0.0 112.595 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.7 t -93.88 -21.1 19.45 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.897 0.879 . . . . 0.0 109.709 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.36 -15.07 60.04 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.974 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 34.4 m -127.19 157.81 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 CA-C-O 121.405 0.622 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 32.0 mt-10 -112.73 101.02 9.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 31' ' ' ALA . 20.0 mm -74.19 132.57 33.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.197 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.391 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.473 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.6 pp -64.51 -29.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.933 0.397 . . . . 0.0 111.742 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 45.6 mtmt -76.26 -25.58 55.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.637 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -83.86 -38.2 21.47 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.09 -49.28 62.21 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.083 1.353 . . . . 0.0 112.406 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.47 -4.6 25.15 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 57.37 75.52 0.37 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 10.7 tp -127.51 14.47 7.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.988 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -57.57 117.31 4.05 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.676 -172.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.98 169.47 11.67 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.84 120.15 6.86 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 122.218 1.946 . . . . 0.0 110.764 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.805 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.7 pp -104.26 151.44 6.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -143.46 159.28 42.69 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.345 1.058 . . . . 0.0 108.168 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 53' ' ' GLU . 30.8 m -75.2 154.97 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.691 HD12 HG12 ' A' ' 57' ' ' ILE . 36.0 mt -105.05 -32.74 2.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.589 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.919 ' HB2' HD11 ' A' ' 54' ' ' ILE . 55.4 m80 -152.01 -178.59 6.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 53' ' ' GLU . 30.2 tp -119.28 132.98 55.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.08 170.6 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.607 0.718 . . . . 0.0 110.646 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 46.0 pttt -153.32 102.87 2.64 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.841 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.99 125.52 23.97 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.689 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.8 p -111.26 166.55 11.0 Favored 'General case' 0 CA--C 1.452 -2.808 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.472 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m 61.26 174.67 0.11 Allowed 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 125.038 1.461 . . . . 0.0 112.307 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.14 102.96 8.75 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 46' ' ' PHE . 18.7 m -92.01 154.31 3.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.692 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -58.18 -58.95 6.21 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.65 42.09 90.44 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 124.288 0.992 . . . . 0.0 113.696 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.04 -152.57 0.37 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -63.27 -50.13 71.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 4.5 p-10 -82.8 -8.9 59.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.696 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 41.6 mt-10 -91.68 -179.81 5.44 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.571 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.4 tt -88.51 149.0 23.86 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 44' ' ' LEU . 29.9 t -92.08 90.17 7.26 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.726 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.61 176.91 9.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.892 -174.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -139.65 -174.0 3.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 111.612 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 28.9 tt0 -79.17 105.68 10.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 126.532 1.933 . . . . 0.0 108.81 -177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.88 12.15 44.27 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.44 157.8 33.58 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -108.26 96.78 6.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.7 -1.136 . . . . 0.0 107.964 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.693 HD11 HG11 ' A' ' 82' ' ' VAL . 23.1 pt -117.0 159.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.983 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 5.3 pt-20 -133.21 139.23 46.88 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.25 0.2 OUTLIER -102.34 132.48 48.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.822 179.458 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.805 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.37 -31.95 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.919 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.019 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.7 ttm180 -115.76 126.83 54.56 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.713 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 28' ' ' ILE . 51.1 mm -103.3 98.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.733 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.698 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 47.7 mmtm -133.53 155.91 48.74 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 26.1 m0 -108.36 152.49 24.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.35 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.019 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -92.74 110.72 22.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -116.81 176.56 16.32 Favored Glycine 0 N--CA 1.417 -2.63 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.154 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 23.0 ptt180 -151.76 143.13 23.41 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' HG22 ' A' ' 52' ' ' ILE . 4.2 p -77.05 166.15 23.68 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -20.83 66.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -67.33 -26.43 66.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.842 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.83 20.41 11.6 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.509 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 67.1 m -104.41 120.72 41.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 117.875 0.837 . . . . 0.0 108.799 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.6 m-85 -92.58 150.0 21.0 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.983 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.433 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -166.64 155.98 27.53 Favored Glycine 0 C--N 1.305 -1.169 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.15 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 2.0 m-85 -79.19 116.16 19.29 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-O 121.687 0.756 . . . . 0.0 110.015 174.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 78' ' ' LYS . 65.1 mt -100.41 140.2 20.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.761 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.5 mtmt -71.96 139.3 48.6 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.7 p -68.95 -12.69 61.88 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.768 0.794 . . . . 0.0 111.92 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 t -99.42 -12.22 20.44 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.589 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . . . -77.26 -15.89 59.25 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.193 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.1 m -130.39 154.18 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.7 mt-10 -100.84 102.8 13.94 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 31' ' ' ALA . 29.0 mm -79.58 119.2 28.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 . . . . . 0 CA--C 1.477 -1.836 0 CA-C-O 121.779 0.799 . . . . 0.0 110.593 178.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.52 -27.88 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.19 0.519 . . . . 0.0 111.343 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 92.9 mttt -75.04 -18.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.66 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -97.57 -40.52 8.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.92 -49.28 78.32 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.553 1.141 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.9 m-85 -100.83 -0.51 36.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.642 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.41 74.68 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.059 0.933 . . . . 0.0 108.737 -171.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 8.6 tp -121.57 15.01 11.11 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.557 -173.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -64.75 118.27 8.71 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.56 -164.75 21.66 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -66.17 140.07 57.87 Favored 'Trans proline' 0 CA--C 1.5 -1.222 0 C-N-CA 122.174 1.916 . . . . 0.0 109.406 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 55' ' ' ILE 0.359 0.0 OUTLIER -111.74 -66.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.173 -173.035 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' HD13 ' A' ' 25' ' ' ILE . 34.2 mm-40 70.96 161.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.121 0.962 . . . . 0.0 113.556 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.46 127.95 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.237 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.4 mm -98.87 -45.49 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.208 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.933 ' HB2' HD11 ' A' ' 54' ' ' ILE . 78.1 m-70 -152.36 170.45 20.04 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.92 125.68 48.65 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.997 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -106.78 175.18 5.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -153.71 106.59 2.9 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 175.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.869 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.52 138.02 57.79 Favored 'General case' 0 C--N 1.274 -2.683 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.118 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.1 t -126.62 151.86 47.43 Favored 'General case' 0 CA--C 1.447 -3.004 0 O-C-N 123.211 0.319 . . . . 0.0 110.307 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.1 m 71.22 167.42 0.31 Allowed 'General case' 0 N--CA 1.403 -2.805 0 O-C-N 125.976 2.048 . . . . 0.0 111.903 163.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.35 104.87 4.51 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.008 0.909 . . . . 0.0 110.707 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.795 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.7 m -107.49 157.4 7.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 124.633 1.173 . . . . 0.0 110.493 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HD3' ' HE3' ' A' ' 78' ' ' LYS . 13.2 ptmm? -59.11 -53.82 54.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 123.609 0.568 . . . . 0.0 111.164 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 46.89 41.75 14.21 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.901 -0.666 . . . . 0.0 114.121 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.35 -111.13 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.034 1.974 . . . . 0.0 118.034 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.7 -53.79 7.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -112.38 3.29 16.87 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.971 0.891 . . . . 0.0 109.472 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.0 mt-10 -91.92 148.42 22.22 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -69.94 126.96 31.22 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.72 0.771 . . . . 0.0 109.706 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 m -85.26 83.14 8.08 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.829 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.84 -177.44 3.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.222 -178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.5 mtpt -125.73 -173.99 2.97 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.193 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -73.93 -9.14 58.33 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.187 2.195 . . . . 0.0 113.785 -170.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.28 18.65 2.48 Favored Glycine 1 C--N 1.245 -4.491 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.0 mm-40 -79.75 128.21 33.14 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.744 0.783 . . . . 0.0 111.556 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -89.26 96.95 10.93 Favored 'General case' 0 N--CA 1.404 -2.755 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.88 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.871 HD11 HG11 ' A' ' 82' ' ' VAL . 20.8 pt -113.72 157.96 14.23 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.916 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.946 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -131.88 141.58 49.43 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.933 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.28 147.62 7.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.699 -177.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 25' ' ' ILE . 3.6 mp -112.94 -57.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.42 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.926 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 41.9 ttm180 -92.73 125.55 37.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.777 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.38 100.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.054 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.118 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 45.0 mmtm -134.09 166.09 23.56 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.0 m0 -104.27 146.65 28.49 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.926 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -94.91 115.7 27.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -113.64 178.68 18.58 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.8 ptt180 -151.83 138.79 19.04 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.661 ' HA ' HG22 ' A' ' 52' ' ' ILE . 28.8 p -77.87 176.49 9.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.87 -18.12 62.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.927 0.87 . . . . 0.0 109.209 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -78.49 -15.32 58.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.611 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.54 19.44 41.25 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.434 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -98.34 114.18 26.4 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.561 ' HD2' HD11 ' A' ' 66' ' ' LEU . 27.9 m-85 -83.34 150.59 26.02 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.975 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.53 154.01 22.18 Favored Glycine 0 CA--C 1.5 -0.885 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.41 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.429 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 26.8 m-85 -73.85 143.22 45.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.655 0.741 . . . . 0.0 110.959 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.829 HG12 ' HE2' ' A' ' 46' ' ' PHE . 54.0 mt -128.71 136.59 59.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.089 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 88.3 mttt -70.2 140.23 52.46 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.4 p -65.3 -6.77 10.71 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -106.23 -12.22 15.79 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.386 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.46 -10.85 59.71 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.369 0.604 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 52' ' ' ILE . 27.0 m -134.63 153.51 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.396 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.514 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 15.3 mm-40 -96.19 100.53 12.16 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.512 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.8 mm -75.9 131.11 35.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.622 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 CA--C 1.48 -1.731 0 CA-C-O 122.627 1.203 . . . . 0.0 111.1 178.584 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 . . . . . 0 CA--C 1.508 -0.638 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.62 -26.5 40.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.806 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -71.04 -42.64 69.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.514 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.62 -7.88 59.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.076 0.465 . . . . 0.0 110.923 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -100.32 -49.34 4.29 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.095 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.1 m-85 -104.54 -12.1 16.65 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 59.97 79.53 0.23 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.999 0.904 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.44 -36.46 22.33 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.624 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 26.4 p 60.41 -47.55 0.1 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.418 2.287 . . . . 0.0 116.704 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.68 -168.83 11.39 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.74 141.55 49.93 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.529 2.153 . . . . 0.0 111.635 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.986 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.5 pp -118.37 160.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.526 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.501 ' O ' HG13 ' A' ' 27' ' ' VAL . 49.2 mt-30 -110.93 -93.71 0.44 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.189 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 170.92 149.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.608 2.363 . . . . 0.0 109.491 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 29' ' ' HIS . 48.6 mm -110.24 -42.39 5.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.0 m-70 -153.13 176.64 11.69 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.9 mp -105.62 137.37 43.58 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 171.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.84 168.79 9.39 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -151.04 103.25 3.03 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -58.75 132.18 53.11 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.087 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.6 t -115.75 151.32 35.36 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.1 m 68.73 178.46 0.25 Allowed 'General case' 0 N--CA 1.405 -2.709 0 O-C-N 125.67 1.856 . . . . 0.0 110.491 163.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.57 108.04 15.66 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.835 HG21 ' HE1' ' A' ' 46' ' ' PHE . 8.3 m -99.15 155.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.85 -49.91 74.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.178 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 43' ' ' GLU . . . 54.09 41.42 69.21 Favored Glycine 0 C--N 1.352 1.426 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.208 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.89 -102.33 0.01 OUTLIER Glycine 0 C--O 1.245 0.825 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -98.34 -53.72 3.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 34.7 p30 -95.38 0.43 53.5 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.142 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 29.7 mt-10 -90.66 151.26 21.34 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -67.06 146.93 53.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.77 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.419 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.6 m -83.71 70.84 10.4 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.835 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -112.32 -179.79 3.77 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.575 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.1 mtpt -136.3 -173.47 3.41 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.59 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -71.16 -12.39 61.46 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 128.545 2.738 . . . . 0.0 114.652 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.96 19.23 2.34 Favored Glycine 0 C--N 1.259 -3.728 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 6.8 mm-40 -78.68 127.46 32.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.787 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -97.8 96.33 8.15 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.876 HG22 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -107.67 158.32 7.6 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.152 0 CA-C-N 112.086 -2.325 . . . . 0.0 112.427 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.823 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.1 mt-10 -123.08 133.45 54.3 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 120.901 -1.125 . . . . 0.0 109.362 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -96.69 138.54 21.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.642 177.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.986 HG21 ' HB ' ' A' ' 25' ' ' ILE . 3.6 mp -111.63 -35.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.795 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.707 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.3 ttm180 -108.92 125.86 52.46 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.043 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.38 104.56 16.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.279 -2.464 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 CA-C-O 121.024 0.235 . . . . 0.0 113.15 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.552 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.5 mmtm -102.22 145.27 29.66 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -94.11 144.44 25.49 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.881 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -86.51 109.03 18.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -112.38 177.84 18.71 Favored Glycine 0 N--CA 1.419 -2.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.251 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 28.8 ptt180 -151.64 136.1 16.91 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.876 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.1 p -73.34 169.88 16.2 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 118.032 0.378 . . . . 0.0 110.55 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -6.94 52.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.501 0.667 . . . . 0.0 109.209 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.84 -25.02 17.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.541 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 31.8 2.09 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.388 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 m -113.13 116.69 30.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 66' ' ' LEU . 88.7 m-85 -82.93 147.35 28.3 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -164.11 157.07 29.25 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.062 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 1.1 m-30 -80.63 127.48 32.51 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.912 0.863 . . . . 0.0 109.222 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.834 HG12 ' HE2' ' A' ' 46' ' ' PHE . 86.8 mt -107.43 133.87 50.87 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.151 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.113 -175.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 48.7 mtmt -71.01 127.44 32.57 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 167.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.0 p -59.41 -18.29 37.76 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -92.08 -20.89 20.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.709 0.804 . . . . 0.0 109.864 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -75.85 -13.44 60.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 52' ' ' ILE . 34.8 m -127.57 154.55 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.41 101.98 12.7 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.6 mm -78.14 125.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.428 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 CA--C 1.481 -1.699 0 CA-C-O 122.588 1.185 . . . . 0.0 110.707 178.65 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pp -60.3 -26.97 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.018 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.48 -21.41 45.42 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -97.95 -37.51 9.76 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.522 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.9 ttpt -65.53 -36.47 83.9 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.48 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.7 m-85 -110.46 8.43 23.12 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 56.45 38.82 30.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.933 0.873 . . . . 0.0 110.395 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 21' ' ' LEU . 7.1 tp -94.24 17.01 13.47 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.507 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -62.6 122.09 14.95 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.393 0.616 . . . . 0.0 109.371 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.97 162.01 11.05 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.62 134.3 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.364 2.042 . . . . 0.0 112.443 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.717 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -125.66 154.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.453 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.2 mm100 -110.14 -84.31 0.56 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.75 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -177.62 136.78 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 C-N-CA 127.363 2.265 . . . . 0.0 108.407 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG21 HG12 ' A' ' 57' ' ' ILE . 46.9 mm -98.05 -42.83 11.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 1.066 ' HB2' HD11 ' A' ' 54' ' ' ILE . 91.4 m-70 -150.74 168.84 23.19 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -104.62 124.85 50.07 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.81 168.89 8.84 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 15.1 ptpt -153.45 103.86 2.7 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.838 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.65 139.89 57.89 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.31 -177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 44.0 t -123.12 150.68 42.91 Favored 'General case' 0 CA--C 1.452 -2.797 0 CA-C-O 121.219 0.533 . . . . 0.0 110.36 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.4 m 68.81 -179.95 0.23 Allowed 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.016 163.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.51 103.2 15.66 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.909 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.0 m -93.84 155.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.227 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.62 -42.85 75.5 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.284 0.99 . . . . 0.0 110.851 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.0 43.9 31.88 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 115.201 0.841 . . . . 0.0 115.201 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.06 -175.64 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -47.32 -52.29 16.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.457 1.103 . . . . 0.0 113.741 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -88.78 -4.63 58.46 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.367 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.76 166.6 12.68 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.661 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -79.48 145.21 33.38 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.485 0.66 . . . . 0.0 109.375 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 m -85.86 41.95 0.94 Allowed 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.297 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.898 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -82.43 176.78 9.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.589 0.709 . . . . 0.0 112.3 -177.182 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 60.2 mtpt -132.74 -173.86 3.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.0 -173.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 30.6 tt0 -65.59 -15.8 63.08 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 127.121 2.168 . . . . 0.0 115.532 -169.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.47 19.25 2.81 Favored Glycine 0 C--N 1.26 -3.651 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 11.5 mm-40 -77.37 126.47 30.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -89.62 97.34 11.14 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 113.936 -1.484 . . . . 0.0 107.657 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.98 HD11 HG11 ' A' ' 82' ' ' VAL . 24.7 pt -110.4 158.54 10.66 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.343 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.652 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.59 139.38 52.31 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 121.286 -0.884 . . . . 0.0 108.825 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.066 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.61 135.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.889 0.852 . . . . 0.0 110.232 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.97 8.47 6.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.741 -177.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.762 ' HG2' HG23 ' A' ' 58' ' ' THR . 28.7 ttm180 -154.97 117.75 4.34 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.511 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.455 HG12 HG21 ' A' ' 28' ' ' ILE . 51.2 mm -93.28 96.85 6.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.278 -2.54 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.994 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.3 mmtt -133.36 161.66 33.93 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.456 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.5 m0 -101.03 159.18 15.44 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -100.35 115.3 29.66 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.151 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.679 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.49 -178.48 16.52 Favored Glycine 0 N--CA 1.419 -2.473 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.88 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 37.0 ptt180 -151.83 144.42 24.23 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.686 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.8 p -78.85 175.21 10.71 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 118.598 0.635 . . . . 0.0 109.513 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.92 60.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.24 1.019 . . . . 0.0 109.477 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.15 -14.36 41.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.283 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 33.5 14.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.801 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 113.29 26.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 66.1 m-85 -82.89 147.6 28.19 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.776 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.28 154.28 23.56 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.43 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.505 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 27.8 m-85 -73.31 149.35 42.73 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.84 0.828 . . . . 0.0 111.08 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.898 HG12 ' HE2' ' A' ' 46' ' ' PHE . 59.9 mt -130.05 134.07 63.4 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.875 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 77' ' ' ILE . 47.9 mtmt -67.58 139.47 56.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 p -66.92 -12.06 58.26 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.84 0.828 . . . . 0.0 111.742 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' THR . 2.8 t -100.88 -18.04 16.56 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.565 1.146 . . . . 0.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -74.1 -13.89 60.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.758 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.98 HG11 HD11 ' A' ' 52' ' ' ILE . 28.2 m -135.76 161.68 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.83 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 31.1 mm-40 -110.21 113.54 26.3 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.2 mp -84.79 140.47 15.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 122.009 0.909 . . . . 0.0 112.156 -176.997 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 120.788 0.327 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.01 -30.46 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.718 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 96.8 mttt -73.75 -29.72 62.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.95 -40.31 16.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.48 -44.52 64.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.116 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -95.12 -5.16 44.8 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.798 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm 59.5 71.92 0.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.6 tp -107.3 16.65 23.76 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.502 -171.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -49.85 132.41 22.41 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.543 0.737 . . . . 0.0 112.418 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.76 -152.77 17.43 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.97 142.87 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 122.931 2.42 . . . . 0.0 112.84 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.75 109.61 28.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.182 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.26 141.6 39.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.681 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 14.8 m -67.55 152.91 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-O 121.258 0.551 . . . . 0.0 111.356 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 57' ' ' ILE . 21.0 mm -107.65 -31.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 1.051 ' HB2' HD11 ' A' ' 54' ' ' ILE . 47.8 m-70 -153.98 179.57 8.78 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -117.45 128.96 55.52 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.6 169.73 8.76 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.234 0.54 . . . . 0.0 110.599 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -153.7 111.48 3.53 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 174.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.48 138.97 58.44 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.88 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLN . 41.7 t -121.1 148.69 43.83 Favored 'General case' 0 CA--C 1.442 -3.178 0 CA-C-O 121.16 0.505 . . . . 0.0 110.081 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' N ' ' HA ' ' A' ' 48' ' ' GLN . 12.3 m 70.11 176.07 0.28 Allowed 'General case' 0 N--CA 1.401 -2.876 0 O-C-N 126.055 2.097 . . . . 0.0 111.537 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.6 114.37 20.25 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.01 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.831 HG21 ' CE1' ' A' ' 46' ' ' PHE . 13.1 m -115.57 156.48 16.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.671 -174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -47.31 -61.63 1.81 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.339 1.025 . . . . 0.0 109.328 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.11 43.67 83.48 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.449 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.79 -171.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 27.2 mtpp -54.01 -46.07 71.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -174.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.594 HD22 ' HD2' ' A' ' 76' ' ' TYR . 4.0 p-10 -94.46 -4.87 47.46 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.801 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.77 168.28 10.92 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -83.2 126.66 32.87 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -85.84 45.89 1.26 Allowed 'General case' 0 C--N 1.256 -3.46 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.974 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.942 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -75.75 179.26 5.55 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.867 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 54.8 mtpt -122.25 -172.61 2.49 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.233 -174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 39.1 tt0 -69.17 -17.71 63.84 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 126.482 1.913 . . . . 0.0 115.45 -166.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.63 19.2 2.03 Favored Glycine 1 C--N 1.249 -4.261 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.842 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.2 mm-40 -70.36 132.82 46.23 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.12 97.33 11.08 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 123.211 1.482 . . . . 0.0 108.616 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.809 HD11 HG11 ' A' ' 82' ' ' VAL . 18.9 pt -110.83 159.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.726 0 CA-C-N 111.363 -2.653 . . . . 0.0 112.367 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.8 130.02 31.27 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.619 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -91.72 130.04 41.48 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.405 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -113.78 6.44 7.8 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.535 -175.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 37.3 ttm180 -154.29 119.5 5.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.027 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 28' ' ' ILE . 41.7 mm -87.78 111.26 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 170.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.3 p . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.45 0.643 . . . . 0.0 112.618 -171.491 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.073 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.568 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 30.5 mmtp -110.29 142.43 41.92 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.424 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 34.9 m0 -83.93 152.42 24.51 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 123.623 0.577 . . . . 0.0 110.927 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.8 tm? -93.58 107.77 19.58 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.284 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -111.9 174.26 16.3 Favored Glycine 0 N--CA 1.414 -2.814 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.669 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.537 ' HG2' HD12 ' A' ' 55' ' ' ILE . 13.4 ptm180 -151.69 146.36 25.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 52' ' ' ILE . 71.3 p -82.0 169.66 16.48 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.8 31.02 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.234 0.54 . . . . 0.0 110.536 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.87 4.31 47.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.331 0.586 . . . . 0.0 109.852 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.84 17.75 59.24 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.526 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -98.73 109.26 22.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 25.8 m-85 -87.87 146.37 25.61 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.197 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.06 158.21 30.65 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.813 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.594 ' HD2' HD22 ' A' ' 42' ' ' ASN . 27.2 m-85 -74.28 135.35 42.62 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.699 0.761 . . . . 0.0 110.976 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.942 HG12 ' HE2' ' A' ' 46' ' ' PHE . 87.5 mt -114.83 124.44 71.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.338 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.07 128.53 36.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.0 p -60.9 -11.87 9.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.394 0.616 . . . . 0.0 112.656 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 80' ' ' THR . 4.4 t -92.39 -19.83 21.67 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.674 0.79 . . . . 0.0 110.329 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -79.43 -10.6 59.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.972 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.849 HG12 ' HA ' ' A' ' 33' ' ' ALA . 31.6 m -133.29 160.77 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.298 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -102.21 103.93 14.47 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 31' ' ' ALA . 30.0 mm -84.35 121.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.949 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 63.0 m-20 . . . . . 0 C--N 1.309 -1.168 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.434 -1.251 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -26.56 39.25 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.801 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 87.9 mttt -74.03 -22.57 59.52 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.434 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.54 -39.59 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -65.93 -51.03 62.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.004 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -98.87 3.01 47.17 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.92 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm 51.67 76.21 0.18 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.397 1.094 . . . . 0.0 109.912 -173.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.5 tp -127.51 15.93 7.07 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.783 -173.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -57.62 128.66 38.2 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.251 0.548 . . . . 0.0 110.75 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.07 166.97 12.78 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 111.71 3.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.293 1.995 . . . . 0.0 110.651 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.853 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 pp -98.57 142.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -116.21 142.63 46.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.152 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.8 p -71.08 144.65 13.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' CD2' ' A' ' 29' ' ' HIS . 51.2 mm -103.76 -36.03 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.191 0.52 . . . . 0.0 110.757 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.811 ' HB2' HD11 ' A' ' 54' ' ' ILE . 75.1 m-70 -147.94 152.58 37.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.5 mp -92.06 119.71 32.01 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.41 174.88 5.68 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.541 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.35 112.66 3.8 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.69 137.34 56.61 Favored 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.567 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.2 t -127.47 154.22 45.36 Favored 'General case' 0 CA--C 1.444 -3.133 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.777 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.3 m 71.15 175.11 0.29 Allowed 'General case' 0 N--CA 1.4 -2.965 0 O-C-N 125.748 1.905 . . . . 0.0 111.275 163.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.27 110.21 14.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.761 HG21 ' CE1' ' A' ' 46' ' ' PHE . 14.0 m -108.44 155.27 9.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.613 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -56.68 -46.41 81.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.83 43.0 87.15 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.788 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.77 -178.81 0.31 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -29.73 38.13 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -106.76 -6.12 18.0 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.328 0.585 . . . . 0.0 109.945 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.78 164.34 12.79 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.523 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.664 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.8 140.13 38.27 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 t -88.0 43.91 1.15 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.949 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -80.16 -178.98 6.82 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.372 -178.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.9 mtpt -130.53 178.87 6.29 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.069 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 3.7 tt0 -65.2 -12.77 54.77 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 128.236 2.614 . . . . 0.0 114.241 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.39 18.65 3.45 Favored Glycine 0 C--N 1.266 -3.333 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.1 mm-40 -85.22 127.42 34.29 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 112.679 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 97.22 10.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 82' ' ' VAL . 27.6 pt -109.56 157.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.914 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.201 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.892 ' HB3' HG21 ' A' ' 27' ' ' VAL . 43.5 mt-10 -123.71 135.53 53.92 Favored 'General case' 0 C--N 1.281 -2.393 0 O-C-N 121.265 -0.897 . . . . 0.0 109.099 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.25 137.03 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.011 -179.077 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.853 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.7 mp -104.13 -49.09 9.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.203 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.863 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 40.6 ttm180 -97.56 113.89 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.661 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG23 ' CE2' ' A' ' 65' ' ' TRP . 43.1 mm -95.57 98.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--N 1.315 -0.92 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.42 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.677 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.4 mmtt -134.28 167.78 20.08 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 42.8 m0 -104.18 140.36 37.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.768 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.4 tm? -87.2 111.93 21.48 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -109.24 -179.64 21.19 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.14 138.88 19.77 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.755 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.9 p -77.98 171.8 14.46 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -0.18 19.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.603 0.716 . . . . 0.0 109.979 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 71' ' ' ARG . 1.8 mmp_? -101.11 -14.56 17.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.815 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.8 21.38 9.72 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.112 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -103.12 113.66 27.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 117.324 0.562 . . . . 0.0 109.787 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB3' HD21 ' A' ' 66' ' ' LEU . 47.5 m-85 -86.96 144.79 26.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.854 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -167.73 153.32 22.56 Favored Glycine 0 C--N 1.301 -1.396 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.935 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.531 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 41.4 m-85 -73.04 155.13 40.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.393 0.616 . . . . 0.0 111.324 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.949 HG12 ' HE2' ' A' ' 46' ' ' PHE . 53.1 mt -137.87 136.39 45.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 44.0 mtmt -69.16 141.72 54.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 168.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -69.49 -6.82 33.06 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 119.271 0.941 . . . . 0.0 112.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.3 t -96.18 -22.11 17.48 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.069 0.948 . . . . 0.0 109.71 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -73.21 -15.48 61.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -130.69 152.33 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 121.17 0.51 . . . . 0.0 112.13 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -92.65 100.68 13.14 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 82' ' ' VAL . 27.8 mm -92.22 125.02 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.75 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 . . . . . 0 C--N 1.297 -1.711 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.941 174.519 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.542 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.8 pp -55.87 -28.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.314 1.046 . . . . 0.0 111.916 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' HD12 ' A' ' 15' ' ' ILE . 95.9 mttt -72.5 -22.4 61.05 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.97 -45.17 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -59.42 -47.3 85.99 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.149 1.38 . . . . 0.0 111.729 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.45 0.3 19.26 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 33.2 mmtp 56.54 75.24 0.36 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.54 1.162 . . . . 0.0 111.593 -173.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 74' ' ' TYR . 78.8 mt -125.98 16.71 7.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.867 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -72.62 102.46 3.29 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.392 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.63 -155.19 26.37 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -93.32 121.09 0.41 Allowed 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 123.113 2.542 . . . . 0.0 111.65 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -111.79 142.16 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.569 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' C ' HG22 ' A' ' 55' ' ' ILE . 54.3 mt-30 -132.47 138.38 47.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 53' ' ' GLU . 14.0 m -59.94 134.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.346 0.593 . . . . 0.0 111.953 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.87 -34.7 5.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.1 m-70 -155.1 173.59 16.38 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.8 139.88 48.05 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.58 172.01 7.18 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.163 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -152.71 102.64 2.72 Favored 'General case' 0 C--N 1.264 -3.145 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -69.11 137.36 53.39 Favored 'General case' 0 C--N 1.268 -2.978 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.792 -175.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.0 t -124.78 150.08 46.68 Favored 'General case' 0 CA--C 1.436 -3.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.268 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.3 m 72.74 164.7 0.29 Allowed 'General case' 0 N--CA 1.4 -2.958 0 O-C-N 126.234 2.209 . . . . 0.0 111.15 163.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.64 106.76 1.9 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.775 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.9 m -98.81 157.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.445 -173.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -42.52 -65.89 0.42 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 125.001 1.438 . . . . 0.0 110.331 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.08 43.53 90.18 Favored Glycine 0 C--N 1.321 -0.259 0 C-N-CA 119.85 -1.167 . . . . 0.0 114.264 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -57.46 -173.01 0.27 Allowed Glycine 0 CA--C 1.552 2.405 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -64.62 -37.92 89.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -102.2 1.96 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.649 0.737 . . . . 0.0 109.937 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 47.2 mt-10 -92.53 163.26 13.88 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.714 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.73 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -84.73 127.31 34.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -89.93 73.75 7.38 Favored 'General case' 0 C--N 1.253 -3.625 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.791 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -97.73 -176.76 3.56 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.546 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.596 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 47.7 mtpt -131.44 -173.18 3.04 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.822 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' CB ' ' H ' ' A' ' 35' ' ' CYS . 60.5 tt0 -88.06 114.74 24.98 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 125.089 1.356 . . . . 0.0 107.651 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.89 -1.77 51.96 Favored Glycine 0 C--N 1.29 -2.025 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 12.7 mm-40 -72.32 125.18 26.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.548 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.95 96.2 9.96 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-O 123.316 1.532 . . . . 0.0 108.154 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 HG11 ' A' ' 82' ' ' VAL . 23.5 pt -106.59 158.61 6.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.912 -2.404 . . . . 0.0 111.004 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG12 ' A' ' 27' ' ' VAL . 4.8 pt-20 -134.67 130.22 36.01 Favored 'General case' 0 C--N 1.249 -3.785 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.623 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -93.69 136.2 26.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 CA-C-O 122.196 0.998 . . . . 0.0 112.158 -178.381 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.477 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -118.47 7.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.697 -177.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.892 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.7 ttm180 -149.44 123.84 9.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.182 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.421 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 51.0 mm -109.35 99.71 9.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.752 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.432 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.561 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 46.7 mmtm -133.74 161.01 35.85 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.478 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.1 m0 -102.7 161.05 14.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -106.3 115.42 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.961 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.44 179.39 17.7 Favored Glycine 0 N--CA 1.416 -2.668 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.972 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 31.3 ptt180 -152.22 144.4 23.9 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.5 p -74.55 169.89 16.85 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.06 64.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.628 0.728 . . . . 0.0 109.196 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -78.26 -23.86 47.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.653 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.36 26.96 6.68 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.303 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -108.83 111.74 23.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 1.9 m-85 -87.11 148.09 25.37 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.716 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.84 154.19 22.32 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.008 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.445 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 34.6 m-85 -70.44 142.58 51.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.763 0.792 . . . . 0.0 111.626 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.791 HG12 ' HE2' ' A' ' 46' ' ' PHE . 67.2 mt -125.39 136.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.415 -173.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 77' ' ' ILE . 89.5 mttt -72.82 135.98 45.31 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 166.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.8 p -65.23 -10.47 32.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.619 0.723 . . . . 0.0 112.031 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -98.7 -17.66 18.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.209 1.004 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.68 -12.77 60.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.584 0.707 . . . . 0.0 109.224 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.943 HG11 HD11 ' A' ' 52' ' ' ILE . 34.9 m -134.97 155.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.511 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -98.87 100.53 11.73 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.1 mm -79.72 128.46 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--N 1.31 -1.132 0 CA-C-O 121.993 0.901 . . . . 0.0 110.655 178.449 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -60.71 -29.34 44.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 98.2 mttt -80.69 -25.67 38.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.878 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -90.5 -42.67 10.71 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.381 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -69.82 -52.73 22.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.433 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.23 -0.46 53.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 54.08 73.41 0.39 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.947 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HG ' HG21 ' A' ' 25' ' ' ILE . 4.5 tp -127.03 16.61 7.3 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.351 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 16' ' ' LYS . 10.3 t -77.39 126.06 30.32 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 119.184 -1.007 . . . . 0.0 110.433 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.76 -155.72 16.2 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.74 137.11 34.75 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.395 2.73 . . . . 0.0 110.486 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.878 ' HB ' HG21 ' A' ' 55' ' ' ILE . 17.0 pt -127.07 -70.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.859 ' H ' HG13 ' A' ' 25' ' ' ILE . 30.4 mt-30 70.39 131.37 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.14 1.776 . . . . 0.0 113.638 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 88.3 t -76.26 136.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.871 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG22 ' CD2' ' A' ' 29' ' ' HIS . 47.9 mm -99.83 -43.63 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.976 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.93 ' HB2' HD11 ' A' ' 54' ' ' ILE . 65.2 m-70 -140.24 173.88 11.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.86 124.77 51.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.05 172.49 6.77 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.519 0.676 . . . . 0.0 110.302 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 4.4 ttmp? -151.88 106.46 3.22 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.876 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.44 120.57 13.58 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.24 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 42.2 t -93.32 155.8 17.19 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.2 m 62.5 -174.11 0.15 Allowed 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 125.6 1.812 . . . . 0.0 111.127 163.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -91.21 118.27 30.33 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 166.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.904 HG21 ' HE1' ' A' ' 46' ' ' PHE . 20.9 m -97.41 156.89 3.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.614 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -51.43 -47.81 62.9 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.232 0.957 . . . . 0.0 108.703 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.36 95.68 Favored Glycine 0 N--CA 1.438 -1.201 0 O-C-N 124.157 0.911 . . . . 0.0 113.388 173.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.23 178.59 0.13 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.466 0.946 . . . . 0.0 115.466 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.41 -43.56 44.54 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.843 1.257 . . . . 0.0 113.304 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -94.19 -1.58 53.89 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.573 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.4 167.09 12.21 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.164 0.507 . . . . 0.0 110.961 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -79.75 141.95 35.86 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.103 -177.061 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.0 p -87.44 84.73 7.13 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.076 175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.904 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.15 176.89 6.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.631 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 57.6 mtpt -128.44 -172.81 2.79 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.748 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.5 tt0 -83.2 110.25 17.9 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 125.099 1.359 . . . . 0.0 109.945 -175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.76 17.4 48.57 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.5 mm-40 -76.33 130.39 38.03 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.626 0.727 . . . . 0.0 110.99 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.98 96.9 10.43 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.521 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 82' ' ' VAL . 28.7 pt -113.57 157.74 14.16 Favored 'Isoleucine or valine' 1 C--N 1.235 -4.41 0 CA-C-N 111.834 -2.439 . . . . 0.0 111.053 174.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.19 136.94 53.44 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.58 138.7 23.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.806 178.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.878 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.2 -47.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.569 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 57.0 ttt180 -110.17 121.79 46.1 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.325 -172.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.41 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mm -97.72 95.89 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.304 -1.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 175.324 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 45.8 mmtm -121.61 144.33 48.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 35.3 m0 -93.75 162.22 14.01 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.851 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -102.59 117.33 34.44 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.56 176.79 16.3 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.65 142.57 23.0 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 124.536 1.134 . . . . 0.0 108.814 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' ILE . 31.1 p -77.89 168.36 20.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.37 66.42 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.674 0.273 . . . . 0.0 110.633 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -78.8 -27.04 44.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.8 25.81 3.81 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.14 -1.029 . . . . 0.0 114.188 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.1 m -100.03 113.25 25.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB2' HG21 ' A' ' 15' ' ' ILE . 7.0 m-85 -91.93 144.04 25.88 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.533 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 159.64 32.81 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.191 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.621 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 24.2 m-85 -72.0 151.0 43.52 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.15 0.5 . . . . 0.0 110.119 174.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HE2' ' A' ' 46' ' ' PHE . 60.2 mt -135.18 130.9 51.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.871 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.2 mtmt -64.48 136.74 57.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -67.53 -13.05 61.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.859 0.838 . . . . 0.0 111.936 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 78' ' ' LYS . 11.8 t -96.14 -14.15 23.04 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.287 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.53 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.27 -20.27 55.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.876 HG12 ' HA ' ' A' ' 33' ' ' ALA . 34.3 m -128.96 149.64 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 121.361 0.601 . . . . 0.0 112.369 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.5 pt-20 -96.97 102.37 14.14 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.447 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -81.72 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.672 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--N 1.317 -0.84 0 CA-C-O 121.174 0.511 . . . . 0.0 110.303 -178.611 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 119.858 -0.115 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.33 -29.53 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.427 0.691 . . . . 0.0 112.65 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.76 -22.32 58.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.048 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -97.07 -42.83 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.911 0.862 . . . . 0.0 108.744 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -62.65 -50.13 72.41 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.809 1.644 . . . . 0.0 110.732 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -102.05 -2.09 30.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.156 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 58.48 76.42 0.34 Allowed 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 124.096 0.872 . . . . 0.0 108.839 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.62 16.36 9.56 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.865 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -82.46 114.4 20.87 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.889 0.852 . . . . 0.0 110.028 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.96 -170.41 24.55 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.14 117.72 4.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.601 2.2 . . . . 0.0 111.928 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.707 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.9 pp -132.3 139.32 50.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -131.4 140.29 49.63 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.776 0.431 . . . . 0.0 110.448 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.0 p -63.4 141.19 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 O-C-N 123.603 0.565 . . . . 0.0 111.138 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 HG12 ' A' ' 57' ' ' ILE . 54.6 mt -103.6 -33.08 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.157 0.503 . . . . 0.0 111.937 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.809 ' HB2' HD11 ' A' ' 54' ' ' ILE . 67.8 m-70 -154.95 167.5 30.11 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.589 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.0 mp -106.69 137.64 44.34 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -111.42 171.92 7.2 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.257 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 20.4 ptmt -151.17 106.66 3.36 Favored 'General case' 0 N--CA 1.397 -3.09 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -62.86 109.55 1.48 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.461 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.5 t -96.26 150.73 20.22 Favored 'General case' 0 CA--C 1.426 -3.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.573 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.5 m 66.45 -175.84 0.19 Allowed 'General case' 0 N--CA 1.399 -3.005 0 O-C-N 126.078 2.111 . . . . 0.0 109.385 165.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.81 120.63 18.7 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 ' CE1' ' A' ' 46' ' ' PHE . 4.3 m -98.99 154.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -59.38 -69.14 0.22 Allowed 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.813 0.696 . . . . 0.0 109.29 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.98 42.6 84.93 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.242 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.27 -116.51 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -99.61 -52.97 3.32 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.651 -0.911 . . . . 0.0 112.474 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -90.64 2.84 55.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.378 0.609 . . . . 0.0 110.555 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 38.3 mt-10 -90.25 159.16 16.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.145 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.578 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -64.8 149.09 50.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 124.05 0.844 . . . . 0.0 110.207 -176.433 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.8 m -88.81 80.14 7.25 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.665 ' HD2' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -134.79 167.61 20.56 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.46 -177.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.9 mmtp -143.67 -172.8 3.8 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.736 0.779 . . . . 0.0 111.263 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 49.7 tt0 -67.93 120.7 14.64 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 126.492 1.917 . . . . 0.0 109.346 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.17 4.57 68.6 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.034 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 48.5 mm-40 -76.12 126.77 31.62 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.936 0.874 . . . . 0.0 111.355 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -96.12 96.94 9.18 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 69' ' ' THR . 33.1 pt -107.75 159.7 7.18 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.105 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.164 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.803 ' HB3' HG21 ' A' ' 27' ' ' VAL . 50.4 mt-10 -121.29 139.73 53.01 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.259 0.2 OUTLIER -105.06 132.17 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.94 175.462 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.707 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.9 mp -105.42 -34.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.562 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.88 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.8 ttm180 -114.5 119.51 37.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.751 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.675 HG12 HD12 ' A' ' 28' ' ' ILE . 44.0 mm -101.71 98.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.614 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.347 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.4 mmtm -133.49 160.54 37.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 40.5 m0 -101.57 141.87 33.79 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.546 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -88.75 113.64 24.53 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.669 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -115.58 178.32 17.6 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.843 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' SER . 20.7 ptt180 -151.57 135.74 16.7 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 124.261 1.025 . . . . 0.0 108.396 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.878 ' HA ' HG22 ' A' ' 52' ' ' ILE . 10.8 p -72.67 169.17 17.18 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -17.65 62.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.44 -26.52 60.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.99 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.92 12.31 20.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.727 -0.749 . . . . 0.0 114.688 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 21.3 m -91.08 118.93 30.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 118.178 0.989 . . . . 0.0 108.977 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 61.4 m-85 -84.06 144.11 29.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.223 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.4 156.64 28.67 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.541 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 10.3 m-85 -76.72 134.79 39.1 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.67 0.748 . . . . 0.0 110.018 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.669 HD11 ' HA3' ' A' ' 67' ' ' GLY . 71.6 mt -114.94 138.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.685 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.5 mttt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 168.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.6 p -64.62 -18.26 64.76 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.762 0.791 . . . . 0.0 111.751 -171.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 -19.63 27.19 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.18 -17.84 59.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -129.19 151.81 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -98.27 105.78 17.98 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -83.55 123.69 38.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.682 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.258 1.539 0 CA-C-O 122.594 1.187 . . . . 0.0 111.806 -179.163 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.54 0.21 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.13 -26.24 39.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 97.1 mttt -75.27 -18.6 60.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.041 0.448 . . . . 0.0 111.292 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -96.9 -41.13 8.57 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -68.07 -46.89 69.82 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.683 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 57.1 m-85 -108.01 -3.09 19.08 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.389 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 72.9 mmtt 56.69 69.99 0.69 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.068 0.855 . . . . 0.0 110.369 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.66 16.93 15.4 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.392 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -51.99 117.83 3.03 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.801 0.84 . . . . 0.0 112.791 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.1 179.31 15.91 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.557 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 121.71 6.52 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.364 2.709 . . . . 0.0 110.488 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -120.44 163.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.966 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -126.07 155.49 41.48 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.842 0.829 . . . . 0.0 111.194 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 53' ' ' GLU . 59.8 t -90.43 107.96 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.272 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.408 HD12 HG12 ' A' ' 57' ' ' ILE . 49.9 mt -77.63 -37.56 24.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.871 ' HB2' HD11 ' A' ' 54' ' ' ILE . 69.5 m-70 -150.57 168.47 24.16 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 121.04 0.448 . . . . 0.0 110.416 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 3.8 mm? -101.88 119.73 39.26 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.91 164.04 11.96 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -152.46 107.28 3.21 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -60.44 126.27 26.82 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 p -103.1 -11.0 18.4 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -167.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.82 175.02 14.12 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.0 -157.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.36 107.83 5.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.826 HG21 ' HE1' ' A' ' 46' ' ' PHE . 14.7 m -103.96 156.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.691 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -57.91 -48.93 78.45 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.8 42.97 60.15 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.605 1.19 . . . . 0.0 113.634 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.38 -170.44 0.25 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -52.03 -38.81 58.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -100.57 -0.22 38.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.685 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.49 167.23 11.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.98 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -76.08 139.51 41.41 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.933 0.873 . . . . 0.0 111.634 -176.239 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -82.84 76.03 9.71 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.912 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.826 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.05 -178.99 4.37 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.442 179.226 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 28.6 mtpp -139.52 -173.09 3.52 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 123.648 0.593 . . . . 0.0 110.041 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -67.87 -13.14 61.91 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 126.464 1.906 . . . . 0.0 115.619 -168.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.5 15.0 4.73 Favored Glycine 0 C--N 1.254 -3.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.459 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 21.0 mm-40 -72.65 123.32 23.0 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 122.282 1.039 . . . . 0.0 112.892 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -93.66 96.17 9.65 Favored 'General case' 0 N--CA 1.397 -3.077 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.866 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -105.11 159.18 5.59 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.08 0 CA-C-N 111.653 -2.521 . . . . 0.0 112.685 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HG2' ' CD1' ' A' ' 30' ' ' LEU . 35.3 mt-10 -124.63 132.04 53.44 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.277 0.2 OUTLIER -100.47 143.81 13.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 117.503 -1.679 . . . . 0.0 112.284 178.147 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.739 HG12 HD13 ' A' ' 25' ' ' ILE . 2.9 mp -111.6 -21.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.613 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.84 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.2 ttm180 -127.73 121.36 30.09 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.813 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG12 HD12 ' A' ' 28' ' ' ILE . 39.1 mm -112.51 102.91 14.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 103.842 -2.651 . . . . 0.0 103.842 173.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.286 -2.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.614 -170.752 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.856 0 CA-C-O 120.098 -0.279 . . . . 0.0 113.258 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 71.3 mmtt -135.31 -177.91 4.87 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.876 0.846 . . . . 0.0 112.372 -174.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 20.1 m0 -120.66 162.27 19.97 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 106.638 166.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.84 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -105.9 120.7 42.42 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.131 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -124.05 -176.32 14.66 Favored Glycine 0 N--CA 1.422 -2.249 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.206 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 33.5 ptt180 -151.23 146.1 25.84 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.8 p -85.17 166.78 16.3 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.54 25.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -91.42 -19.88 22.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.749 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.82 36.9 3.33 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.526 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -128.61 137.53 51.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 29.9 m-85 -106.19 152.14 23.85 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.551 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -169.8 152.6 19.82 Favored Glycine 0 CA--C 1.478 -2.251 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.067 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.521 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 9.3 m-85 -74.53 152.8 39.29 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HE2' ' A' ' 46' ' ' PHE . 40.7 mt -136.67 134.71 48.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 77' ' ' ILE . 94.3 mttt -70.7 142.67 51.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -65.34 -12.46 52.17 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.757 0.789 . . . . 0.0 112.738 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.2 t -94.86 -15.04 24.02 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -78.9 -19.76 51.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -134.1 163.95 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.316 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.27 106.82 14.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.659 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.4 mp -85.02 127.71 39.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.986 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 121.368 0.604 . . . . 0.0 109.997 175.323 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 CA--C 1.506 -0.718 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -81.73 69.34 8.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.16 0.981 . . . . 0.0 110.42 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.56 86.04 2.88 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.68 -63.38 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -107.0 141.67 37.84 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -111.78 -43.22 3.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 58.05 87.17 0.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.146 1.378 . . . . 0.0 110.914 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -96.51 -59.94 1.72 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -114.55 -153.6 0.53 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -174.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.11 6.32 28.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.23 -42.95 22.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.905 -172.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -65.62 -23.54 66.84 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -49.47 77.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.74 -46.38 66.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.192 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.1 pp -60.62 -25.82 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.162 0.506 . . . . 0.0 112.143 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 94.9 mttt -72.46 -24.49 61.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.291 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -97.78 -46.73 5.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.073 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.7 tttt -66.52 -53.42 35.14 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.87 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 80.0 m-85 -98.46 -8.86 26.02 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.44 0.638 . . . . 0.0 109.375 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.6 ttmt 60.84 75.48 0.41 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.161 1.384 . . . . 0.0 112.534 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 25' ' ' ILE . 8.3 mp -117.58 17.01 14.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.256 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -56.21 104.94 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.395 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.55 -160.17 20.07 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.35 117.68 0.64 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.209 2.606 . . . . 0.0 112.583 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.773 HD13 HG12 ' A' ' 55' ' ' ILE . 2.6 pp -117.01 143.82 26.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 120.666 0.27 . . . . 0.0 111.616 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -120.17 155.22 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.82 137.59 22.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 121.484 0.659 . . . . 0.0 112.19 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.505 HG22 ' CD2' ' A' ' 29' ' ' HIS . 46.4 mm -91.46 -41.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 1.02 ' HB2' HD11 ' A' ' 54' ' ' ILE . 73.7 m-70 -152.84 177.86 10.28 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 3.4 mm? -116.12 117.41 29.99 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.62 168.24 9.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.17 107.77 3.5 Favored 'General case' 0 C--N 1.255 -3.526 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 176.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.837 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.03 132.69 51.33 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.511 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.8 t -116.73 148.14 41.38 Favored 'General case' 0 CA--C 1.44 -3.257 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.3 m 70.29 178.56 0.25 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.273 163.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.13 112.78 15.43 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.834 HG21 ' CE1' ' A' ' 46' ' ' PHE . 9.3 m -110.4 156.79 11.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.682 -174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 17.2 ttmm -49.44 -66.46 0.39 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.926 0.766 . . . . 0.0 110.843 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.11 42.75 98.64 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.148 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.16 -158.6 0.83 Allowed Glycine 0 CA--C 1.54 1.595 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -65.09 -31.38 72.56 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 29.3 p-10 -93.08 -17.83 23.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.376 -0.529 . . . . 0.0 109.897 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' OE1' ' HG2' ' A' ' 38' ' ' LYS . 42.9 mt-10 -92.64 170.55 9.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.426 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -83.56 138.8 33.23 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -86.01 59.04 5.4 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 121.999 0.904 . . . . 0.0 109.004 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.866 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -95.82 -174.89 3.26 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.587 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 56.3 mtpt -143.86 -173.1 3.89 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.565 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.22 114.99 18.6 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 126.17 1.788 . . . . 0.0 108.95 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.91 10.44 57.58 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 10.1 mm-40 -79.32 123.9 27.9 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 111.208 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -87.23 97.08 10.57 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.171 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.822 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -109.94 159.39 9.62 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.256 0 CA-C-N 111.554 -2.567 . . . . 0.0 112.207 176.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.87 140.2 53.14 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.02 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -104.98 127.3 59.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.219 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -101.65 -21.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.335 -173.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.5 ttm180 -136.15 126.42 26.5 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.561 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.79 98.45 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -90.05 141.91 28.22 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.779 -176.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -114.14 8.29 16.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.08 143.82 98.05 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.179 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -38.5 -26.81 0.1 Allowed 'Trans proline' 0 C--N 1.376 1.999 1 C-N-CA 126.533 4.822 . . . . 0.0 116.97 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.4 mm-40 -57.5 -31.57 66.16 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.74 28.09 73.37 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mmtm -131.37 157.4 43.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.2 m0 -99.72 162.5 12.97 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 123.731 0.644 . . . . 0.0 110.494 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -99.7 114.39 27.47 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.774 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.85 175.55 16.07 Favored Glycine 0 N--CA 1.423 -2.175 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.2 ptt180 -151.69 141.09 21.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 52' ' ' ILE . 16.9 p -81.26 164.07 22.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.59 -8.28 53.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.409 1.1 . . . . 0.0 109.237 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -87.02 -4.64 59.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.339 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.44 32.29 19.79 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.858 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 9.1 m -118.11 124.08 47.16 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.651 ' HB2' HG21 ' A' ' 15' ' ' ILE . 8.0 m-85 -101.6 140.31 36.06 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.39 162.8 36.11 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 119.157 -1.497 . . . . 0.0 113.218 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.565 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 28.3 m-85 -71.87 149.43 45.19 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.203 0.525 . . . . 0.0 110.107 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 46' ' ' PHE . 74.7 mt -131.99 129.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.605 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG2' ' HE3' ' A' ' 64' ' ' LYS . 98.8 mttt -66.58 136.97 56.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 166.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -69.12 -8.75 48.35 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 122.337 1.065 . . . . 0.0 111.447 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.3 t -97.31 -16.18 20.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.652 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.41 59.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 33' ' ' ALA . 33.9 m -133.16 159.78 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 CA-C-O 121.365 0.602 . . . . 0.0 112.273 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 34.1 mt-10 -97.5 102.24 13.95 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 82' ' ' VAL . 29.2 mm -88.36 120.36 37.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.684 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -123.55 154.51 39.13 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.352 0.596 . . . . 0.0 111.22 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.518 ' HA ' HD23 ' A' ' 89' ' ' LEU . 82.9 t80 -98.06 -26.53 14.58 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.88 -49.97 61.93 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.225 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.58 ' HA ' HD23 ' A' ' 91' ' ' LEU . 15.7 m -60.57 -10.09 4.66 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 29' ' ' HIS . 4.1 mm? -77.19 -28.63 54.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.426 0.631 . . . . 0.0 109.518 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.671 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -108.43 -34.84 6.66 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.466 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 88' ' ' SER . 96.3 mt 64.72 84.56 0.15 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 124.548 1.139 . . . . 0.0 108.26 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 23.66 11.63 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.438 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -68.84 -50.57 48.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.479 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.49 -57.02 3.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt 57.55 72.75 0.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.281 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.414 -178.204 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.577 0.227 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -124.52 -83.47 0.64 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.687 -0.633 . . . . 0.0 110.812 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.07 81.33 1.91 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -132.69 -36.57 1.07 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.507 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 65.08 21.53 12.23 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.528 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -114.24 105.83 13.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.12 110.38 1.36 Allowed 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.655 0.74 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -69.74 -27.95 65.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.192 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.8 4.44 52.84 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.896 0.855 . . . . 0.0 110.157 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -105.97 -4.91 20.03 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -50.49 62.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.287 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.979 ' HA ' HG13 ' A' ' 15' ' ' ILE 0.341 0.0 OUTLIER -78.35 -8.13 58.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.574 -176.816 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.34 -38.14 50.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.87 -57.2 4.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.065 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.979 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.3 pp -61.08 -25.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 15.4 ttmm -76.5 -32.17 58.15 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.616 0.722 . . . . 0.0 109.525 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -97.03 -39.95 9.09 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.407 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.6 ttpt -66.09 -43.68 86.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.817 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 26.9 m-85 -97.68 3.17 50.32 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.533 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 53.92 74.44 0.33 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.977 0.894 . . . . 0.0 109.841 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' NH2' ' A' ' 56' ' ' ARG . 6.8 tp -107.75 13.48 26.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.485 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.33 109.78 0.66 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.49 0.662 . . . . 0.0 111.858 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.72 171.89 12.35 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.93 110.4 1.09 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.449 2.1 . . . . 0.0 111.673 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -89.29 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -126.91 139.21 53.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.58 0.705 . . . . 0.0 110.723 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 53' ' ' GLU . 41.4 t -68.76 116.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.701 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.675 HG22 ' HD2' ' A' ' 29' ' ' HIS . 46.4 mm -84.46 -44.8 17.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.343 0.592 . . . . 0.0 109.927 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.675 ' HD2' HG22 ' A' ' 28' ' ' ILE . 38.7 m-70 -153.72 171.24 19.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.2 mp -102.61 129.64 49.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 170.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.54 166.22 10.56 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 18.9 pttp -150.14 101.9 3.04 Favored 'General case' 0 C--N 1.255 -3.535 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.84 133.06 50.17 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.456 -2.156 . . . . 0.0 110.685 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -119.37 152.3 37.03 Favored 'General case' 0 CA--C 1.445 -3.068 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.0 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.1 m 70.91 169.47 0.32 Allowed 'General case' 0 N--CA 1.397 -3.11 0 O-C-N 125.771 1.919 . . . . 0.0 111.745 162.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -69.72 101.91 1.78 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.497 0.665 . . . . 0.0 109.988 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.829 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.3 m -97.18 156.52 3.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.21 -59.05 5.18 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.19 43.72 95.25 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.361 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.48 -172.04 0.51 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -51.78 -53.21 42.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.37 -2.04 58.07 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.92 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -92.27 169.04 10.91 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.665 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -80.06 139.55 36.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.392 0.615 . . . . 0.0 109.944 -177.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -81.07 40.3 0.54 Allowed 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.652 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.91 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -82.43 -177.83 6.82 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.487 0.661 . . . . 0.0 111.895 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -142.63 -172.89 3.73 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.643 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 8.9 tt0 -84.32 114.89 22.19 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.1 1.36 . . . . 0.0 109.123 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.49 3.02 56.5 Favored Glycine 0 C--N 1.29 -1.985 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -75.27 122.42 23.68 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.783 0.802 . . . . 0.0 111.699 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.61 97.21 9.57 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -104.66 158.37 5.54 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.595 0 CA-C-N 111.79 -2.459 . . . . 0.0 111.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.8 mt-10 -121.09 131.73 54.44 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.075 -1.016 . . . . 0.0 109.018 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -92.73 133.37 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.05 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -120.66 11.52 6.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.942 -176.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.835 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 44.8 ttm180 -152.34 125.68 8.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.004 176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 28' ' ' ILE . 47.3 mm -111.5 98.01 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.5 138.73 32.62 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.057 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -115.3 -30.91 6.14 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.458 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -71.77 151.21 93.3 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.722 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -46.74 105.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.617 3.545 . . . . 0.0 115.684 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -162.94 -58.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.05 13.72 60.16 Favored Glycine 0 CA--C 1.474 -2.496 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.007 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.633 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.2 mmtp -134.4 154.32 51.43 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 33.3 m0 -98.35 157.17 16.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.835 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -101.08 111.49 23.71 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.874 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.8 179.69 18.87 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.506 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 39.0 ptt180 -152.15 144.28 23.88 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.9 p -81.85 169.35 16.96 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.64 36.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.564 1.173 . . . . 0.0 107.877 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -89.32 -4.92 57.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.418 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.34 33.06 32.93 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.46 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -124.07 121.64 35.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.1 m-85 -89.03 153.68 20.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -173.08 156.36 24.48 Favored Glycine 0 C--N 1.318 -0.446 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.637 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 39.9 m-85 -74.96 139.5 43.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 112.411 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.91 HG12 ' HE2' ' A' ' 46' ' ' PHE . 63.0 mt -121.24 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.633 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.633 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 94.7 mttt -73.41 135.91 44.26 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.7 p -65.21 -9.93 27.47 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -98.13 -14.12 20.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.788 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -80.78 -13.45 58.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.386 0.613 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 31.2 m -129.7 156.16 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.841 0.829 . . . . 0.0 112.01 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.49 100.71 11.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 82' ' ' VAL . 22.5 mm -88.84 108.25 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.918 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -124.67 157.48 35.48 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.237 0.541 . . . . 0.0 112.236 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.548 ' HA ' HD23 ' A' ' 89' ' ' LEU . 45.5 t80 -88.62 -4.31 58.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.1 -32.14 70.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.703 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -77.82 -3.91 43.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.163 0.506 . . . . 0.0 111.173 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD21 ' HA ' ' A' ' 29' ' ' HIS . 3.1 mm? -103.06 -63.59 1.16 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -90.45 119.96 31.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.694 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.9 107.95 13.08 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -71.9 125.97 28.56 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.269 0.557 . . . . 0.0 112.159 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -153.71 178.91 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.637 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.86 -47.77 4.69 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 tt -165.33 -51.59 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.317 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -141.76 -50.8 0.41 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -82.57 93.25 7.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.32 160.24 7.59 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -117.67 -44.75 2.72 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.873 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tptt 179.37 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.242 0.68 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -178.27 74.99 0.02 OUTLIER 'General case' 0 C--O 1.248 0.998 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.15 111.65 11.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.523 -176.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 44.7 mt-10 -130.35 -166.91 1.74 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.51 ' HD3' ' HG3' ' A' ' 14' ' ' GLU . 48.1 mmtt -80.89 -12.34 59.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -69.52 0.55 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.706 ' HA ' HG13 ' A' ' 15' ' ' ILE 0.31 0.0 OUTLIER -95.04 -22.14 18.12 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -173.838 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HB3' ' O ' ' A' ' 9' ' ' GLU . 6.0 tt0 -64.3 -39.42 93.89 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.611 0.72 . . . . 0.0 110.259 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HG3' ' HD3' ' A' ' 10' ' ' LYS . 5.8 mm-40 -81.33 -33.96 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.495 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.8 pp -69.56 -26.57 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.717 ' HB3' HG23 ' A' ' 22' ' ' THR . 90.1 mttt -71.43 -16.13 62.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.246 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -94.06 -56.95 2.68 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.7 -44.19 81.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.133 1.373 . . . . 0.0 112.106 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.5 -3.33 22.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.726 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 56.29 78.62 0.2 Allowed 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.326 1.06 . . . . 0.0 110.967 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 66' ' ' LEU . 88.2 mt -126.01 16.42 7.92 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.398 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 16' ' ' LYS . 4.6 p -72.9 98.84 2.55 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.75 -159.63 28.23 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -89.16 103.84 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.874 2.383 . . . . 0.0 112.393 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 21' ' ' LEU . 2.7 pp -109.12 142.21 22.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 120.859 0.362 . . . . 0.0 110.732 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -127.23 148.47 50.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.3 p -75.62 145.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG13 HG12 ' A' ' 57' ' ' ILE . 37.4 mm -98.7 -39.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.261 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.673 ' HB2' HD11 ' A' ' 54' ' ' ILE . 43.7 m-70 -156.45 171.73 19.75 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 109.938 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.23 127.49 44.2 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.615 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -107.18 167.88 9.6 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.594 ' HE2' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.4 102.37 2.9 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.72 137.04 55.19 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 113.204 -1.816 . . . . 0.0 111.205 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.8 t -123.16 149.81 44.11 Favored 'General case' 0 CA--C 1.439 -3.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.926 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.6 m 72.64 162.87 0.26 Allowed 'General case' 0 N--CA 1.396 -3.163 0 O-C-N 126.129 2.143 . . . . 0.0 111.868 162.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.93 103.33 1.45 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 109.356 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 46' ' ' PHE . 24.1 m -102.33 156.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.751 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -48.3 -54.15 14.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.668 1.23 . . . . 0.0 109.165 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.9 43.02 60.8 Favored Glycine 0 C--N 1.346 1.114 0 O-C-N 123.859 0.724 . . . . 0.0 114.69 175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.31 -168.51 0.39 Allowed Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.756 1.063 . . . . 0.0 115.756 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -55.7 -49.24 73.54 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 113.426 -174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.14 -10.72 54.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.556 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -92.09 163.92 13.79 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.517 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -82.57 131.89 35.2 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 m -86.04 71.38 10.59 Favored 'General case' 0 C--N 1.255 -3.538 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.531 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.798 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -99.07 179.03 4.74 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.812 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.611 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mtpm? -134.49 -173.05 3.17 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -87.88 113.95 24.03 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 124.549 1.139 . . . . 0.0 108.665 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.08 -3.09 44.26 Favored Glycine 0 C--N 1.284 -2.332 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.8 mm-40 -66.93 123.96 21.65 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.763 0.792 . . . . 0.0 111.415 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -94.01 96.78 9.9 Favored 'General case' 0 N--CA 1.409 -2.483 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.951 HD11 HG11 ' A' ' 82' ' ' VAL . 32.7 pt -110.57 158.28 10.99 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.169 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.372 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.76 ' HB3' HG21 ' A' ' 27' ' ' VAL . 48.1 mt-10 -121.27 136.84 54.91 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.268 0.2 OUTLIER -97.81 124.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.224 175.173 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.09 -16.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.647 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -144.29 122.07 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.373 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' ILE . 44.3 mm -88.98 101.56 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p -83.34 154.51 24.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-O 121.568 0.699 . . . . 0.0 112.231 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -114.98 8.57 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.686 1.231 . . . . 0.0 108.438 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -69.42 157.65 88.88 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.738 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.39 -17.68 49.41 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.999 2.466 . . . . 0.0 111.62 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.91 -37.33 66.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.832 0.853 . . . . 0.0 110.514 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.08 29.4 66.83 Favored Glycine 0 CA--C 1.489 -1.549 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.27 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 42.5 mmtm -133.27 138.31 46.4 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.452 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.2 m0 -87.57 159.8 18.45 Favored 'General case' 0 C--N 1.279 -2.485 0 O-C-N 123.725 0.641 . . . . 0.0 109.968 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -97.12 112.14 24.06 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.815 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.26 174.21 15.13 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' SER . 36.1 ptt180 -152.2 139.91 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.627 ' HA ' HG22 ' A' ' 52' ' ' ILE . 63.6 p -78.73 177.13 8.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -16.89 61.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 110.27 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -87.86 -19.96 26.68 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.12 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 29.6 5.4 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.033 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.9 m -98.91 115.45 28.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.6 m-85 -91.77 139.06 31.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 122.714 0.406 . . . . 0.0 110.717 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.12 158.86 31.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.857 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.448 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.2 m-85 -73.97 135.15 43.17 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.917 0.865 . . . . 0.0 111.285 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.815 HD11 ' HA3' ' A' ' 67' ' ' GLY . 67.5 mt -116.42 128.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.697 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 77' ' ' ILE . 54.8 mttm -65.14 137.14 57.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.0 p -68.7 -7.16 30.94 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.128 0.966 . . . . 0.0 111.469 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -104.16 -13.15 16.33 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.153 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.4 -13.08 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.291 0.567 . . . . 0.0 109.736 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.951 HG11 HD11 ' A' ' 52' ' ' ILE . 35.3 m -131.99 154.56 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.368 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 55.1 mm-40 -103.54 113.13 26.41 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 172.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.5 mm -81.13 141.74 14.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.793 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.85 124.74 23.79 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-O 123.094 1.426 . . . . 0.0 112.443 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.467 ' HA ' HD23 ' A' ' 89' ' ' LEU . 51.2 m-85 -100.44 4.73 43.98 Favored 'General case' 0 C--N 1.255 -3.507 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.057 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.5 -39.14 89.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.709 1.204 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -68.56 -15.25 63.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.336 0.589 . . . . 0.0 111.857 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 86' ' ' TYR . 2.0 mm? -104.25 -3.75 23.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -91.31 111.4 22.88 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.905 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.03 -73.1 0.66 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -166.76 52.39 0.08 Allowed 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -78.69 -31.52 46.65 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.5 t70 55.2 -96.21 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.963 1.705 . . . . 0.0 110.343 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.0 mt -159.8 160.61 34.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.293 -1.866 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.133 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -101.07 -40.74 7.06 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -159.22 138.6 11.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.684 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 64.59 115.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.15 0.98 . . . . 0.0 112.588 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -105.37 89.45 3.12 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -139.58 129.01 24.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.41 101.95 7.54 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 8' ' ' LYS . 15.4 ptpt -98.24 85.46 3.44 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.472 1.13 . . . . 0.0 110.403 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 26.8 tt0 -80.86 138.71 36.2 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.155 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -67.74 6.15 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.31 -20.12 64.72 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.36 -23.42 63.75 Favored 'General case' 0 C--O 1.208 -1.093 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.56 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -67.6 -33.61 75.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -51.37 24.77 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.0 pp -61.82 -25.46 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.774 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 92.1 mttt -75.64 -25.86 57.22 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.882 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.24 -38.8 13.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -63.01 -50.88 68.96 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.253 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -103.1 -5.91 22.79 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.44 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 37.7 mtmm 55.35 81.1 0.12 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.556 0.742 . . . . 0.0 110.078 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 21' ' ' LEU . 10.9 tp -83.93 -45.5 13.11 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.13 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 p 46.83 96.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.49 178.83 38.25 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.21 136.53 24.57 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.856 2.371 . . . . 0.0 110.535 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.848 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -124.68 160.51 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -128.63 148.22 50.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 53' ' ' GLU . 7.1 p -74.7 145.72 10.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.614 0.245 . . . . 0.0 110.812 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -97.99 -44.78 12.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.129 0.49 . . . . 0.0 111.013 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.978 ' HB2' HD11 ' A' ' 54' ' ' ILE . 7.3 m-70 -139.29 162.89 33.89 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.35 122.19 42.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.923 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.38 164.43 11.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.679 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 51.3 pttt -151.43 105.21 3.15 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -72.17 125.73 28.04 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.417 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.7 t -112.14 148.76 33.3 Favored 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.791 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.7 m 74.32 167.74 0.3 Allowed 'General case' 0 N--CA 1.405 -2.713 0 O-C-N 126.032 2.083 . . . . 0.0 111.422 162.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.41 102.56 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.758 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.1 m -96.16 156.64 3.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.902 -175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -49.81 -53.92 22.38 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.96 43.3 96.92 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.557 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.57 179.2 0.02 OUTLIER Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.324 1.29 . . . . 0.0 116.324 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -61.47 -34.42 75.42 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -86.26 -16.15 38.53 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.114 0.483 . . . . 0.0 111.207 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 78' ' ' LYS . 45.0 mt-10 -92.66 170.4 9.75 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.781 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.659 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 1.1 tt -79.07 140.92 37.77 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.921 0.867 . . . . 0.0 110.338 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 m -81.12 47.07 0.97 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.58 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.945 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -87.44 175.58 7.9 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.445 0.641 . . . . 0.0 111.879 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.4 mtpt -133.78 -172.76 3.06 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.394 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 47.6 tt0 -81.69 124.79 29.89 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 125.398 1.479 . . . . 0.0 107.821 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.03 4.93 66.48 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.6 mm-40 -74.26 121.87 21.97 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 122.163 0.983 . . . . 0.0 112.283 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -85.51 96.18 9.53 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 82' ' ' VAL . 40.0 pt -111.41 158.41 11.9 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.538 0 CA-C-N 112.836 -1.983 . . . . 0.0 112.071 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 27' ' ' VAL . 51.3 mt-10 -125.43 134.05 52.25 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.21 127.72 54.18 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.291 175.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.848 HG12 HD13 ' A' ' 25' ' ' ILE . 2.7 mp -97.87 -34.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.165 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.7 ttm180 -116.12 110.01 18.27 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.455 -174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.41 98.56 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -116.08 141.71 47.76 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.598 0.713 . . . . 0.0 112.75 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -93.34 5.25 52.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.664 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 38.7 t30 -58.44 133.05 85.27 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.125 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' OD1' ' A' ' 60' ' ' ASN . 18.7 Cg_exo -34.2 -28.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.749 1 C-N-CA 126.03 4.487 . . . . 0.0 117.286 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.1 -34.8 70.58 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 110.774 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.75 31.53 73.25 Favored Glycine 0 CA--C 1.5 -0.861 0 CA-C-N 115.758 -0.655 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 69.6 mmtt -119.57 157.38 28.5 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -102.06 142.15 33.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -86.25 108.93 18.6 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -115.18 177.03 17.07 Favored Glycine 0 N--CA 1.415 -2.764 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.411 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 29.6 ptt180 -151.93 142.89 23.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.279 1.032 . . . . 0.0 108.311 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 52' ' ' ILE . 19.2 p -79.71 173.24 12.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.92 0.866 . . . . 0.0 109.135 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.49 -7.87 59.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.981 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.78 31.82 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.501 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.2 m -103.18 113.38 26.81 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.7 m-85 -89.52 147.7 23.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.583 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.88 161.09 34.76 Favored Glycine 0 C--N 1.298 -1.537 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.81 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.2 m-85 -70.11 161.73 29.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.945 HG12 ' HE2' ' A' ' 46' ' ' PHE . 83.9 mt -142.44 126.65 15.67 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' O ' HG22 ' A' ' 77' ' ' ILE . 61.0 mttp -64.5 132.53 50.19 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 167.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.3 p -66.29 -8.51 25.47 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 118.927 0.785 . . . . 0.0 112.575 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 t -98.85 -14.49 19.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.581 0.752 . . . . 0.0 110.282 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.06 -19.78 58.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 108.909 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 52' ' ' ILE . 34.1 m -125.79 166.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.788 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 29.0 mt-10 -125.44 112.22 16.02 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' HIS . 1.7 mp -88.92 123.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 120.922 0.391 . . . . 0.0 110.135 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -100.78 140.57 34.87 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.233 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -93.03 -21.68 19.6 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.869 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 34.7 t70 -59.52 -38.79 81.89 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.301 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 49.8 m -64.28 -21.65 66.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.845 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 29' ' ' HIS . 71.5 mt -85.19 -30.34 23.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.869 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 6.4 mtpm? -71.95 -44.12 64.12 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.851 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 91' ' ' LEU . 3.5 tm? -73.54 -22.35 60.11 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.118 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 88' ' ' SER . 6.4 tmtm? -59.19 112.39 1.69 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.598 0.759 . . . . 0.0 109.538 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -148.81 -44.19 0.15 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.67 141.39 52.7 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.395 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.93 91.09 8.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.814 0.816 . . . . 0.0 111.434 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.675 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -137.97 93.53 2.78 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -118.05 -23.72 7.3 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.323 -175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.679 ' HG2' ' HB2' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -98.57 108.32 20.99 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -127.44 -28.39 2.79 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.131 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -133.92 23.65 3.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 33.0 mt-10 -115.43 82.69 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.668 0.747 . . . . 0.0 110.188 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -127.97 108.23 10.51 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.612 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 3.2 mp0 -66.14 114.8 5.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.631 -177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -107.74 -60.82 1.65 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.709 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -80.3 -18.02 50.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.992 0.901 . . . . 0.0 108.774 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.616 ' O ' HG13 ' A' ' 15' ' ' ILE . 14.2 mp0 -83.14 -7.27 59.65 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.259 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -62.15 -39.45 92.66 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.44 -29.76 30.5 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.789 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.0 pp -65.95 -29.78 47.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.389 0.614 . . . . 0.0 111.063 -172.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE2' ' HG2' ' A' ' 9' ' ' GLU . 67.9 mttm -68.23 -27.63 66.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.666 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.14 -46.24 8.21 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.734 0.778 . . . . 0.0 109.231 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.05 -44.65 83.95 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 112.379 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -109.35 -8.6 15.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.66 75.22 0.35 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 111.286 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.13 17.81 19.23 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.072 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -68.35 84.7 0.26 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.239 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.83 41.69 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.39 105.47 0.89 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.978 2.452 . . . . 0.0 113.012 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.34 161.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 27' ' ' VAL . 18.4 mm-40 -133.83 -81.48 0.46 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.66 ' HA ' HG22 ' A' ' 55' ' ' ILE . 1.4 m 178.74 152.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 C-N-CA 128.906 2.882 . . . . 0.0 105.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 29' ' ' HIS . 38.3 mm -99.31 -44.91 12.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' HD2' HG22 ' A' ' 28' ' ' ILE . 70.5 m-70 -160.74 -176.93 5.83 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.08 169.58 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 21.7 pttm -152.3 107.05 3.21 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.0 135.82 57.49 Favored 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.049 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -112.05 172.86 6.66 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m 58.39 175.87 0.06 Allowed 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 125.101 1.501 . . . . 0.0 114.39 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.49 95.43 9.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.88 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.841 HG21 ' HE1' ' A' ' 46' ' ' PHE . 27.7 m -89.98 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.36 -40.85 75.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.535 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.08 43.18 62.37 Favored Glycine 0 C--N 1.355 1.592 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.892 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -53.14 -173.71 0.05 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 116.879 1.512 . . . . 0.0 116.879 -173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -63.2 -36.78 84.78 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -100.81 2.21 40.91 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.632 0.729 . . . . 0.0 109.789 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.4 mt-10 -95.68 179.42 5.13 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.68 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -94.7 135.73 35.83 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -85.83 76.19 9.93 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.131 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.869 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.37 174.11 6.43 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.997 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 30.3 mmtp -140.79 -175.51 4.32 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.829 0.823 . . . . 0.0 111.497 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.09 108.21 1.77 Allowed 'General case' 0 C--N 1.272 -2.791 0 C-N-CA 127.856 2.463 . . . . 0.0 109.886 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.75 5.25 41.99 Favored Glycine 0 C--N 1.294 -1.8 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.5 mm-40 -80.03 116.69 20.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.031 0.92 . . . . 0.0 112.729 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.55 96.99 9.81 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.895 HD11 HG11 ' A' ' 82' ' ' VAL . 27.8 pt -110.87 158.66 11.25 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.244 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.045 175.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -118.57 134.25 55.24 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.607 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -96.09 136.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.184 173.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -119.56 3.68 6.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.188 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 58' ' ' THR . 58.2 ttt180 -150.27 141.15 22.83 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.749 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 28' ' ' ILE . 44.4 mm -109.02 96.97 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -86.68 141.32 29.02 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.784 -178.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -114.22 -2.86 13.27 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.712 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -54.59 150.19 18.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.739 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -36.24 -37.46 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.973 1 C-N-CA 126.021 4.481 . . . . 0.0 116.047 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -52.35 -36.1 52.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 31.55 68.99 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.5 mmtp -129.29 148.88 51.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 35.0 m0 -94.64 160.81 14.46 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.682 0.614 . . . . 0.0 109.848 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.58 109.65 21.5 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.705 0.764 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -114.08 175.92 16.67 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.1 ptt180 -152.77 146.39 25.05 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.819 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.6 p -73.15 178.59 4.32 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 117.941 0.337 . . . . 0.0 110.847 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -34.22 73.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.123 0.487 . . . . 0.0 110.533 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 71' ' ' ARG . 39.2 mtm-85 -82.16 -0.4 44.76 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.172 0.51 . . . . 0.0 111.599 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.34 27.27 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 114.528 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.0 m -91.46 112.55 24.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.563 1.182 . . . . 0.0 107.813 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 79.2 m-85 -82.48 145.18 29.95 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.128 -172.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.83 27.95 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.163 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 7.7 m-85 -71.45 142.68 50.23 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.87 0.843 . . . . 0.0 112.302 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.869 HG12 ' HE2' ' A' ' 46' ' ' PHE . 61.3 mt -126.59 129.28 71.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.565 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 77' ' ' ILE . 92.3 mttt -65.93 140.95 58.37 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.4 p -69.06 -9.16 51.18 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.0 112.056 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -103.93 -8.67 19.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.519 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.628 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.79 -11.04 59.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 52' ' ' ILE . 27.1 m -133.1 158.27 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.015 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 38.0 mt-10 -104.5 112.94 26.19 Favored 'General case' 0 N--CA 1.394 -3.234 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 31' ' ' ALA . 21.1 mm -94.75 135.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.73 0 C-N-CA 124.038 0.935 . . . . 0.0 109.68 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -77.43 153.72 33.32 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.493 0.663 . . . . 0.0 109.948 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -101.75 -22.83 14.31 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.579 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -65.4 -17.79 64.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB3' ' ND1' ' A' ' 29' ' ' HIS . 44.4 t -64.97 -17.48 64.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 118.179 0.445 . . . . 0.0 111.639 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.7 mt -73.15 -24.87 60.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -99.62 158.93 15.41 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.9 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -136.14 88.12 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -139.75 126.41 20.53 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.736 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -80.82 106.22 12.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -140.26 81.39 1.81 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.999 0.904 . . . . 0.0 109.733 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.3 mt -105.29 -47.92 3.83 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.205 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.2 139.35 50.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.934 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.1 90.62 3.06 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 65.83 170.41 0.22 Allowed 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.202 0.938 . . . . 0.0 109.558 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -79.92 124.64 28.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -107.79 99.15 8.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -73.99 123.75 24.93 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -139.56 77.11 1.6 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.583 -3.117 . . . . 0.0 102.583 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.678 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 6.4 mm-40 -72.03 139.56 48.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.263 -168.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 72.0 mmtt -80.48 -11.9 59.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.767 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.678 ' HG2' ' HB3' ' A' ' 9' ' ' GLU . 9.6 ptpp? -81.0 -28.03 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.264 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.754 ' HA ' HG13 ' A' ' 15' ' ' ILE . 12.4 pt-20 -77.52 -23.82 50.12 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.818 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 29.7 pt20 -65.25 -29.56 70.36 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -77.77 -55.43 5.34 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.308 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -57.49 -28.04 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 22' ' ' THR . 43.3 mtmt -79.68 -23.9 42.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -89.37 -41.22 12.25 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 87.3 tttt -60.56 -48.4 81.94 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 112.089 -175.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -100.56 -6.02 25.98 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 59.94 74.39 0.45 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 122.869 1.319 . . . . 0.0 108.059 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 12.5 tp -125.26 14.53 8.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.913 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -69.42 90.51 0.53 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.487 0.66 . . . . 0.0 112.035 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.78 -177.04 45.5 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.95 123.57 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.711 2.274 . . . . 0.0 112.024 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.628 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.6 pp -109.33 147.08 14.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 120.872 0.368 . . . . 0.0 111.827 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -127.79 138.1 52.62 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.645 ' HA ' HG22 ' A' ' 55' ' ' ILE . 21.9 t -74.08 112.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.556 HG22 ' CD2' ' A' ' 29' ' ' HIS . 38.7 mm -83.67 -44.66 18.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.759 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 54' ' ' ILE . 54.6 m-70 -150.49 167.42 27.22 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.66 117.94 31.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.58 165.06 11.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 42.7 pttt -150.22 102.54 3.09 Favored 'General case' 0 C--N 1.255 -3.514 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.82 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.38 125.96 26.76 Favored 'General case' 0 C--N 1.271 -2.806 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.699 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.2 t -109.69 148.08 32.01 Favored 'General case' 0 CA--C 1.432 -3.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.2 m 68.1 -179.14 0.22 Allowed 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 125.99 2.057 . . . . 0.0 110.344 164.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.6 113.53 14.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 46' ' ' PHE . 5.5 m -106.74 156.37 7.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.225 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 15.0 ptpt -50.72 -66.93 0.3 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.353 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . 61.84 43.32 99.37 Favored Glycine 0 C--O 1.246 0.881 0 C-N-CA 119.754 -1.212 . . . . 0.0 112.542 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -61.41 -150.83 0.02 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 116.729 1.451 . . . . 0.0 116.729 -173.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -73.45 -38.22 65.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -171.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -103.28 -0.42 30.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.991 0.901 . . . . 0.0 109.455 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 68.9 mt-10 -99.37 163.53 12.49 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.643 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -79.23 128.36 33.2 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -86.26 67.56 9.98 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-O 122.542 1.163 . . . . 0.0 108.948 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -98.25 -167.18 1.47 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.521 177.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 54.8 tttp -147.92 -173.59 4.34 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.758 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 54.3 tt0 -79.0 105.6 10.45 Favored 'General case' 1 C--N 1.243 -4.027 0 C-N-CA 127.112 2.165 . . . . 0.0 109.302 -176.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 8.19 48.01 Favored Glycine 0 C--N 1.285 -2.3 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.005 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.4 128.82 36.22 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.516 0.674 . . . . 0.0 110.759 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.73 97.03 10.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 22.7 pt -107.27 158.36 7.2 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.093 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.672 176.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.47 128.79 43.62 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -90.98 132.64 35.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.299 177.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.11 11.73 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 33.1 ttt180 -155.08 114.15 3.61 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.076 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 28' ' ' ILE . 46.3 mm -99.12 95.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.91 140.86 36.64 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -110.26 -46.05 3.49 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.086 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.568 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 25.6 t-20 -82.06 -58.83 0.45 Allowed Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.963 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 40.0 Cg_exo -60.02 103.63 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.618 2.212 . . . . 0.0 113.164 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.679 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 15.0 tp10 72.2 -24.62 0.19 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.007 1.323 . . . . 0.0 113.029 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.06 54.38 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.1 mmtm -131.57 162.95 29.13 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 38.8 m0 -102.0 153.54 19.79 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -98.93 112.52 24.6 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.682 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -109.52 177.48 20.07 Favored Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 114.293 -1.322 . . . . 0.0 110.572 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.2 ptm180 -151.32 141.26 22.01 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 52' ' ' ILE . 64.9 p -79.43 167.85 20.27 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.27 64.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.799 0.809 . . . . 0.0 109.869 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -84.47 -22.37 30.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.073 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.53 19.4 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.091 -1.052 . . . . 0.0 114.314 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.5 m -94.31 110.37 22.13 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.446 ' HB2' HG21 ' A' ' 15' ' ' ILE . 38.5 m-85 -87.49 138.43 31.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.64 155.87 27.12 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.355 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.3 m-85 -69.35 143.79 53.65 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.713 0.768 . . . . 0.0 110.7 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.787 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.9 mt -124.53 132.89 70.69 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.687 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 mtmt -73.57 132.34 42.71 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.6 p -63.73 -10.25 18.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.593 0.711 . . . . 0.0 112.857 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -99.98 -16.05 18.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.651 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -14.17 59.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 52' ' ' ILE . 33.2 m -131.39 156.21 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.689 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 9.3 mm-40 -106.36 106.22 16.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 31' ' ' ALA . 23.4 mm -83.62 115.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.538 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -84.24 150.48 25.42 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.52 0.676 . . . . 0.0 110.95 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.03 -6.86 27.74 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.145 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.66 -5.93 40.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.545 1.138 . . . . 0.0 110.964 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.405 ' CB ' ' HA ' ' A' ' 29' ' ' HIS . 23.4 m -61.19 -24.56 66.41 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.15 -45.1 43.07 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.337 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -177.47 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -159.97 158.65 31.05 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -70.69 122.51 19.95 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.74 0.781 . . . . 0.0 112.008 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -146.22 38.45 1.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.961 -1.472 . . . . 0.0 107.696 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.96 -50.97 52.73 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.303 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 96' ' ' GLU . 5.4 tt -163.63 147.6 10.41 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' N ' HD23 ' A' ' 95' ' ' LEU . 51.5 mm-40 . . . . . 0 CA--C 1.508 -0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 110.486 -176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.526 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -106.88 -49.99 3.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -95.92 163.96 12.93 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.858 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 37.1 tt0 -140.98 81.0 1.77 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 169.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.27 100.74 5.49 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 80.43 14.98 0.75 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 125.087 1.492 . . . . 0.0 108.635 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 1.8 mp0 -93.14 65.62 3.98 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.246 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -99.58 -6.66 27.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.68 95.39 10.05 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -107.78 -4.49 18.05 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.502 0.668 . . . . 0.0 110.129 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -57.32 -55.48 34.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.931 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.638 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -84.78 -9.79 57.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.118 -175.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.08 -50.03 65.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.779 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.16 -41.02 82.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.6 pp -65.86 -24.49 34.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.974 0.416 . . . . 0.0 111.83 -176.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 46.1 mtmt -68.8 -24.37 64.39 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.189 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -97.88 -43.97 6.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.629 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.0 tttt -62.69 -57.25 11.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' HD2' ' HB ' ' A' ' 15' ' ' ILE . 66.6 m-85 -97.59 -13.01 21.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.364 0.602 . . . . 0.0 109.726 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 53.0 mttp 62.39 77.59 0.32 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.185 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 15' ' ' ILE . 73.9 mt -121.1 16.85 11.62 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.602 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -61.61 131.47 50.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.474 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.02 -177.18 18.05 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.34 115.01 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.36 2.04 . . . . 0.0 111.577 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 55' ' ' ILE . 2.7 pp -109.98 145.31 16.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.764 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.03 130.06 55.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.308 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.914 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.5 p -71.9 144.44 13.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 123.253 0.346 . . . . 0.0 110.41 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.44 HG22 ' CD2' ' A' ' 29' ' ' HIS . 45.4 mm -95.98 -44.71 13.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.709 ' HB2' HD11 ' A' ' 54' ' ' ILE . 74.6 m-70 -154.17 179.99 8.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 123.658 0.783 . . . . 0.0 109.065 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 5.7 mp -108.07 136.52 47.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -108.58 176.03 5.26 Favored 'General case' 0 C--N 1.263 -3.174 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 14.8 ptmm? -150.57 102.58 3.04 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.93 122.71 18.76 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.47 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 38.3 t -117.25 152.75 34.19 Favored 'General case' 0 CA--C 1.444 -3.1 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.147 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 m 70.78 177.64 0.27 Allowed 'General case' 0 N--CA 1.404 -2.725 0 O-C-N 125.818 1.949 . . . . 0.0 110.583 162.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.16 100.44 6.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.615 1.198 . . . . 0.0 110.541 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.02 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.3 m -87.74 156.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.946 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -61.7 -52.7 63.21 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.66 43.14 99.41 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.345 -0.931 . . . . 0.0 114.763 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.39 -179.33 1.03 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -63.61 -27.95 69.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 29.5 p-10 -90.3 -13.95 34.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 45.7 mt-10 -92.33 159.82 15.41 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.462 -177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' HD2' ' A' ' 46' ' ' PHE . 1.4 tt -70.79 137.51 49.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.631 0.729 . . . . 0.0 109.844 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 44' ' ' LEU . 15.1 m -82.96 43.81 0.88 Allowed 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.436 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.02 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -84.93 -161.05 0.53 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.273 178.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.882 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 74.1 tttt -145.54 -171.57 3.7 Favored 'General case' 0 N--CA 1.389 -3.525 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.882 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 7.7 tt0 -75.73 -8.83 57.79 Favored 'General case' 0 C--N 1.254 -3.568 0 C-N-CA 128.746 2.818 . . . . 0.0 114.337 -168.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.47 19.9 1.69 Allowed Glycine 0 C--N 1.27 -3.094 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 18.6 mm-40 -80.56 129.78 34.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -96.88 97.57 9.39 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.912 HD11 HG11 ' A' ' 82' ' ' VAL . 36.6 pt -105.55 159.73 5.7 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.883 -2.417 . . . . 0.0 112.55 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.914 ' HB3' HG21 ' A' ' 27' ' ' VAL . 40.7 mt-10 -120.05 136.0 54.73 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.4 128.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.866 0.841 . . . . 0.0 112.072 177.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -100.59 -35.03 4.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.209 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.02 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.1 ttm180 -114.84 121.36 43.0 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.715 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.9 mm -99.09 98.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.27 141.65 34.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -106.45 -16.15 14.62 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -39.58 140.83 0.77 Allowed Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 126.659 1.984 . . . . 0.0 113.06 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -35.6 -25.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.751 1 C-N-CA 126.283 4.655 . . . . 0.0 117.49 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 27.3 mm-40 -59.69 -28.82 67.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.741 0.7 . . . . 0.0 110.22 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.36 29.76 75.52 Favored Glycine 0 CA--C 1.495 -1.174 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.013 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 44.9 mmtm -133.74 155.2 50.2 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.4 m0 -100.75 153.16 19.68 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.516 0.51 . . . . 0.0 110.171 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -95.03 116.37 28.61 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.756 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.04 178.62 16.66 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.765 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 36.3 ptt180 -151.91 147.33 26.46 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.735 ' HA ' HG22 ' A' ' 52' ' ' ILE . 67.0 p -80.05 179.02 7.83 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 118.198 0.454 . . . . 0.0 109.811 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -15.87 61.89 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -80.82 -25.89 37.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.38 9.36 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.348 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 8.0 p -94.1 111.55 23.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.794 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 m-85 -83.13 148.98 27.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -171.62 160.74 32.78 Favored Glycine 0 C--N 1.318 -0.446 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.19 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 m-85 -76.21 143.21 41.18 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-O 121.67 0.748 . . . . 0.0 111.522 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.756 HD11 ' HA3' ' A' ' 67' ' ' GLY . 44.2 mt -125.39 139.15 52.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.061 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 77' ' ' ILE . 55.7 mttm -74.1 136.47 42.98 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 168.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.6 p -64.56 -13.32 52.3 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.537 0.685 . . . . 0.0 112.143 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -97.27 -16.24 20.43 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.541 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.45 -17.65 59.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 52' ' ' ILE . 27.5 m -130.58 153.17 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.75 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 49.0 mm-40 -102.85 100.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 31' ' ' ALA . 22.0 mm -70.57 133.14 32.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.098 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.0 149.98 37.49 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.004 0.907 . . . . 0.0 111.692 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -101.84 10.02 40.23 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 114.266 -1.333 . . . . 0.0 107.499 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -100.33 -17.54 17.21 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -162.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -53.83 -22.67 10.2 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.24 -62.91 1.52 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -136.07 135.41 39.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.07 113.57 3.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.525 0.516 . . . . 0.0 110.046 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -149.03 27.52 0.86 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.589 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -60.15 138.99 57.79 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.648 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -109.39 173.92 6.1 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.0 mp 60.58 76.63 0.36 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 122.279 1.038 . . . . 0.0 109.59 -172.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--N 1.286 -2.194 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.751 -175.378 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -105.87 -60.72 1.6 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.809 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp 74.47 -53.13 0.68 Allowed 'General case' 0 C--O 1.253 1.278 0 C-N-CA 125.017 1.327 . . . . 0.0 109.48 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 69.94 8.52 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.04 0.924 . . . . 0.0 108.937 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -127.87 -12.03 5.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.132 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -118.19 -0.28 11.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 45.68 76.16 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.418 1.074 . . . . 0.0 110.993 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 21.5 ptmt -107.99 -175.94 2.92 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.474 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.14 93.96 4.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.697 0.761 . . . . 0.0 111.522 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -106.1 -12.21 15.84 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -47.48 -68.21 0.21 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.622 1.969 . . . . 0.0 112.336 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 3.3 pm0 -79.95 -7.1 58.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.51 -44.51 14.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.812 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -71.68 -38.61 70.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.744 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -59.51 -31.44 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.722 ' HB3' HG23 ' A' ' 22' ' ' THR . 54.1 mttp -72.27 -22.78 61.17 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.596 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -94.11 -40.21 10.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.573 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.7 ttpt -65.32 -42.1 93.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.779 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.2 m-85 -111.82 1.54 16.64 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.234 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 34.9 ttmt 53.37 72.22 0.45 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.928 1.347 . . . . 0.0 110.336 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.61 HD21 ' HG ' ' A' ' 66' ' ' LEU . 94.9 mt -112.5 16.47 19.81 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.984 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -71.93 94.4 1.45 Allowed 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.301 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.96 170.53 25.7 Favored Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.18 128.23 11.97 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.908 2.405 . . . . 0.0 111.452 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.26 159.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -136.71 144.1 43.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 53' ' ' GLU . 8.0 p -71.43 137.4 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 57' ' ' ILE . 40.0 mm -98.87 -37.79 6.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.195 0.521 . . . . 0.0 109.872 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.599 ' HB2' HD11 ' A' ' 54' ' ' ILE . 53.6 m-70 -153.65 164.16 38.76 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.65 HD13 ' HB3' ' A' ' 88' ' ' SER . 9.4 mp -103.26 132.28 49.65 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.43 171.89 7.11 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.796 0.808 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 14.3 ptpt -151.64 102.72 2.89 Favored 'General case' 0 C--N 1.26 -3.297 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.81 112.77 3.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -96.95 150.73 20.43 Favored 'General case' 0 CA--C 1.431 -3.599 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.655 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.4 m 67.91 -179.32 0.22 Allowed 'General case' 0 N--CA 1.402 -2.845 0 O-C-N 125.635 1.835 . . . . 0.0 110.782 163.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -79.72 105.29 10.9 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 46' ' ' PHE . 16.9 m -87.76 156.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.896 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -52.58 -58.58 6.32 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.41 41.79 99.74 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.818 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.82 178.29 0.3 Allowed Glycine 0 CA--C 1.526 0.723 0 O-C-N 123.914 0.42 . . . . 0.0 113.528 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -64.42 -32.85 74.65 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 122.104 -0.645 . . . . 0.0 111.547 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -88.08 -7.81 56.43 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.048 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 47.7 mt-10 -92.14 171.96 8.74 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HG ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -73.23 148.63 43.51 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' H ' HD23 ' A' ' 44' ' ' LEU . 17.8 m -89.89 38.45 0.92 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.749 1.261 . . . . 0.0 108.536 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.813 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -85.17 163.45 18.71 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.12 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.627 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 28.1 mmtp -133.65 -173.35 3.21 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.882 0.849 . . . . 0.0 111.997 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 56.6 tt0 -64.7 119.48 10.64 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 126.528 1.931 . . . . 0.0 109.978 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.18 19.07 40.41 Favored Glycine 0 C--N 1.292 -1.901 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.545 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.813 ' HG2' ' HB2' ' A' ' 46' ' ' PHE . 6.6 tp10 -78.64 137.53 37.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.155 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.56 96.68 8.47 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.842 HD11 HG11 ' A' ' 82' ' ' VAL . 22.5 pt -111.86 158.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 112.691 -2.05 . . . . 0.0 113.578 173.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HB3' HG21 ' A' ' 27' ' ' VAL . 3.8 mp0 -128.18 137.75 52.19 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 67' ' ' GLY 0.288 0.2 OUTLIER -102.21 124.77 56.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.866 176.213 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -107.95 -4.08 10.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.838 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.832 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.1 ttm180 -138.97 114.56 9.83 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.96 0.409 . . . . 0.0 110.81 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 HG13 ' A' ' 28' ' ' ILE . 51.1 mm -94.72 98.49 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.05 139.41 31.18 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.6 2.43 14.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.62 126.87 89.44 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.312 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.91 120.11 7.71 Favored 'Trans proline' 0 C--O 1.251 1.147 0 C-N-CA 123.336 2.691 . . . . 0.0 114.533 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.52 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.31 29.11 6.14 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.722 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 26.7 mmtp -134.93 158.3 44.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.003 0.43 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 17.6 m0 -109.41 162.23 14.55 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -104.04 112.48 25.49 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.561 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.11 177.6 18.24 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.164 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 7.0 ptm180 -150.02 145.88 26.67 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 52' ' ' ILE . 43.9 p -84.75 171.83 11.99 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.42 -23.92 67.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.351 0.596 . . . . 0.0 110.05 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -75.89 -14.93 60.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.106 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.68 28.49 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.285 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.1 m -92.95 109.01 20.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 26.2 m-85 -84.12 140.28 31.89 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.206 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -165.74 156.22 28.02 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.624 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.596 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 12.5 m-85 -68.96 150.18 48.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.603 0.716 . . . . 0.0 111.102 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 67' ' ' GLY . 70.3 mt -134.77 128.68 50.82 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 77' ' ' ILE . 91.5 mttt -68.21 143.05 55.48 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 168.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 p -68.96 -16.02 63.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.158 0.98 . . . . 0.0 111.546 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 80' ' ' THR . 5.4 t -89.79 -15.94 31.29 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.723 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -17.18 56.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.469 0.652 . . . . 0.0 110.472 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -129.63 156.88 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.805 0 CA-C-O 121.464 0.649 . . . . 0.0 112.509 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -98.29 100.65 11.96 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.2 mm -82.63 109.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.75 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 1.3 m-20 -93.87 154.83 17.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.048 0.928 . . . . 0.0 112.409 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' HD13 ' A' ' 91' ' ' LEU . 64.6 m-85 -92.34 -20.98 20.53 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 15.5 t70 -44.26 -32.16 1.2 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.491 2.316 . . . . 0.0 112.751 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 30' ' ' LEU . 6.7 m -52.17 -43.6 64.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.436 1.094 . . . . 0.0 111.508 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 88' ' ' SER . 1.9 mm? -101.67 -31.23 10.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 64.68 95.63 0.05 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.794 1.638 . . . . 0.0 111.017 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 86' ' ' TYR . 5.9 mp -96.43 -175.48 3.35 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -86.62 75.09 9.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.53 96.13 3.64 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.899 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.71 111.75 23.15 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.0 mt 77.25 86.23 0.08 Allowed 'General case' 0 C--O 1.244 0.813 0 O-C-N 125.116 1.51 . . . . 0.0 109.139 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -177.359 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.505 -0.753 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 55.86 81.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.966 0.888 . . . . 0.0 113.093 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.24 97.6 8.37 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.957 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.09 126.3 53.04 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.099 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -109.55 116.29 31.5 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -118.0 76.68 1.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.803 0.811 . . . . 0.0 111.305 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.95 29.5 4.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -78.93 101.86 7.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.982 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 56.61 41.35 28.6 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.474 1.108 . . . . 0.0 109.967 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -107.64 7.52 28.62 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.212 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -66.4 -26.93 67.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.202 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.88 -22.97 60.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.562 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.11 -37.36 84.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -71.43 -59.04 2.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.481 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.5 pp -56.33 -25.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.37 -35.18 68.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.482 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.86 -32.52 15.29 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.902 0.858 . . . . 0.0 109.323 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -66.82 -45.71 77.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.37 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 65.1 m-85 -108.02 -3.36 18.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 2.9 mptp? 60.89 75.2 0.42 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.181 0.991 . . . . 0.0 110.006 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 15' ' ' ILE . 8.8 tp -89.76 -24.53 21.48 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.904 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.252 77.3 p 64.79 -69.12 0.1 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.845 1.658 . . . . 0.0 112.473 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.39 -107.97 0.21 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.49 145.51 71.06 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.441 2.094 . . . . 0.0 109.942 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.4 pp -138.66 -48.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.624 ' H ' HD12 ' A' ' 25' ' ' ILE . 31.1 mm-40 71.01 123.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.834 1.302 . . . . 0.0 114.129 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.19 140.5 18.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 112.548 -2.115 . . . . 0.0 111.156 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.95 -44.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.831 0.348 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.951 ' HB2' HD11 ' A' ' 54' ' ' ILE . 92.0 m-70 -142.83 177.08 8.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 89' ' ' LEU . 11.1 mp -110.54 119.25 38.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.453 0.644 . . . . 0.0 111.386 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.53 167.01 10.03 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.802 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 17.2 pttp -153.14 102.78 2.66 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.813 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.36 139.61 56.87 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.136 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.9 t -127.61 155.18 44.27 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.6 m 69.45 175.9 0.28 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 125.889 1.993 . . . . 0.0 111.456 162.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.79 113.25 16.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.796 HG21 ' CE1' ' A' ' 46' ' ' PHE . 17.4 m -112.16 155.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.79 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.66 -46.8 83.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.311 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.58 43.01 45.35 Favored Glycine 0 C--N 1.359 1.813 0 O-C-N 123.896 0.747 . . . . 0.0 113.738 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.28 -153.04 0.04 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 116.255 1.262 . . . . 0.0 116.255 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.27 -51.34 25.01 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.95 -6.8 59.49 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.283 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.48 172.73 8.19 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -83.0 141.67 31.91 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -81.62 45.17 0.86 Allowed 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.456 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.888 ' HE2' HG12 ' A' ' 77' ' ' ILE . 1.2 p90 -86.05 179.19 7.02 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.833 0.825 . . . . 0.0 112.021 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.788 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 28.1 mtpp -132.92 -172.06 2.83 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.995 -172.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 24.6 tt0 -76.6 -12.02 59.95 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 126.881 2.073 . . . . 0.0 113.677 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.7 19.59 2.39 Favored Glycine 0 C--N 1.268 -3.208 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 9.6 mm-40 -77.12 125.46 29.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.86 0.838 . . . . 0.0 113.182 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.38 97.75 9.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 82' ' ' VAL . 36.0 pt -112.64 159.1 12.8 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.047 0 CA-C-N 112.511 -2.131 . . . . 0.0 112.62 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.33 139.15 53.52 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -103.02 134.97 42.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.318 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -105.73 -24.45 4.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.415 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 9.3 ttt85 -127.38 122.94 34.98 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.382 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mm -104.6 96.75 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.55 140.38 41.09 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.463 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -114.26 -21.89 10.22 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -64.26 148.62 95.64 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.814 1.246 . . . . 0.0 107.977 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.39 47.66 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 124.042 3.161 . . . . 0.0 115.483 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -78.68 -33.12 47.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.08 -19.42 52.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.881 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.1 mmtp -133.28 156.38 47.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 32.5 m0 -93.11 162.35 14.06 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.712 0.633 . . . . 0.0 109.973 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -103.62 115.02 29.73 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.217 0.532 . . . . 0.0 110.327 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.728 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.48 -179.16 16.61 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.279 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 36.1 ptt180 -151.78 144.7 24.46 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.1 p -78.31 170.44 16.63 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.63 -14.67 59.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.214 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.66 0.03 57.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.217 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.83 68.35 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 m -97.83 113.2 24.94 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 23.0 m-85 -82.47 151.64 26.44 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.801 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -170.94 159.02 30.94 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.644 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.7 m-85 -71.63 147.97 47.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.623 0.725 . . . . 0.0 111.606 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.888 HG12 ' HE2' ' A' ' 46' ' ' PHE . 69.3 mt -133.0 133.27 58.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.761 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 77' ' ' ILE . 98.2 mttt -69.43 135.37 50.15 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 167.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.5 p -66.23 -8.11 22.51 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.628 0.728 . . . . 0.0 111.885 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -106.2 -6.96 18.12 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 124.064 0.946 . . . . 0.0 109.731 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -85.99 -14.13 45.5 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 52' ' ' ILE . 33.4 m -129.1 152.89 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.138 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.153 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.657 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 37.0 mt-10 -94.65 100.46 12.4 Favored 'General case' 0 N--CA 1.397 -3.11 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 27.3 mm -90.77 106.03 17.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.1 134.42 54.23 Favored 'General case' 0 CA--C 1.471 -2.069 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.883 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -74.26 -28.57 61.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -50.17 -36.46 30.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 111.151 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -65.68 -18.73 65.54 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.279 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 30' ' ' LEU . 3.6 mm? -103.93 -48.32 3.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 39.1 ttmt -158.55 150.89 21.74 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 87.7 mt -61.67 141.76 57.62 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.048 0.451 . . . . 0.0 111.025 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.86 123.74 19.71 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.736 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt 69.91 20.86 6.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.062 0.945 . . . . 0.0 110.159 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 27.9 t70 -77.38 140.39 39.92 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.88 140.21 29.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.036 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 124.025 0.93 . . . . 0.0 111.527 -179.044 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.236 0.357 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -99.86 111.35 23.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.779 0.799 . . . . 0.0 111.265 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.772 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -113.33 16.26 19.04 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.298 175.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.37 -69.2 0.3 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.16 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -125.25 -68.85 0.82 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttm 49.22 68.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 111.849 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -80.17 -26.33 39.35 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.515 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 59.27 72.09 0.55 Allowed 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.837 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 173.96 -62.79 0.01 OUTLIER 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.76 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -61.19 -42.97 99.53 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.458 -173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 15' ' ' ILE . 12.9 mptt -65.37 -47.62 75.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' HA ' HG12 ' A' ' 15' ' ' ILE . 26.8 mp0 -77.49 -11.97 59.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -81.85 -23.33 36.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -89.94 -33.49 16.39 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.758 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 11' ' ' LYS . 2.6 pp -54.88 -31.87 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -73.94 -24.53 59.66 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -96.94 -28.06 14.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 31.5 tttp -61.33 -52.28 65.32 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.257 1.423 . . . . 0.0 110.478 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 42.4 m-85 -99.03 -5.88 29.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.101 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 61.16 76.04 0.39 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.717 1.246 . . . . 0.0 108.304 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 25' ' ' ILE . 10.4 tp -116.36 16.09 15.75 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.212 -172.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -75.92 122.79 24.68 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.109 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.52 168.53 18.54 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 121.61 8.84 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.789 2.992 . . . . 0.0 112.196 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.854 HG13 ' H ' ' A' ' 26' ' ' GLN . 18.2 pt -106.37 -76.82 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.854 ' H ' HG13 ' A' ' 25' ' ' ILE 0.258 23.8 mt-30 72.41 141.12 0.06 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.186 1.394 . . . . 0.0 114.316 -177.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 53' ' ' GLU . 60.6 t -81.4 137.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.218 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.494 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.12 -42.3 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.92 ' HB2' HD11 ' A' ' 54' ' ' ILE . 84.8 m-70 -142.46 178.89 7.29 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' A' ' 88' ' ' SER . 45.2 tp -115.27 125.66 53.57 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.63 171.49 7.3 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.64 0.734 . . . . 0.0 109.95 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 61.4 pttt -151.08 107.53 3.48 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -70.15 130.97 43.5 Favored 'General case' 0 C--N 1.255 -3.531 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.589 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.05 166.42 12.02 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 6.3 m 63.73 164.94 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 125.219 1.574 . . . . 0.0 114.444 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.98 111.18 5.49 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.833 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.3 m -111.89 156.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.087 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -56.33 -60.8 2.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 43' ' ' GLU . . . 49.6 41.48 34.14 Favored Glycine 0 C--O 1.21 -1.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.809 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.13 -110.26 0.01 OUTLIER Glycine 0 CA--C 1.542 1.724 0 N-CA-C 118.727 2.251 . . . . 0.0 118.727 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 9.4 mmpt? -98.87 -53.76 3.19 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 122.271 -0.546 . . . . 0.0 111.535 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -95.43 1.96 54.33 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' C ' ' A' ' 39' ' ' GLY . 39.2 mt-10 -92.65 157.52 16.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.684 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.048 0.927 . . . . 0.0 111.269 -173.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.6 m -84.07 69.75 10.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.671 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.925 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.86 -175.69 2.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.58 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -145.1 -172.66 3.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 124.036 0.835 . . . . 0.0 109.234 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.7 tt0 -85.7 107.44 17.58 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 125.429 1.492 . . . . 0.0 109.576 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.97 29.98 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.93 126.82 34.38 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.625 0.726 . . . . 0.0 111.629 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.93 96.44 10.68 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 33.3 pt -109.51 158.09 9.65 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.052 0 CA-C-N 112.495 -2.138 . . . . 0.0 112.704 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB3' HG11 ' A' ' 27' ' ' VAL . 30.3 mt-10 -121.83 134.64 54.89 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -97.33 129.27 47.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.288 175.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.665 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.5 mp -98.99 -40.28 8.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.008 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.9 ttm180 -121.87 119.7 32.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.758 -174.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.41 98.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 t -125.34 146.11 49.72 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.264 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -114.02 9.32 17.32 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.43 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.667 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 5.0 m-20 -61.41 170.79 1.54 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.259 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 60' ' ' ASN . 51.8 Cg_exo -19.68 -52.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.86 1 C-N-CA 126.95 5.1 . . . . 0.0 117.874 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.671 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 11.9 mm-40 -64.35 -36.81 85.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.77 31.74 73.4 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 33.0 mmtp -123.66 159.93 28.26 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.453 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.5 m0 -95.98 152.04 18.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.6 tm? -93.69 114.03 26.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -118.32 179.67 17.02 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.31 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 35.1 ptt180 -152.29 139.69 19.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.87 ' HA ' HG22 ' A' ' 52' ' ' ILE . 5.5 p -76.0 171.49 14.35 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 117.948 0.34 . . . . 0.0 110.446 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.45 -16.19 60.35 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -72.56 -17.48 61.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.558 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.11 23.53 22.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 23.6 m -113.43 128.09 56.33 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 41.2 m-85 -89.67 151.85 21.66 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.525 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -174.89 160.29 29.25 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 17.5 m-85 -74.73 146.45 42.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.388 0.613 . . . . 0.0 111.011 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.925 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.0 mt -128.29 129.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.673 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' O ' HG22 ' A' ' 77' ' ' ILE . 63.0 mttm -69.77 132.43 46.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 165.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.3 p -63.14 -10.75 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.737 0.78 . . . . 0.0 112.595 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.7 t -93.88 -21.1 19.45 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.897 0.879 . . . . 0.0 109.709 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.36 -15.07 60.04 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.974 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 34.4 m -127.19 157.81 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 CA-C-O 121.405 0.622 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 32.0 mt-10 -112.73 101.02 9.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 31' ' ' ALA . 20.0 mm -74.19 132.57 33.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.197 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -109.74 146.78 34.36 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -99.81 -37.91 8.87 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.002 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.78 -33.58 75.48 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.167 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.794 ' HB3' HD23 ' A' ' 30' ' ' LEU . 38.9 m -72.05 1.62 7.06 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 29' ' ' HIS . 4.2 mm? -81.79 -3.72 54.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.111 0.958 . . . . 0.0 109.78 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -111.8 154.02 25.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.65 83.97 3.3 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -167.06 130.6 1.85 Allowed 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -160.4 112.02 1.93 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 133.13 54.88 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -65.18 131.12 45.71 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.259 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 C--N 1.304 -1.387 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.22 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -87.77 130.11 34.95 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -115.86 72.77 0.82 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 59.29 27.06 16.02 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.134 0.968 . . . . 0.0 108.791 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 58.37 85.38 0.09 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.439 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -14.3 60.06 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.206 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.24 130.81 44.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -94.81 -10.53 31.15 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.573 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 69.07 99.12 0.06 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.39 1.076 . . . . 0.0 112.701 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.5 -25.08 67.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.032 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -61.1 -43.29 99.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.232 0.539 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 15' ' ' ILE . 9.5 pt-20 -84.52 -26.85 27.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.02 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.18 -42.15 94.41 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.175 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.3 -41.87 66.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.617 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -64.51 -29.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.933 0.397 . . . . 0.0 111.742 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 45.6 mtmt -76.26 -25.58 55.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.637 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -83.86 -38.2 21.47 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.09 -49.28 62.21 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.083 1.353 . . . . 0.0 112.406 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.47 -4.6 25.15 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 57.37 75.52 0.37 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 10.7 tp -127.51 14.47 7.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.988 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -57.57 117.31 4.05 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.676 -172.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.98 169.47 11.67 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.84 120.15 6.86 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 122.218 1.946 . . . . 0.0 110.764 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.805 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.7 pp -104.26 151.44 6.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -143.46 159.28 42.69 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.345 1.058 . . . . 0.0 108.168 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 53' ' ' GLU . 30.8 m -75.2 154.97 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.691 HD12 HG12 ' A' ' 57' ' ' ILE . 36.0 mt -105.05 -32.74 2.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.589 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.919 ' HB2' HD11 ' A' ' 54' ' ' ILE . 55.4 m80 -152.01 -178.59 6.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 53' ' ' GLU . 30.2 tp -119.28 132.98 55.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.08 170.6 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.607 0.718 . . . . 0.0 110.646 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 46.0 pttt -153.32 102.87 2.64 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.841 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.99 125.52 23.97 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.689 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.8 p -111.26 166.55 11.0 Favored 'General case' 0 CA--C 1.452 -2.808 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.472 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m 61.26 174.67 0.11 Allowed 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 125.038 1.461 . . . . 0.0 112.307 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.14 102.96 8.75 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 46' ' ' PHE . 18.7 m -92.01 154.31 3.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.692 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -58.18 -58.95 6.21 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.65 42.09 90.44 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 124.288 0.992 . . . . 0.0 113.696 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.04 -152.57 0.37 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -63.27 -50.13 71.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 4.5 p-10 -82.8 -8.9 59.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.696 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 41.6 mt-10 -91.68 -179.81 5.44 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.571 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.4 tt -88.51 149.0 23.86 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 44' ' ' LEU . 29.9 t -92.08 90.17 7.26 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.726 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.61 176.91 9.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.892 -174.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -139.65 -174.0 3.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 111.612 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 28.9 tt0 -79.17 105.68 10.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 126.532 1.933 . . . . 0.0 108.81 -177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.88 12.15 44.27 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.44 157.8 33.58 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -108.26 96.78 6.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.7 -1.136 . . . . 0.0 107.964 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.693 HD11 HG11 ' A' ' 82' ' ' VAL . 23.1 pt -117.0 159.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.983 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 5.3 pt-20 -133.21 139.23 46.88 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.25 0.2 OUTLIER -102.34 132.48 48.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.822 179.458 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.805 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.37 -31.95 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.919 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.019 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.7 ttm180 -115.76 126.83 54.56 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.713 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 28' ' ' ILE . 51.1 mm -103.3 98.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.69 141.7 31.17 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.733 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -110.12 -13.86 14.3 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -43.09 142.2 1.58 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.27 1.828 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -43.34 -20.15 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.971 1 C-N-CA 125.784 4.323 . . . . 0.0 116.173 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 11.3 tp10 -55.92 -36.08 67.31 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.75 31.62 76.29 Favored Glycine 0 CA--C 1.487 -1.698 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.958 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 47.7 mmtm -133.53 155.91 48.74 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 26.1 m0 -108.36 152.49 24.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.35 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.019 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -92.74 110.72 22.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -116.81 176.56 16.32 Favored Glycine 0 N--CA 1.417 -2.63 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.154 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 23.0 ptt180 -151.76 143.13 23.41 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' HG22 ' A' ' 52' ' ' ILE . 4.2 p -77.05 166.15 23.68 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -20.83 66.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -67.33 -26.43 66.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.842 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.83 20.41 11.6 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.509 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 67.1 m -104.41 120.72 41.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 117.875 0.837 . . . . 0.0 108.799 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.6 m-85 -92.58 150.0 21.0 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.983 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.433 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -166.64 155.98 27.53 Favored Glycine 0 C--N 1.305 -1.169 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.15 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 2.0 m-85 -79.19 116.16 19.29 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-O 121.687 0.756 . . . . 0.0 110.015 174.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 78' ' ' LYS . 65.1 mt -100.41 140.2 20.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.761 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.5 mtmt -71.96 139.3 48.6 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.7 p -68.95 -12.69 61.88 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.768 0.794 . . . . 0.0 111.92 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 t -99.42 -12.22 20.44 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.589 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . . . -77.26 -15.89 59.25 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.193 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.1 m -130.39 154.18 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.7 mt-10 -100.84 102.8 13.94 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 31' ' ' ALA . 29.0 mm -79.58 119.2 28.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -97.06 140.99 30.75 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.779 0.799 . . . . 0.0 110.593 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -98.31 -34.52 10.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.265 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -69.66 -8.43 47.57 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.405 HD21 ' N ' ' A' ' 30' ' ' LEU . 3.3 mm? -102.01 -3.81 27.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.642 0.734 . . . . 0.0 109.157 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -106.81 -70.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.058 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD22 ' HG ' ' A' ' 95' ' ' LEU . 93.6 mt 51.96 89.37 0.03 OUTLIER 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 113.08 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -114.17 -61.51 1.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -149.02 74.07 1.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' H ' HD12 ' A' ' 95' ' ' LEU . 8.9 p-10 -172.13 27.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.259 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' HG ' HD22 ' A' ' 91' ' ' LEU . 5.2 mp -94.23 88.44 5.59 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.169 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 174.427 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.613 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.242 0.705 0 CA-C-O 121.572 0.701 . . . . 0.0 112.413 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -115.15 -43.34 3.09 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -147.11 25.51 1.12 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.613 ' HB2' ' HA ' ' A' ' 1' ' ' GLU . 1.8 mp0 -101.02 -147.14 0.35 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.844 -173.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.422 ' H ' ' HB3' ' A' ' 4' ' ' GLU . 52.1 tt0 72.41 34.64 1.28 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 123.981 1.848 . . . . 0.0 107.182 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.5 154.9 39.71 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.571 -2.104 . . . . 0.0 107.323 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 9' ' ' GLU . 2.4 mp0 -54.76 147.27 15.18 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.436 0.636 . . . . 0.0 110.748 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.57 14.44 28.41 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HG2' ' HB3' ' A' ' 7' ' ' GLU . 16.9 mm-40 -74.25 95.22 2.6 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.826 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -108.03 -33.87 7.06 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.673 0.749 . . . . 0.0 109.2 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.75 -23.83 67.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -81.2 -16.58 52.39 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.495 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -80.95 -34.82 32.95 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -46.27 89.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.146 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.52 -27.88 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.19 0.519 . . . . 0.0 111.343 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 92.9 mttt -75.04 -18.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.66 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -97.57 -40.52 8.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.92 -49.28 78.32 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.553 1.141 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.9 m-85 -100.83 -0.51 36.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.642 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.41 74.68 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.059 0.933 . . . . 0.0 108.737 -171.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 8.6 tp -121.57 15.01 11.11 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.557 -173.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -64.75 118.27 8.71 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.56 -164.75 21.66 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -66.17 140.07 57.87 Favored 'Trans proline' 0 CA--C 1.5 -1.222 0 C-N-CA 122.174 1.916 . . . . 0.0 109.406 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 55' ' ' ILE 0.359 0.0 OUTLIER -111.74 -66.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.173 -173.035 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' HD13 ' A' ' 25' ' ' ILE . 34.2 mm-40 70.96 161.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.121 0.962 . . . . 0.0 113.556 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.46 127.95 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.237 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.4 mm -98.87 -45.49 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.208 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.933 ' HB2' HD11 ' A' ' 54' ' ' ILE . 78.1 m-70 -152.36 170.45 20.04 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.92 125.68 48.65 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.997 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -106.78 175.18 5.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -153.71 106.59 2.9 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 175.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.869 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.52 138.02 57.79 Favored 'General case' 0 C--N 1.274 -2.683 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.118 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.1 t -126.62 151.86 47.43 Favored 'General case' 0 CA--C 1.447 -3.004 0 O-C-N 123.211 0.319 . . . . 0.0 110.307 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.1 m 71.22 167.42 0.31 Allowed 'General case' 0 N--CA 1.403 -2.805 0 O-C-N 125.976 2.048 . . . . 0.0 111.903 163.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.35 104.87 4.51 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.008 0.909 . . . . 0.0 110.707 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.795 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.7 m -107.49 157.4 7.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 124.633 1.173 . . . . 0.0 110.493 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HD3' ' HE3' ' A' ' 78' ' ' LYS . 13.2 ptmm? -59.11 -53.82 54.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 123.609 0.568 . . . . 0.0 111.164 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 46.89 41.75 14.21 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.901 -0.666 . . . . 0.0 114.121 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.35 -111.13 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.034 1.974 . . . . 0.0 118.034 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.7 -53.79 7.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -112.38 3.29 16.87 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.971 0.891 . . . . 0.0 109.472 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.0 mt-10 -91.92 148.42 22.22 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -69.94 126.96 31.22 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.72 0.771 . . . . 0.0 109.706 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 m -85.26 83.14 8.08 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.829 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.84 -177.44 3.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.222 -178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.5 mtpt -125.73 -173.99 2.97 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.193 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -73.93 -9.14 58.33 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.187 2.195 . . . . 0.0 113.785 -170.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.28 18.65 2.48 Favored Glycine 1 C--N 1.245 -4.491 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.0 mm-40 -79.75 128.21 33.14 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.744 0.783 . . . . 0.0 111.556 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -89.26 96.95 10.93 Favored 'General case' 0 N--CA 1.404 -2.755 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.88 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.871 HD11 HG11 ' A' ' 82' ' ' VAL . 20.8 pt -113.72 157.96 14.23 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.916 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.946 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -131.88 141.58 49.43 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.933 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.28 147.62 7.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.699 -177.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 25' ' ' ILE . 3.6 mp -112.94 -57.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.42 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.926 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 41.9 ttm180 -92.73 125.55 37.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.777 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.38 100.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 1.3 p -136.15 148.35 48.15 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 8.6 m-20 -114.04 -38.47 4.17 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.646 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.689 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 52.9 t30 -77.76 -63.07 0.49 Allowed Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.746 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 52.8 Cg_exo -59.14 103.76 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.296 1.997 . . . . 0.0 112.216 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 69.97 -12.45 0.48 Allowed 'General case' 0 C--O 1.251 1.135 0 C-N-CA 125.081 1.352 . . . . 0.0 113.733 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 59' ' ' ASP . . . 66.49 31.03 77.56 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -175.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 45.0 mmtm -134.09 166.09 23.56 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.0 m0 -104.27 146.65 28.49 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.926 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -94.91 115.7 27.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -113.64 178.68 18.58 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.8 ptt180 -151.83 138.79 19.04 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.661 ' HA ' HG22 ' A' ' 52' ' ' ILE . 28.8 p -77.87 176.49 9.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.87 -18.12 62.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.927 0.87 . . . . 0.0 109.209 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -78.49 -15.32 58.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.611 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.54 19.44 41.25 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.434 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -98.34 114.18 26.4 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' HD2' HD11 ' A' ' 66' ' ' LEU . 27.9 m-85 -83.34 150.59 26.02 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.975 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.53 154.01 22.18 Favored Glycine 0 CA--C 1.5 -0.885 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.41 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.429 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 26.8 m-85 -73.85 143.22 45.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.655 0.741 . . . . 0.0 110.959 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.829 HG12 ' HE2' ' A' ' 46' ' ' PHE . 54.0 mt -128.71 136.59 59.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.089 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 88.3 mttt -70.2 140.23 52.46 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.4 p -65.3 -6.77 10.71 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -106.23 -12.22 15.79 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.386 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.46 -10.85 59.71 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.369 0.604 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 52' ' ' ILE . 27.0 m -134.63 153.51 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.396 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.514 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 15.3 mm-40 -96.19 100.53 12.16 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.512 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.8 mm -75.9 131.11 35.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.622 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.15 114.85 20.96 Favored 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 122.627 1.203 . . . . 0.0 111.1 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.483 ' HA ' HD23 ' A' ' 89' ' ' LEU . 85.7 m-85 -100.84 -20.03 15.69 Favored 'General case' 1 C--N 1.242 -4.072 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.422 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 48.5 m-20 -64.98 -44.88 87.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.075 -173.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -73.87 -5.56 41.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 112.007 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 86' ' ' TYR . 3.5 mm? -78.02 -20.13 53.08 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.602 -0.686 . . . . 0.0 110.527 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -125.14 80.96 1.92 Allowed 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.4 mt 70.37 -76.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.204 1.401 . . . . 0.0 111.467 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 33.2 ttmt -171.19 -43.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.523 0.329 . . . . 0.0 110.923 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 55.3 mttp 62.44 91.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -84.47 -12.84 53.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.8 tp -168.17 -48.32 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.442 1.897 . . . . 0.0 106.398 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.182 177.85 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp 71.87 21.69 4.1 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.087 1.755 . . . . 0.0 110.769 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -127.96 13.31 6.78 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -87.05 116.55 25.19 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.958 -1.473 . . . . 0.0 108.597 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -62.73 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -90.89 125.17 35.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.837 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' HG3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -70.54 169.19 14.71 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.56 1.144 . . . . 0.0 109.235 -178.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 8' ' ' LYS 0.314 1.0 OUTLIER -77.15 101.69 6.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.622 1.201 . . . . 0.0 114.136 -176.778 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -89.86 -34.39 16.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.855 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -37.97 79.19 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.56 -175.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -53.85 -50.31 66.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.296 0.997 . . . . 0.0 110.297 176.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 15' ' ' ILE . 9.8 pt-20 -78.31 -25.43 46.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.959 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -64.82 -40.81 95.8 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -63.98 -46.75 83.22 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.421 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.3 pp -64.62 -26.5 40.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.806 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -71.04 -42.64 69.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.514 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.62 -7.88 59.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.076 0.465 . . . . 0.0 110.923 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -100.32 -49.34 4.29 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.095 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.1 m-85 -104.54 -12.1 16.65 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 59.97 79.53 0.23 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.999 0.904 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.44 -36.46 22.33 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.624 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 26.4 p 60.41 -47.55 0.1 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.418 2.287 . . . . 0.0 116.704 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.68 -168.83 11.39 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.74 141.55 49.93 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.529 2.153 . . . . 0.0 111.635 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.986 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.5 pp -118.37 160.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.526 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.501 ' O ' HG13 ' A' ' 27' ' ' VAL . 49.2 mt-30 -110.93 -93.71 0.44 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.189 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 170.92 149.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.608 2.363 . . . . 0.0 109.491 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 29' ' ' HIS . 48.6 mm -110.24 -42.39 5.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.832 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 76.0 m-70 -153.13 176.64 11.69 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.9 mp -105.62 137.37 43.58 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 171.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.84 168.79 9.39 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -151.04 103.25 3.03 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -58.75 132.18 53.11 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.087 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.6 t -115.75 151.32 35.36 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.1 m 68.73 178.46 0.25 Allowed 'General case' 0 N--CA 1.405 -2.709 0 O-C-N 125.67 1.856 . . . . 0.0 110.491 163.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.57 108.04 15.66 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.835 HG21 ' HE1' ' A' ' 46' ' ' PHE . 8.3 m -99.15 155.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.85 -49.91 74.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.178 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 43' ' ' GLU . . . 54.09 41.42 69.21 Favored Glycine 0 C--N 1.352 1.426 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.208 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.89 -102.33 0.01 OUTLIER Glycine 0 C--O 1.245 0.825 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -98.34 -53.72 3.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 34.7 p30 -95.38 0.43 53.5 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.142 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 29.7 mt-10 -90.66 151.26 21.34 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -67.06 146.93 53.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.77 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.419 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.6 m -83.71 70.84 10.4 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.835 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -112.32 -179.79 3.77 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.575 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.1 mtpt -136.3 -173.47 3.41 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.59 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -71.16 -12.39 61.46 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 128.545 2.738 . . . . 0.0 114.652 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.96 19.23 2.34 Favored Glycine 0 C--N 1.259 -3.728 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 6.8 mm-40 -78.68 127.46 32.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.787 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -97.8 96.33 8.15 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.876 HG22 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -107.67 158.32 7.6 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.152 0 CA-C-N 112.086 -2.325 . . . . 0.0 112.427 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.823 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.1 mt-10 -123.08 133.45 54.3 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 120.901 -1.125 . . . . 0.0 109.362 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -96.69 138.54 21.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.642 177.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.986 HG21 ' HB ' ' A' ' 25' ' ' ILE . 3.6 mp -111.63 -35.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.795 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.707 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.3 ttm180 -108.92 125.86 52.46 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.043 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.38 104.56 16.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 141.62 37.75 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.18 -25.68 9.19 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.497 -1.228 . . . . 0.0 107.911 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -51.15 145.18 13.43 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.932 1.293 . . . . 0.0 110.682 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 93.5 Cg_exo -21.91 136.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.461 1 C-N-CA 126.629 4.886 . . . . 0.0 115.199 177.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 47.7 mm-40 87.52 -35.6 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 112.271 -172.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.6 32.17 83.32 Favored Glycine 0 CA--C 1.496 -1.145 0 O-C-N 123.601 0.563 . . . . 0.0 113.15 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.552 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.5 mmtm -102.22 145.27 29.66 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -94.11 144.44 25.49 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.881 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -86.51 109.03 18.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -112.38 177.84 18.71 Favored Glycine 0 N--CA 1.419 -2.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.251 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 28.8 ptt180 -151.64 136.1 16.91 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.876 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.1 p -73.34 169.88 16.2 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 118.032 0.378 . . . . 0.0 110.55 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -6.94 52.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.501 0.667 . . . . 0.0 109.209 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.84 -25.02 17.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.541 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 31.8 2.09 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.388 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 m -113.13 116.69 30.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 66' ' ' LEU . 88.7 m-85 -82.93 147.35 28.3 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -164.11 157.07 29.25 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.062 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 1.1 m-30 -80.63 127.48 32.51 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.912 0.863 . . . . 0.0 109.222 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.834 HG12 ' HE2' ' A' ' 46' ' ' PHE . 86.8 mt -107.43 133.87 50.87 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.151 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.113 -175.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 48.7 mtmt -71.01 127.44 32.57 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 167.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.0 p -59.41 -18.29 37.76 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -92.08 -20.89 20.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.709 0.804 . . . . 0.0 109.864 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -75.85 -13.44 60.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 52' ' ' ILE . 34.8 m -127.57 154.55 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.41 101.98 12.7 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.6 mm -78.14 125.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.428 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' O ' HD23 ' A' ' 89' ' ' LEU . 19.0 t70 -88.69 121.34 30.97 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.588 1.185 . . . . 0.0 110.707 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.65 -31.73 11.43 Favored 'General case' 0 C--N 1.248 -3.817 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.085 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.26 -50.23 73.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -81.66 -18.6 44.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.193 0.52 . . . . 0.0 110.528 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.832 ' HG ' ' HA ' ' A' ' 29' ' ' HIS . 3.8 mm? -88.48 -23.55 23.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 90' ' ' LYS . 34.6 mmtp 74.12 -32.35 0.23 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.419 1.488 . . . . 0.0 114.253 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.58 107.86 2.66 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 122.591 0.356 . . . . 0.0 110.195 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -158.27 119.45 3.47 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.186 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -121.96 122.11 38.61 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -121.3 102.92 8.6 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 mp 63.12 93.13 0.06 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.056 0.942 . . . . 0.0 110.341 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.495 -175.775 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -120.27 70.49 0.88 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.71 0.767 . . . . 0.0 109.347 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -107.9 -55.05 2.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.73 -37.33 6.76 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 56.83 64.99 1.5 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.433 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -100.16 -26.29 13.99 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.436 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.06 92.61 2.65 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.309 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -124.98 162.47 24.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.96 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.677 ' HA ' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mp0 -73.24 -20.59 60.81 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.87 -31.15 68.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.837 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 11' ' ' LYS . 42.5 tptt -80.15 -43.62 21.3 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.735 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 9' ' ' GLU . 6.6 pt-20 -68.82 -18.85 64.23 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 120.932 0.396 . . . . 0.0 110.439 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.97 -30.97 72.0 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.49 -59.29 3.08 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.738 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.5 pp -60.3 -26.97 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.018 -175.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.48 -21.41 45.42 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -97.95 -37.51 9.76 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.522 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.9 ttpt -65.53 -36.47 83.9 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.48 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.7 m-85 -110.46 8.43 23.12 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 56.45 38.82 30.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.933 0.873 . . . . 0.0 110.395 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 21' ' ' LEU . 7.1 tp -94.24 17.01 13.47 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.507 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -62.6 122.09 14.95 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.393 0.616 . . . . 0.0 109.371 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.97 162.01 11.05 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.62 134.3 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.364 2.042 . . . . 0.0 112.443 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.717 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -125.66 154.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.453 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.2 mm100 -110.14 -84.31 0.56 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.75 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -177.62 136.78 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 C-N-CA 127.363 2.265 . . . . 0.0 108.407 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG21 HG12 ' A' ' 57' ' ' ILE . 46.9 mm -98.05 -42.83 11.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 1.066 ' HB2' HD11 ' A' ' 54' ' ' ILE . 91.4 m-70 -150.74 168.84 23.19 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -104.62 124.85 50.07 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.81 168.89 8.84 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 15.1 ptpt -153.45 103.86 2.7 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.838 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.65 139.89 57.89 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.31 -177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 44.0 t -123.12 150.68 42.91 Favored 'General case' 0 CA--C 1.452 -2.797 0 CA-C-O 121.219 0.533 . . . . 0.0 110.36 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.4 m 68.81 -179.95 0.23 Allowed 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.016 163.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.51 103.2 15.66 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.909 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.0 m -93.84 155.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.227 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.62 -42.85 75.5 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.284 0.99 . . . . 0.0 110.851 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.0 43.9 31.88 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 115.201 0.841 . . . . 0.0 115.201 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.06 -175.64 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -47.32 -52.29 16.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.457 1.103 . . . . 0.0 113.741 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -88.78 -4.63 58.46 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.367 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.76 166.6 12.68 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.661 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -79.48 145.21 33.38 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.485 0.66 . . . . 0.0 109.375 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 m -85.86 41.95 0.94 Allowed 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.297 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.898 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -82.43 176.78 9.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.589 0.709 . . . . 0.0 112.3 -177.182 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 60.2 mtpt -132.74 -173.86 3.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.0 -173.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 30.6 tt0 -65.59 -15.8 63.08 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 127.121 2.168 . . . . 0.0 115.532 -169.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.47 19.25 2.81 Favored Glycine 0 C--N 1.26 -3.651 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 11.5 mm-40 -77.37 126.47 30.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -89.62 97.34 11.14 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 113.936 -1.484 . . . . 0.0 107.657 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.98 HD11 HG11 ' A' ' 82' ' ' VAL . 24.7 pt -110.4 158.54 10.66 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.343 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.652 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.59 139.38 52.31 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 121.286 -0.884 . . . . 0.0 108.825 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.066 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.61 135.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.889 0.852 . . . . 0.0 110.232 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.97 8.47 6.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.741 -177.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.762 ' HG2' HG23 ' A' ' 58' ' ' THR . 28.7 ttm180 -154.97 117.75 4.34 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.511 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.455 HG12 HG21 ' A' ' 28' ' ' ILE . 51.2 mm -93.28 96.85 6.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -94.69 139.48 31.17 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.994 -175.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -115.4 8.82 15.41 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 58' ' ' THR . 14.3 m120 -57.62 162.59 4.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.977 1.711 . . . . 0.0 111.318 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.23 12.41 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 124.04 3.16 . . . . 0.0 114.667 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -84.1 -37.0 22.57 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.44 19.9 75.6 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.514 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.3 mmtt -133.36 161.66 33.93 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.456 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.5 m0 -101.03 159.18 15.44 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -100.35 115.3 29.66 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.151 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.679 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.49 -178.48 16.52 Favored Glycine 0 N--CA 1.419 -2.473 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.88 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 37.0 ptt180 -151.83 144.42 24.23 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.686 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.8 p -78.85 175.21 10.71 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 118.598 0.635 . . . . 0.0 109.513 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.92 60.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.24 1.019 . . . . 0.0 109.477 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.15 -14.36 41.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.283 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 33.5 14.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.801 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 113.29 26.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 66.1 m-85 -82.89 147.6 28.19 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.776 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.28 154.28 23.56 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.43 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.505 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 27.8 m-85 -73.31 149.35 42.73 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.84 0.828 . . . . 0.0 111.08 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.898 HG12 ' HE2' ' A' ' 46' ' ' PHE . 59.9 mt -130.05 134.07 63.4 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.875 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 77' ' ' ILE . 47.9 mtmt -67.58 139.47 56.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 p -66.92 -12.06 58.26 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.84 0.828 . . . . 0.0 111.742 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' THR . 2.8 t -100.88 -18.04 16.56 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.565 1.146 . . . . 0.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -74.1 -13.89 60.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.758 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.98 HG11 HD11 ' A' ' 52' ' ' ILE . 28.2 m -135.76 161.68 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.83 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 31.1 mm-40 -110.21 113.54 26.3 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.2 mp -84.79 140.47 15.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.19 154.68 30.9 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 122.009 0.909 . . . . 0.0 112.156 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -98.83 -19.65 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.772 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.03 -39.07 74.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.437 1.095 . . . . 0.0 111.915 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 p -54.81 -27.16 39.79 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.084 0.954 . . . . 0.0 112.535 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD21 ' CE1' ' A' ' 29' ' ' HIS . 27.9 mt -93.48 -63.94 1.15 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -104.98 99.26 8.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.54 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.49 100.03 6.71 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -125.74 136.81 53.59 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.699 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.54 113.7 20.45 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.894 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -91.61 113.52 25.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.86 97.08 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.26 1.607 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.32 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.684 ' HD2' ' HB2' ' A' ' 6' ' ' LYS . 13.5 tppt? -145.33 49.45 1.25 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -82.38 2.69 31.21 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.735 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -85.24 -3.47 58.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 6.2 tp60 64.96 95.07 0.05 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.514 1.926 . . . . 0.0 112.979 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.684 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 65.7 mttm -152.64 174.05 14.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -87.02 -91.12 0.11 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -159.51 92.71 1.07 Allowed 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 125.119 1.368 . . . . 0.0 107.591 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 38.5 mt-10 -85.72 16.9 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.813 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -56.55 -34.85 67.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.09 -54.86 5.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.448 0.642 . . . . 0.0 109.429 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.689 ' HA ' HG13 ' A' ' 15' ' ' ILE . 14.9 pt-20 -68.47 -28.12 66.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -171.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' A' ' 9' ' ' GLU . 94.1 mt-30 -60.21 -32.81 71.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.422 0.556 . . . . 0.0 111.865 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.26 -46.65 11.6 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.689 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.2 pp -61.01 -30.46 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.718 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 96.8 mttt -73.75 -29.72 62.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.95 -40.31 16.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.48 -44.52 64.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.116 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -95.12 -5.16 44.8 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.798 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm 59.5 71.92 0.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.6 tp -107.3 16.65 23.76 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.502 -171.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -49.85 132.41 22.41 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.543 0.737 . . . . 0.0 112.418 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.76 -152.77 17.43 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.97 142.87 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 122.931 2.42 . . . . 0.0 112.84 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.75 109.61 28.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.182 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.26 141.6 39.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.681 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 14.8 m -67.55 152.91 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-O 121.258 0.551 . . . . 0.0 111.356 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 57' ' ' ILE . 21.0 mm -107.65 -31.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 1.051 ' HB2' HD11 ' A' ' 54' ' ' ILE . 47.8 m-70 -153.98 179.57 8.78 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -117.45 128.96 55.52 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.6 169.73 8.76 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.234 0.54 . . . . 0.0 110.599 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -153.7 111.48 3.53 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 174.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.48 138.97 58.44 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.88 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLN . 41.7 t -121.1 148.69 43.83 Favored 'General case' 0 CA--C 1.442 -3.178 0 CA-C-O 121.16 0.505 . . . . 0.0 110.081 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' N ' ' HA ' ' A' ' 48' ' ' GLN . 12.3 m 70.11 176.07 0.28 Allowed 'General case' 0 N--CA 1.401 -2.876 0 O-C-N 126.055 2.097 . . . . 0.0 111.537 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.6 114.37 20.25 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.01 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.831 HG21 ' CE1' ' A' ' 46' ' ' PHE . 13.1 m -115.57 156.48 16.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.671 -174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -47.31 -61.63 1.81 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.339 1.025 . . . . 0.0 109.328 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.11 43.67 83.48 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.449 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.79 -171.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 27.2 mtpp -54.01 -46.07 71.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -174.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.594 HD22 ' HD2' ' A' ' 76' ' ' TYR . 4.0 p-10 -94.46 -4.87 47.46 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.801 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.77 168.28 10.92 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -83.2 126.66 32.87 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -85.84 45.89 1.26 Allowed 'General case' 0 C--N 1.256 -3.46 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.974 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.942 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -75.75 179.26 5.55 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.867 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 54.8 mtpt -122.25 -172.61 2.49 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.233 -174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 39.1 tt0 -69.17 -17.71 63.84 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 126.482 1.913 . . . . 0.0 115.45 -166.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.63 19.2 2.03 Favored Glycine 1 C--N 1.249 -4.261 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.842 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.2 mm-40 -70.36 132.82 46.23 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.12 97.33 11.08 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 123.211 1.482 . . . . 0.0 108.616 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.809 HD11 HG11 ' A' ' 82' ' ' VAL . 18.9 pt -110.83 159.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.726 0 CA-C-N 111.363 -2.653 . . . . 0.0 112.367 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.8 130.02 31.27 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.619 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -91.72 130.04 41.48 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.405 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -113.78 6.44 7.8 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.535 -175.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 37.3 ttm180 -154.29 119.5 5.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.027 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 28' ' ' ILE . 41.7 mm -87.78 111.26 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 170.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.3 p -91.43 146.18 24.01 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.45 0.643 . . . . 0.0 112.618 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.22 0.98 19.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -53.75 145.97 28.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 111.874 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.16 -30.69 15.03 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.657 3.571 . . . . 0.0 115.247 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.74 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 12.9 mm-40 -59.82 -37.8 80.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.83 79.06 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -175.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.74 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 30.5 mmtp -110.29 142.43 41.92 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.424 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 34.9 m0 -83.93 152.42 24.51 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 123.623 0.577 . . . . 0.0 110.927 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.8 tm? -93.58 107.77 19.58 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.284 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -111.9 174.26 16.3 Favored Glycine 0 N--CA 1.414 -2.814 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.669 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' HG2' HD12 ' A' ' 55' ' ' ILE . 13.4 ptm180 -151.69 146.36 25.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 52' ' ' ILE . 71.3 p -82.0 169.66 16.48 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.8 31.02 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.234 0.54 . . . . 0.0 110.536 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.87 4.31 47.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.331 0.586 . . . . 0.0 109.852 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.84 17.75 59.24 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.526 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -98.73 109.26 22.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 25.8 m-85 -87.87 146.37 25.61 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.197 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.06 158.21 30.65 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.813 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.594 ' HD2' HD22 ' A' ' 42' ' ' ASN . 27.2 m-85 -74.28 135.35 42.62 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.699 0.761 . . . . 0.0 110.976 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.942 HG12 ' HE2' ' A' ' 46' ' ' PHE . 87.5 mt -114.83 124.44 71.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.338 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.07 128.53 36.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.0 p -60.9 -11.87 9.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.394 0.616 . . . . 0.0 112.656 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 80' ' ' THR . 4.4 t -92.39 -19.83 21.67 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.674 0.79 . . . . 0.0 110.329 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -79.43 -10.6 59.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.972 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.849 HG12 ' HA ' ' A' ' 33' ' ' ALA . 31.6 m -133.29 160.77 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.298 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -102.21 103.93 14.47 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 31' ' ' ALA . 30.0 mm -84.35 121.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.949 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 63.0 m-20 -88.48 149.32 23.72 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.676 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 80.5 m-85 -99.52 0.9 43.32 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.725 0.774 . . . . 0.0 109.693 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.42 -29.45 61.59 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.561 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.8 t -63.42 -24.12 67.7 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.169 0.293 . . . . 0.0 110.89 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.37 -29.31 10.82 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.676 ' HE3' ' HB2' ' A' ' 86' ' ' TYR . 97.9 mttt -61.39 -53.65 53.87 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.39 0.614 . . . . 0.0 109.386 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.8 tp -124.8 86.95 2.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -78.74 163.14 25.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.274 -171.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -134.74 -82.83 0.43 Allowed 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 46.38 38.51 5.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.195 1.398 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.1 tp -145.53 145.09 30.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.344 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -83.02 -43.44 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -89.96 86.0 6.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.138 0.971 . . . . 0.0 111.169 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -84.52 -37.16 21.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.54 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.13 86.82 4.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.601 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.827 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.65 116.24 26.76 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.779 177.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.21 164.16 11.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -173.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 9' ' ' GLU . 7.1 tmtm? -87.92 142.61 27.67 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.583 ' HB2' ' CG ' ' A' ' 12' ' ' GLU . 11.8 pt-20 -72.85 46.13 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 51.6 mtpt -62.8 -35.96 81.57 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 111.545 -177.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -67.04 -41.72 86.06 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 120.99 0.424 . . . . 0.0 109.956 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.845 ' HA ' HG13 ' A' ' 15' ' ' ILE . 11.4 pt-20 -79.91 -27.03 39.99 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 54.1 mt-30 -59.24 -39.6 83.29 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.233 1.016 . . . . 0.0 108.532 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -72.61 -46.88 52.0 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.486 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.845 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -65.66 -26.56 39.25 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.801 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 87.9 mttt -74.03 -22.57 59.52 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.434 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.54 -39.59 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -65.93 -51.03 62.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.004 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -98.87 3.01 47.17 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.92 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm 51.67 76.21 0.18 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.397 1.094 . . . . 0.0 109.912 -173.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.5 tp -127.51 15.93 7.07 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.783 -173.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -57.62 128.66 38.2 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.251 0.548 . . . . 0.0 110.75 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.07 166.97 12.78 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 111.71 3.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.293 1.995 . . . . 0.0 110.651 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.853 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 pp -98.57 142.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -116.21 142.63 46.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.152 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.8 p -71.08 144.65 13.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' CD2' ' A' ' 29' ' ' HIS . 51.2 mm -103.76 -36.03 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.191 0.52 . . . . 0.0 110.757 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.811 ' HB2' HD11 ' A' ' 54' ' ' ILE . 75.1 m-70 -147.94 152.58 37.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.5 mp -92.06 119.71 32.01 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.41 174.88 5.68 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.541 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.35 112.66 3.8 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.69 137.34 56.61 Favored 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.567 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.2 t -127.47 154.22 45.36 Favored 'General case' 0 CA--C 1.444 -3.133 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.777 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.3 m 71.15 175.11 0.29 Allowed 'General case' 0 N--CA 1.4 -2.965 0 O-C-N 125.748 1.905 . . . . 0.0 111.275 163.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.27 110.21 14.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.761 HG21 ' CE1' ' A' ' 46' ' ' PHE . 14.0 m -108.44 155.27 9.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.613 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -56.68 -46.41 81.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.83 43.0 87.15 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.788 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.77 -178.81 0.31 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -29.73 38.13 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -106.76 -6.12 18.0 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.328 0.585 . . . . 0.0 109.945 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.78 164.34 12.79 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.523 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.8 140.13 38.27 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 t -88.0 43.91 1.15 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.949 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -80.16 -178.98 6.82 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.372 -178.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.9 mtpt -130.53 178.87 6.29 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.069 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 3.7 tt0 -65.2 -12.77 54.77 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 128.236 2.614 . . . . 0.0 114.241 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.39 18.65 3.45 Favored Glycine 0 C--N 1.266 -3.333 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.1 mm-40 -85.22 127.42 34.29 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 112.679 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 97.22 10.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 82' ' ' VAL . 27.6 pt -109.56 157.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.914 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.201 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.892 ' HB3' HG21 ' A' ' 27' ' ' VAL . 43.5 mt-10 -123.71 135.53 53.92 Favored 'General case' 0 C--N 1.281 -2.393 0 O-C-N 121.265 -0.897 . . . . 0.0 109.099 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.25 137.03 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.011 -179.077 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.853 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.7 mp -104.13 -49.09 9.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.203 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.863 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 40.6 ttm180 -97.56 113.89 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.661 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG23 ' CE2' ' A' ' 65' ' ' TRP . 43.1 mm -95.57 98.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.876 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 20.7 p -134.76 141.64 46.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.54 -29.08 6.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 48.0 t-20 -73.38 -62.84 1.11 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.116 -0.945 . . . . 0.0 112.865 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.876 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.4 Cg_exo -56.6 -78.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.242 1.961 . . . . 0.0 114.37 -173.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 25.9 mm-40 -98.86 -10.01 23.49 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.014 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 22.66 76.68 Favored Glycine 0 CA--C 1.503 -0.677 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.4 mmtt -134.28 167.78 20.08 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 42.8 m0 -104.18 140.36 37.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.768 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.4 tm? -87.2 111.93 21.48 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -109.24 -179.64 21.19 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.14 138.88 19.77 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.755 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.9 p -77.98 171.8 14.46 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -0.18 19.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.603 0.716 . . . . 0.0 109.979 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 71' ' ' ARG . 1.8 mmp_? -101.11 -14.56 17.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.815 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.8 21.38 9.72 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.112 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -103.12 113.66 27.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 117.324 0.562 . . . . 0.0 109.787 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB3' HD21 ' A' ' 66' ' ' LEU . 47.5 m-85 -86.96 144.79 26.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.854 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -167.73 153.32 22.56 Favored Glycine 0 C--N 1.301 -1.396 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.935 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.531 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 41.4 m-85 -73.04 155.13 40.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.393 0.616 . . . . 0.0 111.324 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.949 HG12 ' HE2' ' A' ' 46' ' ' PHE . 53.1 mt -137.87 136.39 45.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 44.0 mtmt -69.16 141.72 54.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 168.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -69.49 -6.82 33.06 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 119.271 0.941 . . . . 0.0 112.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.3 t -96.18 -22.11 17.48 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.069 0.948 . . . . 0.0 109.71 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -73.21 -15.48 61.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -130.69 152.33 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 121.17 0.51 . . . . 0.0 112.13 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -92.65 100.68 13.14 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 82' ' ' VAL . 27.8 mm -92.22 125.02 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.75 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -102.84 140.31 37.28 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.941 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.448 ' HA ' ' CE1' ' A' ' 29' ' ' HIS . 75.4 m-85 -79.6 -23.76 42.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -51.11 -20.15 1.37 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.379 1.472 . . . . 0.0 114.552 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -62.32 -60.09 4.06 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 117.779 0.263 . . . . 0.0 111.125 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 28' ' ' ILE . 45.8 mt -105.99 -21.18 13.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -100.84 94.22 5.94 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.7 113.47 19.71 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.61 -173.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -98.27 -33.23 11.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.17 101.63 11.1 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.311 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.77 102.08 14.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.4 tp -116.06 91.55 3.63 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.313 -0.98 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.284 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -115.89 -43.1 3.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.725 ' HG3' ' HG3' ' A' ' 5' ' ' GLN . 19.8 ptpt -125.0 20.22 8.31 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.111 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 75.1 -65.81 0.32 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.52 1.128 . . . . 0.0 112.383 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.725 ' HG3' ' HG3' ' A' ' 3' ' ' LYS . 90.3 mt-30 62.78 -59.77 0.14 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -116.04 12.56 15.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.69 82.09 8.58 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.518 0.675 . . . . 0.0 110.031 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.8 126.59 31.17 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.89 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.23 167.93 19.69 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.148 0.499 . . . . 0.0 110.941 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -80.6 6.8 11.57 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' ILE . 67.1 mttm -74.18 -29.79 61.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' CG1' ' A' ' 15' ' ' ILE 0.383 0.0 OUTLIER -69.74 -19.79 63.53 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 -170.893 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -94.36 -12.27 28.28 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.654 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.49 -44.56 12.61 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.542 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.8 pp -55.87 -28.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.314 1.046 . . . . 0.0 111.916 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' HD12 ' A' ' 15' ' ' ILE . 95.9 mttt -72.5 -22.4 61.05 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.97 -45.17 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -59.42 -47.3 85.99 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.149 1.38 . . . . 0.0 111.729 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.45 0.3 19.26 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 33.2 mmtp 56.54 75.24 0.36 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.54 1.162 . . . . 0.0 111.593 -173.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 74' ' ' TYR . 78.8 mt -125.98 16.71 7.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.867 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -72.62 102.46 3.29 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.392 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.63 -155.19 26.37 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -93.32 121.09 0.41 Allowed 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 123.113 2.542 . . . . 0.0 111.65 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -111.79 142.16 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.569 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' C ' HG22 ' A' ' 55' ' ' ILE . 54.3 mt-30 -132.47 138.38 47.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 53' ' ' GLU . 14.0 m -59.94 134.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.346 0.593 . . . . 0.0 111.953 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.87 -34.7 5.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.1 m-70 -155.1 173.59 16.38 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.8 139.88 48.05 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.58 172.01 7.18 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.163 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -152.71 102.64 2.72 Favored 'General case' 0 C--N 1.264 -3.145 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -69.11 137.36 53.39 Favored 'General case' 0 C--N 1.268 -2.978 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.792 -175.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.0 t -124.78 150.08 46.68 Favored 'General case' 0 CA--C 1.436 -3.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.268 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.3 m 72.74 164.7 0.29 Allowed 'General case' 0 N--CA 1.4 -2.958 0 O-C-N 126.234 2.209 . . . . 0.0 111.15 163.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.64 106.76 1.9 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.775 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.9 m -98.81 157.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.445 -173.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -42.52 -65.89 0.42 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 125.001 1.438 . . . . 0.0 110.331 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.08 43.53 90.18 Favored Glycine 0 C--N 1.321 -0.259 0 C-N-CA 119.85 -1.167 . . . . 0.0 114.264 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -57.46 -173.01 0.27 Allowed Glycine 0 CA--C 1.552 2.405 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -64.62 -37.92 89.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -102.2 1.96 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.649 0.737 . . . . 0.0 109.937 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 47.2 mt-10 -92.53 163.26 13.88 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.714 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.73 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -84.73 127.31 34.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -89.93 73.75 7.38 Favored 'General case' 0 C--N 1.253 -3.625 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.791 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -97.73 -176.76 3.56 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.546 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.596 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 47.7 mtpt -131.44 -173.18 3.04 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.822 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' CB ' ' H ' ' A' ' 35' ' ' CYS . 60.5 tt0 -88.06 114.74 24.98 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 125.089 1.356 . . . . 0.0 107.651 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.89 -1.77 51.96 Favored Glycine 0 C--N 1.29 -2.025 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 12.7 mm-40 -72.32 125.18 26.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.548 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.95 96.2 9.96 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-O 123.316 1.532 . . . . 0.0 108.154 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 HG11 ' A' ' 82' ' ' VAL . 23.5 pt -106.59 158.61 6.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.912 -2.404 . . . . 0.0 111.004 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG12 ' A' ' 27' ' ' VAL . 4.8 pt-20 -134.67 130.22 36.01 Favored 'General case' 0 C--N 1.249 -3.785 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.623 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -93.69 136.2 26.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 CA-C-O 122.196 0.998 . . . . 0.0 112.158 -178.381 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.477 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -118.47 7.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.697 -177.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.892 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.7 ttm180 -149.44 123.84 9.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.182 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.421 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 51.0 mm -109.35 99.71 9.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.6 p -128.15 140.41 51.94 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -108.92 -14.29 14.59 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -46.59 136.03 7.56 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 125.67 1.588 . . . . 0.0 110.209 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -26.1 94.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.481 1 C-N-CA 125.929 4.419 . . . . 0.0 114.81 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 173.58 -51.61 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.64 21.06 67.25 Favored Glycine 0 CA--C 1.491 -1.432 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.162 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.561 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 46.7 mmtm -133.74 161.01 35.85 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.478 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.1 m0 -102.7 161.05 14.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -106.3 115.42 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.961 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.44 179.39 17.7 Favored Glycine 0 N--CA 1.416 -2.668 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.972 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 31.3 ptt180 -152.22 144.4 23.9 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.5 p -74.55 169.89 16.85 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.06 64.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.628 0.728 . . . . 0.0 109.196 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -78.26 -23.86 47.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.653 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.36 26.96 6.68 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.303 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -108.83 111.74 23.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 1.9 m-85 -87.11 148.09 25.37 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.716 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.84 154.19 22.32 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.008 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.445 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 34.6 m-85 -70.44 142.58 51.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.763 0.792 . . . . 0.0 111.626 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.791 HG12 ' HE2' ' A' ' 46' ' ' PHE . 67.2 mt -125.39 136.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.415 -173.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 77' ' ' ILE . 89.5 mttt -72.82 135.98 45.31 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 166.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.8 p -65.23 -10.47 32.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.619 0.723 . . . . 0.0 112.031 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -98.7 -17.66 18.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.209 1.004 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.68 -12.77 60.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.584 0.707 . . . . 0.0 109.224 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.943 HG11 HD11 ' A' ' 52' ' ' ILE . 34.9 m -134.97 155.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.511 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -98.87 100.53 11.73 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.1 mm -79.72 128.46 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -110.21 148.82 31.1 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.993 0.901 . . . . 0.0 110.655 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.738 ' HD1' ' HE1' ' A' ' 29' ' ' HIS . 51.9 t80 -99.06 -27.45 13.83 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.908 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -50.02 -45.62 52.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.307 1.843 . . . . 0.0 114.124 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m -67.68 -14.9 63.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.649 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.866 HD21 ' HA ' ' A' ' 29' ' ' HIS . 2.1 mm? -104.36 -64.22 1.13 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -142.25 174.8 10.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.92 152.75 36.92 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.07 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -101.15 -0.99 35.08 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.79 0.805 . . . . 0.0 109.402 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.0 141.9 58.62 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.911 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.71 135.31 51.12 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.53 -75.75 0.45 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.939 0.4 . . . . 0.0 110.807 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--N 1.308 -1.221 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.135 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -85.13 93.24 8.59 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.379 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.29 -41.47 5.53 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.51 111.8 13.65 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.672 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -110.71 84.17 1.88 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.857 0.837 . . . . 0.0 109.817 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -102.12 -61.74 1.35 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 40.33 72.01 0.17 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.793 1.637 . . . . 0.0 111.264 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.79 107.71 0.87 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.047 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 65.0 mm-40 -90.95 144.98 25.11 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.762 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -92.6 -3.63 54.69 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.636 0.731 . . . . 0.0 109.77 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 mmtm -61.5 -38.32 86.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.658 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.785 ' HA ' HG13 ' A' ' 15' ' ' ILE . 10.4 pt-20 -63.79 -30.73 71.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -40.88 90.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -72.97 -54.82 7.64 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.879 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.785 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.0 pp -60.71 -29.34 44.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 98.2 mttt -80.69 -25.67 38.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.878 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -90.5 -42.67 10.71 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.381 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -69.82 -52.73 22.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.433 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.23 -0.46 53.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 54.08 73.41 0.39 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.947 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HG ' HG21 ' A' ' 25' ' ' ILE . 4.5 tp -127.03 16.61 7.3 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.351 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 16' ' ' LYS . 10.3 t -77.39 126.06 30.32 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 119.184 -1.007 . . . . 0.0 110.433 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.76 -155.72 16.2 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.74 137.11 34.75 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.395 2.73 . . . . 0.0 110.486 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.878 ' HB ' HG21 ' A' ' 55' ' ' ILE . 17.0 pt -127.07 -70.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.859 ' H ' HG13 ' A' ' 25' ' ' ILE . 30.4 mt-30 70.39 131.37 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.14 1.776 . . . . 0.0 113.638 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 88.3 t -76.26 136.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.871 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG22 ' CD2' ' A' ' 29' ' ' HIS . 47.9 mm -99.83 -43.63 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.976 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.93 ' HB2' HD11 ' A' ' 54' ' ' ILE . 65.2 m-70 -140.24 173.88 11.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.86 124.77 51.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.05 172.49 6.77 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.519 0.676 . . . . 0.0 110.302 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 4.4 ttmp? -151.88 106.46 3.22 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.876 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.44 120.57 13.58 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.24 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 42.2 t -93.32 155.8 17.19 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.2 m 62.5 -174.11 0.15 Allowed 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 125.6 1.812 . . . . 0.0 111.127 163.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -91.21 118.27 30.33 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 166.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.904 HG21 ' HE1' ' A' ' 46' ' ' PHE . 20.9 m -97.41 156.89 3.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.614 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -51.43 -47.81 62.9 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.232 0.957 . . . . 0.0 108.703 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.36 95.68 Favored Glycine 0 N--CA 1.438 -1.201 0 O-C-N 124.157 0.911 . . . . 0.0 113.388 173.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.23 178.59 0.13 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.466 0.946 . . . . 0.0 115.466 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.41 -43.56 44.54 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.843 1.257 . . . . 0.0 113.304 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -94.19 -1.58 53.89 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.573 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.4 167.09 12.21 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.164 0.507 . . . . 0.0 110.961 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -79.75 141.95 35.86 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.103 -177.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.0 p -87.44 84.73 7.13 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.076 175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.904 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.15 176.89 6.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.631 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 57.6 mtpt -128.44 -172.81 2.79 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.748 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.5 tt0 -83.2 110.25 17.9 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 125.099 1.359 . . . . 0.0 109.945 -175.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.76 17.4 48.57 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.5 mm-40 -76.33 130.39 38.03 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.626 0.727 . . . . 0.0 110.99 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.98 96.9 10.43 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.521 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 82' ' ' VAL . 28.7 pt -113.57 157.74 14.16 Favored 'Isoleucine or valine' 1 C--N 1.235 -4.41 0 CA-C-N 111.834 -2.439 . . . . 0.0 111.053 174.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.19 136.94 53.44 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.58 138.7 23.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.806 178.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.878 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.2 -47.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.569 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 57.0 ttt180 -110.17 121.79 46.1 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.325 -172.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.41 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mm -97.72 95.89 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 t -137.15 148.92 46.94 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.19 -0.26 21.08 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.22 -52.99 69.29 Favored Pre-proline 0 C--O 1.212 -0.916 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.61 65.82 6.57 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.087 1.858 . . . . 0.0 111.733 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 56.18 38.64 30.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.945 1.298 . . . . 0.0 112.674 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.7 34.19 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 114.96 -1.018 . . . . 0.0 115.498 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 45.8 mmtm -121.61 144.33 48.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 35.3 m0 -93.75 162.22 14.01 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.851 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -102.59 117.33 34.44 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.56 176.79 16.3 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.65 142.57 23.0 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 124.536 1.134 . . . . 0.0 108.814 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' ILE . 31.1 p -77.89 168.36 20.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.37 66.42 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.674 0.273 . . . . 0.0 110.633 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -78.8 -27.04 44.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.8 25.81 3.81 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.14 -1.029 . . . . 0.0 114.188 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.1 m -100.03 113.25 25.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB2' HG21 ' A' ' 15' ' ' ILE . 7.0 m-85 -91.93 144.04 25.88 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.533 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 159.64 32.81 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.191 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.621 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 24.2 m-85 -72.0 151.0 43.52 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.15 0.5 . . . . 0.0 110.119 174.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HE2' ' A' ' 46' ' ' PHE . 60.2 mt -135.18 130.9 51.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.871 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.2 mtmt -64.48 136.74 57.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -67.53 -13.05 61.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.859 0.838 . . . . 0.0 111.936 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 78' ' ' LYS . 11.8 t -96.14 -14.15 23.04 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.287 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.53 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.27 -20.27 55.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.876 HG12 ' HA ' ' A' ' 33' ' ' ALA . 34.3 m -128.96 149.64 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 121.361 0.601 . . . . 0.0 112.369 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.5 pt-20 -96.97 102.37 14.14 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.447 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -81.72 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.672 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.58 154.31 21.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.174 0.511 . . . . 0.0 110.303 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -99.67 -27.13 13.82 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.534 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.06 -29.7 45.13 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.82 -35.07 30.37 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 123.903 0.881 . . . . 0.0 112.678 175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.7 mt -81.19 -38.57 26.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.151 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp 66.94 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.712 1.205 . . . . 0.0 111.475 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.82 HD21 HD13 ' A' ' 95' ' ' LEU . 61.8 tp 69.37 109.8 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.66 0.784 . . . . 0.0 110.624 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -94.26 25.92 3.59 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -146.33 140.21 26.26 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -84.0 132.38 34.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.82 HD13 HD21 ' A' ' 91' ' ' LEU . 10.2 mp -111.28 -37.42 5.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.731 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -105.84 -50.1 3.26 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.11 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 65.52 -177.67 0.18 Allowed 'General case' 0 C--O 1.242 0.689 0 O-C-N 124.263 0.977 . . . . 0.0 109.536 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -81.67 131.76 35.28 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.66 -36.4 84.16 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 48.5 mtpt -103.65 94.0 5.22 Favored 'General case' 0 C--O 1.255 1.39 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.503 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.8 85.64 6.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -160.57 88.86 0.8 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.6 tp10 -109.73 137.05 48.09 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.014 -176.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.42 -11.43 59.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.18 0.514 . . . . 0.0 111.285 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 68.6 mttm -59.4 -43.3 92.99 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.92 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HA ' ' CG1' ' A' ' 15' ' ' ILE 0.264 0.0 OUTLIER -71.47 -9.93 58.96 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.613 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -85.66 -47.62 9.64 Favored 'General case' 0 C--O 1.251 1.183 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.19 -45.07 86.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.006 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -56.33 -29.53 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.427 0.691 . . . . 0.0 112.65 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.76 -22.32 58.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.048 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -97.07 -42.83 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.911 0.862 . . . . 0.0 108.744 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -62.65 -50.13 72.41 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.809 1.644 . . . . 0.0 110.732 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -102.05 -2.09 30.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.156 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 58.48 76.42 0.34 Allowed 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 124.096 0.872 . . . . 0.0 108.839 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.62 16.36 9.56 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.865 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -82.46 114.4 20.87 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.889 0.852 . . . . 0.0 110.028 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.96 -170.41 24.55 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.14 117.72 4.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.601 2.2 . . . . 0.0 111.928 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.707 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.9 pp -132.3 139.32 50.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -131.4 140.29 49.63 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.776 0.431 . . . . 0.0 110.448 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.0 p -63.4 141.19 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 O-C-N 123.603 0.565 . . . . 0.0 111.138 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 HG12 ' A' ' 57' ' ' ILE . 54.6 mt -103.6 -33.08 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.157 0.503 . . . . 0.0 111.937 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.809 ' HB2' HD11 ' A' ' 54' ' ' ILE . 67.8 m-70 -154.95 167.5 30.11 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.589 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.0 mp -106.69 137.64 44.34 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -111.42 171.92 7.2 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.257 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 20.4 ptmt -151.17 106.66 3.36 Favored 'General case' 0 N--CA 1.397 -3.09 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -62.86 109.55 1.48 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.461 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.5 t -96.26 150.73 20.22 Favored 'General case' 0 CA--C 1.426 -3.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.573 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.5 m 66.45 -175.84 0.19 Allowed 'General case' 0 N--CA 1.399 -3.005 0 O-C-N 126.078 2.111 . . . . 0.0 109.385 165.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.81 120.63 18.7 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 ' CE1' ' A' ' 46' ' ' PHE . 4.3 m -98.99 154.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -59.38 -69.14 0.22 Allowed 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.813 0.696 . . . . 0.0 109.29 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.98 42.6 84.93 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.242 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.27 -116.51 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -99.61 -52.97 3.32 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.651 -0.911 . . . . 0.0 112.474 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -90.64 2.84 55.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.378 0.609 . . . . 0.0 110.555 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 38.3 mt-10 -90.25 159.16 16.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.145 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.578 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -64.8 149.09 50.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 124.05 0.844 . . . . 0.0 110.207 -176.433 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.8 m -88.81 80.14 7.25 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.665 ' HD2' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -134.79 167.61 20.56 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.46 -177.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.9 mmtp -143.67 -172.8 3.8 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.736 0.779 . . . . 0.0 111.263 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 49.7 tt0 -67.93 120.7 14.64 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 126.492 1.917 . . . . 0.0 109.346 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.17 4.57 68.6 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.034 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 48.5 mm-40 -76.12 126.77 31.62 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.936 0.874 . . . . 0.0 111.355 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -96.12 96.94 9.18 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 69' ' ' THR . 33.1 pt -107.75 159.7 7.18 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.105 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.164 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.803 ' HB3' HG21 ' A' ' 27' ' ' VAL . 50.4 mt-10 -121.29 139.73 53.01 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.259 0.2 OUTLIER -105.06 132.17 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.94 175.462 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.707 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.9 mp -105.42 -34.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.562 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.88 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.8 ttm180 -114.5 119.51 37.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.751 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.675 HG12 HD12 ' A' ' 28' ' ' ILE . 44.0 mm -101.71 98.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 3.0 p -136.83 141.71 42.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -115.25 -30.64 6.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.998 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 86.5 m-20 -66.2 -55.16 21.82 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 31.5 Cg_exo -58.54 -80.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.796 1.664 . . . . 0.0 113.647 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.79 6.66 13.23 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.797 0.332 . . . . 0.0 111.25 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.89 31.2 78.9 Favored Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.132 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.4 mmtm -133.49 160.54 37.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 40.5 m0 -101.57 141.87 33.79 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.546 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -88.75 113.64 24.53 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.669 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -115.58 178.32 17.6 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.843 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' SER . 20.7 ptt180 -151.57 135.74 16.7 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 124.261 1.025 . . . . 0.0 108.396 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.878 ' HA ' HG22 ' A' ' 52' ' ' ILE . 10.8 p -72.67 169.17 17.18 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -17.65 62.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.44 -26.52 60.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.99 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.92 12.31 20.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.727 -0.749 . . . . 0.0 114.688 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 21.3 m -91.08 118.93 30.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 118.178 0.989 . . . . 0.0 108.977 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 61.4 m-85 -84.06 144.11 29.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.223 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.4 156.64 28.67 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.541 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 10.3 m-85 -76.72 134.79 39.1 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.67 0.748 . . . . 0.0 110.018 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.669 HD11 ' HA3' ' A' ' 67' ' ' GLY . 71.6 mt -114.94 138.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.685 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.5 mttt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 168.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.6 p -64.62 -18.26 64.76 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.762 0.791 . . . . 0.0 111.751 -171.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 -19.63 27.19 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.18 -17.84 59.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -129.19 151.81 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -98.27 105.78 17.98 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -83.55 123.69 38.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.682 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 145.43 24.72 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.594 1.187 . . . . 0.0 111.806 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.776 ' HB3' HD13 ' A' ' 91' ' ' LEU . 84.5 m-85 -99.6 -13.02 19.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.291 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.53 -47.93 72.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.935 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -69.35 -14.71 63.07 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 29' ' ' HIS . 3.0 mm? -102.07 -17.61 15.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.0 mttp 53.7 80.49 0.11 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.557 -1.201 . . . . 0.0 114.099 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 86' ' ' TYR . 6.5 mp -89.06 87.29 7.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 37.5 mtmt -91.6 -55.03 3.64 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.499 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -174.75 115.03 0.17 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.59 78.68 2.39 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -178.3 102.8 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 C--O 1.259 1.566 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.87 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.666 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -86.99 -60.48 1.97 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -136.82 -50.02 0.65 Allowed 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -100.9 172.76 6.84 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -89.62 -47.09 8.18 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.732 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 59.16 23.84 12.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.785 0.802 . . . . 0.0 111.147 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.47 25.0 1.54 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -80.02 128.36 33.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.3 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.567 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.5 tp10 -136.09 157.06 47.73 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 174.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 38.4 mtmt -92.44 1.85 57.0 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.845 0.831 . . . . 0.0 109.683 -176.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 25.2 ttmm -80.05 -12.95 59.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.95 -172.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' HA ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.37 -19.57 63.83 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.389 -177.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' O ' ' HE2' ' A' ' 17' ' ' LYS . 43.6 tt0 -54.92 -44.3 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.6 0.714 . . . . 0.0 109.476 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -80.97 -43.88 19.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.408 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.2 pp -65.13 -26.24 39.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 97.1 mttt -75.27 -18.6 60.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.041 0.448 . . . . 0.0 111.292 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 13' ' ' GLN . 53.0 mtmt -96.9 -41.13 8.57 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -68.07 -46.89 69.82 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.683 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 57.1 m-85 -108.01 -3.09 19.08 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.389 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 72.9 mmtt 56.69 69.99 0.69 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.068 0.855 . . . . 0.0 110.369 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.66 16.93 15.4 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.392 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -51.99 117.83 3.03 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.801 0.84 . . . . 0.0 112.791 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.1 179.31 15.91 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.557 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 121.71 6.52 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.364 2.709 . . . . 0.0 110.488 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -120.44 163.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.966 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -126.07 155.49 41.48 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.842 0.829 . . . . 0.0 111.194 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 53' ' ' GLU . 59.8 t -90.43 107.96 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.272 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.408 HD12 HG12 ' A' ' 57' ' ' ILE . 49.9 mt -77.63 -37.56 24.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.871 ' HB2' HD11 ' A' ' 54' ' ' ILE . 69.5 m-70 -150.57 168.47 24.16 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 121.04 0.448 . . . . 0.0 110.416 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 3.8 mm? -101.88 119.73 39.26 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.91 164.04 11.96 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -152.46 107.28 3.21 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -60.44 126.27 26.82 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 p -103.1 -11.0 18.4 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -167.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.82 175.02 14.12 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.0 -157.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.36 107.83 5.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.826 HG21 ' HE1' ' A' ' 46' ' ' PHE . 14.7 m -103.96 156.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.691 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -57.91 -48.93 78.45 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.8 42.97 60.15 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.605 1.19 . . . . 0.0 113.634 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.38 -170.44 0.25 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -52.03 -38.81 58.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -100.57 -0.22 38.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.685 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.49 167.23 11.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.98 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -76.08 139.51 41.41 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.933 0.873 . . . . 0.0 111.634 -176.239 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -82.84 76.03 9.71 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.912 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.826 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.05 -178.99 4.37 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.442 179.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 28.6 mtpp -139.52 -173.09 3.52 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 123.648 0.593 . . . . 0.0 110.041 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -67.87 -13.14 61.91 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 126.464 1.906 . . . . 0.0 115.619 -168.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.5 15.0 4.73 Favored Glycine 0 C--N 1.254 -3.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.459 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 21.0 mm-40 -72.65 123.32 23.0 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 122.282 1.039 . . . . 0.0 112.892 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -93.66 96.17 9.65 Favored 'General case' 0 N--CA 1.397 -3.077 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.866 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -105.11 159.18 5.59 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.08 0 CA-C-N 111.653 -2.521 . . . . 0.0 112.685 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HG2' ' CD1' ' A' ' 30' ' ' LEU . 35.3 mt-10 -124.63 132.04 53.44 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.277 0.2 OUTLIER -100.47 143.81 13.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 117.503 -1.679 . . . . 0.0 112.284 178.147 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.739 HG12 HD13 ' A' ' 25' ' ' ILE . 2.9 mp -111.6 -21.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.613 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.84 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.2 ttm180 -127.73 121.36 30.09 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.813 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG12 HD12 ' A' ' 28' ' ' ILE . 39.1 mm -112.51 102.91 14.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 103.842 -2.651 . . . . 0.0 103.842 173.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t -128.08 157.47 40.63 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.614 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -108.93 0.56 20.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.53 121.91 56.56 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.74 83.88 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.185 2.59 . . . . 0.0 114.955 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.28 -16.74 5.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.8 9.55 74.32 Favored Glycine 0 CA--C 1.5 -0.856 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.258 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 71.3 mmtt -135.31 -177.91 4.87 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.876 0.846 . . . . 0.0 112.372 -174.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 20.1 m0 -120.66 162.27 19.97 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 106.638 166.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.84 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -105.9 120.7 42.42 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.131 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -124.05 -176.32 14.66 Favored Glycine 0 N--CA 1.422 -2.249 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.206 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 33.5 ptt180 -151.23 146.1 25.84 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.8 p -85.17 166.78 16.3 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.54 25.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -91.42 -19.88 22.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.749 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.82 36.9 3.33 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.526 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -128.61 137.53 51.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 29.9 m-85 -106.19 152.14 23.85 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.551 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -169.8 152.6 19.82 Favored Glycine 0 CA--C 1.478 -2.251 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.067 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.521 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 9.3 m-85 -74.53 152.8 39.29 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HE2' ' A' ' 46' ' ' PHE . 40.7 mt -136.67 134.71 48.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 77' ' ' ILE . 94.3 mttt -70.7 142.67 51.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -65.34 -12.46 52.17 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.757 0.789 . . . . 0.0 112.738 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.2 t -94.86 -15.04 24.02 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -78.9 -19.76 51.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -134.1 163.95 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.316 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.27 106.82 14.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.659 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.4 mp -85.02 127.71 39.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.986 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -119.98 154.21 34.85 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.368 0.604 . . . . 0.0 109.997 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.583 ' HA ' HD23 ' A' ' 89' ' ' LEU . 85.3 t80 -98.66 -24.56 15.02 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.989 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.19 -45.04 72.07 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -72.79 -1.46 16.67 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 29' ' ' HIS . 4.3 mm? -76.48 -21.16 56.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 122.064 -0.397 . . . . 0.0 110.65 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -110.67 133.84 52.97 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -78.01 112.17 14.65 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.628 ' HE2' HD22 ' A' ' 95' ' ' LEU . 60.9 tttm -112.98 90.93 3.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.659 0.742 . . . . 0.0 110.883 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.52 -39.74 3.13 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -112.52 139.47 48.08 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.628 HD22 ' HE2' ' A' ' 92' ' ' LYS . 39.5 tp -137.46 -74.95 0.41 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.615 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 N--CA 1.427 -1.611 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 120.346 0.117 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.1 pp -60.62 -25.82 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.162 0.506 . . . . 0.0 112.143 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 94.9 mttt -72.46 -24.49 61.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.291 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -97.78 -46.73 5.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.073 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.7 tttt -66.52 -53.42 35.14 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.87 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 80.0 m-85 -98.46 -8.86 26.02 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.44 0.638 . . . . 0.0 109.375 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.6 ttmt 60.84 75.48 0.41 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.161 1.384 . . . . 0.0 112.534 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 25' ' ' ILE . 8.3 mp -117.58 17.01 14.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.256 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -56.21 104.94 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.395 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.55 -160.17 20.07 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.35 117.68 0.64 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.209 2.606 . . . . 0.0 112.583 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.773 HD13 HG12 ' A' ' 55' ' ' ILE . 2.6 pp -117.01 143.82 26.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 120.666 0.27 . . . . 0.0 111.616 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -120.17 155.22 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.82 137.59 22.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 121.484 0.659 . . . . 0.0 112.19 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.505 HG22 ' CD2' ' A' ' 29' ' ' HIS . 46.4 mm -91.46 -41.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 1.02 ' HB2' HD11 ' A' ' 54' ' ' ILE . 73.7 m-70 -152.84 177.86 10.28 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.12 117.41 29.99 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.62 168.24 9.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.17 107.77 3.5 Favored 'General case' 0 C--N 1.255 -3.526 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 176.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.837 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.03 132.69 51.33 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.511 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.8 t -116.73 148.14 41.38 Favored 'General case' 0 CA--C 1.44 -3.257 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.3 m 70.29 178.56 0.25 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.273 163.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.13 112.78 15.43 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.834 HG21 ' CE1' ' A' ' 46' ' ' PHE . 9.3 m -110.4 156.79 11.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.682 -174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 17.2 ttmm -49.44 -66.46 0.39 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.926 0.766 . . . . 0.0 110.843 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.11 42.75 98.64 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.148 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.16 -158.6 0.83 Allowed Glycine 0 CA--C 1.54 1.595 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -65.09 -31.38 72.56 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 29.3 p-10 -93.08 -17.83 23.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.376 -0.529 . . . . 0.0 109.897 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' OE1' ' HG2' ' A' ' 38' ' ' LYS . 42.9 mt-10 -92.64 170.55 9.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.426 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -83.56 138.8 33.23 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -86.01 59.04 5.4 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 121.999 0.904 . . . . 0.0 109.004 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.866 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -95.82 -174.89 3.26 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.587 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 56.3 mtpt -143.86 -173.1 3.89 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.565 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.22 114.99 18.6 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 126.17 1.788 . . . . 0.0 108.95 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.91 10.44 57.58 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 10.1 mm-40 -79.32 123.9 27.9 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 111.208 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -87.23 97.08 10.57 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.171 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.822 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -109.94 159.39 9.62 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.256 0 CA-C-N 111.554 -2.567 . . . . 0.0 112.207 176.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.87 140.2 53.14 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.02 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -104.98 127.3 59.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.219 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -101.65 -21.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.335 -173.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.5 ttm180 -136.15 126.42 26.5 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.561 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.79 98.45 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.275 -2.659 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.779 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.881 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mmtm -131.37 157.4 43.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.2 m0 -99.72 162.5 12.97 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 123.731 0.644 . . . . 0.0 110.494 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -99.7 114.39 27.47 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.774 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.85 175.55 16.07 Favored Glycine 0 N--CA 1.423 -2.175 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.2 ptt180 -151.69 141.09 21.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 52' ' ' ILE . 16.9 p -81.26 164.07 22.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.59 -8.28 53.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.409 1.1 . . . . 0.0 109.237 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -87.02 -4.64 59.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.339 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.44 32.29 19.79 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.858 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 9.1 m -118.11 124.08 47.16 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.651 ' HB2' HG21 ' A' ' 15' ' ' ILE . 8.0 m-85 -101.6 140.31 36.06 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.39 162.8 36.11 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 119.157 -1.497 . . . . 0.0 113.218 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.565 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 28.3 m-85 -71.87 149.43 45.19 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.203 0.525 . . . . 0.0 110.107 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 46' ' ' PHE . 74.7 mt -131.99 129.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.605 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG2' ' HE3' ' A' ' 64' ' ' LYS . 98.8 mttt -66.58 136.97 56.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 166.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -69.12 -8.75 48.35 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 122.337 1.065 . . . . 0.0 111.447 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.3 t -97.31 -16.18 20.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.652 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.41 59.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 33' ' ' ALA . 33.9 m -133.16 159.78 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 CA-C-O 121.365 0.602 . . . . 0.0 112.273 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 34.1 mt-10 -97.5 102.24 13.95 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 82' ' ' VAL . 29.2 mm -88.36 120.36 37.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.684 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 121.352 0.596 . . . . 0.0 111.22 179.813 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.439 -1.005 0 CA-C-O 120.967 0.413 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.3 pp -61.08 -25.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' N ' HD12 ' A' ' 15' ' ' ILE . 15.4 ttmm -76.5 -32.17 58.15 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.616 0.722 . . . . 0.0 109.525 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -97.03 -39.95 9.09 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.407 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.6 ttpt -66.09 -43.68 86.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.817 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 26.9 m-85 -97.68 3.17 50.32 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.533 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 53.92 74.44 0.33 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.977 0.894 . . . . 0.0 109.841 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' NH2' ' A' ' 56' ' ' ARG . 6.8 tp -107.75 13.48 26.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.485 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.33 109.78 0.66 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.49 0.662 . . . . 0.0 111.858 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.72 171.89 12.35 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.93 110.4 1.09 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.449 2.1 . . . . 0.0 111.673 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -89.29 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -126.91 139.21 53.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.58 0.705 . . . . 0.0 110.723 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 53' ' ' GLU . 41.4 t -68.76 116.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.701 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.675 HG22 ' HD2' ' A' ' 29' ' ' HIS . 46.4 mm -84.46 -44.8 17.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.343 0.592 . . . . 0.0 109.927 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.675 ' HD2' HG22 ' A' ' 28' ' ' ILE . 38.7 m-70 -153.72 171.24 19.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.2 mp -102.61 129.64 49.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 170.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.54 166.22 10.56 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 18.9 pttp -150.14 101.9 3.04 Favored 'General case' 0 C--N 1.255 -3.535 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.84 133.06 50.17 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.456 -2.156 . . . . 0.0 110.685 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -119.37 152.3 37.03 Favored 'General case' 0 CA--C 1.445 -3.068 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.0 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.1 m 70.91 169.47 0.32 Allowed 'General case' 0 N--CA 1.397 -3.11 0 O-C-N 125.771 1.919 . . . . 0.0 111.745 162.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -69.72 101.91 1.78 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.497 0.665 . . . . 0.0 109.988 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.829 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.3 m -97.18 156.52 3.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.21 -59.05 5.18 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.19 43.72 95.25 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.361 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.48 -172.04 0.51 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -51.78 -53.21 42.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.37 -2.04 58.07 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.92 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -92.27 169.04 10.91 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.665 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -80.06 139.55 36.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.392 0.615 . . . . 0.0 109.944 -177.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -81.07 40.3 0.54 Allowed 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.652 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.91 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -82.43 -177.83 6.82 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.487 0.661 . . . . 0.0 111.895 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -142.63 -172.89 3.73 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.643 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 8.9 tt0 -84.32 114.89 22.19 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.1 1.36 . . . . 0.0 109.123 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.49 3.02 56.5 Favored Glycine 0 C--N 1.29 -1.985 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -75.27 122.42 23.68 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.783 0.802 . . . . 0.0 111.699 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.61 97.21 9.57 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -104.66 158.37 5.54 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.595 0 CA-C-N 111.79 -2.459 . . . . 0.0 111.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.8 mt-10 -121.09 131.73 54.44 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.075 -1.016 . . . . 0.0 109.018 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -92.73 133.37 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.05 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -120.66 11.52 6.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.942 -176.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.835 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 44.8 ttm180 -152.34 125.68 8.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.004 176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 28' ' ' ILE . 47.3 mm -111.5 98.01 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.404 -2.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.057 -167.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.496 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.633 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.2 mmtp -134.4 154.32 51.43 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 33.3 m0 -98.35 157.17 16.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.835 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -101.08 111.49 23.71 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.874 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.8 179.69 18.87 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.506 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 39.0 ptt180 -152.15 144.28 23.88 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.9 p -81.85 169.35 16.96 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.64 36.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.564 1.173 . . . . 0.0 107.877 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -89.32 -4.92 57.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.418 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.34 33.06 32.93 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.46 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -124.07 121.64 35.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.1 m-85 -89.03 153.68 20.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -173.08 156.36 24.48 Favored Glycine 0 C--N 1.318 -0.446 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.637 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 39.9 m-85 -74.96 139.5 43.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 112.411 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.91 HG12 ' HE2' ' A' ' 46' ' ' PHE . 63.0 mt -121.24 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.633 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.633 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 94.7 mttt -73.41 135.91 44.26 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.7 p -65.21 -9.93 27.47 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -98.13 -14.12 20.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.788 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -80.78 -13.45 58.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.386 0.613 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 31.2 m -129.7 156.16 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.841 0.829 . . . . 0.0 112.01 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.49 100.71 11.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 82' ' ' VAL . 22.5 mm -88.84 108.25 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.918 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 121.237 0.541 . . . . 0.0 112.236 177.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 120.509 0.195 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.8 pp -69.56 -26.57 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.717 ' HB3' HG23 ' A' ' 22' ' ' THR . 90.1 mttt -71.43 -16.13 62.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.246 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -94.06 -56.95 2.68 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.7 -44.19 81.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.133 1.373 . . . . 0.0 112.106 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.5 -3.33 22.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.726 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 56.29 78.62 0.2 Allowed 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.326 1.06 . . . . 0.0 110.967 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 66' ' ' LEU . 88.2 mt -126.01 16.42 7.92 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.398 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 16' ' ' LYS . 4.6 p -72.9 98.84 2.55 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.75 -159.63 28.23 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -89.16 103.84 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.874 2.383 . . . . 0.0 112.393 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 21' ' ' LEU . 2.7 pp -109.12 142.21 22.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 120.859 0.362 . . . . 0.0 110.732 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -127.23 148.47 50.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.3 p -75.62 145.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.411 HG13 HG12 ' A' ' 57' ' ' ILE . 37.4 mm -98.7 -39.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.261 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.673 ' HB2' HD11 ' A' ' 54' ' ' ILE . 43.7 m-70 -156.45 171.73 19.75 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 109.938 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.23 127.49 44.2 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.615 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -107.18 167.88 9.6 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.594 ' HE2' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.4 102.37 2.9 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.72 137.04 55.19 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 113.204 -1.816 . . . . 0.0 111.205 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.8 t -123.16 149.81 44.11 Favored 'General case' 0 CA--C 1.439 -3.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.926 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.6 m 72.64 162.87 0.26 Allowed 'General case' 0 N--CA 1.396 -3.163 0 O-C-N 126.129 2.143 . . . . 0.0 111.868 162.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.93 103.33 1.45 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 109.356 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 46' ' ' PHE . 24.1 m -102.33 156.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.751 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -48.3 -54.15 14.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.668 1.23 . . . . 0.0 109.165 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.9 43.02 60.8 Favored Glycine 0 C--N 1.346 1.114 0 O-C-N 123.859 0.724 . . . . 0.0 114.69 175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.31 -168.51 0.39 Allowed Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.756 1.063 . . . . 0.0 115.756 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -55.7 -49.24 73.54 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 113.426 -174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.14 -10.72 54.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.556 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -92.09 163.92 13.79 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.517 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -82.57 131.89 35.2 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 m -86.04 71.38 10.59 Favored 'General case' 0 C--N 1.255 -3.538 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.531 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.798 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -99.07 179.03 4.74 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.812 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.611 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mtpm? -134.49 -173.05 3.17 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -87.88 113.95 24.03 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 124.549 1.139 . . . . 0.0 108.665 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.08 -3.09 44.26 Favored Glycine 0 C--N 1.284 -2.332 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.8 mm-40 -66.93 123.96 21.65 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.763 0.792 . . . . 0.0 111.415 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -94.01 96.78 9.9 Favored 'General case' 0 N--CA 1.409 -2.483 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.951 HD11 HG11 ' A' ' 82' ' ' VAL . 32.7 pt -110.57 158.28 10.99 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.169 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.372 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.76 ' HB3' HG21 ' A' ' 27' ' ' VAL . 48.1 mt-10 -121.27 136.84 54.91 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.268 0.2 OUTLIER -97.81 124.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.224 175.173 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.09 -16.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.647 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -144.29 122.07 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.373 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' ILE . 44.3 mm -88.98 101.56 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.281 -2.399 0 CA-C-O 121.568 0.699 . . . . 0.0 112.231 -173.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.549 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 42.5 mmtm -133.27 138.31 46.4 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.452 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.2 m0 -87.57 159.8 18.45 Favored 'General case' 0 C--N 1.279 -2.485 0 O-C-N 123.725 0.641 . . . . 0.0 109.968 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -97.12 112.14 24.06 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.815 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.26 174.21 15.13 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' SER . 36.1 ptt180 -152.2 139.91 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.627 ' HA ' HG22 ' A' ' 52' ' ' ILE . 63.6 p -78.73 177.13 8.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -16.89 61.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 110.27 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -87.86 -19.96 26.68 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.12 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 29.6 5.4 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.033 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.9 m -98.91 115.45 28.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.6 m-85 -91.77 139.06 31.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 122.714 0.406 . . . . 0.0 110.717 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.12 158.86 31.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.857 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.448 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.2 m-85 -73.97 135.15 43.17 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.917 0.865 . . . . 0.0 111.285 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.815 HD11 ' HA3' ' A' ' 67' ' ' GLY . 67.5 mt -116.42 128.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.697 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 77' ' ' ILE . 54.8 mttm -65.14 137.14 57.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.0 p -68.7 -7.16 30.94 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.128 0.966 . . . . 0.0 111.469 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -104.16 -13.15 16.33 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.153 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.4 -13.08 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.291 0.567 . . . . 0.0 109.736 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.951 HG11 HD11 ' A' ' 52' ' ' ILE . 35.3 m -131.99 154.56 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.368 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 55.1 mm-40 -103.54 113.13 26.41 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 172.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.5 mm -81.13 141.74 14.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.793 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.478 -1.802 0 CA-C-O 123.094 1.426 . . . . 0.0 112.443 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -61.82 -25.46 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.774 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 92.1 mttt -75.64 -25.86 57.22 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.882 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.24 -38.8 13.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -63.01 -50.88 68.96 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.253 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -103.1 -5.91 22.79 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.44 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 37.7 mtmm 55.35 81.1 0.12 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.556 0.742 . . . . 0.0 110.078 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 21' ' ' LEU . 10.9 tp -83.93 -45.5 13.11 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.13 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 p 46.83 96.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.49 178.83 38.25 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.21 136.53 24.57 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.856 2.371 . . . . 0.0 110.535 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.848 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -124.68 160.51 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -128.63 148.22 50.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 53' ' ' GLU . 7.1 p -74.7 145.72 10.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.614 0.245 . . . . 0.0 110.812 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -97.99 -44.78 12.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.129 0.49 . . . . 0.0 111.013 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.978 ' HB2' HD11 ' A' ' 54' ' ' ILE . 7.3 m-70 -139.29 162.89 33.89 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.35 122.19 42.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.923 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.38 164.43 11.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.679 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 51.3 pttt -151.43 105.21 3.15 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -72.17 125.73 28.04 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.417 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.7 t -112.14 148.76 33.3 Favored 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.791 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.7 m 74.32 167.74 0.3 Allowed 'General case' 0 N--CA 1.405 -2.713 0 O-C-N 126.032 2.083 . . . . 0.0 111.422 162.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.41 102.56 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.758 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.1 m -96.16 156.64 3.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.902 -175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -49.81 -53.92 22.38 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.96 43.3 96.92 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.557 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.57 179.2 0.02 OUTLIER Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.324 1.29 . . . . 0.0 116.324 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -61.47 -34.42 75.42 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -86.26 -16.15 38.53 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.114 0.483 . . . . 0.0 111.207 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 78' ' ' LYS . 45.0 mt-10 -92.66 170.4 9.75 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.781 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.659 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 1.1 tt -79.07 140.92 37.77 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.921 0.867 . . . . 0.0 110.338 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 m -81.12 47.07 0.97 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.58 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.945 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -87.44 175.58 7.9 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.445 0.641 . . . . 0.0 111.879 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.4 mtpt -133.78 -172.76 3.06 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.394 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 47.6 tt0 -81.69 124.79 29.89 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 125.398 1.479 . . . . 0.0 107.821 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.03 4.93 66.48 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.6 mm-40 -74.26 121.87 21.97 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 122.163 0.983 . . . . 0.0 112.283 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -85.51 96.18 9.53 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 82' ' ' VAL . 40.0 pt -111.41 158.41 11.9 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.538 0 CA-C-N 112.836 -1.983 . . . . 0.0 112.071 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 27' ' ' VAL . 51.3 mt-10 -125.43 134.05 52.25 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.21 127.72 54.18 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.291 175.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.848 HG12 HD13 ' A' ' 25' ' ' ILE . 2.7 mp -97.87 -34.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.165 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.7 ttm180 -116.12 110.01 18.27 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.455 -174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.41 98.56 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.288 -2.09 0 CA-C-O 121.598 0.713 . . . . 0.0 112.75 -172.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.861 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 69.6 mmtt -119.57 157.38 28.5 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -102.06 142.15 33.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -86.25 108.93 18.6 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -115.18 177.03 17.07 Favored Glycine 0 N--CA 1.415 -2.764 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.411 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 29.6 ptt180 -151.93 142.89 23.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.279 1.032 . . . . 0.0 108.311 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 52' ' ' ILE . 19.2 p -79.71 173.24 12.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.92 0.866 . . . . 0.0 109.135 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.49 -7.87 59.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.981 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.78 31.82 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.501 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.2 m -103.18 113.38 26.81 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.7 m-85 -89.52 147.7 23.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.583 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.88 161.09 34.76 Favored Glycine 0 C--N 1.298 -1.537 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.81 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.2 m-85 -70.11 161.73 29.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.945 HG12 ' HE2' ' A' ' 46' ' ' PHE . 83.9 mt -142.44 126.65 15.67 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' O ' HG22 ' A' ' 77' ' ' ILE . 61.0 mttp -64.5 132.53 50.19 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 167.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.3 p -66.29 -8.51 25.47 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 118.927 0.785 . . . . 0.0 112.575 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 t -98.85 -14.49 19.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.581 0.752 . . . . 0.0 110.282 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.06 -19.78 58.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 108.909 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 52' ' ' ILE . 34.1 m -125.79 166.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.788 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 29.0 mt-10 -125.44 112.22 16.02 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' HIS . 1.7 mp -88.92 123.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 120.922 0.391 . . . . 0.0 110.135 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 . . . . . 0 CA--C 1.476 -1.872 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.233 176.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.95 -29.78 47.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.389 0.614 . . . . 0.0 111.063 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.23 -27.63 66.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.666 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.14 -46.24 8.21 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.734 0.778 . . . . 0.0 109.231 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.05 -44.65 83.95 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 112.379 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -109.35 -8.6 15.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.66 75.22 0.35 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 111.286 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.13 17.81 19.23 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.072 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -68.35 84.7 0.26 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.239 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.83 41.69 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.39 105.47 0.89 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.978 2.452 . . . . 0.0 113.012 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.34 161.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 27' ' ' VAL . 18.4 mm-40 -133.83 -81.48 0.46 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.66 ' HA ' HG22 ' A' ' 55' ' ' ILE . 1.4 m 178.74 152.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 C-N-CA 128.906 2.882 . . . . 0.0 105.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 29' ' ' HIS . 38.3 mm -99.31 -44.91 12.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' HD2' HG22 ' A' ' 28' ' ' ILE . 70.5 m-70 -160.74 -176.93 5.83 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.08 169.58 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 21.7 pttm -152.3 107.05 3.21 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.0 135.82 57.49 Favored 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.049 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -112.05 172.86 6.66 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m 58.39 175.87 0.06 Allowed 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 125.101 1.501 . . . . 0.0 114.39 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.49 95.43 9.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.88 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.841 HG21 ' HE1' ' A' ' 46' ' ' PHE . 27.7 m -89.98 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.36 -40.85 75.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.535 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.08 43.18 62.37 Favored Glycine 0 C--N 1.355 1.592 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.892 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -53.14 -173.71 0.05 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 116.879 1.512 . . . . 0.0 116.879 -173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -63.2 -36.78 84.78 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -100.81 2.21 40.91 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.632 0.729 . . . . 0.0 109.789 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.4 mt-10 -95.68 179.42 5.13 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.68 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -94.7 135.73 35.83 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -85.83 76.19 9.93 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.131 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.869 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.37 174.11 6.43 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.997 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 30.3 mmtp -140.79 -175.51 4.32 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.829 0.823 . . . . 0.0 111.497 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -65.09 108.21 1.77 Allowed 'General case' 0 C--N 1.272 -2.791 0 C-N-CA 127.856 2.463 . . . . 0.0 109.886 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.75 5.25 41.99 Favored Glycine 0 C--N 1.294 -1.8 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.5 mm-40 -80.03 116.69 20.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.031 0.92 . . . . 0.0 112.729 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -85.55 96.99 9.81 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.895 HD11 HG11 ' A' ' 82' ' ' VAL . 27.8 pt -110.87 158.66 11.25 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.244 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.045 175.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -118.57 134.25 55.24 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.607 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -96.09 136.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.184 173.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -119.56 3.68 6.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.188 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 58' ' ' THR . 58.2 ttt180 -150.27 141.15 22.83 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.749 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 28' ' ' ILE . 44.4 mm -109.02 96.97 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.217 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.784 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.194 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.5 mmtp -129.29 148.88 51.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 35.0 m0 -94.64 160.81 14.46 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.682 0.614 . . . . 0.0 109.848 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.58 109.65 21.5 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.705 0.764 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -114.08 175.92 16.67 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.1 ptt180 -152.77 146.39 25.05 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.819 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.6 p -73.15 178.59 4.32 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 117.941 0.337 . . . . 0.0 110.847 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -34.22 73.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.123 0.487 . . . . 0.0 110.533 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 71' ' ' ARG . 39.2 mtm-85 -82.16 -0.4 44.76 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.172 0.51 . . . . 0.0 111.599 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.34 27.27 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 114.528 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.0 m -91.46 112.55 24.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.563 1.182 . . . . 0.0 107.813 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 79.2 m-85 -82.48 145.18 29.95 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.128 -172.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.83 27.95 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.163 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 7.7 m-85 -71.45 142.68 50.23 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.87 0.843 . . . . 0.0 112.302 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.869 HG12 ' HE2' ' A' ' 46' ' ' PHE . 61.3 mt -126.59 129.28 71.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.565 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 77' ' ' ILE . 92.3 mttt -65.93 140.95 58.37 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.4 p -69.06 -9.16 51.18 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.0 112.056 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -103.93 -8.67 19.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.519 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.628 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.79 -11.04 59.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 52' ' ' ILE . 27.1 m -133.1 158.27 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.015 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 38.0 mt-10 -104.5 112.94 26.19 Favored 'General case' 0 N--CA 1.394 -3.234 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 31' ' ' ALA . 21.1 mm -94.75 135.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.73 0 C-N-CA 124.038 0.935 . . . . 0.0 109.68 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 CA--C 1.498 -1.048 0 CA-C-O 121.493 0.663 . . . . 0.0 109.948 178.104 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.6 pp -57.49 -28.04 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 22' ' ' THR . 43.3 mtmt -79.68 -23.9 42.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -89.37 -41.22 12.25 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 87.3 tttt -60.56 -48.4 81.94 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 112.089 -175.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -100.56 -6.02 25.98 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 59.94 74.39 0.45 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 122.869 1.319 . . . . 0.0 108.059 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 12.5 tp -125.26 14.53 8.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.913 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -69.42 90.51 0.53 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.487 0.66 . . . . 0.0 112.035 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.78 -177.04 45.5 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.95 123.57 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.711 2.274 . . . . 0.0 112.024 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.628 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.6 pp -109.33 147.08 14.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 120.872 0.368 . . . . 0.0 111.827 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -127.79 138.1 52.62 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.645 ' HA ' HG22 ' A' ' 55' ' ' ILE . 21.9 t -74.08 112.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.556 HG22 ' CD2' ' A' ' 29' ' ' HIS . 38.7 mm -83.67 -44.66 18.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.759 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 54' ' ' ILE . 54.6 m-70 -150.49 167.42 27.22 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.66 117.94 31.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.58 165.06 11.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 42.7 pttt -150.22 102.54 3.09 Favored 'General case' 0 C--N 1.255 -3.514 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.82 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.38 125.96 26.76 Favored 'General case' 0 C--N 1.271 -2.806 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.699 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.2 t -109.69 148.08 32.01 Favored 'General case' 0 CA--C 1.432 -3.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.2 m 68.1 -179.14 0.22 Allowed 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 125.99 2.057 . . . . 0.0 110.344 164.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.6 113.53 14.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 46' ' ' PHE . 5.5 m -106.74 156.37 7.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.225 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 15.0 ptpt -50.72 -66.93 0.3 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.353 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . 61.84 43.32 99.37 Favored Glycine 0 C--O 1.246 0.881 0 C-N-CA 119.754 -1.212 . . . . 0.0 112.542 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -61.41 -150.83 0.02 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 116.729 1.451 . . . . 0.0 116.729 -173.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -73.45 -38.22 65.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -171.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -103.28 -0.42 30.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.991 0.901 . . . . 0.0 109.455 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 68.9 mt-10 -99.37 163.53 12.49 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.643 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -79.23 128.36 33.2 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -86.26 67.56 9.98 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-O 122.542 1.163 . . . . 0.0 108.948 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -98.25 -167.18 1.47 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.521 177.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 54.8 tttp -147.92 -173.59 4.34 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.758 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 8.7 tt0 -79.0 105.6 10.45 Favored 'General case' 1 C--N 1.243 -4.027 0 C-N-CA 127.112 2.165 . . . . 0.0 109.302 -176.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 8.19 48.01 Favored Glycine 0 C--N 1.285 -2.3 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.005 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.4 128.82 36.22 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.516 0.674 . . . . 0.0 110.759 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 97.03 10.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 22.7 pt -107.27 158.36 7.2 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.093 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.672 176.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.47 128.79 43.62 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -90.98 132.64 35.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.299 177.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.11 11.73 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 33.1 ttt180 -155.08 114.15 3.61 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.076 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 28' ' ' ILE . 46.3 mm -99.12 95.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.293 -1.89 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 173.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.559 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 76' ' ' TYR . 46.1 mmtm -131.57 162.95 29.13 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 38.8 m0 -102.0 153.54 19.79 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -98.93 112.52 24.6 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.682 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -109.52 177.48 20.07 Favored Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 114.293 -1.322 . . . . 0.0 110.572 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.2 ptm180 -151.32 141.26 22.01 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 52' ' ' ILE . 64.9 p -79.43 167.85 20.27 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.27 64.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.799 0.809 . . . . 0.0 109.869 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -84.47 -22.37 30.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.073 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.53 19.4 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.091 -1.052 . . . . 0.0 114.314 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.5 m -94.31 110.37 22.13 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.446 ' HB2' HG21 ' A' ' 15' ' ' ILE . 38.5 m-85 -87.49 138.43 31.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.64 155.87 27.12 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.355 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.3 m-85 -69.35 143.79 53.65 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.713 0.768 . . . . 0.0 110.7 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.787 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.9 mt -124.53 132.89 70.69 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.687 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 mtmt -73.57 132.34 42.71 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.6 p -63.73 -10.25 18.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.593 0.711 . . . . 0.0 112.857 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -99.98 -16.05 18.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.651 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -14.17 59.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 52' ' ' ILE . 33.2 m -131.39 156.21 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.689 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 9.3 mm-40 -106.36 106.22 16.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 31' ' ' ALA . 23.4 mm -83.62 115.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.538 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 . . . . . 0 CA--C 1.494 -1.175 0 CA-C-O 121.52 0.676 . . . . 0.0 110.95 179.039 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 120.756 0.312 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.6 pp -65.86 -24.49 34.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.974 0.416 . . . . 0.0 111.83 -176.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 46.1 mtmt -68.8 -24.37 64.39 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.189 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -97.88 -43.97 6.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.629 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.0 tttt -62.69 -57.25 11.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' HD2' ' HB ' ' A' ' 15' ' ' ILE . 66.6 m-85 -97.59 -13.01 21.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.364 0.602 . . . . 0.0 109.726 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 53.0 mttp 62.39 77.59 0.32 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.185 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 15' ' ' ILE . 73.9 mt -121.1 16.85 11.62 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.602 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -61.61 131.47 50.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.474 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.02 -177.18 18.05 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.34 115.01 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.36 2.04 . . . . 0.0 111.577 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 55' ' ' ILE . 2.7 pp -109.98 145.31 16.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.764 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.03 130.06 55.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.308 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.914 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.5 p -71.9 144.44 13.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 123.253 0.346 . . . . 0.0 110.41 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.44 HG22 ' CD2' ' A' ' 29' ' ' HIS . 45.4 mm -95.98 -44.71 13.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.709 ' HB2' HD11 ' A' ' 54' ' ' ILE . 74.6 m-70 -154.17 179.99 8.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 123.658 0.783 . . . . 0.0 109.065 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 5.7 mp -108.07 136.52 47.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -108.58 176.03 5.26 Favored 'General case' 0 C--N 1.263 -3.174 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 14.8 ptmm? -150.57 102.58 3.04 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.93 122.71 18.76 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.47 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 38.3 t -117.25 152.75 34.19 Favored 'General case' 0 CA--C 1.444 -3.1 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.147 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 m 70.78 177.64 0.27 Allowed 'General case' 0 N--CA 1.404 -2.725 0 O-C-N 125.818 1.949 . . . . 0.0 110.583 162.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.16 100.44 6.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.615 1.198 . . . . 0.0 110.541 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.02 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.3 m -87.74 156.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.946 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -61.7 -52.7 63.21 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.66 43.14 99.41 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.345 -0.931 . . . . 0.0 114.763 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.39 -179.33 1.03 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -63.61 -27.95 69.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 29.5 p-10 -90.3 -13.95 34.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 45.7 mt-10 -92.33 159.82 15.41 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.462 -177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' HD2' ' A' ' 46' ' ' PHE . 1.4 tt -70.79 137.51 49.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.631 0.729 . . . . 0.0 109.844 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 44' ' ' LEU . 15.1 m -82.96 43.81 0.88 Allowed 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.436 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.02 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -84.93 -161.05 0.53 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.273 178.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.882 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 74.1 tttt -145.54 -171.57 3.7 Favored 'General case' 0 N--CA 1.389 -3.525 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.882 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 7.7 tt0 -75.73 -8.83 57.79 Favored 'General case' 0 C--N 1.254 -3.568 0 C-N-CA 128.746 2.818 . . . . 0.0 114.337 -168.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.47 19.9 1.69 Allowed Glycine 0 C--N 1.27 -3.094 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 18.6 mm-40 -80.56 129.78 34.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -96.88 97.57 9.39 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.912 HD11 HG11 ' A' ' 82' ' ' VAL . 36.6 pt -105.55 159.73 5.7 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.883 -2.417 . . . . 0.0 112.55 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.914 ' HB3' HG21 ' A' ' 27' ' ' VAL . 40.7 mt-10 -120.05 136.0 54.73 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.4 128.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.866 0.841 . . . . 0.0 112.072 177.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -100.59 -35.03 4.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.209 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.02 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.1 ttm180 -114.84 121.36 43.0 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.715 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.9 mm -99.09 98.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.083 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.174 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 44.9 mmtm -133.74 155.2 50.2 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.4 m0 -100.75 153.16 19.68 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.516 0.51 . . . . 0.0 110.171 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -95.03 116.37 28.61 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.756 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.04 178.62 16.66 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.765 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 36.3 ptt180 -151.91 147.33 26.46 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.735 ' HA ' HG22 ' A' ' 52' ' ' ILE . 67.0 p -80.05 179.02 7.83 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 118.198 0.454 . . . . 0.0 109.811 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -15.87 61.89 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -80.82 -25.89 37.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.38 9.36 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.348 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 8.0 p -94.1 111.55 23.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.794 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 m-85 -83.13 148.98 27.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -171.62 160.74 32.78 Favored Glycine 0 C--N 1.318 -0.446 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.19 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 m-85 -76.21 143.21 41.18 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-O 121.67 0.748 . . . . 0.0 111.522 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.756 HD11 ' HA3' ' A' ' 67' ' ' GLY . 44.2 mt -125.39 139.15 52.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.061 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 77' ' ' ILE . 55.7 mttm -74.1 136.47 42.98 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 168.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.6 p -64.56 -13.32 52.3 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.537 0.685 . . . . 0.0 112.143 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -97.27 -16.24 20.43 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.541 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.45 -17.65 59.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 52' ' ' ILE . 27.5 m -130.58 153.17 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.75 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 49.0 mm-40 -102.85 100.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 31' ' ' ALA . 22.0 mm -70.57 133.14 32.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.098 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.004 0.907 . . . . 0.0 111.692 -178.697 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.479 0.18 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.51 -31.44 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.722 ' HB3' HG23 ' A' ' 22' ' ' THR . 54.1 mttp -72.27 -22.78 61.17 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.596 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -94.11 -40.21 10.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.573 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.7 ttpt -65.32 -42.1 93.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.779 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.2 m-85 -111.82 1.54 16.64 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.234 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 34.9 ttmt 53.37 72.22 0.45 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.928 1.347 . . . . 0.0 110.336 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.61 HD21 ' HG ' ' A' ' 66' ' ' LEU . 94.9 mt -112.5 16.47 19.81 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.984 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -71.93 94.4 1.45 Allowed 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.301 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.96 170.53 25.7 Favored Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.18 128.23 11.97 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.908 2.405 . . . . 0.0 111.452 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.26 159.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -136.71 144.1 43.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 53' ' ' GLU . 8.0 p -71.43 137.4 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 57' ' ' ILE . 40.0 mm -98.87 -37.79 6.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.195 0.521 . . . . 0.0 109.872 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.599 ' HB2' HD11 ' A' ' 54' ' ' ILE . 53.6 m-70 -153.65 164.16 38.76 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.26 132.28 49.65 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.43 171.89 7.11 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.796 0.808 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 14.3 ptpt -151.64 102.72 2.89 Favored 'General case' 0 C--N 1.26 -3.297 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.81 112.77 3.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -96.95 150.73 20.43 Favored 'General case' 0 CA--C 1.431 -3.599 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.655 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.4 m 67.91 -179.32 0.22 Allowed 'General case' 0 N--CA 1.402 -2.845 0 O-C-N 125.635 1.835 . . . . 0.0 110.782 163.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -79.72 105.29 10.9 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 46' ' ' PHE . 16.9 m -87.76 156.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.896 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -52.58 -58.58 6.32 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.41 41.79 99.74 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.818 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.82 178.29 0.3 Allowed Glycine 0 CA--C 1.526 0.723 0 O-C-N 123.914 0.42 . . . . 0.0 113.528 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -64.42 -32.85 74.65 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 122.104 -0.645 . . . . 0.0 111.547 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -88.08 -7.81 56.43 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.048 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 47.7 mt-10 -92.14 171.96 8.74 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HG ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -73.23 148.63 43.51 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.417 ' H ' HD23 ' A' ' 44' ' ' LEU . 17.8 m -89.89 38.45 0.92 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.749 1.261 . . . . 0.0 108.536 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.813 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -85.17 163.45 18.71 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.12 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.627 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 28.1 mmtp -133.65 -173.35 3.21 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.882 0.849 . . . . 0.0 111.997 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 9.4 tt0 -64.7 119.48 10.64 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 126.528 1.931 . . . . 0.0 109.978 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.18 19.07 40.41 Favored Glycine 0 C--N 1.292 -1.901 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.545 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.813 ' HG2' ' HB2' ' A' ' 46' ' ' PHE . 6.6 tp10 -78.64 137.53 37.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.155 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.56 96.68 8.47 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.842 HD11 HG11 ' A' ' 82' ' ' VAL . 22.5 pt -111.86 158.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 112.691 -2.05 . . . . 0.0 113.578 173.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HB3' HG21 ' A' ' 27' ' ' VAL . 3.8 mp0 -128.18 137.75 52.19 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 67' ' ' GLY 0.288 0.2 OUTLIER -102.21 124.77 56.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.866 176.213 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -107.95 -4.08 10.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.838 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.832 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.1 ttm180 -138.97 114.56 9.83 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.96 0.409 . . . . 0.0 110.81 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 HG13 ' A' ' 28' ' ' ILE . 51.1 mm -94.72 98.49 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.489 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 26.7 mmtp -134.93 158.3 44.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.003 0.43 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 17.6 m0 -109.41 162.23 14.55 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -104.04 112.48 25.49 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.561 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.11 177.6 18.24 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.164 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 7.0 ptm180 -150.02 145.88 26.67 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 52' ' ' ILE . 43.9 p -84.75 171.83 11.99 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.42 -23.92 67.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.351 0.596 . . . . 0.0 110.05 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -75.89 -14.93 60.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.106 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.68 28.49 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.285 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.1 m -92.95 109.01 20.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 26.2 m-85 -84.12 140.28 31.89 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.206 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -165.74 156.22 28.02 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.624 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.596 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 12.5 m-85 -68.96 150.18 48.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.603 0.716 . . . . 0.0 111.102 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 67' ' ' GLY . 70.3 mt -134.77 128.68 50.82 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 77' ' ' ILE . 91.5 mttt -68.21 143.05 55.48 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 168.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 p -68.96 -16.02 63.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.158 0.98 . . . . 0.0 111.546 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 80' ' ' THR . 5.4 t -89.79 -15.94 31.29 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.723 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -17.18 56.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.469 0.652 . . . . 0.0 110.472 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -129.63 156.88 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.805 0 CA-C-O 121.464 0.649 . . . . 0.0 112.509 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -98.29 100.65 11.96 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.2 mm -82.63 109.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.75 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.305 -1.334 0 CA-C-O 122.048 0.928 . . . . 0.0 112.409 178.901 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 120.583 0.23 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 2.5 pp -56.33 -25.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.37 -35.18 68.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.482 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.86 -32.52 15.29 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.902 0.858 . . . . 0.0 109.323 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -66.82 -45.71 77.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.37 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 65.1 m-85 -108.02 -3.36 18.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 2.9 mptp? 60.89 75.2 0.42 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.181 0.991 . . . . 0.0 110.006 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 15' ' ' ILE . 8.8 tp -89.76 -24.53 21.48 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.904 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.252 77.3 p 64.79 -69.12 0.1 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.845 1.658 . . . . 0.0 112.473 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.39 -107.97 0.21 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.49 145.51 71.06 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.441 2.094 . . . . 0.0 109.942 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.4 pp -138.66 -48.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.624 ' H ' HD12 ' A' ' 25' ' ' ILE . 31.1 mm-40 71.01 123.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.834 1.302 . . . . 0.0 114.129 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.19 140.5 18.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 112.548 -2.115 . . . . 0.0 111.156 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.95 -44.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.831 0.348 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.951 ' HB2' HD11 ' A' ' 54' ' ' ILE . 92.0 m-70 -142.83 177.08 8.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.54 119.25 38.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.453 0.644 . . . . 0.0 111.386 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.53 167.01 10.03 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.802 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 17.2 pttp -153.14 102.78 2.66 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.813 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.36 139.61 56.87 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.136 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.9 t -127.61 155.18 44.27 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.6 m 69.45 175.9 0.28 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 125.889 1.993 . . . . 0.0 111.456 162.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.79 113.25 16.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.796 HG21 ' CE1' ' A' ' 46' ' ' PHE . 17.4 m -112.16 155.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.79 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.66 -46.8 83.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.311 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.58 43.01 45.35 Favored Glycine 0 C--N 1.359 1.813 0 O-C-N 123.896 0.747 . . . . 0.0 113.738 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.28 -153.04 0.04 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 116.255 1.262 . . . . 0.0 116.255 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.27 -51.34 25.01 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.95 -6.8 59.49 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.283 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.48 172.73 8.19 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -83.0 141.67 31.91 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -81.62 45.17 0.86 Allowed 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.456 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.888 ' HE2' HG12 ' A' ' 77' ' ' ILE . 1.2 p90 -86.05 179.19 7.02 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.833 0.825 . . . . 0.0 112.021 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.788 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 28.1 mtpp -132.92 -172.06 2.83 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.995 -172.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 24.6 tt0 -76.6 -12.02 59.95 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 126.881 2.073 . . . . 0.0 113.677 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.7 19.59 2.39 Favored Glycine 0 C--N 1.268 -3.208 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 9.6 mm-40 -77.12 125.46 29.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.86 0.838 . . . . 0.0 113.182 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.38 97.75 9.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 82' ' ' VAL . 36.0 pt -112.64 159.1 12.8 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.047 0 CA-C-N 112.511 -2.131 . . . . 0.0 112.62 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.33 139.15 53.52 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -103.02 134.97 42.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.318 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -105.73 -24.45 4.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.415 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 9.3 ttt85 -127.38 122.94 34.98 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.382 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mm -104.6 96.75 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.976 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.463 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 CA-C-O 120.898 0.165 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.1 mmtp -133.28 156.38 47.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 32.5 m0 -93.11 162.35 14.06 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.712 0.633 . . . . 0.0 109.973 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -103.62 115.02 29.73 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.217 0.532 . . . . 0.0 110.327 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.728 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.48 -179.16 16.61 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.279 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 36.1 ptt180 -151.78 144.7 24.46 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.1 p -78.31 170.44 16.63 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.63 -14.67 59.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.214 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.66 0.03 57.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.217 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.83 68.35 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 m -97.83 113.2 24.94 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 23.0 m-85 -82.47 151.64 26.44 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.801 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -170.94 159.02 30.94 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.644 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.7 m-85 -71.63 147.97 47.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.623 0.725 . . . . 0.0 111.606 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.888 HG12 ' HE2' ' A' ' 46' ' ' PHE . 69.3 mt -133.0 133.27 58.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.761 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 77' ' ' ILE . 98.2 mttt -69.43 135.37 50.15 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 167.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.5 p -66.23 -8.11 22.51 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.628 0.728 . . . . 0.0 111.885 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -106.2 -6.96 18.12 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 124.064 0.946 . . . . 0.0 109.731 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -85.99 -14.13 45.5 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 52' ' ' ILE . 33.4 m -129.1 152.89 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.138 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.153 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.657 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 37.0 mt-10 -94.65 100.46 12.4 Favored 'General case' 0 N--CA 1.397 -3.11 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 27.3 mm -90.77 106.03 17.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 CA--C 1.471 -2.069 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.883 -174.8 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 N--CA 1.438 -1.075 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 2.6 pp -54.88 -31.87 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -73.94 -24.53 59.66 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -96.94 -28.06 14.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 31.5 tttp -61.33 -52.28 65.32 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.257 1.423 . . . . 0.0 110.478 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 42.4 m-85 -99.03 -5.88 29.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.101 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 61.16 76.04 0.39 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.717 1.246 . . . . 0.0 108.304 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 25' ' ' ILE . 10.4 tp -116.36 16.09 15.75 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.212 -172.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -75.92 122.79 24.68 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.109 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.52 168.53 18.54 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 121.61 8.84 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.789 2.992 . . . . 0.0 112.196 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.854 HG13 ' H ' ' A' ' 26' ' ' GLN . 18.2 pt -106.37 -76.82 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.854 ' H ' HG13 ' A' ' 25' ' ' ILE 0.258 23.8 mt-30 72.41 141.12 0.06 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.186 1.394 . . . . 0.0 114.316 -177.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 53' ' ' GLU . 60.6 t -81.4 137.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.218 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.494 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.12 -42.3 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.92 ' HB2' HD11 ' A' ' 54' ' ' ILE . 84.8 m-70 -142.46 178.89 7.29 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 45.2 tp -115.27 125.66 53.57 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.63 171.49 7.3 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.64 0.734 . . . . 0.0 109.95 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 61.4 pttt -151.08 107.53 3.48 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -70.15 130.97 43.5 Favored 'General case' 0 C--N 1.255 -3.531 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.589 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.05 166.42 12.02 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 6.3 m 63.73 164.94 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 125.219 1.574 . . . . 0.0 114.444 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.98 111.18 5.49 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.833 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.3 m -111.89 156.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.087 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -56.33 -60.8 2.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 43' ' ' GLU . . . 49.6 41.48 34.14 Favored Glycine 0 C--O 1.21 -1.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.809 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.13 -110.26 0.01 OUTLIER Glycine 0 CA--C 1.542 1.724 0 N-CA-C 118.727 2.251 . . . . 0.0 118.727 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 9.4 mmpt? -98.87 -53.76 3.19 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 122.271 -0.546 . . . . 0.0 111.535 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.578 HD22 ' HD2' ' A' ' 76' ' ' TYR . 2.2 p-10 -95.43 1.96 54.33 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' C ' ' A' ' 39' ' ' GLY . 39.2 mt-10 -92.65 157.52 16.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.684 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.048 0.927 . . . . 0.0 111.269 -173.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.6 m -84.07 69.75 10.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.671 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.925 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.86 -175.69 2.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.58 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -145.1 -172.66 3.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 124.036 0.835 . . . . 0.0 109.234 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.7 tt0 -85.7 107.44 17.58 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 125.429 1.492 . . . . 0.0 109.576 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.97 29.98 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.93 126.82 34.38 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.625 0.726 . . . . 0.0 111.629 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.93 96.44 10.68 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 33.3 pt -109.51 158.09 9.65 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.052 0 CA-C-N 112.495 -2.138 . . . . 0.0 112.704 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB3' HG11 ' A' ' 27' ' ' VAL . 30.3 mt-10 -121.83 134.64 54.89 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -97.33 129.27 47.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.288 175.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.665 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.5 mp -98.99 -40.28 8.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.008 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.9 ttm180 -121.87 119.7 32.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.758 -174.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.41 98.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.376 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.264 -175.528 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.939 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 33.0 mmtp -123.66 159.93 28.26 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.453 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.5 m0 -95.98 152.04 18.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.6 tm? -93.69 114.03 26.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -118.32 179.67 17.02 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.31 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 35.1 ptt180 -152.29 139.69 19.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.87 ' HA ' HG22 ' A' ' 52' ' ' ILE . 5.5 p -76.0 171.49 14.35 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 117.948 0.34 . . . . 0.0 110.446 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.45 -16.19 60.35 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -72.56 -17.48 61.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.558 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.11 23.53 22.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 23.6 m -113.43 128.09 56.33 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 41.2 m-85 -89.67 151.85 21.66 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.525 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -174.89 160.29 29.25 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.578 ' HD2' HD22 ' A' ' 42' ' ' ASN . 17.5 m-85 -74.73 146.45 42.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.388 0.613 . . . . 0.0 111.011 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.925 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.0 mt -128.29 129.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.673 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' O ' HG22 ' A' ' 77' ' ' ILE . 63.0 mttm -69.77 132.43 46.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 165.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.3 p -63.14 -10.75 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.737 0.78 . . . . 0.0 112.595 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.7 t -93.88 -21.1 19.45 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.897 0.879 . . . . 0.0 109.709 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.36 -15.07 60.04 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.974 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 34.4 m -127.19 157.81 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 CA-C-O 121.405 0.622 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 32.0 mt-10 -112.73 101.02 9.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 31' ' ' ALA . 20.0 mm -74.19 132.57 33.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.197 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.391 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.473 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.6 pp -64.51 -29.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.933 0.397 . . . . 0.0 111.742 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 45.6 mtmt -76.26 -25.58 55.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.637 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -83.86 -38.2 21.47 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.09 -49.28 62.21 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.083 1.353 . . . . 0.0 112.406 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.47 -4.6 25.15 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 57.37 75.52 0.37 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 10.7 tp -127.51 14.47 7.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.988 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -57.57 117.31 4.05 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.676 -172.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.98 169.47 11.67 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.84 120.15 6.86 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 122.218 1.946 . . . . 0.0 110.764 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.805 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.7 pp -104.26 151.44 6.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -143.46 159.28 42.69 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.345 1.058 . . . . 0.0 108.168 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 53' ' ' GLU . 30.8 m -75.2 154.97 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.691 HD12 HG12 ' A' ' 57' ' ' ILE . 36.0 mt -105.05 -32.74 2.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.589 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.919 ' HB2' HD11 ' A' ' 54' ' ' ILE . 82.9 m-70 -152.01 -178.59 6.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 53' ' ' GLU . 30.2 tp -119.28 132.98 55.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.08 170.6 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.607 0.718 . . . . 0.0 110.646 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 46.0 pttt -153.32 102.87 2.64 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.841 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.99 125.52 23.97 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.689 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.8 p -111.26 166.55 11.0 Favored 'General case' 0 CA--C 1.452 -2.808 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.472 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m 61.26 174.67 0.11 Allowed 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 125.038 1.461 . . . . 0.0 112.307 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.14 102.96 8.75 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 46' ' ' PHE . 18.7 m -92.01 154.31 3.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.692 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -58.18 -58.95 6.21 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.65 42.09 90.44 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 124.288 0.992 . . . . 0.0 113.696 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.04 -152.57 0.37 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -63.27 -50.13 71.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 4.5 p-10 -82.8 -8.9 59.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.696 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 41.6 mt-10 -91.68 -179.81 5.44 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.571 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.4 tt -88.51 149.0 23.86 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 44' ' ' LEU . 29.9 t -92.08 90.17 7.26 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.726 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.61 176.91 9.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.892 -174.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -139.65 -174.0 3.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 111.612 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 28.9 tt0 -79.17 105.68 10.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 126.532 1.933 . . . . 0.0 108.81 -177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.88 12.15 44.27 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.44 157.8 33.58 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -108.26 96.78 6.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.7 -1.136 . . . . 0.0 107.964 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.693 HD11 HG11 ' A' ' 82' ' ' VAL . 23.1 pt -117.0 159.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.983 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 5.3 pt-20 -133.21 139.23 46.88 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.25 0.2 OUTLIER -102.34 132.48 48.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.822 179.458 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.805 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.37 -31.95 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.919 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.019 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.7 ttm180 -115.76 126.83 54.56 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.713 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 28' ' ' ILE . 51.1 mm -103.3 98.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.733 -176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.698 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 47.7 mmtm -133.53 155.91 48.74 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 26.1 m0 -108.36 152.49 24.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.35 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.019 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -92.74 110.72 22.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -116.81 176.56 16.32 Favored Glycine 0 N--CA 1.417 -2.63 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.154 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 23.0 ptt180 -151.76 143.13 23.41 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' HG22 ' A' ' 52' ' ' ILE . 4.2 p -77.05 166.15 23.68 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -20.83 66.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -67.33 -26.43 66.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.842 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.83 20.41 11.6 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.509 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 67.1 m -104.41 120.72 41.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 117.875 0.837 . . . . 0.0 108.799 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.6 m-85 -92.58 150.0 21.0 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.983 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.433 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -166.64 155.98 27.53 Favored Glycine 0 C--N 1.305 -1.169 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.15 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 2.0 m-85 -79.19 116.16 19.29 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-O 121.687 0.756 . . . . 0.0 110.015 174.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 78' ' ' LYS . 65.1 mt -100.41 140.2 20.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.761 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.5 mtmt -71.96 139.3 48.6 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.7 p -68.95 -12.69 61.88 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.768 0.794 . . . . 0.0 111.92 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 t -99.42 -12.22 20.44 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.589 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . . . -77.26 -15.89 59.25 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.193 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.1 m -130.39 154.18 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.7 mt-10 -100.84 102.8 13.94 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 31' ' ' ALA . 29.0 mm -79.58 119.2 28.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 . . . . . 0 CA--C 1.477 -1.836 0 CA-C-O 121.779 0.799 . . . . 0.0 110.593 178.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.52 -27.88 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.19 0.519 . . . . 0.0 111.343 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 92.9 mttt -75.04 -18.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.66 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -97.57 -40.52 8.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.92 -49.28 78.32 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.553 1.141 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.9 m-85 -100.83 -0.51 36.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.642 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.41 74.68 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.059 0.933 . . . . 0.0 108.737 -171.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 8.6 tp -121.57 15.01 11.11 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.557 -173.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -64.75 118.27 8.71 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.56 -164.75 21.66 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -66.17 140.07 57.87 Favored 'Trans proline' 0 CA--C 1.5 -1.222 0 C-N-CA 122.174 1.916 . . . . 0.0 109.406 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 55' ' ' ILE 0.359 0.0 OUTLIER -111.74 -66.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.173 -173.035 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' HD13 ' A' ' 25' ' ' ILE . 34.2 mm-40 70.96 161.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.121 0.962 . . . . 0.0 113.556 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.46 127.95 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.237 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.4 mm -98.87 -45.49 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.208 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.933 ' HB2' HD11 ' A' ' 54' ' ' ILE . 78.1 m-70 -152.36 170.45 20.04 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.92 125.68 48.65 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.997 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -106.78 175.18 5.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -153.71 106.59 2.9 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 175.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.869 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.52 138.02 57.79 Favored 'General case' 0 C--N 1.274 -2.683 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.118 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.1 t -126.62 151.86 47.43 Favored 'General case' 0 CA--C 1.447 -3.004 0 O-C-N 123.211 0.319 . . . . 0.0 110.307 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.1 m 71.22 167.42 0.31 Allowed 'General case' 0 N--CA 1.403 -2.805 0 O-C-N 125.976 2.048 . . . . 0.0 111.903 163.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.35 104.87 4.51 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.008 0.909 . . . . 0.0 110.707 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.795 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.7 m -107.49 157.4 7.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 124.633 1.173 . . . . 0.0 110.493 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HD3' ' HE3' ' A' ' 78' ' ' LYS . 13.2 ptmm? -59.11 -53.82 54.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 123.609 0.568 . . . . 0.0 111.164 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 46.89 41.75 14.21 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.901 -0.666 . . . . 0.0 114.121 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.35 -111.13 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.034 1.974 . . . . 0.0 118.034 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.7 -53.79 7.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -112.38 3.29 16.87 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.971 0.891 . . . . 0.0 109.472 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.0 mt-10 -91.92 148.42 22.22 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -69.94 126.96 31.22 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.72 0.771 . . . . 0.0 109.706 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 m -85.26 83.14 8.08 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.829 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.84 -177.44 3.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.222 -178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.5 mtpt -125.73 -173.99 2.97 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.193 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -73.93 -9.14 58.33 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.187 2.195 . . . . 0.0 113.785 -170.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.28 18.65 2.48 Favored Glycine 1 C--N 1.245 -4.491 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.0 mm-40 -79.75 128.21 33.14 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.744 0.783 . . . . 0.0 111.556 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -89.26 96.95 10.93 Favored 'General case' 0 N--CA 1.404 -2.755 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.88 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.871 HD11 HG11 ' A' ' 82' ' ' VAL . 20.8 pt -113.72 157.96 14.23 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.916 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.946 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -131.88 141.58 49.43 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.933 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.28 147.62 7.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.699 -177.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 25' ' ' ILE . 3.6 mp -112.94 -57.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.42 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.926 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 41.9 ttm180 -92.73 125.55 37.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.777 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.38 100.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.054 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.118 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 45.0 mmtm -134.09 166.09 23.56 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.0 m0 -104.27 146.65 28.49 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.926 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -94.91 115.7 27.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -113.64 178.68 18.58 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.8 ptt180 -151.83 138.79 19.04 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.661 ' HA ' HG22 ' A' ' 52' ' ' ILE . 28.8 p -77.87 176.49 9.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.87 -18.12 62.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.927 0.87 . . . . 0.0 109.209 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -78.49 -15.32 58.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.611 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.54 19.44 41.25 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.434 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -98.34 114.18 26.4 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.561 ' HD2' HD11 ' A' ' 66' ' ' LEU . 27.9 m-85 -83.34 150.59 26.02 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.975 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.53 154.01 22.18 Favored Glycine 0 CA--C 1.5 -0.885 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.41 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.429 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 26.8 m-85 -73.85 143.22 45.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.655 0.741 . . . . 0.0 110.959 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.829 HG12 ' HE2' ' A' ' 46' ' ' PHE . 54.0 mt -128.71 136.59 59.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.089 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 88.3 mttt -70.2 140.23 52.46 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.4 p -65.3 -6.77 10.71 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -106.23 -12.22 15.79 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.386 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.46 -10.85 59.71 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.369 0.604 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 52' ' ' ILE . 27.0 m -134.63 153.51 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.396 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.514 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 15.3 mm-40 -96.19 100.53 12.16 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.512 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.8 mm -75.9 131.11 35.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.622 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 CA--C 1.48 -1.731 0 CA-C-O 122.627 1.203 . . . . 0.0 111.1 178.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 . . . . . 0 CA--C 1.508 -0.638 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.62 -26.5 40.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.806 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -71.04 -42.64 69.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.514 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.62 -7.88 59.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.076 0.465 . . . . 0.0 110.923 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -100.32 -49.34 4.29 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.095 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.1 m-85 -104.54 -12.1 16.65 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 59.97 79.53 0.23 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.999 0.904 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.44 -36.46 22.33 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.624 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 26.4 p 60.41 -47.55 0.1 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.418 2.287 . . . . 0.0 116.704 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.68 -168.83 11.39 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.74 141.55 49.93 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.529 2.153 . . . . 0.0 111.635 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.986 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.5 pp -118.37 160.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.526 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.501 ' O ' HG13 ' A' ' 27' ' ' VAL . 49.2 mt-30 -110.93 -93.71 0.44 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.189 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 170.92 149.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.608 2.363 . . . . 0.0 109.491 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 29' ' ' HIS . 48.6 mm -110.24 -42.39 5.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.0 m-70 -153.13 176.64 11.69 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.9 mp -105.62 137.37 43.58 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 171.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.84 168.79 9.39 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -151.04 103.25 3.03 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -58.75 132.18 53.11 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.087 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.6 t -115.75 151.32 35.36 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.1 m 68.73 178.46 0.25 Allowed 'General case' 0 N--CA 1.405 -2.709 0 O-C-N 125.67 1.856 . . . . 0.0 110.491 163.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.57 108.04 15.66 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.835 HG21 ' HE1' ' A' ' 46' ' ' PHE . 8.3 m -99.15 155.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.85 -49.91 74.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.178 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 43' ' ' GLU . . . 54.09 41.42 69.21 Favored Glycine 0 C--N 1.352 1.426 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.208 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.89 -102.33 0.01 OUTLIER Glycine 0 C--O 1.245 0.825 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -98.34 -53.72 3.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 34.7 p30 -95.38 0.43 53.5 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.142 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 29.7 mt-10 -90.66 151.26 21.34 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -67.06 146.93 53.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.77 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.419 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.6 m -83.71 70.84 10.4 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.835 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -112.32 -179.79 3.77 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.575 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.1 mtpt -136.3 -173.47 3.41 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.59 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -71.16 -12.39 61.46 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 128.545 2.738 . . . . 0.0 114.652 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.96 19.23 2.34 Favored Glycine 0 C--N 1.259 -3.728 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 6.8 mm-40 -78.68 127.46 32.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.787 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -97.8 96.33 8.15 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.876 HG22 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -107.67 158.32 7.6 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.152 0 CA-C-N 112.086 -2.325 . . . . 0.0 112.427 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.823 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.1 mt-10 -123.08 133.45 54.3 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 120.901 -1.125 . . . . 0.0 109.362 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -96.69 138.54 21.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.642 177.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.986 HG21 ' HB ' ' A' ' 25' ' ' ILE . 3.6 mp -111.63 -35.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.795 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.707 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.3 ttm180 -108.92 125.86 52.46 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.043 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.38 104.56 16.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.279 -2.464 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 CA-C-O 121.024 0.235 . . . . 0.0 113.15 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.552 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.5 mmtm -102.22 145.27 29.66 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -94.11 144.44 25.49 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.881 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -86.51 109.03 18.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -112.38 177.84 18.71 Favored Glycine 0 N--CA 1.419 -2.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.251 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 28.8 ptt180 -151.64 136.1 16.91 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.876 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.1 p -73.34 169.88 16.2 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 118.032 0.378 . . . . 0.0 110.55 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -6.94 52.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.501 0.667 . . . . 0.0 109.209 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.84 -25.02 17.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.541 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 31.8 2.09 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.388 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 m -113.13 116.69 30.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 66' ' ' LEU . 88.7 m-85 -82.93 147.35 28.3 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -164.11 157.07 29.25 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.062 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 1.1 m-30 -80.63 127.48 32.51 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.912 0.863 . . . . 0.0 109.222 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.834 HG12 ' HE2' ' A' ' 46' ' ' PHE . 86.8 mt -107.43 133.87 50.87 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.151 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.113 -175.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 48.7 mtmt -71.01 127.44 32.57 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 167.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.0 p -59.41 -18.29 37.76 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -92.08 -20.89 20.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.709 0.804 . . . . 0.0 109.864 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -75.85 -13.44 60.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 52' ' ' ILE . 34.8 m -127.57 154.55 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.41 101.98 12.7 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.6 mm -78.14 125.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.428 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 CA--C 1.481 -1.699 0 CA-C-O 122.588 1.185 . . . . 0.0 110.707 178.65 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.5 pp -60.3 -26.97 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.018 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.48 -21.41 45.42 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -97.95 -37.51 9.76 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.522 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.9 ttpt -65.53 -36.47 83.9 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.48 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.7 m-85 -110.46 8.43 23.12 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 56.45 38.82 30.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.933 0.873 . . . . 0.0 110.395 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 21' ' ' LEU . 7.1 tp -94.24 17.01 13.47 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.507 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -62.6 122.09 14.95 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.393 0.616 . . . . 0.0 109.371 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.97 162.01 11.05 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.62 134.3 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.364 2.042 . . . . 0.0 112.443 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.717 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -125.66 154.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.453 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.2 mm100 -110.14 -84.31 0.56 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.75 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -177.62 136.78 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 C-N-CA 127.363 2.265 . . . . 0.0 108.407 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG21 HG12 ' A' ' 57' ' ' ILE . 46.9 mm -98.05 -42.83 11.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 1.066 ' HB2' HD11 ' A' ' 54' ' ' ILE . 91.4 m-70 -150.74 168.84 23.19 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -104.62 124.85 50.07 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.81 168.89 8.84 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 15.1 ptpt -153.45 103.86 2.7 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.838 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.65 139.89 57.89 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.31 -177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 44.0 t -123.12 150.68 42.91 Favored 'General case' 0 CA--C 1.452 -2.797 0 CA-C-O 121.219 0.533 . . . . 0.0 110.36 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.4 m 68.81 -179.95 0.23 Allowed 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.016 163.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.51 103.2 15.66 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.909 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.0 m -93.84 155.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.227 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.62 -42.85 75.5 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.284 0.99 . . . . 0.0 110.851 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.0 43.9 31.88 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 115.201 0.841 . . . . 0.0 115.201 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.06 -175.64 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -47.32 -52.29 16.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.457 1.103 . . . . 0.0 113.741 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -88.78 -4.63 58.46 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.367 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.76 166.6 12.68 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.661 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -79.48 145.21 33.38 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.485 0.66 . . . . 0.0 109.375 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 m -85.86 41.95 0.94 Allowed 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.297 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.898 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -82.43 176.78 9.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.589 0.709 . . . . 0.0 112.3 -177.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 60.2 mtpt -132.74 -173.86 3.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.0 -173.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 30.6 tt0 -65.59 -15.8 63.08 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 127.121 2.168 . . . . 0.0 115.532 -169.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.47 19.25 2.81 Favored Glycine 0 C--N 1.26 -3.651 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 11.5 mm-40 -77.37 126.47 30.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -89.62 97.34 11.14 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 113.936 -1.484 . . . . 0.0 107.657 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.98 HD11 HG11 ' A' ' 82' ' ' VAL . 24.7 pt -110.4 158.54 10.66 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.343 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.652 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.59 139.38 52.31 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 121.286 -0.884 . . . . 0.0 108.825 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.066 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.61 135.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.889 0.852 . . . . 0.0 110.232 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.97 8.47 6.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.741 -177.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.762 ' HG2' HG23 ' A' ' 58' ' ' THR . 28.7 ttm180 -154.97 117.75 4.34 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.511 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.455 HG12 HG21 ' A' ' 28' ' ' ILE . 51.2 mm -93.28 96.85 6.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.278 -2.54 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.994 -175.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.3 mmtt -133.36 161.66 33.93 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.456 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.5 m0 -101.03 159.18 15.44 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -100.35 115.3 29.66 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.151 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.679 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.49 -178.48 16.52 Favored Glycine 0 N--CA 1.419 -2.473 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.88 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 37.0 ptt180 -151.83 144.42 24.23 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.686 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.8 p -78.85 175.21 10.71 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 118.598 0.635 . . . . 0.0 109.513 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.92 60.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.24 1.019 . . . . 0.0 109.477 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.15 -14.36 41.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.283 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 33.5 14.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.801 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 113.29 26.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 66.1 m-85 -82.89 147.6 28.19 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.776 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.28 154.28 23.56 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.43 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.505 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 27.8 m-85 -73.31 149.35 42.73 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.84 0.828 . . . . 0.0 111.08 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.898 HG12 ' HE2' ' A' ' 46' ' ' PHE . 59.9 mt -130.05 134.07 63.4 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.875 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 77' ' ' ILE . 47.9 mtmt -67.58 139.47 56.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 p -66.92 -12.06 58.26 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.84 0.828 . . . . 0.0 111.742 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' THR . 2.8 t -100.88 -18.04 16.56 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.565 1.146 . . . . 0.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -74.1 -13.89 60.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.758 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.98 HG11 HD11 ' A' ' 52' ' ' ILE . 28.2 m -135.76 161.68 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.83 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 31.1 mm-40 -110.21 113.54 26.3 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.2 mp -84.79 140.47 15.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 122.009 0.909 . . . . 0.0 112.156 -176.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.442 -0.826 0 CA-C-O 120.788 0.327 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.01 -30.46 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.718 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 96.8 mttt -73.75 -29.72 62.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.95 -40.31 16.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.48 -44.52 64.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.116 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -95.12 -5.16 44.8 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.798 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm 59.5 71.92 0.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.6 tp -107.3 16.65 23.76 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.502 -171.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -49.85 132.41 22.41 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.543 0.737 . . . . 0.0 112.418 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.76 -152.77 17.43 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.97 142.87 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 122.931 2.42 . . . . 0.0 112.84 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.75 109.61 28.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.182 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.26 141.6 39.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.681 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 14.8 m -67.55 152.91 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-O 121.258 0.551 . . . . 0.0 111.356 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 57' ' ' ILE . 21.0 mm -107.65 -31.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 1.051 ' HB2' HD11 ' A' ' 54' ' ' ILE . 47.8 m-70 -153.98 179.57 8.78 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -117.45 128.96 55.52 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.6 169.73 8.76 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.234 0.54 . . . . 0.0 110.599 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -153.7 111.48 3.53 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 174.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.48 138.97 58.44 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.88 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLN . 41.7 t -121.1 148.69 43.83 Favored 'General case' 0 CA--C 1.442 -3.178 0 CA-C-O 121.16 0.505 . . . . 0.0 110.081 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' N ' ' HA ' ' A' ' 48' ' ' GLN . 12.3 m 70.11 176.07 0.28 Allowed 'General case' 0 N--CA 1.401 -2.876 0 O-C-N 126.055 2.097 . . . . 0.0 111.537 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.6 114.37 20.25 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.01 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.831 HG21 ' CE1' ' A' ' 46' ' ' PHE . 13.1 m -115.57 156.48 16.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.671 -174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -47.31 -61.63 1.81 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.339 1.025 . . . . 0.0 109.328 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.11 43.67 83.48 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.449 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.79 -171.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 27.2 mtpp -54.01 -46.07 71.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -174.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.594 HD22 ' HD2' ' A' ' 76' ' ' TYR . 4.0 p-10 -94.46 -4.87 47.46 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.801 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.77 168.28 10.92 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -83.2 126.66 32.87 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -85.84 45.89 1.26 Allowed 'General case' 0 C--N 1.256 -3.46 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.974 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.942 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -75.75 179.26 5.55 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.867 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 54.8 mtpt -122.25 -172.61 2.49 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.233 -174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 39.1 tt0 -69.17 -17.71 63.84 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 126.482 1.913 . . . . 0.0 115.45 -166.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.63 19.2 2.03 Favored Glycine 1 C--N 1.249 -4.261 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.842 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.2 mm-40 -70.36 132.82 46.23 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.12 97.33 11.08 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 123.211 1.482 . . . . 0.0 108.616 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.809 HD11 HG11 ' A' ' 82' ' ' VAL . 18.9 pt -110.83 159.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.726 0 CA-C-N 111.363 -2.653 . . . . 0.0 112.367 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.8 130.02 31.27 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.619 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -91.72 130.04 41.48 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.405 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -113.78 6.44 7.8 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.535 -175.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 37.3 ttm180 -154.29 119.5 5.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.027 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 28' ' ' ILE . 41.7 mm -87.78 111.26 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 170.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.3 p . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.45 0.643 . . . . 0.0 112.618 -171.491 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.073 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.568 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 30.5 mmtp -110.29 142.43 41.92 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.424 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 34.9 m0 -83.93 152.42 24.51 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 123.623 0.577 . . . . 0.0 110.927 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.8 tm? -93.58 107.77 19.58 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.284 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -111.9 174.26 16.3 Favored Glycine 0 N--CA 1.414 -2.814 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.669 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.537 ' HG2' HD12 ' A' ' 55' ' ' ILE . 13.4 ptm180 -151.69 146.36 25.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 52' ' ' ILE . 71.3 p -82.0 169.66 16.48 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.8 31.02 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.234 0.54 . . . . 0.0 110.536 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.87 4.31 47.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.331 0.586 . . . . 0.0 109.852 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.84 17.75 59.24 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.526 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -98.73 109.26 22.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 25.8 m-85 -87.87 146.37 25.61 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.197 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.06 158.21 30.65 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.813 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.594 ' HD2' HD22 ' A' ' 42' ' ' ASN . 27.2 m-85 -74.28 135.35 42.62 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.699 0.761 . . . . 0.0 110.976 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.942 HG12 ' HE2' ' A' ' 46' ' ' PHE . 87.5 mt -114.83 124.44 71.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.338 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.07 128.53 36.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.0 p -60.9 -11.87 9.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.394 0.616 . . . . 0.0 112.656 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 80' ' ' THR . 4.4 t -92.39 -19.83 21.67 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.674 0.79 . . . . 0.0 110.329 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -79.43 -10.6 59.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.972 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.849 HG12 ' HA ' ' A' ' 33' ' ' ALA . 31.6 m -133.29 160.77 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.298 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -102.21 103.93 14.47 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 31' ' ' ALA . 30.0 mm -84.35 121.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.949 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 63.0 m-20 . . . . . 0 C--N 1.309 -1.168 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 N--CA 1.434 -1.251 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -26.56 39.25 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.801 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 87.9 mttt -74.03 -22.57 59.52 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.434 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.54 -39.59 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -65.93 -51.03 62.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.004 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -98.87 3.01 47.17 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.92 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm 51.67 76.21 0.18 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.397 1.094 . . . . 0.0 109.912 -173.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.5 tp -127.51 15.93 7.07 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.783 -173.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -57.62 128.66 38.2 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.251 0.548 . . . . 0.0 110.75 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.07 166.97 12.78 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 111.71 3.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.293 1.995 . . . . 0.0 110.651 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.853 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 pp -98.57 142.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -116.21 142.63 46.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.152 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.8 p -71.08 144.65 13.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' CD2' ' A' ' 29' ' ' HIS . 51.2 mm -103.76 -36.03 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.191 0.52 . . . . 0.0 110.757 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.811 ' HB2' HD11 ' A' ' 54' ' ' ILE . 75.1 m-70 -147.94 152.58 37.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.5 mp -92.06 119.71 32.01 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.41 174.88 5.68 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.541 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.35 112.66 3.8 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.69 137.34 56.61 Favored 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.567 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.2 t -127.47 154.22 45.36 Favored 'General case' 0 CA--C 1.444 -3.133 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.777 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.3 m 71.15 175.11 0.29 Allowed 'General case' 0 N--CA 1.4 -2.965 0 O-C-N 125.748 1.905 . . . . 0.0 111.275 163.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.27 110.21 14.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.761 HG21 ' CE1' ' A' ' 46' ' ' PHE . 14.0 m -108.44 155.27 9.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.613 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -56.68 -46.41 81.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.83 43.0 87.15 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.788 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.77 -178.81 0.31 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -29.73 38.13 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -106.76 -6.12 18.0 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.328 0.585 . . . . 0.0 109.945 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.78 164.34 12.79 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.523 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.664 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.8 140.13 38.27 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 t -88.0 43.91 1.15 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.949 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -80.16 -178.98 6.82 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.372 -178.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.9 mtpt -130.53 178.87 6.29 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.069 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 3.7 tt0 -65.2 -12.77 54.77 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 128.236 2.614 . . . . 0.0 114.241 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.39 18.65 3.45 Favored Glycine 0 C--N 1.266 -3.333 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.1 mm-40 -85.22 127.42 34.29 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 112.679 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 97.22 10.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 82' ' ' VAL . 27.6 pt -109.56 157.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.914 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.201 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.892 ' HB3' HG21 ' A' ' 27' ' ' VAL . 43.5 mt-10 -123.71 135.53 53.92 Favored 'General case' 0 C--N 1.281 -2.393 0 O-C-N 121.265 -0.897 . . . . 0.0 109.099 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.25 137.03 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.011 -179.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.853 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.7 mp -104.13 -49.09 9.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.203 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.863 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 40.6 ttm180 -97.56 113.89 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.661 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG23 ' CE2' ' A' ' 65' ' ' TRP . 43.1 mm -95.57 98.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--N 1.315 -0.92 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.42 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.677 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.4 mmtt -134.28 167.78 20.08 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 42.8 m0 -104.18 140.36 37.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.768 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.4 tm? -87.2 111.93 21.48 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -109.24 -179.64 21.19 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.14 138.88 19.77 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.755 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.9 p -77.98 171.8 14.46 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -0.18 19.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.603 0.716 . . . . 0.0 109.979 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 71' ' ' ARG . 1.8 mmp_? -101.11 -14.56 17.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.815 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.8 21.38 9.72 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.112 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -103.12 113.66 27.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 117.324 0.562 . . . . 0.0 109.787 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB3' HD21 ' A' ' 66' ' ' LEU . 47.5 m-85 -86.96 144.79 26.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.854 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -167.73 153.32 22.56 Favored Glycine 0 C--N 1.301 -1.396 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.935 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.531 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 41.4 m-85 -73.04 155.13 40.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.393 0.616 . . . . 0.0 111.324 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.949 HG12 ' HE2' ' A' ' 46' ' ' PHE . 53.1 mt -137.87 136.39 45.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 44.0 mtmt -69.16 141.72 54.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 168.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -69.49 -6.82 33.06 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 119.271 0.941 . . . . 0.0 112.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.3 t -96.18 -22.11 17.48 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.069 0.948 . . . . 0.0 109.71 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -73.21 -15.48 61.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -130.69 152.33 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 121.17 0.51 . . . . 0.0 112.13 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -92.65 100.68 13.14 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 82' ' ' VAL . 27.8 mm -92.22 125.02 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.75 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 . . . . . 0 C--N 1.297 -1.711 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.941 174.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.448 -0.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.542 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.8 pp -55.87 -28.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.314 1.046 . . . . 0.0 111.916 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' HD12 ' A' ' 15' ' ' ILE . 95.9 mttt -72.5 -22.4 61.05 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.97 -45.17 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -59.42 -47.3 85.99 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.149 1.38 . . . . 0.0 111.729 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.45 0.3 19.26 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 33.2 mmtp 56.54 75.24 0.36 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.54 1.162 . . . . 0.0 111.593 -173.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 74' ' ' TYR . 78.8 mt -125.98 16.71 7.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.867 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -72.62 102.46 3.29 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.392 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.63 -155.19 26.37 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -93.32 121.09 0.41 Allowed 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 123.113 2.542 . . . . 0.0 111.65 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -111.79 142.16 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.569 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' C ' HG22 ' A' ' 55' ' ' ILE . 54.3 mt-30 -132.47 138.38 47.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 53' ' ' GLU . 14.0 m -59.94 134.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.346 0.593 . . . . 0.0 111.953 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.87 -34.7 5.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.1 m-70 -155.1 173.59 16.38 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.8 139.88 48.05 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.58 172.01 7.18 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.163 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -152.71 102.64 2.72 Favored 'General case' 0 C--N 1.264 -3.145 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -69.11 137.36 53.39 Favored 'General case' 0 C--N 1.268 -2.978 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.792 -175.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.0 t -124.78 150.08 46.68 Favored 'General case' 0 CA--C 1.436 -3.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.268 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.3 m 72.74 164.7 0.29 Allowed 'General case' 0 N--CA 1.4 -2.958 0 O-C-N 126.234 2.209 . . . . 0.0 111.15 163.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.64 106.76 1.9 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.775 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.9 m -98.81 157.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.445 -173.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -42.52 -65.89 0.42 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 125.001 1.438 . . . . 0.0 110.331 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.08 43.53 90.18 Favored Glycine 0 C--N 1.321 -0.259 0 C-N-CA 119.85 -1.167 . . . . 0.0 114.264 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -57.46 -173.01 0.27 Allowed Glycine 0 CA--C 1.552 2.405 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -64.62 -37.92 89.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -102.2 1.96 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.649 0.737 . . . . 0.0 109.937 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 47.2 mt-10 -92.53 163.26 13.88 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.714 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.73 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -84.73 127.31 34.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -89.93 73.75 7.38 Favored 'General case' 0 C--N 1.253 -3.625 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.791 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -97.73 -176.76 3.56 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.546 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.596 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 47.7 mtpt -131.44 -173.18 3.04 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.822 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' CB ' ' H ' ' A' ' 35' ' ' CYS . 60.5 tt0 -88.06 114.74 24.98 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 125.089 1.356 . . . . 0.0 107.651 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.89 -1.77 51.96 Favored Glycine 0 C--N 1.29 -2.025 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 12.7 mm-40 -72.32 125.18 26.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.548 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.95 96.2 9.96 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-O 123.316 1.532 . . . . 0.0 108.154 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 HG11 ' A' ' 82' ' ' VAL . 23.5 pt -106.59 158.61 6.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.912 -2.404 . . . . 0.0 111.004 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG12 ' A' ' 27' ' ' VAL . 4.8 pt-20 -134.67 130.22 36.01 Favored 'General case' 0 C--N 1.249 -3.785 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.623 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -93.69 136.2 26.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 CA-C-O 122.196 0.998 . . . . 0.0 112.158 -178.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.477 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -118.47 7.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.697 -177.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.892 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.7 ttm180 -149.44 123.84 9.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.182 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.421 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 51.0 mm -109.35 99.71 9.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.752 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.432 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.561 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 46.7 mmtm -133.74 161.01 35.85 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.478 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.1 m0 -102.7 161.05 14.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -106.3 115.42 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.961 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.44 179.39 17.7 Favored Glycine 0 N--CA 1.416 -2.668 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.972 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 31.3 ptt180 -152.22 144.4 23.9 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.5 p -74.55 169.89 16.85 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.06 64.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.628 0.728 . . . . 0.0 109.196 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -78.26 -23.86 47.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.653 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.36 26.96 6.68 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.303 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -108.83 111.74 23.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 1.9 m-85 -87.11 148.09 25.37 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.716 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.84 154.19 22.32 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.008 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.445 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 34.6 m-85 -70.44 142.58 51.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.763 0.792 . . . . 0.0 111.626 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.791 HG12 ' HE2' ' A' ' 46' ' ' PHE . 67.2 mt -125.39 136.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.415 -173.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 77' ' ' ILE . 89.5 mttt -72.82 135.98 45.31 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 166.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.8 p -65.23 -10.47 32.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.619 0.723 . . . . 0.0 112.031 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -98.7 -17.66 18.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.209 1.004 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.68 -12.77 60.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.584 0.707 . . . . 0.0 109.224 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.943 HG11 HD11 ' A' ' 52' ' ' ILE . 34.9 m -134.97 155.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.511 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -98.87 100.53 11.73 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.1 mm -79.72 128.46 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--N 1.31 -1.132 0 CA-C-O 121.993 0.901 . . . . 0.0 110.655 178.449 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 . . . . . 0 CA--C 1.496 -1.124 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.0 pp -60.71 -29.34 44.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 98.2 mttt -80.69 -25.67 38.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.878 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -90.5 -42.67 10.71 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.381 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -69.82 -52.73 22.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.433 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.23 -0.46 53.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 54.08 73.41 0.39 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.947 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HG ' HG21 ' A' ' 25' ' ' ILE . 4.5 tp -127.03 16.61 7.3 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.351 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 16' ' ' LYS . 10.3 t -77.39 126.06 30.32 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 119.184 -1.007 . . . . 0.0 110.433 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.76 -155.72 16.2 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.74 137.11 34.75 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.395 2.73 . . . . 0.0 110.486 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.878 ' HB ' HG21 ' A' ' 55' ' ' ILE . 17.0 pt -127.07 -70.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.859 ' H ' HG13 ' A' ' 25' ' ' ILE . 30.4 mt-30 70.39 131.37 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.14 1.776 . . . . 0.0 113.638 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 88.3 t -76.26 136.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.871 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG22 ' CD2' ' A' ' 29' ' ' HIS . 47.9 mm -99.83 -43.63 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.976 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.93 ' HB2' HD11 ' A' ' 54' ' ' ILE . 65.2 m-70 -140.24 173.88 11.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.86 124.77 51.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.05 172.49 6.77 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.519 0.676 . . . . 0.0 110.302 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 4.4 ttmp? -151.88 106.46 3.22 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.876 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.44 120.57 13.58 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.24 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 42.2 t -93.32 155.8 17.19 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.2 m 62.5 -174.11 0.15 Allowed 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 125.6 1.812 . . . . 0.0 111.127 163.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -91.21 118.27 30.33 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 166.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.904 HG21 ' HE1' ' A' ' 46' ' ' PHE . 20.9 m -97.41 156.89 3.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.614 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -51.43 -47.81 62.9 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.232 0.957 . . . . 0.0 108.703 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.36 95.68 Favored Glycine 0 N--CA 1.438 -1.201 0 O-C-N 124.157 0.911 . . . . 0.0 113.388 173.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.23 178.59 0.13 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.466 0.946 . . . . 0.0 115.466 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.41 -43.56 44.54 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.843 1.257 . . . . 0.0 113.304 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -94.19 -1.58 53.89 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.573 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.4 167.09 12.21 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.164 0.507 . . . . 0.0 110.961 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -79.75 141.95 35.86 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.103 -177.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.0 p -87.44 84.73 7.13 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.076 175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.904 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.15 176.89 6.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.631 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 57.6 mtpt -128.44 -172.81 2.79 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.748 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.5 tt0 -83.2 110.25 17.9 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 125.099 1.359 . . . . 0.0 109.945 -175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.76 17.4 48.57 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.5 mm-40 -76.33 130.39 38.03 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.626 0.727 . . . . 0.0 110.99 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.98 96.9 10.43 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.521 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 82' ' ' VAL . 28.7 pt -113.57 157.74 14.16 Favored 'Isoleucine or valine' 1 C--N 1.235 -4.41 0 CA-C-N 111.834 -2.439 . . . . 0.0 111.053 174.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.19 136.94 53.44 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.58 138.7 23.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.806 178.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.878 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.2 -47.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.569 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 57.0 ttt180 -110.17 121.79 46.1 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.325 -172.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.41 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mm -97.72 95.89 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.304 -1.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 175.324 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.123 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 45.8 mmtm -121.61 144.33 48.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 35.3 m0 -93.75 162.22 14.01 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.851 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -102.59 117.33 34.44 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.56 176.79 16.3 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.65 142.57 23.0 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 124.536 1.134 . . . . 0.0 108.814 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' ILE . 31.1 p -77.89 168.36 20.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.37 66.42 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.674 0.273 . . . . 0.0 110.633 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -78.8 -27.04 44.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.8 25.81 3.81 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.14 -1.029 . . . . 0.0 114.188 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.1 m -100.03 113.25 25.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB2' HG21 ' A' ' 15' ' ' ILE . 7.0 m-85 -91.93 144.04 25.88 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.533 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 159.64 32.81 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.191 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.621 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 24.2 m-85 -72.0 151.0 43.52 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.15 0.5 . . . . 0.0 110.119 174.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HE2' ' A' ' 46' ' ' PHE . 60.2 mt -135.18 130.9 51.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.871 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.2 mtmt -64.48 136.74 57.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -67.53 -13.05 61.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.859 0.838 . . . . 0.0 111.936 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 78' ' ' LYS . 11.8 t -96.14 -14.15 23.04 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.287 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.53 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.27 -20.27 55.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.876 HG12 ' HA ' ' A' ' 33' ' ' ALA . 34.3 m -128.96 149.64 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 121.361 0.601 . . . . 0.0 112.369 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.5 pt-20 -96.97 102.37 14.14 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.447 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -81.72 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.672 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--N 1.317 -0.84 0 CA-C-O 121.174 0.511 . . . . 0.0 110.303 -178.611 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 119.858 -0.115 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.33 -29.53 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.427 0.691 . . . . 0.0 112.65 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.76 -22.32 58.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.048 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -97.07 -42.83 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.911 0.862 . . . . 0.0 108.744 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -62.65 -50.13 72.41 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.809 1.644 . . . . 0.0 110.732 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -102.05 -2.09 30.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.156 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 58.48 76.42 0.34 Allowed 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 124.096 0.872 . . . . 0.0 108.839 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.62 16.36 9.56 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.865 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -82.46 114.4 20.87 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.889 0.852 . . . . 0.0 110.028 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.96 -170.41 24.55 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.14 117.72 4.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.601 2.2 . . . . 0.0 111.928 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.707 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.9 pp -132.3 139.32 50.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -131.4 140.29 49.63 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.776 0.431 . . . . 0.0 110.448 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.0 p -63.4 141.19 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 O-C-N 123.603 0.565 . . . . 0.0 111.138 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 HG12 ' A' ' 57' ' ' ILE . 54.6 mt -103.6 -33.08 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.157 0.503 . . . . 0.0 111.937 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.809 ' HB2' HD11 ' A' ' 54' ' ' ILE . 67.8 m-70 -154.95 167.5 30.11 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.589 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.0 mp -106.69 137.64 44.34 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -111.42 171.92 7.2 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.257 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 20.4 ptmt -151.17 106.66 3.36 Favored 'General case' 0 N--CA 1.397 -3.09 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -62.86 109.55 1.48 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.461 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.5 t -96.26 150.73 20.22 Favored 'General case' 0 CA--C 1.426 -3.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.573 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.5 m 66.45 -175.84 0.19 Allowed 'General case' 0 N--CA 1.399 -3.005 0 O-C-N 126.078 2.111 . . . . 0.0 109.385 165.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.81 120.63 18.7 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 ' CE1' ' A' ' 46' ' ' PHE . 4.3 m -98.99 154.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -59.38 -69.14 0.22 Allowed 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.813 0.696 . . . . 0.0 109.29 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.98 42.6 84.93 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.242 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.27 -116.51 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -99.61 -52.97 3.32 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.651 -0.911 . . . . 0.0 112.474 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -90.64 2.84 55.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.378 0.609 . . . . 0.0 110.555 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 38.3 mt-10 -90.25 159.16 16.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.145 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.578 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -64.8 149.09 50.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 124.05 0.844 . . . . 0.0 110.207 -176.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.8 m -88.81 80.14 7.25 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.665 ' HD2' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -134.79 167.61 20.56 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.46 -177.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.9 mmtp -143.67 -172.8 3.8 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.736 0.779 . . . . 0.0 111.263 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 49.7 tt0 -67.93 120.7 14.64 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 126.492 1.917 . . . . 0.0 109.346 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.17 4.57 68.6 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.034 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 48.5 mm-40 -76.12 126.77 31.62 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.936 0.874 . . . . 0.0 111.355 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -96.12 96.94 9.18 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 69' ' ' THR . 33.1 pt -107.75 159.7 7.18 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.105 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.164 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.803 ' HB3' HG21 ' A' ' 27' ' ' VAL . 50.4 mt-10 -121.29 139.73 53.01 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.259 0.2 OUTLIER -105.06 132.17 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.94 175.462 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.707 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.9 mp -105.42 -34.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.562 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.88 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.8 ttm180 -114.5 119.51 37.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.751 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.675 HG12 HD12 ' A' ' 28' ' ' ILE . 44.0 mm -101.71 98.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.347 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.4 mmtm -133.49 160.54 37.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 40.5 m0 -101.57 141.87 33.79 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.546 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -88.75 113.64 24.53 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.669 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -115.58 178.32 17.6 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.843 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' SER . 20.7 ptt180 -151.57 135.74 16.7 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 124.261 1.025 . . . . 0.0 108.396 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.878 ' HA ' HG22 ' A' ' 52' ' ' ILE . 10.8 p -72.67 169.17 17.18 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -17.65 62.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.44 -26.52 60.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.99 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.92 12.31 20.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.727 -0.749 . . . . 0.0 114.688 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 21.3 m -91.08 118.93 30.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 118.178 0.989 . . . . 0.0 108.977 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 61.4 m-85 -84.06 144.11 29.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.223 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.4 156.64 28.67 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.541 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 10.3 m-85 -76.72 134.79 39.1 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.67 0.748 . . . . 0.0 110.018 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.669 HD11 ' HA3' ' A' ' 67' ' ' GLY . 71.6 mt -114.94 138.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.685 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.5 mttt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 168.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.6 p -64.62 -18.26 64.76 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.762 0.791 . . . . 0.0 111.751 -171.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 -19.63 27.19 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.18 -17.84 59.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -129.19 151.81 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -98.27 105.78 17.98 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -83.55 123.69 38.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.682 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.258 1.539 0 CA-C-O 122.594 1.187 . . . . 0.0 111.806 -179.163 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.54 0.21 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.13 -26.24 39.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 97.1 mttt -75.27 -18.6 60.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.041 0.448 . . . . 0.0 111.292 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -96.9 -41.13 8.57 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -68.07 -46.89 69.82 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.683 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 57.1 m-85 -108.01 -3.09 19.08 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.389 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 72.9 mmtt 56.69 69.99 0.69 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.068 0.855 . . . . 0.0 110.369 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.66 16.93 15.4 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.392 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -51.99 117.83 3.03 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.801 0.84 . . . . 0.0 112.791 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.1 179.31 15.91 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.557 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 121.71 6.52 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.364 2.709 . . . . 0.0 110.488 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -120.44 163.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.966 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -126.07 155.49 41.48 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.842 0.829 . . . . 0.0 111.194 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 53' ' ' GLU . 59.8 t -90.43 107.96 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.272 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.408 HD12 HG12 ' A' ' 57' ' ' ILE . 49.9 mt -77.63 -37.56 24.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.871 ' HB2' HD11 ' A' ' 54' ' ' ILE . 69.5 m-70 -150.57 168.47 24.16 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 121.04 0.448 . . . . 0.0 110.416 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 3.8 mm? -101.88 119.73 39.26 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.91 164.04 11.96 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -152.46 107.28 3.21 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -60.44 126.27 26.82 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 p -103.1 -11.0 18.4 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -167.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.82 175.02 14.12 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.0 -157.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.36 107.83 5.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.826 HG21 ' HE1' ' A' ' 46' ' ' PHE . 14.7 m -103.96 156.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.691 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -57.91 -48.93 78.45 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.8 42.97 60.15 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.605 1.19 . . . . 0.0 113.634 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.38 -170.44 0.25 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -52.03 -38.81 58.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -100.57 -0.22 38.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.685 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.49 167.23 11.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.98 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -76.08 139.51 41.41 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.933 0.873 . . . . 0.0 111.634 -176.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -82.84 76.03 9.71 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.912 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.826 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.05 -178.99 4.37 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.442 179.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 28.6 mtpp -139.52 -173.09 3.52 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 123.648 0.593 . . . . 0.0 110.041 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -67.87 -13.14 61.91 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 126.464 1.906 . . . . 0.0 115.619 -168.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.5 15.0 4.73 Favored Glycine 0 C--N 1.254 -3.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.459 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 21.0 mm-40 -72.65 123.32 23.0 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 122.282 1.039 . . . . 0.0 112.892 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -93.66 96.17 9.65 Favored 'General case' 0 N--CA 1.397 -3.077 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.866 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -105.11 159.18 5.59 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.08 0 CA-C-N 111.653 -2.521 . . . . 0.0 112.685 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HG2' ' CD1' ' A' ' 30' ' ' LEU . 35.3 mt-10 -124.63 132.04 53.44 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.277 0.2 OUTLIER -100.47 143.81 13.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 117.503 -1.679 . . . . 0.0 112.284 178.147 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.739 HG12 HD13 ' A' ' 25' ' ' ILE . 2.9 mp -111.6 -21.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.613 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.84 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.2 ttm180 -127.73 121.36 30.09 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.813 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG12 HD12 ' A' ' 28' ' ' ILE . 39.1 mm -112.51 102.91 14.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 103.842 -2.651 . . . . 0.0 103.842 173.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.286 -2.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.614 -170.752 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.856 0 CA-C-O 120.098 -0.279 . . . . 0.0 113.258 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 71.3 mmtt -135.31 -177.91 4.87 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.876 0.846 . . . . 0.0 112.372 -174.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 20.1 m0 -120.66 162.27 19.97 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 106.638 166.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.84 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -105.9 120.7 42.42 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.131 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -124.05 -176.32 14.66 Favored Glycine 0 N--CA 1.422 -2.249 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.206 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 33.5 ptt180 -151.23 146.1 25.84 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.8 p -85.17 166.78 16.3 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.54 25.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -91.42 -19.88 22.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.749 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.82 36.9 3.33 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.526 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -128.61 137.53 51.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 29.9 m-85 -106.19 152.14 23.85 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.551 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -169.8 152.6 19.82 Favored Glycine 0 CA--C 1.478 -2.251 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.067 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.521 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 9.3 m-85 -74.53 152.8 39.29 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HE2' ' A' ' 46' ' ' PHE . 40.7 mt -136.67 134.71 48.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 77' ' ' ILE . 94.3 mttt -70.7 142.67 51.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -65.34 -12.46 52.17 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.757 0.789 . . . . 0.0 112.738 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.2 t -94.86 -15.04 24.02 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -78.9 -19.76 51.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -134.1 163.95 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.316 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.27 106.82 14.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.659 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.4 mp -85.02 127.71 39.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.986 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-O 121.368 0.604 . . . . 0.0 109.997 175.323 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 CA--C 1.506 -0.718 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -81.73 69.34 8.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.16 0.981 . . . . 0.0 110.42 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.56 86.04 2.88 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.68 -63.38 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -107.0 141.67 37.84 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -111.78 -43.22 3.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 58.05 87.17 0.07 Allowed 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.146 1.378 . . . . 0.0 110.914 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -96.51 -59.94 1.72 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -114.55 -153.6 0.53 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -174.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.11 6.32 28.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.23 -42.95 22.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.905 -172.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -65.62 -23.54 66.84 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.97 -49.47 77.33 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.74 -46.38 66.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.192 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.1 pp -60.62 -25.82 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.162 0.506 . . . . 0.0 112.143 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 94.9 mttt -72.46 -24.49 61.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.291 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -97.78 -46.73 5.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.073 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 87.7 tttt -66.52 -53.42 35.14 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.87 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 18' ' ' LYS . 80.0 m-85 -98.46 -8.86 26.02 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.44 0.638 . . . . 0.0 109.375 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.6 ttmt 60.84 75.48 0.41 Allowed 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.161 1.384 . . . . 0.0 112.534 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 25' ' ' ILE . 8.3 mp -117.58 17.01 14.56 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.256 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -56.21 104.94 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.395 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.55 -160.17 20.07 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.35 117.68 0.64 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.209 2.606 . . . . 0.0 112.583 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.773 HD13 HG12 ' A' ' 55' ' ' ILE . 2.6 pp -117.01 143.82 26.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 120.666 0.27 . . . . 0.0 111.616 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -120.17 155.22 33.54 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -73.82 137.59 22.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 121.484 0.659 . . . . 0.0 112.19 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.505 HG22 ' CD2' ' A' ' 29' ' ' HIS . 46.4 mm -91.46 -41.35 13.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 1.02 ' HB2' HD11 ' A' ' 54' ' ' ILE . 73.7 m-70 -152.84 177.86 10.28 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.567 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 3.4 mm? -116.12 117.41 29.99 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.62 168.24 9.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.17 107.77 3.5 Favored 'General case' 0 C--N 1.255 -3.526 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 176.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.837 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.03 132.69 51.33 Favored 'General case' 0 C--N 1.264 -3.147 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.511 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.8 t -116.73 148.14 41.38 Favored 'General case' 0 CA--C 1.44 -3.257 0 CA-C-O 121.389 0.614 . . . . 0.0 110.658 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.3 m 70.29 178.56 0.25 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.273 163.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.13 112.78 15.43 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.834 HG21 ' CE1' ' A' ' 46' ' ' PHE . 9.3 m -110.4 156.79 11.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.682 -174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HG2' ' OE1' ' A' ' 43' ' ' GLU . 17.2 ttmm -49.44 -66.46 0.39 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.926 0.766 . . . . 0.0 110.843 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.11 42.75 98.64 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 120.403 -0.903 . . . . 0.0 114.148 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.16 -158.6 0.83 Allowed Glycine 0 CA--C 1.54 1.595 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -65.09 -31.38 72.56 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 29.3 p-10 -93.08 -17.83 23.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.376 -0.529 . . . . 0.0 109.897 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' OE1' ' HG2' ' A' ' 38' ' ' LYS . 42.9 mt-10 -92.64 170.55 9.64 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.426 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -83.56 138.8 33.23 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -86.01 59.04 5.4 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-O 121.999 0.904 . . . . 0.0 109.004 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.866 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -95.82 -174.89 3.26 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.587 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 56.3 mtpt -143.86 -173.1 3.89 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.565 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -79.22 114.99 18.6 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 126.17 1.788 . . . . 0.0 108.95 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.91 10.44 57.58 Favored Glycine 0 C--N 1.289 -2.036 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 10.1 mm-40 -79.32 123.9 27.9 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-O 122.0 0.905 . . . . 0.0 111.208 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -87.23 97.08 10.57 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.171 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.822 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -109.94 159.39 9.62 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.256 0 CA-C-N 111.554 -2.567 . . . . 0.0 112.207 176.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.87 140.2 53.14 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.02 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -104.98 127.3 59.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.086 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.219 175.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -101.65 -21.51 5.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.335 -173.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.5 ttm180 -136.15 126.42 26.5 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.472 -1.291 . . . . 0.0 112.561 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -93.79 98.45 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -90.05 141.91 28.22 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.779 -176.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -114.14 8.29 16.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.08 143.82 98.05 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.179 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -38.5 -26.81 0.1 Allowed 'Trans proline' 0 C--N 1.376 1.999 1 C-N-CA 126.533 4.822 . . . . 0.0 116.97 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 30.4 mm-40 -57.5 -31.57 66.16 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.74 28.09 73.37 Favored Glycine 0 CA--C 1.5 -0.881 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 44.0 mmtm -131.37 157.4 43.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.2 m0 -99.72 162.5 12.97 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 123.731 0.644 . . . . 0.0 110.494 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -99.7 114.39 27.47 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.774 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.688 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.85 175.55 16.07 Favored Glycine 0 N--CA 1.423 -2.175 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.2 ptt180 -151.69 141.09 21.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 52' ' ' ILE . 16.9 p -81.26 164.07 22.52 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.59 -8.28 53.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.409 1.1 . . . . 0.0 109.237 173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -87.02 -4.64 59.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.339 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.44 32.29 19.79 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 121.237 -0.506 . . . . 0.0 113.858 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 9.1 m -118.11 124.08 47.16 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.651 ' HB2' HG21 ' A' ' 15' ' ' ILE . 8.0 m-85 -101.6 140.31 36.06 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.39 162.8 36.11 Favored Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 119.157 -1.497 . . . . 0.0 113.218 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.565 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 28.3 m-85 -71.87 149.43 45.19 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.203 0.525 . . . . 0.0 110.107 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 46' ' ' PHE . 74.7 mt -131.99 129.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.605 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG2' ' HE3' ' A' ' 64' ' ' LYS . 98.8 mttt -66.58 136.97 56.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 166.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -69.12 -8.75 48.35 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 122.337 1.065 . . . . 0.0 111.447 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.3 t -97.31 -16.18 20.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.652 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.41 59.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 33' ' ' ALA . 33.9 m -133.16 159.78 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 CA-C-O 121.365 0.602 . . . . 0.0 112.273 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 34.1 mt-10 -97.5 102.24 13.95 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 82' ' ' VAL . 29.2 mm -88.36 120.36 37.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.684 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -123.55 154.51 39.13 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.352 0.596 . . . . 0.0 111.22 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.518 ' HA ' HD23 ' A' ' 89' ' ' LEU . 82.9 t80 -98.06 -26.53 14.58 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.88 -49.97 61.93 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.225 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.58 ' HA ' HD23 ' A' ' 91' ' ' LEU . 15.7 m -60.57 -10.09 4.66 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 29' ' ' HIS . 4.1 mm? -77.19 -28.63 54.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.426 0.631 . . . . 0.0 109.518 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.671 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 0.2 OUTLIER -108.43 -34.84 6.66 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.466 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 88' ' ' SER . 96.3 mt 64.72 84.56 0.15 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 124.548 1.139 . . . . 0.0 108.26 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.44 23.66 11.63 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.438 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -68.84 -50.57 48.87 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.479 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -81.49 -57.02 3.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt 57.55 72.75 0.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.281 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.414 -178.204 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.577 0.227 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -124.52 -83.47 0.64 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.687 -0.633 . . . . 0.0 110.812 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.07 81.33 1.91 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -132.69 -36.57 1.07 Allowed 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.507 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 65.08 21.53 12.23 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.528 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -114.24 105.83 13.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.12 110.38 1.36 Allowed 'General case' 0 C--O 1.247 0.956 0 CA-C-O 121.655 0.74 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -69.74 -27.95 65.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.192 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -91.8 4.44 52.84 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.896 0.855 . . . . 0.0 110.157 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -105.97 -4.91 20.03 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -50.49 62.53 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.287 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.979 ' HA ' HG13 ' A' ' 15' ' ' ILE 0.341 0.0 OUTLIER -78.35 -8.13 58.09 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.574 -176.816 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.34 -38.14 50.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.87 -57.2 4.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.065 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.979 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.3 pp -61.08 -25.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 15.4 ttmm -76.5 -32.17 58.15 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.616 0.722 . . . . 0.0 109.525 -172.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -97.03 -39.95 9.09 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.407 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.6 ttpt -66.09 -43.68 86.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.817 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 26.9 m-85 -97.68 3.17 50.32 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.533 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 53.92 74.44 0.33 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.977 0.894 . . . . 0.0 109.841 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' NH2' ' A' ' 56' ' ' ARG . 6.8 tp -107.75 13.48 26.43 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.485 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.33 109.78 0.66 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.49 0.662 . . . . 0.0 111.858 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.72 171.89 12.35 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.93 110.4 1.09 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.449 2.1 . . . . 0.0 111.673 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -89.29 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -126.91 139.21 53.23 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.58 0.705 . . . . 0.0 110.723 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 53' ' ' GLU . 41.4 t -68.76 116.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.701 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.675 HG22 ' HD2' ' A' ' 29' ' ' HIS . 46.4 mm -84.46 -44.8 17.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.343 0.592 . . . . 0.0 109.927 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.675 ' HD2' HG22 ' A' ' 28' ' ' ILE . 38.7 m-70 -153.72 171.24 19.17 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.2 mp -102.61 129.64 49.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 170.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.54 166.22 10.56 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 18.9 pttp -150.14 101.9 3.04 Favored 'General case' 0 C--N 1.255 -3.535 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.84 133.06 50.17 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.456 -2.156 . . . . 0.0 110.685 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -119.37 152.3 37.03 Favored 'General case' 0 CA--C 1.445 -3.068 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.0 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.1 m 70.91 169.47 0.32 Allowed 'General case' 0 N--CA 1.397 -3.11 0 O-C-N 125.771 1.919 . . . . 0.0 111.745 162.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -69.72 101.91 1.78 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.497 0.665 . . . . 0.0 109.988 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.829 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.3 m -97.18 156.52 3.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.21 -59.05 5.18 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.19 43.72 95.25 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.361 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.48 -172.04 0.51 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -51.78 -53.21 42.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.37 -2.04 58.07 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 118.567 -1.253 . . . . 0.0 110.92 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -92.27 169.04 10.91 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.665 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -80.06 139.55 36.87 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.392 0.615 . . . . 0.0 109.944 -177.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -81.07 40.3 0.54 Allowed 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.652 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.91 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -82.43 -177.83 6.82 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.487 0.661 . . . . 0.0 111.895 -178.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -142.63 -172.89 3.73 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.643 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 8.9 tt0 -84.32 114.89 22.19 Favored 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.1 1.36 . . . . 0.0 109.123 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.49 3.02 56.5 Favored Glycine 0 C--N 1.29 -1.985 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -75.27 122.42 23.68 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.783 0.802 . . . . 0.0 111.699 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.61 97.21 9.57 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -104.66 158.37 5.54 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.595 0 CA-C-N 111.79 -2.459 . . . . 0.0 111.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.8 mt-10 -121.09 131.73 54.44 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 121.075 -1.016 . . . . 0.0 109.018 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.634 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -92.73 133.37 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.05 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.649 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -120.66 11.52 6.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.942 -176.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.835 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 44.8 ttm180 -152.34 125.68 8.74 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.004 176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 28' ' ' ILE . 47.3 mm -111.5 98.01 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.5 138.73 32.62 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.057 -167.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -115.3 -30.91 6.14 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.458 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -71.77 151.21 93.3 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.722 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -46.74 105.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.617 3.545 . . . . 0.0 115.684 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -162.94 -58.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.05 13.72 60.16 Favored Glycine 0 CA--C 1.474 -2.496 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.007 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.633 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.2 mmtp -134.4 154.32 51.43 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 33.3 m0 -98.35 157.17 16.35 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.835 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -101.08 111.49 23.71 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.874 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.8 179.69 18.87 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.506 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 39.0 ptt180 -152.15 144.28 23.88 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.9 p -81.85 169.35 16.96 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.64 36.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.564 1.173 . . . . 0.0 107.877 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -89.32 -4.92 57.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.418 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.34 33.06 32.93 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.46 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -124.07 121.64 35.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.1 m-85 -89.03 153.68 20.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -173.08 156.36 24.48 Favored Glycine 0 C--N 1.318 -0.446 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.637 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 39.9 m-85 -74.96 139.5 43.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 112.411 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.91 HG12 ' HE2' ' A' ' 46' ' ' PHE . 63.0 mt -121.24 131.37 73.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.633 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.633 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 94.7 mttt -73.41 135.91 44.26 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.7 p -65.21 -9.93 27.47 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.6 t -98.13 -14.12 20.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.788 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -80.78 -13.45 58.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.386 0.613 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 31.2 m -129.7 156.16 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.841 0.829 . . . . 0.0 112.01 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.49 100.71 11.78 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 82' ' ' VAL . 22.5 mm -88.84 108.25 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.918 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -124.67 157.48 35.48 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.237 0.541 . . . . 0.0 112.236 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.548 ' HA ' HD23 ' A' ' 89' ' ' LEU . 45.5 t80 -88.62 -4.31 58.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.1 -32.14 70.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.703 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -77.82 -3.91 43.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.163 0.506 . . . . 0.0 111.173 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD21 ' HA ' ' A' ' 29' ' ' HIS . 3.1 mm? -103.06 -63.59 1.16 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -90.45 119.96 31.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.694 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.9 107.95 13.08 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -71.9 125.97 28.56 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-O 121.269 0.557 . . . . 0.0 112.159 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -153.71 178.91 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.637 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -100.86 -47.77 4.69 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 tt -165.33 -51.59 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.317 178.24 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -141.76 -50.8 0.41 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -82.57 93.25 7.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.32 160.24 7.59 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -117.67 -44.75 2.72 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.873 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tptt 179.37 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.242 0.68 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -178.27 74.99 0.02 OUTLIER 'General case' 0 C--O 1.248 0.998 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.15 111.65 11.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.523 -176.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 44.7 mt-10 -130.35 -166.91 1.74 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.51 ' HD3' ' HG3' ' A' ' 14' ' ' GLU . 48.1 mmtt -80.89 -12.34 59.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.4 -69.52 0.55 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.706 ' HA ' HG13 ' A' ' 15' ' ' ILE 0.31 0.0 OUTLIER -95.04 -22.14 18.12 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -173.838 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HB3' ' O ' ' A' ' 9' ' ' GLU . 6.0 tt0 -64.3 -39.42 93.89 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.611 0.72 . . . . 0.0 110.259 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HG3' ' HD3' ' A' ' 10' ' ' LYS . 5.8 mm-40 -81.33 -33.96 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.495 -176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.807 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.8 pp -69.56 -26.57 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.312 0.577 . . . . 0.0 110.85 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.717 ' HB3' HG23 ' A' ' 22' ' ' THR . 90.1 mttt -71.43 -16.13 62.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.246 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -94.06 -56.95 2.68 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.7 -44.19 81.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.133 1.373 . . . . 0.0 112.106 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.5 -3.33 22.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.726 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 56.29 78.62 0.2 Allowed 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.326 1.06 . . . . 0.0 110.967 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 66' ' ' LEU . 88.2 mt -126.01 16.42 7.92 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.398 -174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 16' ' ' LYS . 4.6 p -72.9 98.84 2.55 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.75 -159.63 28.23 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -89.16 103.84 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.874 2.383 . . . . 0.0 112.393 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 21' ' ' LEU . 2.7 pp -109.12 142.21 22.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 120.859 0.362 . . . . 0.0 110.732 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -127.23 148.47 50.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.76 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.3 p -75.62 145.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG13 HG12 ' A' ' 57' ' ' ILE . 37.4 mm -98.7 -39.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 120.926 0.393 . . . . 0.0 110.261 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.673 ' HB2' HD11 ' A' ' 54' ' ' ILE . 43.7 m-70 -156.45 171.73 19.75 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 109.938 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.23 127.49 44.2 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.615 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -107.18 167.88 9.6 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.594 ' HE2' ' HB2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -151.4 102.37 2.9 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.723 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.72 137.04 55.19 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 113.204 -1.816 . . . . 0.0 111.205 -174.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.8 t -123.16 149.81 44.11 Favored 'General case' 0 CA--C 1.439 -3.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.926 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.6 m 72.64 162.87 0.26 Allowed 'General case' 0 N--CA 1.396 -3.163 0 O-C-N 126.129 2.143 . . . . 0.0 111.868 162.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.93 103.33 1.45 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.499 0.666 . . . . 0.0 109.356 171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 46' ' ' PHE . 24.1 m -102.33 156.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.751 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -48.3 -54.15 14.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.668 1.23 . . . . 0.0 109.165 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.9 43.02 60.8 Favored Glycine 0 C--N 1.346 1.114 0 O-C-N 123.859 0.724 . . . . 0.0 114.69 175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.31 -168.51 0.39 Allowed Glycine 0 CA--C 1.539 1.587 0 N-CA-C 115.756 1.063 . . . . 0.0 115.756 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -55.7 -49.24 73.54 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.655 1.182 . . . . 0.0 113.426 -174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.14 -10.72 54.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.556 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -92.09 163.92 13.79 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.517 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.698 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -82.57 131.89 35.2 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 m -86.04 71.38 10.59 Favored 'General case' 0 C--N 1.255 -3.538 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.531 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.798 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.8 OUTLIER -99.07 179.03 4.74 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.812 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.611 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mtpm? -134.49 -173.05 3.17 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -87.88 113.95 24.03 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 124.549 1.139 . . . . 0.0 108.665 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.08 -3.09 44.26 Favored Glycine 0 C--N 1.284 -2.332 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.8 mm-40 -66.93 123.96 21.65 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.763 0.792 . . . . 0.0 111.415 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -94.01 96.78 9.9 Favored 'General case' 0 N--CA 1.409 -2.483 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.951 HD11 HG11 ' A' ' 82' ' ' VAL . 32.7 pt -110.57 158.28 10.99 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.169 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.372 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.76 ' HB3' HG21 ' A' ' 27' ' ' VAL . 48.1 mt-10 -121.27 136.84 54.91 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.268 0.2 OUTLIER -97.81 124.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.224 175.173 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.09 -16.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.647 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -144.29 122.07 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.373 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 28' ' ' ILE . 44.3 mm -88.98 101.56 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p -83.34 154.51 24.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-O 121.568 0.699 . . . . 0.0 112.231 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -114.98 8.57 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.686 1.231 . . . . 0.0 108.438 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -69.42 157.65 88.88 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.738 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.39 -17.68 49.41 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.999 2.466 . . . . 0.0 111.62 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.91 -37.33 66.23 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.832 0.853 . . . . 0.0 110.514 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.08 29.4 66.83 Favored Glycine 0 CA--C 1.489 -1.549 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.27 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 42.5 mmtm -133.27 138.31 46.4 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.452 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.2 m0 -87.57 159.8 18.45 Favored 'General case' 0 C--N 1.279 -2.485 0 O-C-N 123.725 0.641 . . . . 0.0 109.968 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -97.12 112.14 24.06 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.815 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.26 174.21 15.13 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' SER . 36.1 ptt180 -152.2 139.91 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.627 ' HA ' HG22 ' A' ' 52' ' ' ILE . 63.6 p -78.73 177.13 8.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -16.89 61.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 110.27 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -87.86 -19.96 26.68 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.12 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 29.6 5.4 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.033 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.9 m -98.91 115.45 28.9 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.807 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.6 m-85 -91.77 139.06 31.04 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 122.714 0.406 . . . . 0.0 110.717 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.12 158.86 31.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.857 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.448 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.2 m-85 -73.97 135.15 43.17 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.917 0.865 . . . . 0.0 111.285 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.815 HD11 ' HA3' ' A' ' 67' ' ' GLY . 67.5 mt -116.42 128.66 73.7 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.697 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 77' ' ' ILE . 54.8 mttm -65.14 137.14 57.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.0 p -68.7 -7.16 30.94 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 122.128 0.966 . . . . 0.0 111.469 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -104.16 -13.15 16.33 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.153 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.4 -13.08 58.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.291 0.567 . . . . 0.0 109.736 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.951 HG11 HD11 ' A' ' 52' ' ' ILE . 35.3 m -131.99 154.56 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.368 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 55.1 mm-40 -103.54 113.13 26.41 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 172.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.615 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.5 mm -81.13 141.74 14.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.793 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.85 124.74 23.79 Favored 'General case' 0 CA--C 1.478 -1.802 0 CA-C-O 123.094 1.426 . . . . 0.0 112.443 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.467 ' HA ' HD23 ' A' ' 89' ' ' LEU . 51.2 m-85 -100.44 4.73 43.98 Favored 'General case' 0 C--N 1.255 -3.507 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.057 170.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.5 -39.14 89.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.709 1.204 . . . . 0.0 112.085 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -68.56 -15.25 63.47 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.336 0.589 . . . . 0.0 111.857 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 86' ' ' TYR . 2.0 mm? -104.25 -3.75 23.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -91.31 111.4 22.88 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.905 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.7 mt -101.03 -73.1 0.66 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -166.76 52.39 0.08 Allowed 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -78.69 -31.52 46.65 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.5 t70 55.2 -96.21 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.963 1.705 . . . . 0.0 110.343 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.0 mt -159.8 160.61 34.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.293 -1.866 0 CA-C-O 117.545 -1.217 . . . . 0.0 110.133 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -101.07 -40.74 7.06 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -159.22 138.6 11.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.684 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 64.59 115.1 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.15 0.98 . . . . 0.0 112.588 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.37 89.45 3.12 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -139.58 129.01 24.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.41 101.95 7.54 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 8' ' ' LYS . 15.4 ptpt -98.24 85.46 3.44 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.472 1.13 . . . . 0.0 110.403 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 26.8 tt0 -80.86 138.71 36.2 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.155 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -67.74 6.15 0.72 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.31 -20.12 64.72 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.547 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.36 -23.42 63.75 Favored 'General case' 0 C--O 1.208 -1.093 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.56 178.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -67.6 -33.61 75.35 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -51.37 24.77 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.0 pp -61.82 -25.46 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.774 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 92.1 mttt -75.64 -25.86 57.22 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.882 -177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.24 -38.8 13.19 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -63.01 -50.88 68.96 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.253 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -103.1 -5.91 22.79 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.44 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 37.7 mtmm 55.35 81.1 0.12 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.556 0.742 . . . . 0.0 110.078 -174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 21' ' ' LEU . 10.9 tp -83.93 -45.5 13.11 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.13 -175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 p 46.83 96.07 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.49 178.83 38.25 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.21 136.53 24.57 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.856 2.371 . . . . 0.0 110.535 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.848 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -124.68 160.51 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.157 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -128.63 148.22 50.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 53' ' ' GLU . 7.1 p -74.7 145.72 10.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.614 0.245 . . . . 0.0 110.812 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.7 mm -97.99 -44.78 12.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.129 0.49 . . . . 0.0 111.013 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.978 ' HB2' HD11 ' A' ' 54' ' ' ILE . 7.3 m-70 -139.29 162.89 33.89 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -175.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.35 122.19 42.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.923 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.38 164.43 11.65 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.679 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 51.3 pttt -151.43 105.21 3.15 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -72.17 125.73 28.04 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.417 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.7 t -112.14 148.76 33.3 Favored 'General case' 0 CA--C 1.448 -2.975 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.791 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.7 m 74.32 167.74 0.3 Allowed 'General case' 0 N--CA 1.405 -2.713 0 O-C-N 126.032 2.083 . . . . 0.0 111.422 162.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.41 102.56 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.758 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.1 m -96.16 156.64 3.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.902 -175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -49.81 -53.92 22.38 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.96 43.3 96.92 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.557 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -49.57 179.2 0.02 OUTLIER Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.324 1.29 . . . . 0.0 116.324 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -61.47 -34.42 75.42 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -86.26 -16.15 38.53 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.114 0.483 . . . . 0.0 111.207 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' OE1' ' HG3' ' A' ' 78' ' ' LYS . 45.0 mt-10 -92.66 170.4 9.75 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.781 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.659 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 1.1 tt -79.07 140.92 37.77 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.921 0.867 . . . . 0.0 110.338 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.9 m -81.12 47.07 0.97 Allowed 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.58 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.945 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -87.44 175.58 7.9 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.445 0.641 . . . . 0.0 111.879 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.4 mtpt -133.78 -172.76 3.06 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.394 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 47.6 tt0 -81.69 124.79 29.89 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 125.398 1.479 . . . . 0.0 107.821 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.03 4.93 66.48 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.6 mm-40 -74.26 121.87 21.97 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 122.163 0.983 . . . . 0.0 112.283 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -85.51 96.18 9.53 Favored 'General case' 0 N--CA 1.398 -3.049 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 82' ' ' VAL . 40.0 pt -111.41 158.41 11.9 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.538 0 CA-C-N 112.836 -1.983 . . . . 0.0 112.071 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 27' ' ' VAL . 51.3 mt-10 -125.43 134.05 52.25 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.21 127.72 54.18 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.291 175.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.848 HG12 HD13 ' A' ' 25' ' ' ILE . 2.7 mp -97.87 -34.96 4.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.165 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.795 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.7 ttm180 -116.12 110.01 18.27 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.455 -174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.41 98.56 8.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -116.08 141.71 47.76 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.598 0.713 . . . . 0.0 112.75 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -93.34 5.25 52.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.664 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' HD2' ' A' ' 61' ' ' PRO . 38.7 t30 -58.44 133.05 85.27 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.125 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' OD1' ' A' ' 60' ' ' ASN . 18.7 Cg_exo -34.2 -28.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.749 1 C-N-CA 126.03 4.487 . . . . 0.0 117.286 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.1 -34.8 70.58 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 110.774 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.75 31.53 73.25 Favored Glycine 0 CA--C 1.5 -0.861 0 CA-C-N 115.758 -0.655 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 69.6 mmtt -119.57 157.38 28.5 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -102.06 142.15 33.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -86.25 108.93 18.6 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -115.18 177.03 17.07 Favored Glycine 0 N--CA 1.415 -2.764 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.411 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 29.6 ptt180 -151.93 142.89 23.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.279 1.032 . . . . 0.0 108.311 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 52' ' ' ILE . 19.2 p -79.71 173.24 12.79 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.92 0.866 . . . . 0.0 109.135 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.49 -7.87 59.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.981 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.92 23.78 31.82 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.501 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.2 m -103.18 113.38 26.81 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' HB2' HG21 ' A' ' 15' ' ' ILE . 10.7 m-85 -89.52 147.7 23.82 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.583 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.88 161.09 34.76 Favored Glycine 0 C--N 1.298 -1.537 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.81 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 10.2 m-85 -70.11 161.73 29.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.945 HG12 ' HE2' ' A' ' 46' ' ' PHE . 83.9 mt -142.44 126.65 15.67 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' O ' HG22 ' A' ' 77' ' ' ILE . 61.0 mttp -64.5 132.53 50.19 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 167.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.3 p -66.29 -8.51 25.47 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 118.927 0.785 . . . . 0.0 112.575 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.3 t -98.85 -14.49 19.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.581 0.752 . . . . 0.0 110.282 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.06 -19.78 58.3 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 108.909 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 52' ' ' ILE . 34.1 m -125.79 166.18 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.788 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 29.0 mt-10 -125.44 112.22 16.02 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' HIS . 1.7 mp -88.92 123.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 120.922 0.391 . . . . 0.0 110.135 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -100.78 140.57 34.87 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.233 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -93.03 -21.68 19.6 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.869 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 34.7 t70 -59.52 -38.79 81.89 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.301 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 49.8 m -64.28 -21.65 66.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.845 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 29' ' ' HIS . 71.5 mt -85.19 -30.34 23.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.869 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 6.4 mtpm? -71.95 -44.12 64.12 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.851 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 91' ' ' LEU . 3.5 tm? -73.54 -22.35 60.11 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.118 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 88' ' ' SER . 6.4 tmtm? -59.19 112.39 1.69 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.598 0.759 . . . . 0.0 109.538 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -148.81 -44.19 0.15 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -58.67 141.39 52.7 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.395 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.8 mt -85.93 91.09 8.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 121.814 0.816 . . . . 0.0 111.434 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.675 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -137.97 93.53 2.78 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -118.05 -23.72 7.3 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.323 -175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.679 ' HG2' ' HB2' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -98.57 108.32 20.99 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -127.44 -28.39 2.79 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.131 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -133.92 23.65 3.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.223 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.679 ' HB2' ' HG2' ' A' ' 4' ' ' GLU . 33.0 mt-10 -115.43 82.69 1.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.668 0.747 . . . . 0.0 110.188 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -127.97 108.23 10.51 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.612 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 3.2 mp0 -66.14 114.8 5.54 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.631 -177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -107.74 -60.82 1.65 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.709 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -80.3 -18.02 50.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.992 0.901 . . . . 0.0 108.774 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.616 ' O ' HG13 ' A' ' 15' ' ' ILE . 14.2 mp0 -83.14 -7.27 59.65 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.259 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -62.15 -39.45 92.66 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.44 -29.76 30.5 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.789 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.0 pp -65.95 -29.78 47.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.389 0.614 . . . . 0.0 111.063 -172.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE2' ' HG2' ' A' ' 9' ' ' GLU . 67.9 mttm -68.23 -27.63 66.53 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.666 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -91.14 -46.24 8.21 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.734 0.778 . . . . 0.0 109.231 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.05 -44.65 83.95 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.647 1.179 . . . . 0.0 112.379 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -109.35 -8.6 15.05 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 65.66 75.22 0.35 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 111.286 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.13 17.81 19.23 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.072 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -68.35 84.7 0.26 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.239 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.83 41.69 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.39 105.47 0.89 Allowed 'Trans proline' 0 C--O 1.25 1.08 0 C-N-CA 122.978 2.452 . . . . 0.0 113.012 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.34 161.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 27' ' ' VAL . 18.4 mm-40 -133.83 -81.48 0.46 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.66 ' HA ' HG22 ' A' ' 55' ' ' ILE . 1.4 m 178.74 152.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.36 0 C-N-CA 128.906 2.882 . . . . 0.0 105.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.523 HG22 ' HD2' ' A' ' 29' ' ' HIS . 38.3 mm -99.31 -44.91 12.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' HD2' HG22 ' A' ' 28' ' ' ILE . 70.5 m-70 -160.74 -176.93 5.83 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.3 tp -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.402 -2.853 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.08 169.58 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 21.7 pttm -152.3 107.05 3.21 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.0 135.82 57.49 Favored 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.049 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -112.05 172.86 6.66 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m 58.39 175.87 0.06 Allowed 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 125.101 1.501 . . . . 0.0 114.39 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.49 95.43 9.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.88 166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.841 HG21 ' HE1' ' A' ' 46' ' ' PHE . 27.7 m -89.98 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.36 -40.85 75.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.535 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.08 43.18 62.37 Favored Glycine 0 C--N 1.355 1.592 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.892 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -53.14 -173.71 0.05 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 116.879 1.512 . . . . 0.0 116.879 -173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -63.2 -36.78 84.78 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -100.81 2.21 40.91 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.632 0.729 . . . . 0.0 109.789 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.4 mt-10 -95.68 179.42 5.13 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.68 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -94.7 135.73 35.83 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -85.83 76.19 9.93 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.131 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.869 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -118.37 174.11 6.43 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.997 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 30.3 mmtp -140.79 -175.51 4.32 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.829 0.823 . . . . 0.0 111.497 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -65.09 108.21 1.77 Allowed 'General case' 0 C--N 1.272 -2.791 0 C-N-CA 127.856 2.463 . . . . 0.0 109.886 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.75 5.25 41.99 Favored Glycine 0 C--N 1.294 -1.8 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.5 mm-40 -80.03 116.69 20.3 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 122.031 0.92 . . . . 0.0 112.729 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -85.55 96.99 9.81 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.895 HD11 HG11 ' A' ' 82' ' ' VAL . 27.8 pt -110.87 158.66 11.25 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.244 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.045 175.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -118.57 134.25 55.24 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.607 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -96.09 136.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.184 173.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -119.56 3.68 6.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.188 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 58' ' ' THR . 58.2 ttt180 -150.27 141.15 22.83 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.749 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 28' ' ' ILE . 44.4 mm -109.02 96.97 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -86.68 141.32 29.02 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.784 -178.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -114.22 -2.86 13.27 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.712 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -54.59 150.19 18.62 Favored Pre-proline 0 N--CA 1.475 0.795 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.739 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -36.24 -37.46 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.973 1 C-N-CA 126.021 4.481 . . . . 0.0 116.047 -177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -52.35 -36.1 52.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.22 31.55 68.99 Favored Glycine 0 CA--C 1.495 -1.194 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.5 mmtp -129.29 148.88 51.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 35.0 m0 -94.64 160.81 14.46 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.682 0.614 . . . . 0.0 109.848 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.58 109.65 21.5 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.705 0.764 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -114.08 175.92 16.67 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.1 ptt180 -152.77 146.39 25.05 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.819 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.6 p -73.15 178.59 4.32 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 117.941 0.337 . . . . 0.0 110.847 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.32 -34.22 73.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.123 0.487 . . . . 0.0 110.533 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 71' ' ' ARG . 39.2 mtm-85 -82.16 -0.4 44.76 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.172 0.51 . . . . 0.0 111.599 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.34 27.27 Favored Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 114.528 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 29.0 m -91.46 112.55 24.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.563 1.182 . . . . 0.0 107.813 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 68' ' ' ARG . 79.2 m-85 -82.48 145.18 29.95 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.128 -172.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.83 27.95 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.163 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 7.7 m-85 -71.45 142.68 50.23 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.87 0.843 . . . . 0.0 112.302 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.869 HG12 ' HE2' ' A' ' 46' ' ' PHE . 61.3 mt -126.59 129.28 71.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.565 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 77' ' ' ILE . 92.3 mttt -65.93 140.95 58.37 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.4 p -69.06 -9.16 51.18 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.0 112.056 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -103.93 -8.67 19.48 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.519 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.628 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -81.79 -11.04 59.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 52' ' ' ILE . 27.1 m -133.1 158.27 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.015 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 38.0 mt-10 -104.5 112.94 26.19 Favored 'General case' 0 N--CA 1.394 -3.234 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD13 ' HB2' ' A' ' 31' ' ' ALA . 21.1 mm -94.75 135.58 28.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.73 0 C-N-CA 124.038 0.935 . . . . 0.0 109.68 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -77.43 153.72 33.32 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.493 0.663 . . . . 0.0 109.948 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -101.75 -22.83 14.31 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.579 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -65.4 -17.79 64.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB3' ' ND1' ' A' ' 29' ' ' HIS . 44.4 t -64.97 -17.48 64.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 118.179 0.445 . . . . 0.0 111.639 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.7 mt -73.15 -24.87 60.64 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -99.62 158.93 15.41 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.9 177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -136.14 88.12 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -139.75 126.41 20.53 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.736 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -80.82 106.22 12.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -140.26 81.39 1.81 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.999 0.904 . . . . 0.0 109.733 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.3 mt -105.29 -47.92 3.83 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.205 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.2 139.35 50.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.934 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.1 90.62 3.06 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 65.83 170.41 0.22 Allowed 'General case' 0 C--O 1.249 1.04 0 O-C-N 124.202 0.938 . . . . 0.0 109.558 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.92 124.64 28.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -107.79 99.15 8.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -73.99 123.75 24.93 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.257 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -139.56 77.11 1.6 Allowed 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.583 -3.117 . . . . 0.0 102.583 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.678 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 6.4 mm-40 -72.03 139.56 48.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.263 -168.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 72.0 mmtt -80.48 -11.9 59.62 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.767 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.678 ' HG2' ' HB3' ' A' ' 9' ' ' GLU . 9.6 ptpp? -81.0 -28.03 35.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.264 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.754 ' HA ' HG13 ' A' ' 15' ' ' ILE . 12.4 pt-20 -77.52 -23.82 50.12 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.818 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 29.7 pt20 -65.25 -29.56 70.36 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -77.77 -55.43 5.34 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.308 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -57.49 -28.04 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HB3' HG23 ' A' ' 22' ' ' THR . 43.3 mtmt -79.68 -23.9 42.14 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -89.37 -41.22 12.25 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 87.3 tttt -60.56 -48.4 81.94 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 112.089 -175.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -100.56 -6.02 25.98 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp 59.94 74.39 0.45 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 122.869 1.319 . . . . 0.0 108.059 -171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 12.5 tp -125.26 14.53 8.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.913 -169.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -69.42 90.51 0.53 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.487 0.66 . . . . 0.0 112.035 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.78 -177.04 45.5 Favored Glycine 0 N--CA 1.423 -2.203 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.95 123.57 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.711 2.274 . . . . 0.0 112.024 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.628 ' HB ' ' HB ' ' A' ' 55' ' ' ILE . 2.6 pp -109.33 147.08 14.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 120.872 0.368 . . . . 0.0 111.827 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -127.79 138.1 52.62 Favored 'General case' 0 CA--C 1.465 -2.295 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.645 ' HA ' HG22 ' A' ' 55' ' ' ILE . 21.9 t -74.08 112.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.556 HG22 ' CD2' ' A' ' 29' ' ' HIS . 38.7 mm -83.67 -44.66 18.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.759 -173.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 54' ' ' ILE . 54.6 m-70 -150.49 167.42 27.22 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.66 117.94 31.41 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -102.58 165.06 11.29 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 42.7 pttt -150.22 102.54 3.09 Favored 'General case' 0 C--N 1.255 -3.514 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.82 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.38 125.96 26.76 Favored 'General case' 0 C--N 1.271 -2.806 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.699 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.2 t -109.69 148.08 32.01 Favored 'General case' 0 CA--C 1.432 -3.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.073 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 8.2 m 68.1 -179.14 0.22 Allowed 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 125.99 2.057 . . . . 0.0 110.344 164.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.6 113.53 14.33 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 46' ' ' PHE . 5.5 m -106.74 156.37 7.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.225 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 15.0 ptpt -50.72 -66.93 0.3 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.353 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . 61.84 43.32 99.37 Favored Glycine 0 C--O 1.246 0.881 0 C-N-CA 119.754 -1.212 . . . . 0.0 112.542 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -61.41 -150.83 0.02 OUTLIER Glycine 0 CA--C 1.534 1.276 0 N-CA-C 116.729 1.451 . . . . 0.0 116.729 -173.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -73.45 -38.22 65.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -171.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -103.28 -0.42 30.32 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.991 0.901 . . . . 0.0 109.455 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 68.9 mt-10 -99.37 163.53 12.49 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.643 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -79.23 128.36 33.2 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -86.26 67.56 9.98 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-O 122.542 1.163 . . . . 0.0 108.948 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -98.25 -167.18 1.47 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.521 177.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 54.8 tttp -147.92 -173.59 4.34 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -173.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.758 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 8.7 tt0 -79.0 105.6 10.45 Favored 'General case' 1 C--N 1.243 -4.027 0 C-N-CA 127.112 2.165 . . . . 0.0 109.302 -176.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.16 8.19 48.01 Favored Glycine 0 C--N 1.285 -2.3 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.005 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.4 128.82 36.22 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.516 0.674 . . . . 0.0 110.759 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.73 97.03 10.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 82' ' ' VAL . 22.7 pt -107.27 158.36 7.2 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.093 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.672 176.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -129.47 128.79 43.62 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -90.98 132.64 35.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 118.374 -1.33 . . . . 0.0 110.299 177.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -118.11 11.73 7.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.754 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 33.1 ttt180 -155.08 114.15 3.61 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.076 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 28' ' ' ILE . 46.3 mm -99.12 95.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.91 140.86 36.64 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 173.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -110.26 -46.05 3.49 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.086 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.568 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 25.6 t-20 -82.06 -58.83 0.45 Allowed Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.963 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 40.0 Cg_exo -60.02 103.63 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.618 2.212 . . . . 0.0 113.164 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.679 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 15.0 tp10 72.2 -24.62 0.19 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.007 1.323 . . . . 0.0 113.029 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.06 54.38 Favored Glycine 0 CA--C 1.489 -1.559 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 46.1 mmtm -131.57 162.95 29.13 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 38.8 m0 -102.0 153.54 19.79 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -98.93 112.52 24.6 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.682 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -109.52 177.48 20.07 Favored Glycine 0 N--CA 1.406 -3.31 0 CA-C-N 114.293 -1.322 . . . . 0.0 110.572 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.2 ptm180 -151.32 141.26 22.01 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 52' ' ' ILE . 64.9 p -79.43 167.85 20.27 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.27 64.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.799 0.809 . . . . 0.0 109.869 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -84.47 -22.37 30.32 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.073 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.53 19.4 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.091 -1.052 . . . . 0.0 114.314 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.5 m -94.31 110.37 22.13 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.446 ' HB2' HG21 ' A' ' 15' ' ' ILE . 38.5 m-85 -87.49 138.43 31.48 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.64 155.87 27.12 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.355 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 64' ' ' LYS . 16.3 m-85 -69.35 143.79 53.65 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.713 0.768 . . . . 0.0 110.7 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.787 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.9 mt -124.53 132.89 70.69 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.687 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 mtmt -73.57 132.34 42.71 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.6 p -63.73 -10.25 18.59 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.593 0.711 . . . . 0.0 112.857 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -99.98 -16.05 18.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.651 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -14.17 59.11 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 52' ' ' ILE . 33.2 m -131.39 156.21 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.689 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 9.3 mm-40 -106.36 106.22 16.63 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.56 HD13 ' HB2' ' A' ' 31' ' ' ALA . 23.4 mm -83.62 115.16 25.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.538 -177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -84.24 150.48 25.42 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.52 0.676 . . . . 0.0 110.95 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.03 -6.86 27.74 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.145 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.66 -5.93 40.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.545 1.138 . . . . 0.0 110.964 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.405 ' CB ' ' HA ' ' A' ' 29' ' ' HIS . 23.4 m -61.19 -24.56 66.41 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.15 -45.1 43.07 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.337 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -177.47 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -159.97 158.65 31.05 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -70.69 122.51 19.95 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.74 0.781 . . . . 0.0 112.008 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -146.22 38.45 1.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.961 -1.472 . . . . 0.0 107.696 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.96 -50.97 52.73 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.303 -176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 96' ' ' GLU . 5.4 tt -163.63 147.6 10.41 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' N ' HD23 ' A' ' 95' ' ' LEU . 51.5 mm-40 . . . . . 0 CA--C 1.508 -0.669 0 C-N-CA 123.977 0.911 . . . . 0.0 110.486 -176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.526 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -106.88 -49.99 3.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -95.92 163.96 12.93 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.858 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 37.1 tt0 -140.98 81.0 1.77 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 169.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.27 100.74 5.49 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 80.43 14.98 0.75 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 125.087 1.492 . . . . 0.0 108.635 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 1.8 mp0 -93.14 65.62 3.98 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.246 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -99.58 -6.66 27.0 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.68 95.39 10.05 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -107.78 -4.49 18.05 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.502 0.668 . . . . 0.0 110.129 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -57.32 -55.48 34.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.931 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.638 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -84.78 -9.79 57.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.118 -175.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.08 -50.03 65.54 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.779 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.16 -41.02 82.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.6 pp -65.86 -24.49 34.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.974 0.416 . . . . 0.0 111.83 -176.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 46.1 mtmt -68.8 -24.37 64.39 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.189 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -97.88 -43.97 6.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.496 0.665 . . . . 0.0 109.629 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.0 tttt -62.69 -57.25 11.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' HD2' ' HB ' ' A' ' 15' ' ' ILE . 66.6 m-85 -97.59 -13.01 21.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.364 0.602 . . . . 0.0 109.726 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 53.0 mttp 62.39 77.59 0.32 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.185 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD12 HD13 ' A' ' 15' ' ' ILE . 73.9 mt -121.1 16.85 11.62 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.602 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -61.61 131.47 50.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.474 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.02 -177.18 18.05 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.34 115.01 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.36 2.04 . . . . 0.0 111.577 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 55' ' ' ILE . 2.7 pp -109.98 145.31 16.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 120.785 0.326 . . . . 0.0 111.764 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -118.03 130.06 55.95 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.308 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.914 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.5 p -71.9 144.44 13.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 123.253 0.346 . . . . 0.0 110.41 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.44 HG22 ' CD2' ' A' ' 29' ' ' HIS . 45.4 mm -95.98 -44.71 13.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.709 ' HB2' HD11 ' A' ' 54' ' ' ILE . 74.6 m-70 -154.17 179.99 8.43 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 123.658 0.783 . . . . 0.0 109.065 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 5.7 mp -108.07 136.52 47.62 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -108.58 176.03 5.26 Favored 'General case' 0 C--N 1.263 -3.174 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 173.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 14.8 ptmm? -150.57 102.58 3.04 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.613 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.93 122.71 18.76 Favored 'General case' 0 C--N 1.266 -3.056 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.47 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 38.3 t -117.25 152.75 34.19 Favored 'General case' 0 CA--C 1.444 -3.1 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.147 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 m 70.78 177.64 0.27 Allowed 'General case' 0 N--CA 1.404 -2.725 0 O-C-N 125.818 1.949 . . . . 0.0 110.583 162.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.16 100.44 6.6 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.615 1.198 . . . . 0.0 110.541 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.02 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.3 m -87.74 156.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.946 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -61.7 -52.7 63.21 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.66 43.14 99.41 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.345 -0.931 . . . . 0.0 114.763 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.39 -179.33 1.03 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -63.61 -27.95 69.59 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 29.5 p-10 -90.3 -13.95 34.2 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 45.7 mt-10 -92.33 159.82 15.41 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.462 -177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD13 ' HD2' ' A' ' 46' ' ' PHE . 1.4 tt -70.79 137.51 49.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.631 0.729 . . . . 0.0 109.844 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 44' ' ' LEU . 15.1 m -82.96 43.81 0.88 Allowed 'General case' 0 C--N 1.277 -2.553 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.436 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.02 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -84.93 -161.05 0.53 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.273 178.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.882 ' HG2' ' H ' ' A' ' 48' ' ' GLN . 74.1 tttt -145.54 -171.57 3.7 Favored 'General case' 0 N--CA 1.389 -3.525 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.882 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 7.7 tt0 -75.73 -8.83 57.79 Favored 'General case' 0 C--N 1.254 -3.568 0 C-N-CA 128.746 2.818 . . . . 0.0 114.337 -168.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.47 19.9 1.69 Allowed Glycine 0 C--N 1.27 -3.094 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 47' ' ' LYS . 18.6 mm-40 -80.56 129.78 34.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -96.88 97.57 9.39 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.912 HD11 HG11 ' A' ' 82' ' ' VAL . 36.6 pt -105.55 159.73 5.7 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.883 -2.417 . . . . 0.0 112.55 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.914 ' HB3' HG21 ' A' ' 27' ' ' VAL . 40.7 mt-10 -120.05 136.0 54.73 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.4 128.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.866 0.841 . . . . 0.0 112.072 177.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG12 HD13 ' A' ' 25' ' ' ILE . 2.5 mp -100.59 -35.03 4.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.209 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.02 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.1 ttm180 -114.84 121.36 43.0 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.715 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.9 mm -99.09 98.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.27 141.65 34.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -106.45 -16.15 14.62 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -39.58 140.83 0.77 Allowed Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 126.659 1.984 . . . . 0.0 113.06 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -35.6 -25.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.751 1 C-N-CA 126.283 4.655 . . . . 0.0 117.49 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 27.3 mm-40 -59.69 -28.82 67.62 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.741 0.7 . . . . 0.0 110.22 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.36 29.76 75.52 Favored Glycine 0 CA--C 1.495 -1.174 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.013 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 44.9 mmtm -133.74 155.2 50.2 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.4 m0 -100.75 153.16 19.68 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.516 0.51 . . . . 0.0 110.171 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -95.03 116.37 28.61 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.756 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.04 178.62 16.66 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.765 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 36.3 ptt180 -151.91 147.33 26.46 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.735 ' HA ' HG22 ' A' ' 52' ' ' ILE . 67.0 p -80.05 179.02 7.83 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 118.198 0.454 . . . . 0.0 109.811 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -15.87 61.89 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.475 0.655 . . . . 0.0 109.327 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -80.82 -25.89 37.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.0 22.38 9.36 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.348 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 8.0 p -94.1 111.55 23.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.794 ' HB2' HG21 ' A' ' 15' ' ' ILE . 53.7 m-85 -83.13 148.98 27.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.365 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -171.62 160.74 32.78 Favored Glycine 0 C--N 1.318 -0.446 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.19 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 m-85 -76.21 143.21 41.18 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-O 121.67 0.748 . . . . 0.0 111.522 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.756 HD11 ' HA3' ' A' ' 67' ' ' GLY . 44.2 mt -125.39 139.15 52.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.061 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.592 ' O ' HG22 ' A' ' 77' ' ' ILE . 55.7 mttm -74.1 136.47 42.98 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 168.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.6 p -64.56 -13.32 52.3 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.537 0.685 . . . . 0.0 112.143 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -97.27 -16.24 20.43 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.541 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.45 -17.65 59.21 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 52' ' ' ILE . 27.5 m -130.58 153.17 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.75 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 49.0 mm-40 -102.85 100.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 31' ' ' ALA . 22.0 mm -70.57 133.14 32.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.098 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.0 149.98 37.49 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.004 0.907 . . . . 0.0 111.692 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -101.84 10.02 40.23 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 114.266 -1.333 . . . . 0.0 107.499 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -100.33 -17.54 17.21 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -162.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -53.83 -22.67 10.2 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.24 -62.91 1.52 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -136.07 135.41 39.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.07 113.57 3.6 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 123.525 0.516 . . . . 0.0 110.046 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -149.03 27.52 0.86 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.589 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -60.15 138.99 57.79 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.648 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -109.39 173.92 6.1 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.0 mp 60.58 76.63 0.36 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 122.279 1.038 . . . . 0.0 109.59 -172.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--N 1.286 -2.194 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.751 -175.378 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -105.87 -60.72 1.6 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.809 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp 74.47 -53.13 0.68 Allowed 'General case' 0 C--O 1.253 1.278 0 C-N-CA 125.017 1.327 . . . . 0.0 109.48 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.74 69.94 8.52 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.04 0.924 . . . . 0.0 108.937 172.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -127.87 -12.03 5.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.132 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -118.19 -0.28 11.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 45.68 76.16 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.418 1.074 . . . . 0.0 110.993 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 21.5 ptmt -107.99 -175.94 2.92 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.474 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.14 93.96 4.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.697 0.761 . . . . 0.0 111.522 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -106.1 -12.21 15.84 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 171.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -47.48 -68.21 0.21 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.622 1.969 . . . . 0.0 112.336 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 3.3 pm0 -79.95 -7.1 58.6 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.51 -44.51 14.61 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.812 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -71.68 -38.61 70.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.744 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -59.51 -31.44 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.722 ' HB3' HG23 ' A' ' 22' ' ' THR . 54.1 mttp -72.27 -22.78 61.17 Favored 'General case' 0 C--O 1.205 -1.265 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.596 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -94.11 -40.21 10.17 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.573 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.7 ttpt -65.32 -42.1 93.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.779 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.2 m-85 -111.82 1.54 16.64 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.234 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 34.9 ttmt 53.37 72.22 0.45 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 122.928 1.347 . . . . 0.0 110.336 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.61 HD21 ' HG ' ' A' ' 66' ' ' LEU . 94.9 mt -112.5 16.47 19.81 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.984 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.722 HG23 ' HB3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -71.93 94.4 1.45 Allowed 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.301 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.96 170.53 25.7 Favored Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.18 128.23 11.97 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.908 2.405 . . . . 0.0 111.452 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.26 159.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -136.71 144.1 43.7 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 53' ' ' GLU . 8.0 p -71.43 137.4 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG13 HG12 ' A' ' 57' ' ' ILE . 40.0 mm -98.87 -37.79 6.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.195 0.521 . . . . 0.0 109.872 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.599 ' HB2' HD11 ' A' ' 54' ' ' ILE . 53.6 m-70 -153.65 164.16 38.76 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.65 HD13 ' HB3' ' A' ' 88' ' ' SER . 9.4 mp -103.26 132.28 49.65 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.43 171.89 7.11 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.796 0.808 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 14.3 ptpt -151.64 102.72 2.89 Favored 'General case' 0 C--N 1.26 -3.297 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -63.81 112.77 3.04 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 41.0 t -96.95 150.73 20.43 Favored 'General case' 0 CA--C 1.431 -3.599 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.655 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.4 m 67.91 -179.32 0.22 Allowed 'General case' 0 N--CA 1.402 -2.845 0 O-C-N 125.635 1.835 . . . . 0.0 110.782 163.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -79.72 105.29 10.9 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 46' ' ' PHE . 16.9 m -87.76 156.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.896 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -52.58 -58.58 6.32 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.41 41.79 99.74 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.818 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.82 178.29 0.3 Allowed Glycine 0 CA--C 1.526 0.723 0 O-C-N 123.914 0.42 . . . . 0.0 113.528 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -64.42 -32.85 74.65 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 122.104 -0.645 . . . . 0.0 111.547 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -88.08 -7.81 56.43 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.048 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 76' ' ' TYR . 47.7 mt-10 -92.14 171.96 8.74 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HG ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -73.23 148.63 43.51 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' H ' HD23 ' A' ' 44' ' ' LEU . 17.8 m -89.89 38.45 0.92 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.749 1.261 . . . . 0.0 108.536 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.813 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -85.17 163.45 18.71 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.65 -1.614 . . . . 0.0 110.12 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.627 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 28.1 mmtp -133.65 -173.35 3.21 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.882 0.849 . . . . 0.0 111.997 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 9.4 tt0 -64.7 119.48 10.64 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 126.528 1.931 . . . . 0.0 109.978 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.18 19.07 40.41 Favored Glycine 0 C--N 1.292 -1.901 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.545 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.813 ' HG2' ' HB2' ' A' ' 46' ' ' PHE . 6.6 tp10 -78.64 137.53 37.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.155 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.56 96.68 8.47 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.842 HD11 HG11 ' A' ' 82' ' ' VAL . 22.5 pt -111.86 158.89 12.15 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 112.691 -2.05 . . . . 0.0 113.578 173.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HB3' HG21 ' A' ' 27' ' ' VAL . 3.8 mp0 -128.18 137.75 52.19 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 67' ' ' GLY 0.288 0.2 OUTLIER -102.21 124.77 56.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.866 176.213 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -107.95 -4.08 10.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.838 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.832 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.1 ttm180 -138.97 114.56 9.83 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.96 0.409 . . . . 0.0 110.81 177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.547 HG12 HG13 ' A' ' 28' ' ' ILE . 51.1 mm -94.72 98.49 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.05 139.41 31.18 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.6 2.43 14.53 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.62 126.87 89.44 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.312 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.91 120.11 7.71 Favored 'Trans proline' 0 C--O 1.251 1.147 0 C-N-CA 123.336 2.691 . . . . 0.0 114.533 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.52 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.31 29.11 6.14 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.722 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 26.7 mmtp -134.93 158.3 44.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.003 0.43 . . . . 0.0 110.541 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 17.6 m0 -109.41 162.23 14.55 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -104.04 112.48 25.49 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.561 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -113.11 177.6 18.24 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.164 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 7.0 ptm180 -150.02 145.88 26.67 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 52' ' ' ILE . 43.9 p -84.75 171.83 11.99 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.42 -23.92 67.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.351 0.596 . . . . 0.0 110.05 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -75.89 -14.93 60.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.106 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.68 28.49 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.285 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.1 m -92.95 109.01 20.45 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 26.2 m-85 -84.12 140.28 31.89 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.206 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -165.74 156.22 28.02 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.624 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.596 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 12.5 m-85 -68.96 150.18 48.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.603 0.716 . . . . 0.0 111.102 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 67' ' ' GLY . 70.3 mt -134.77 128.68 50.82 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 77' ' ' ILE . 91.5 mttt -68.21 143.05 55.48 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 168.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 p -68.96 -16.02 63.63 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.158 0.98 . . . . 0.0 111.546 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 80' ' ' THR . 5.4 t -89.79 -15.94 31.29 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.723 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -17.18 56.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.469 0.652 . . . . 0.0 110.472 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -129.63 156.88 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.805 0 CA-C-O 121.464 0.649 . . . . 0.0 112.509 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 18.5 mm-40 -98.29 100.65 11.96 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.2 mm -82.63 109.38 16.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.75 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 1.3 m-20 -93.87 154.83 17.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.048 0.928 . . . . 0.0 112.409 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.402 ' HB3' HD13 ' A' ' 91' ' ' LEU . 64.6 m-85 -92.34 -20.98 20.53 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 85' ' ' ASP . 15.5 t70 -44.26 -32.16 1.2 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.491 2.316 . . . . 0.0 112.751 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 30' ' ' LEU . 6.7 m -52.17 -43.6 64.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.436 1.094 . . . . 0.0 111.508 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 88' ' ' SER . 1.9 mm? -101.67 -31.23 10.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 64.68 95.63 0.05 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.794 1.638 . . . . 0.0 111.017 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 86' ' ' TYR . 5.9 mp -96.43 -175.48 3.35 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -86.62 75.09 9.74 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.53 96.13 3.64 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.899 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.71 111.75 23.15 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.0 mt 77.25 86.23 0.08 Allowed 'General case' 0 C--O 1.244 0.813 0 O-C-N 125.116 1.51 . . . . 0.0 109.139 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -177.359 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.505 -0.753 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 55.86 81.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.966 0.888 . . . . 0.0 113.093 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.24 97.6 8.37 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.287 -0.87 . . . . 0.0 108.957 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.09 126.3 53.04 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.099 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -109.55 116.29 31.5 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -118.0 76.68 1.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.803 0.811 . . . . 0.0 111.305 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.95 29.5 4.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -78.93 101.86 7.96 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.982 -173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 56.61 41.35 28.6 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.474 1.108 . . . . 0.0 109.967 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -107.64 7.52 28.62 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.212 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -66.4 -26.93 67.47 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.202 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.88 -22.97 60.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.562 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.11 -37.36 84.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -71.43 -59.04 2.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.481 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.5 pp -56.33 -25.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -72.37 -35.18 68.43 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.482 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -91.86 -32.52 15.29 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.902 0.858 . . . . 0.0 109.323 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -66.82 -45.71 77.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.37 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 65.1 m-85 -108.02 -3.36 18.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 20' ' ' LYS . 2.9 mptp? 60.89 75.2 0.42 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.181 0.991 . . . . 0.0 110.006 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 15' ' ' ILE . 8.8 tp -89.76 -24.53 21.48 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.904 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.252 77.3 p 64.79 -69.12 0.1 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.845 1.658 . . . . 0.0 112.473 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.39 -107.97 0.21 Allowed Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.49 145.51 71.06 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.441 2.094 . . . . 0.0 109.942 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' HG21 ' A' ' 55' ' ' ILE . 1.4 pp -138.66 -48.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.624 ' H ' HD12 ' A' ' 25' ' ' ILE . 31.1 mm-40 71.01 123.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.834 1.302 . . . . 0.0 114.129 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.19 140.5 18.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-N 112.548 -2.115 . . . . 0.0 111.156 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.95 -44.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.831 0.348 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.951 ' HB2' HD11 ' A' ' 54' ' ' ILE . 92.0 m-70 -142.83 177.08 8.58 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 89' ' ' LEU . 11.1 mp -110.54 119.25 38.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.453 0.644 . . . . 0.0 111.386 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.53 167.01 10.03 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.802 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 17.2 pttp -153.14 102.78 2.66 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.813 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.36 139.61 56.87 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.136 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.9 t -127.61 155.18 44.27 Favored 'General case' 0 CA--C 1.446 -3.055 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.6 m 69.45 175.9 0.28 Allowed 'General case' 0 N--CA 1.406 -2.654 0 O-C-N 125.889 1.993 . . . . 0.0 111.456 162.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.79 113.25 16.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.796 HG21 ' CE1' ' A' ' 46' ' ' PHE . 17.4 m -112.16 155.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.79 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -57.66 -46.8 83.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.311 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.58 43.01 45.35 Favored Glycine 0 C--N 1.359 1.813 0 O-C-N 123.896 0.747 . . . . 0.0 113.738 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.28 -153.04 0.04 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 116.255 1.262 . . . . 0.0 116.255 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -71.27 -51.34 25.01 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.95 -6.8 59.49 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.283 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.48 172.73 8.19 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.673 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -83.0 141.67 31.91 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -81.62 45.17 0.86 Allowed 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.456 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.888 ' HE2' HG12 ' A' ' 77' ' ' ILE . 1.2 p90 -86.05 179.19 7.02 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.833 0.825 . . . . 0.0 112.021 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.788 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 28.1 mtpp -132.92 -172.06 2.83 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.995 -172.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 24.6 tt0 -76.6 -12.02 59.95 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 126.881 2.073 . . . . 0.0 113.677 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.7 19.59 2.39 Favored Glycine 0 C--N 1.268 -3.208 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 9.6 mm-40 -77.12 125.46 29.36 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.86 0.838 . . . . 0.0 113.182 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -84.38 97.75 9.66 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.909 HD11 HG11 ' A' ' 82' ' ' VAL . 36.0 pt -112.64 159.1 12.8 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.047 0 CA-C-N 112.511 -2.131 . . . . 0.0 112.62 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.33 139.15 53.52 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.951 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -103.02 134.97 42.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.318 177.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.724 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -105.73 -24.45 4.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.415 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.783 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 9.3 ttt85 -127.38 122.94 34.98 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.382 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.7 mm -104.6 96.75 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.55 140.38 41.09 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.463 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -114.26 -21.89 10.22 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -64.26 148.62 95.64 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.814 1.246 . . . . 0.0 107.977 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.39 47.66 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 124.042 3.161 . . . . 0.0 115.483 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -78.68 -33.12 47.24 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.08 -19.42 52.32 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.881 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 78' ' ' LYS . 33.1 mmtp -133.28 156.38 47.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -174.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 32.5 m0 -93.11 162.35 14.06 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.712 0.633 . . . . 0.0 109.973 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -103.62 115.02 29.73 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.217 0.532 . . . . 0.0 110.327 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.728 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.48 -179.16 16.61 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.279 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 36.1 ptt180 -151.78 144.7 24.46 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.77 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.1 p -78.31 170.44 16.63 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.63 -14.67 59.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.214 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.66 0.03 57.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.217 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.83 68.35 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 114.474 0.55 . . . . 0.0 114.474 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 m -97.83 113.2 24.94 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 23.0 m-85 -82.47 151.64 26.44 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.801 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -170.94 159.02 30.94 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.644 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.7 m-85 -71.63 147.97 47.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.623 0.725 . . . . 0.0 111.606 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.888 HG12 ' HE2' ' A' ' 46' ' ' PHE . 69.3 mt -133.0 133.27 58.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.761 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' O ' HG22 ' A' ' 77' ' ' ILE . 98.2 mttt -69.43 135.37 50.15 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 167.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.5 p -66.23 -8.11 22.51 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.628 0.728 . . . . 0.0 111.885 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -106.2 -6.96 18.12 Favored 'General case' 0 N--CA 1.428 -1.573 0 C-N-CA 124.064 0.946 . . . . 0.0 109.731 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -85.99 -14.13 45.5 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.909 HG11 HD11 ' A' ' 52' ' ' ILE . 33.4 m -129.1 152.89 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.138 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.153 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.657 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 37.0 mt-10 -94.65 100.46 12.4 Favored 'General case' 0 N--CA 1.397 -3.11 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 31' ' ' ALA . 27.3 mm -90.77 106.03 17.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 175.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.1 134.42 54.23 Favored 'General case' 0 CA--C 1.471 -2.069 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.883 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -74.26 -28.57 61.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -50.17 -36.46 30.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.331 1.452 . . . . 0.0 111.151 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -65.68 -18.73 65.54 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.279 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 30' ' ' LEU . 3.6 mm? -103.93 -48.32 3.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.008 0.432 . . . . 0.0 109.922 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 39.1 ttmt -158.55 150.89 21.74 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 94' ' ' ASP . 87.7 mt -61.67 141.76 57.62 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.048 0.451 . . . . 0.0 111.025 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -63.86 123.74 19.71 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.736 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt 69.91 20.86 6.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.062 0.945 . . . . 0.0 110.159 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 27.9 t70 -77.38 140.39 39.92 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.88 140.21 29.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.036 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 124.025 0.93 . . . . 0.0 111.527 -179.044 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.236 0.357 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -99.86 111.35 23.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.779 0.799 . . . . 0.0 111.265 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.772 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -113.33 16.26 19.04 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.298 175.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.37 -69.2 0.3 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.16 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -125.25 -68.85 0.82 Allowed 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttm 49.22 68.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 111.849 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -80.17 -26.33 39.35 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.515 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 59.27 72.09 0.55 Allowed 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.837 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 173.96 -62.79 0.01 OUTLIER 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.76 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -61.19 -42.97 99.53 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.458 -173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 15' ' ' ILE . 12.9 mptt -65.37 -47.62 75.76 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' HA ' HG12 ' A' ' 15' ' ' ILE . 26.8 mp0 -77.49 -11.97 59.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -81.85 -23.33 36.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -89.94 -33.49 16.39 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.758 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 11' ' ' LYS . 2.6 pp -54.88 -31.87 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -73.94 -24.53 59.66 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -96.94 -28.06 14.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 31.5 tttp -61.33 -52.28 65.32 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.257 1.423 . . . . 0.0 110.478 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 42.4 m-85 -99.03 -5.88 29.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.101 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 61.16 76.04 0.39 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.717 1.246 . . . . 0.0 108.304 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 25' ' ' ILE . 10.4 tp -116.36 16.09 15.75 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.212 -172.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -75.92 122.79 24.68 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.109 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.52 168.53 18.54 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.57 121.61 8.84 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 123.789 2.992 . . . . 0.0 112.196 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.854 HG13 ' H ' ' A' ' 26' ' ' GLN . 18.2 pt -106.37 -76.82 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.854 ' H ' HG13 ' A' ' 25' ' ' ILE 0.258 23.8 mt-30 72.41 141.12 0.06 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 125.186 1.394 . . . . 0.0 114.316 -177.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 53' ' ' GLU . 60.6 t -81.4 137.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.218 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.494 -175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.12 -42.3 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.92 ' HB2' HD11 ' A' ' 54' ' ' ILE . 84.8 m-70 -142.46 178.89 7.29 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' A' ' 88' ' ' SER . 45.2 tp -115.27 125.66 53.57 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -105.63 171.49 7.3 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.64 0.734 . . . . 0.0 109.95 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 61.4 pttt -151.08 107.53 3.48 Favored 'General case' 0 N--CA 1.398 -3.039 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -70.15 130.97 43.5 Favored 'General case' 0 C--N 1.255 -3.531 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.589 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.05 166.42 12.02 Favored 'General case' 0 CA--C 1.469 -2.151 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 6.3 m 63.73 164.94 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 125.219 1.574 . . . . 0.0 114.444 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.98 111.18 5.49 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.833 HG21 ' HE1' ' A' ' 46' ' ' PHE . 19.3 m -111.89 156.6 12.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.087 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -56.33 -60.8 2.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' ' 43' ' ' GLU . . . 49.6 41.48 34.14 Favored Glycine 0 C--O 1.21 -1.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.809 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.13 -110.26 0.01 OUTLIER Glycine 0 CA--C 1.542 1.724 0 N-CA-C 118.727 2.251 . . . . 0.0 118.727 -168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.789 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 9.4 mmpt? -98.87 -53.76 3.19 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 122.271 -0.546 . . . . 0.0 111.535 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.578 HD22 ' HD2' ' A' ' 76' ' ' TYR . 2.2 p-10 -95.43 1.96 54.33 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.075 0.464 . . . . 0.0 110.534 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' C ' ' A' ' 39' ' ' GLY . 39.2 mt-10 -92.65 157.52 16.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.684 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.048 0.927 . . . . 0.0 111.269 -173.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.6 m -84.07 69.75 10.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.671 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.925 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -111.86 -175.69 2.75 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.58 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -145.1 -172.66 3.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 124.036 0.835 . . . . 0.0 109.234 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.7 tt0 -85.7 107.44 17.58 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 125.429 1.492 . . . . 0.0 109.576 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.08 13.97 29.98 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -85.93 126.82 34.38 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.625 0.726 . . . . 0.0 111.629 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -89.93 96.44 10.68 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HG11 ' A' ' 82' ' ' VAL . 33.3 pt -109.51 158.09 9.65 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.052 0 CA-C-N 112.495 -2.138 . . . . 0.0 112.704 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB3' HG11 ' A' ' 27' ' ' VAL . 30.3 mt-10 -121.83 134.64 54.89 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -97.33 129.27 47.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.288 175.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.665 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.5 mp -98.99 -40.28 8.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.008 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.9 ttm180 -121.87 119.7 32.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.531 -0.867 . . . . 0.0 112.758 -174.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mm -90.41 98.69 8.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 t -125.34 146.11 49.72 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.264 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -114.02 9.32 17.32 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.43 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.667 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 5.0 m-20 -61.41 170.79 1.54 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.259 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.667 ' HD2' ' HB3' ' A' ' 60' ' ' ASN . 51.8 Cg_exo -19.68 -52.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.86 1 C-N-CA 126.95 5.1 . . . . 0.0 117.874 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.671 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 11.9 mm-40 -64.35 -36.81 85.36 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.77 31.74 73.4 Favored Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 33.0 mmtp -123.66 159.93 28.26 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.453 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 34.5 m0 -95.98 152.04 18.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.6 tm? -93.69 114.03 26.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.694 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -118.32 179.67 17.02 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.31 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 35.1 ptt180 -152.29 139.69 19.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.87 ' HA ' HG22 ' A' ' 52' ' ' ILE . 5.5 p -76.0 171.49 14.35 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 117.948 0.34 . . . . 0.0 110.446 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.45 -16.19 60.35 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -72.56 -17.48 61.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.558 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.11 23.53 22.18 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 114.401 0.52 . . . . 0.0 114.401 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 23.6 m -113.43 128.09 56.33 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 41.2 m-85 -89.67 151.85 21.66 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.525 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -174.89 160.29 29.25 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.578 ' HD2' HD22 ' A' ' 42' ' ' ASN . 17.5 m-85 -74.73 146.45 42.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.388 0.613 . . . . 0.0 111.011 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.925 HG12 ' HE2' ' A' ' 46' ' ' PHE . 70.0 mt -128.29 129.7 69.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.673 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' O ' HG22 ' A' ' 77' ' ' ILE . 63.0 mttm -69.77 132.43 46.07 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 165.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.3 p -63.14 -10.75 16.22 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.737 0.78 . . . . 0.0 112.595 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.7 t -93.88 -21.1 19.45 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 123.897 0.879 . . . . 0.0 109.709 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -76.36 -15.07 60.04 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.974 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG11 HD11 ' A' ' 52' ' ' ILE . 34.4 m -127.19 157.81 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 CA-C-O 121.405 0.622 . . . . 0.0 111.753 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 32.0 mt-10 -112.73 101.02 9.14 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 31' ' ' ALA . 20.0 mm -74.19 132.57 33.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.197 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -109.74 146.78 34.36 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -99.81 -37.91 8.87 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.002 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -62.78 -33.58 75.48 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.167 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.794 ' HB3' HD23 ' A' ' 30' ' ' LEU . 38.9 m -72.05 1.62 7.06 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 29' ' ' HIS . 4.2 mm? -81.79 -3.72 54.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.111 0.958 . . . . 0.0 109.78 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -111.8 154.02 25.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.65 83.97 3.3 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -167.06 130.6 1.85 Allowed 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -160.4 112.02 1.93 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.37 133.13 54.88 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -65.18 131.12 45.71 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.375 0.67 . . . . 0.0 111.259 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 C--N 1.304 -1.387 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.22 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -87.77 130.11 34.95 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -115.86 72.77 0.82 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 59.29 27.06 16.02 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.134 0.968 . . . . 0.0 108.791 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 58.37 85.38 0.09 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.439 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -14.3 60.06 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.206 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.24 130.81 44.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -94.81 -10.53 31.15 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.573 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 69.07 99.12 0.06 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.39 1.076 . . . . 0.0 112.701 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -64.5 -25.08 67.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.032 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -61.1 -43.29 99.11 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.232 0.539 . . . . 0.0 110.877 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 15' ' ' ILE . 9.5 pt-20 -84.52 -26.85 27.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.02 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.18 -42.15 94.41 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.175 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.3 -41.87 66.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.617 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.6 pp -64.51 -29.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.933 0.397 . . . . 0.0 111.742 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 45.6 mtmt -76.26 -25.58 55.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.637 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -83.86 -38.2 21.47 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.09 -49.28 62.21 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.083 1.353 . . . . 0.0 112.406 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.47 -4.6 25.15 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 57.37 75.52 0.37 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 10.7 tp -127.51 14.47 7.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.374 -1.284 . . . . 0.0 107.988 -170.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -57.57 117.31 4.05 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.676 -172.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.98 169.47 11.67 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.84 120.15 6.86 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 122.218 1.946 . . . . 0.0 110.764 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.805 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.7 pp -104.26 151.44 6.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -143.46 159.28 42.69 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.345 1.058 . . . . 0.0 108.168 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 53' ' ' GLU . 30.8 m -75.2 154.97 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.691 HD12 HG12 ' A' ' 57' ' ' ILE . 36.0 mt -105.05 -32.74 2.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.589 168.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.919 ' HB2' HD11 ' A' ' 54' ' ' ILE . 82.9 m-70 -152.01 -178.59 6.86 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 53' ' ' GLU . 30.2 tp -119.28 132.98 55.98 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.08 170.6 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.607 0.718 . . . . 0.0 110.646 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 46.0 pttt -153.32 102.87 2.64 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.841 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -59.99 125.52 23.97 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.689 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.8 p -111.26 166.55 11.0 Favored 'General case' 0 CA--C 1.452 -2.808 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.472 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m 61.26 174.67 0.11 Allowed 'General case' 0 N--CA 1.424 -1.748 0 O-C-N 125.038 1.461 . . . . 0.0 112.307 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.14 102.96 8.75 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 46' ' ' PHE . 18.7 m -92.01 154.31 3.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.692 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -58.18 -58.95 6.21 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.65 42.09 90.44 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 124.288 0.992 . . . . 0.0 113.696 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.04 -152.57 0.37 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.582 0.593 . . . . 0.0 114.582 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -63.27 -50.13 71.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 4.5 p-10 -82.8 -8.9 59.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.696 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 41.6 mt-10 -91.68 -179.81 5.44 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.571 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.4 tt -88.51 149.0 23.86 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 44' ' ' LEU . 29.9 t -92.08 90.17 7.26 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.726 ' CE1' HG21 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.61 176.91 9.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.728 -1.123 . . . . 0.0 109.892 -174.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -139.65 -174.0 3.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 111.612 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 28.9 tt0 -79.17 105.68 10.67 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 126.532 1.933 . . . . 0.0 108.81 -177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.88 12.15 44.27 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.44 157.8 33.58 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -108.26 96.78 6.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.7 -1.136 . . . . 0.0 107.964 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.693 HD11 HG11 ' A' ' 82' ' ' VAL . 23.1 pt -117.0 159.39 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 CA-C-N 112.902 -1.954 . . . . 0.0 112.983 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 5.3 pt-20 -133.21 139.23 46.88 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.25 0.2 OUTLIER -102.34 132.48 48.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.822 179.458 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.805 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.37 -31.95 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.919 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.019 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 39.7 ttm180 -115.76 126.83 54.56 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.713 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.691 HG12 HD12 ' A' ' 28' ' ' ILE . 51.1 mm -103.3 98.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.69 141.7 31.17 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.733 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -110.12 -13.86 14.3 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -43.09 142.2 1.58 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 126.27 1.828 . . . . 0.0 112.471 177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -43.34 -20.15 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.971 1 C-N-CA 125.784 4.323 . . . . 0.0 116.173 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' HG3' ' CG ' ' A' ' 64' ' ' LYS . 11.3 tp10 -55.92 -36.08 67.31 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.75 31.62 76.29 Favored Glycine 0 CA--C 1.487 -1.698 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.958 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 47.7 mmtm -133.53 155.91 48.74 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 26.1 m0 -108.36 152.49 24.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.487 0.715 . . . . 0.0 110.35 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.019 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -92.74 110.72 22.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.769 -0.773 . . . . 0.0 109.95 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -116.81 176.56 16.32 Favored Glycine 0 N--CA 1.417 -2.63 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.154 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 23.0 ptt180 -151.76 143.13 23.41 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.568 ' HA ' HG22 ' A' ' 52' ' ' ILE . 4.2 p -77.05 166.15 23.68 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -20.83 66.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -67.33 -26.43 66.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.842 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.83 20.41 11.6 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.509 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 67.1 m -104.41 120.72 41.86 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 117.875 0.837 . . . . 0.0 108.799 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 5.6 m-85 -92.58 150.0 21.0 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.983 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.433 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -166.64 155.98 27.53 Favored Glycine 0 C--N 1.305 -1.169 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.15 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 2.0 m-85 -79.19 116.16 19.29 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-O 121.687 0.756 . . . . 0.0 110.015 174.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 78' ' ' LYS . 65.1 mt -100.41 140.2 20.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.761 -174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.5 mtmt -71.96 139.3 48.6 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 168.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.7 p -68.95 -12.69 61.88 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.768 0.794 . . . . 0.0 111.92 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 t -99.42 -12.22 20.44 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.589 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . . . -77.26 -15.89 59.25 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.193 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.841 HG12 ' HA ' ' A' ' 33' ' ' ALA . 27.1 m -130.39 154.18 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.477 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 36.7 mt-10 -100.84 102.8 13.94 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.596 HD13 ' HB2' ' A' ' 31' ' ' ALA . 29.0 mm -79.58 119.2 28.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -97.06 140.99 30.75 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.779 0.799 . . . . 0.0 110.593 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -98.31 -34.52 10.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.265 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -69.66 -8.43 47.57 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.405 HD21 ' N ' ' A' ' 30' ' ' LEU . 3.3 mm? -102.01 -3.81 27.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.642 0.734 . . . . 0.0 109.157 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -106.81 -70.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.058 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD22 ' HG ' ' A' ' 95' ' ' LEU . 93.6 mt 51.96 89.37 0.03 OUTLIER 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 113.08 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -114.17 -61.51 1.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -149.02 74.07 1.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' H ' HD12 ' A' ' 95' ' ' LEU . 8.9 p-10 -172.13 27.73 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.259 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' HG ' HD22 ' A' ' 91' ' ' LEU . 5.2 mp -94.23 88.44 5.59 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.169 -175.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 174.427 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.613 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.242 0.705 0 CA-C-O 121.572 0.701 . . . . 0.0 112.413 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -115.15 -43.34 3.09 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -147.11 25.51 1.12 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.613 ' HB2' ' HA ' ' A' ' 1' ' ' GLU . 1.8 mp0 -101.02 -147.14 0.35 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.844 -173.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.422 ' H ' ' HB3' ' A' ' 4' ' ' GLU . 52.1 tt0 72.41 34.64 1.28 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 123.981 1.848 . . . . 0.0 107.182 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -73.5 154.9 39.71 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.571 -2.104 . . . . 0.0 107.323 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 9' ' ' GLU . 2.4 mp0 -54.76 147.27 15.18 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.436 0.636 . . . . 0.0 110.748 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.57 14.44 28.41 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HG2' ' HB3' ' A' ' 7' ' ' GLU . 16.9 mm-40 -74.25 95.22 2.6 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.826 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -108.03 -33.87 7.06 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.673 0.749 . . . . 0.0 109.2 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -63.75 -23.83 67.52 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -81.2 -16.58 52.39 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.495 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -80.95 -34.82 32.95 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.26 -46.27 89.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.146 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.52 -27.88 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.19 0.519 . . . . 0.0 111.343 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 92.9 mttt -75.04 -18.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.66 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -97.57 -40.52 8.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.92 -49.28 78.32 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.553 1.141 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.438 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.9 m-85 -100.83 -0.51 36.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.642 -177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.41 74.68 0.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.059 0.933 . . . . 0.0 108.737 -171.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 8.6 tp -121.57 15.01 11.11 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.557 -173.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -64.75 118.27 8.71 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.734 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.56 -164.75 21.66 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -66.17 140.07 57.87 Favored 'Trans proline' 0 CA--C 1.5 -1.222 0 C-N-CA 122.174 1.916 . . . . 0.0 109.406 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.84 HG12 HG21 ' A' ' 55' ' ' ILE 0.359 0.0 OUTLIER -111.74 -66.29 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.173 -173.035 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' HD13 ' A' ' 25' ' ' ILE . 34.2 mm-40 70.96 161.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.121 0.962 . . . . 0.0 113.556 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.46 127.95 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.237 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.4 mm -98.87 -45.49 12.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.208 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.933 ' HB2' HD11 ' A' ' 54' ' ' ILE . 78.1 m-70 -152.36 170.45 20.04 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.92 125.68 48.65 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.997 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -106.78 175.18 5.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' CG ' ' HB2' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -153.71 106.59 2.9 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 175.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.869 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.52 138.02 57.79 Favored 'General case' 0 C--N 1.274 -2.683 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.118 -177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 40.1 t -126.62 151.86 47.43 Favored 'General case' 0 CA--C 1.447 -3.004 0 O-C-N 123.211 0.319 . . . . 0.0 110.307 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.1 m 71.22 167.42 0.31 Allowed 'General case' 0 N--CA 1.403 -2.805 0 O-C-N 125.976 2.048 . . . . 0.0 111.903 163.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.35 104.87 4.51 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.008 0.909 . . . . 0.0 110.707 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.795 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.7 m -107.49 157.4 7.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 124.633 1.173 . . . . 0.0 110.493 -175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HD3' ' HE3' ' A' ' 78' ' ' LYS . 13.2 ptmm? -59.11 -53.82 54.0 Favored 'General case' 0 N--CA 1.44 -0.969 0 O-C-N 123.609 0.568 . . . . 0.0 111.164 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 46.89 41.75 14.21 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 120.901 -0.666 . . . . 0.0 114.121 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -68.35 -111.13 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 118.034 1.974 . . . . 0.0 118.034 -169.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.7 -53.79 7.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -112.38 3.29 16.87 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.971 0.891 . . . . 0.0 109.472 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 42.0 mt-10 -91.92 148.42 22.22 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -69.94 126.96 31.22 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-O 121.72 0.771 . . . . 0.0 109.706 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 m -85.26 83.14 8.08 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.829 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.84 -177.44 3.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.222 -178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.5 mtpt -125.73 -173.99 2.97 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.193 -175.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -73.93 -9.14 58.33 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.187 2.195 . . . . 0.0 113.785 -170.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.28 18.65 2.48 Favored Glycine 1 C--N 1.245 -4.491 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 13.0 mm-40 -79.75 128.21 33.14 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.744 0.783 . . . . 0.0 111.556 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -89.26 96.95 10.93 Favored 'General case' 0 N--CA 1.404 -2.755 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.88 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.871 HD11 HG11 ' A' ' 82' ' ' VAL . 20.8 pt -113.72 157.96 14.23 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.916 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.946 175.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -131.88 141.58 49.43 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.933 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.28 147.62 7.51 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.699 -177.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.84 HG21 HG12 ' A' ' 25' ' ' ILE . 3.6 mp -112.94 -57.18 4.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.42 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.926 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 41.9 ttm180 -92.73 125.55 37.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.777 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.38 100.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 1.3 p -136.15 148.35 48.15 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 8.6 m-20 -114.04 -38.47 4.17 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.646 176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.689 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 52.9 t30 -77.76 -63.07 0.49 Allowed Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.746 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.689 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 52.8 Cg_exo -59.14 103.76 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.296 1.997 . . . . 0.0 112.216 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 69.97 -12.45 0.48 Allowed 'General case' 0 C--O 1.251 1.135 0 C-N-CA 125.081 1.352 . . . . 0.0 113.733 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 59' ' ' ASP . . . 66.49 31.03 77.56 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -175.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 45.0 mmtm -134.09 166.09 23.56 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.0 m0 -104.27 146.65 28.49 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 173.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.926 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -94.91 115.7 27.79 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -113.64 178.68 18.58 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 40.8 ptt180 -151.83 138.79 19.04 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.661 ' HA ' HG22 ' A' ' 52' ' ' ILE . 28.8 p -77.87 176.49 9.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.87 -18.12 62.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.927 0.87 . . . . 0.0 109.209 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -78.49 -15.32 58.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.611 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.54 19.44 41.25 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.434 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -98.34 114.18 26.4 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' HD2' HD11 ' A' ' 66' ' ' LEU . 27.9 m-85 -83.34 150.59 26.02 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.975 -178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.528 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -170.53 154.01 22.18 Favored Glycine 0 CA--C 1.5 -0.885 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.41 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.429 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 26.8 m-85 -73.85 143.22 45.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.655 0.741 . . . . 0.0 110.959 175.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.829 HG12 ' HE2' ' A' ' 46' ' ' PHE . 54.0 mt -128.71 136.59 59.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.089 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 88.3 mttt -70.2 140.23 52.46 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.4 p -65.3 -6.77 10.71 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -106.23 -12.22 15.79 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.386 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.46 -10.85 59.71 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.369 0.604 . . . . 0.0 109.606 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 52' ' ' ILE . 27.0 m -134.63 153.51 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.498 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.396 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.514 ' HB2' ' CG ' ' A' ' 32' ' ' LYS . 15.3 mm-40 -96.19 100.53 12.16 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.512 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.8 mm -75.9 131.11 35.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.622 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.15 114.85 20.96 Favored 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 122.627 1.203 . . . . 0.0 111.1 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.483 ' HA ' HD23 ' A' ' 89' ' ' LEU . 85.7 m-85 -100.84 -20.03 15.69 Favored 'General case' 1 C--N 1.242 -4.072 0 CA-C-N 111.864 -2.426 . . . . 0.0 109.422 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 48.5 m-20 -64.98 -44.88 87.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.0 113.075 -173.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -73.87 -5.56 41.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 112.007 -174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 86' ' ' TYR . 3.5 mm? -78.02 -20.13 53.08 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 121.602 -0.686 . . . . 0.0 110.527 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -125.14 80.96 1.92 Allowed 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.4 mt 70.37 -76.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.204 1.401 . . . . 0.0 111.467 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 33.2 ttmt -171.19 -43.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.523 0.329 . . . . 0.0 110.923 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 55.3 mttp 62.44 91.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -84.47 -12.84 53.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 66.8 tp -168.17 -48.32 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.442 1.897 . . . . 0.0 106.398 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.436 -1.15 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.182 177.85 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp 71.87 21.69 4.1 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.087 1.755 . . . . 0.0 110.769 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -127.96 13.31 6.78 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -87.05 116.55 25.19 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.958 -1.473 . . . . 0.0 108.597 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -62.73 1.6 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -90.89 125.17 35.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.837 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' HG3' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -70.54 169.19 14.71 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.56 1.144 . . . . 0.0 109.235 -178.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 8' ' ' LYS 0.314 1.0 OUTLIER -77.15 101.69 6.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.622 1.201 . . . . 0.0 114.136 -176.778 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -89.86 -34.39 16.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.855 -174.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -37.97 79.19 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.56 -175.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -53.85 -50.31 66.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.296 0.997 . . . . 0.0 110.297 176.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 15' ' ' ILE . 9.8 pt-20 -78.31 -25.43 46.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.959 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -64.82 -40.81 95.8 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -63.98 -46.75 83.22 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.421 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.3 pp -64.62 -26.5 40.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 110.806 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -71.04 -42.64 69.22 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.514 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -83.62 -7.88 59.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.076 0.465 . . . . 0.0 110.923 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -100.32 -49.34 4.29 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.095 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 60.1 m-85 -104.54 -12.1 16.65 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 59.97 79.53 0.23 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.999 0.904 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.44 -36.46 22.33 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.624 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 26.4 p 60.41 -47.55 0.1 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.418 2.287 . . . . 0.0 116.704 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.68 -168.83 11.39 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.74 141.55 49.93 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.529 2.153 . . . . 0.0 111.635 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.986 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.5 pp -118.37 160.31 18.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.526 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.501 ' O ' HG13 ' A' ' 27' ' ' VAL . 49.2 mt-30 -110.93 -93.71 0.44 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.189 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 170.92 149.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.608 2.363 . . . . 0.0 109.491 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 29' ' ' HIS . 48.6 mm -110.24 -42.39 5.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.832 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 76.0 m-70 -153.13 176.64 11.69 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 8.9 mp -105.62 137.37 43.58 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 171.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.84 168.79 9.39 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -151.04 103.25 3.03 Favored 'General case' 0 C--N 1.252 -3.644 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -58.75 132.18 53.11 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.087 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 43.6 t -115.75 151.32 35.36 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 121.074 0.464 . . . . 0.0 110.542 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.1 m 68.73 178.46 0.25 Allowed 'General case' 0 N--CA 1.405 -2.709 0 O-C-N 125.67 1.856 . . . . 0.0 110.491 163.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.57 108.04 15.66 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.835 HG21 ' HE1' ' A' ' 46' ' ' PHE . 8.3 m -99.15 155.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -56.85 -49.91 74.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.178 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 43' ' ' GLU . . . 54.09 41.42 69.21 Favored Glycine 0 C--N 1.352 1.426 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.208 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.89 -102.33 0.01 OUTLIER Glycine 0 C--O 1.245 0.825 0 N-CA-C 116.696 1.438 . . . . 0.0 116.696 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -98.34 -53.72 3.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 34.7 p30 -95.38 0.43 53.5 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.142 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 29.7 mt-10 -90.66 151.26 21.34 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -67.06 146.93 53.81 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.77 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.419 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.6 m -83.71 70.84 10.4 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 176.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.835 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -112.32 -179.79 3.77 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.575 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 58.1 mtpt -136.3 -173.47 3.41 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.59 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -71.16 -12.39 61.46 Favored 'General case' 0 C--N 1.281 -2.409 0 C-N-CA 128.545 2.738 . . . . 0.0 114.652 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.96 19.23 2.34 Favored Glycine 0 C--N 1.259 -3.728 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.655 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 6.8 mm-40 -78.68 127.46 32.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.393 -0.904 . . . . 0.0 111.787 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -97.8 96.33 8.15 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.876 HG22 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -107.67 158.32 7.6 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.152 0 CA-C-N 112.086 -2.325 . . . . 0.0 112.427 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.823 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 48.1 mt-10 -123.08 133.45 54.3 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 120.901 -1.125 . . . . 0.0 109.362 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -96.69 138.54 21.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.642 177.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.986 HG21 ' HB ' ' A' ' 25' ' ' ILE . 3.6 mp -111.63 -35.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.795 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.707 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.3 ttm180 -108.92 125.86 52.46 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.043 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.38 104.56 16.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.8 141.62 37.75 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -169.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.18 -25.68 9.19 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.497 -1.228 . . . . 0.0 107.911 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -51.15 145.18 13.43 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 124.932 1.293 . . . . 0.0 110.682 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 93.5 Cg_exo -21.91 136.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.461 1 C-N-CA 126.629 4.886 . . . . 0.0 115.199 177.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 47.7 mm-40 87.52 -35.6 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 112.271 -172.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.6 32.17 83.32 Favored Glycine 0 CA--C 1.496 -1.145 0 O-C-N 123.601 0.563 . . . . 0.0 113.15 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.552 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.5 mmtm -102.22 145.27 29.66 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -94.11 144.44 25.49 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.881 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -86.51 109.03 18.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.656 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -112.38 177.84 18.71 Favored Glycine 0 N--CA 1.419 -2.461 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.251 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 28.8 ptt180 -151.64 136.1 16.91 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.876 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.1 p -73.34 169.88 16.2 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 118.032 0.378 . . . . 0.0 110.55 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -6.94 52.62 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.501 0.667 . . . . 0.0 109.209 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.84 -25.02 17.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.541 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 31.8 2.09 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 120.434 -0.888 . . . . 0.0 114.388 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.5 m -113.13 116.69 30.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 66' ' ' LEU . 88.7 m-85 -82.93 147.35 28.3 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA2' ' CZ ' ' A' ' 19' ' ' PHE . . . -164.11 157.07 29.25 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.062 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 1.1 m-30 -80.63 127.48 32.51 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.912 0.863 . . . . 0.0 109.222 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.834 HG12 ' HE2' ' A' ' 46' ' ' PHE . 86.8 mt -107.43 133.87 50.87 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.151 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.113 -175.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 81' ' ' ALA . 48.7 mtmt -71.01 127.44 32.57 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 167.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.0 p -59.41 -18.29 37.76 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -92.08 -20.89 20.81 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.709 0.804 . . . . 0.0 109.864 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -75.85 -13.44 60.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.847 HG11 HD11 ' A' ' 52' ' ' ILE . 34.8 m -127.57 154.55 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 CA-C-O 121.406 0.622 . . . . 0.0 111.937 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.41 101.98 12.7 Favored 'General case' 0 N--CA 1.415 -2.217 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.6 mm -78.14 125.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.428 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' O ' HD23 ' A' ' 89' ' ' LEU . 19.0 t70 -88.69 121.34 30.97 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.588 1.185 . . . . 0.0 110.707 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.65 -31.73 11.43 Favored 'General case' 0 C--N 1.248 -3.817 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.085 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.26 -50.23 73.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -81.66 -18.6 44.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.193 0.52 . . . . 0.0 110.528 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.832 ' HG ' ' HA ' ' A' ' 29' ' ' HIS . 3.8 mm? -88.48 -23.55 23.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 90' ' ' LYS . 34.6 mmtp 74.12 -32.35 0.23 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.419 1.488 . . . . 0.0 114.253 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.58 107.86 2.66 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 122.591 0.356 . . . . 0.0 110.195 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -158.27 119.45 3.47 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.186 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -121.96 122.11 38.61 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -121.3 102.92 8.6 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 mp 63.12 93.13 0.06 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.056 0.942 . . . . 0.0 110.341 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.495 -175.775 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -120.27 70.49 0.88 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.71 0.767 . . . . 0.0 109.347 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -107.9 -55.05 2.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -105.73 -37.33 6.76 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 56.83 64.99 1.5 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.433 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -100.16 -26.29 13.99 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.436 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.06 92.61 2.65 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.309 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -124.98 162.47 24.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.96 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.677 ' HA ' ' HG2' ' A' ' 12' ' ' GLU . 1.5 mp0 -73.24 -20.59 60.81 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.87 -31.15 68.82 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.837 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 11' ' ' LYS . 42.5 tptt -80.15 -43.62 21.3 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.735 -176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 9' ' ' GLU . 6.6 pt-20 -68.82 -18.85 64.23 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 120.932 0.396 . . . . 0.0 110.439 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.97 -30.97 72.0 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.49 -59.29 3.08 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.738 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 12' ' ' GLU . 2.5 pp -60.3 -26.97 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.018 -175.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.48 -21.41 45.42 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -97.95 -37.51 9.76 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.522 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.48 ' HE3' ' CZ ' ' A' ' 19' ' ' PHE . 38.9 ttpt -65.53 -36.47 83.9 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.48 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' CZ ' ' HE3' ' A' ' 18' ' ' LYS . 53.7 m-85 -110.46 8.43 23.12 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 56.45 38.82 30.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.933 0.873 . . . . 0.0 110.395 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 21' ' ' LEU . 7.1 tp -94.24 17.01 13.47 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.603 -1.18 . . . . 0.0 112.507 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -62.6 122.09 14.95 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.393 0.616 . . . . 0.0 109.371 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.97 162.01 11.05 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.62 134.3 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.364 2.042 . . . . 0.0 112.443 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.717 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -125.66 154.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.453 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 27' ' ' VAL . 16.2 mm100 -110.14 -84.31 0.56 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.75 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -177.62 136.78 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 C-N-CA 127.363 2.265 . . . . 0.0 108.407 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG21 HG12 ' A' ' 57' ' ' ILE . 46.9 mm -98.05 -42.83 11.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 1.066 ' HB2' HD11 ' A' ' 54' ' ' ILE . 91.4 m-70 -150.74 168.84 23.19 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -104.62 124.85 50.07 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.81 168.89 8.84 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG3' ' HB2' ' A' ' 83' ' ' GLU . 15.1 ptpt -153.45 103.86 2.7 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.838 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.65 139.89 57.89 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.31 -177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.464 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 44.0 t -123.12 150.68 42.91 Favored 'General case' 0 CA--C 1.452 -2.797 0 CA-C-O 121.219 0.533 . . . . 0.0 110.36 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 10.4 m 68.81 -179.95 0.23 Allowed 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.016 163.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.51 103.2 15.66 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.412 0.625 . . . . 0.0 109.909 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 46' ' ' PHE . 12.0 m -93.84 155.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.227 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -55.62 -42.85 75.5 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.284 0.99 . . . . 0.0 110.851 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.0 43.9 31.88 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 115.201 0.841 . . . . 0.0 115.201 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.06 -175.64 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -47.32 -52.29 16.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.457 1.103 . . . . 0.0 113.741 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -88.78 -4.63 58.46 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.367 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.76 166.6 12.68 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.661 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -79.48 145.21 33.38 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.485 0.66 . . . . 0.0 109.375 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 m -85.86 41.95 0.94 Allowed 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.297 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.898 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -82.43 176.78 9.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.589 0.709 . . . . 0.0 112.3 -177.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 60.2 mtpt -132.74 -173.86 3.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.0 -173.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 30.6 tt0 -65.59 -15.8 63.08 Favored 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 127.121 2.168 . . . . 0.0 115.532 -169.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.47 19.25 2.81 Favored Glycine 0 C--N 1.26 -3.651 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 11.5 mm-40 -77.37 126.47 30.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -89.62 97.34 11.14 Favored 'General case' 0 N--CA 1.409 -2.522 0 CA-C-N 113.936 -1.484 . . . . 0.0 107.657 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.98 HD11 HG11 ' A' ' 82' ' ' VAL . 24.7 pt -110.4 158.54 10.66 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.343 0 CA-C-N 112.44 -2.164 . . . . 0.0 111.652 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.59 139.38 52.31 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 121.286 -0.884 . . . . 0.0 108.825 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.066 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -99.61 135.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.889 0.852 . . . . 0.0 110.232 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.97 8.47 6.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.741 -177.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.762 ' HG2' HG23 ' A' ' 58' ' ' THR . 28.7 ttm180 -154.97 117.75 4.34 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.511 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.455 HG12 HG21 ' A' ' 28' ' ' ILE . 51.2 mm -93.28 96.85 6.51 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -94.69 139.48 31.17 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.994 -175.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -115.4 8.82 15.41 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 172.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' OD1' HG22 ' A' ' 58' ' ' THR . 14.3 m120 -57.62 162.59 4.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.977 1.711 . . . . 0.0 111.318 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.23 12.41 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 124.04 3.16 . . . . 0.0 114.667 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -84.1 -37.0 22.57 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.44 19.9 75.6 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.514 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.3 mmtt -133.36 161.66 33.93 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.456 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 30.5 m0 -101.03 159.18 15.44 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 172.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.0 tm? -100.35 115.3 29.66 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.151 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.679 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -119.49 -178.48 16.52 Favored Glycine 0 N--CA 1.419 -2.473 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.88 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 37.0 ptt180 -151.83 144.42 24.23 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.686 ' HA ' HG22 ' A' ' 52' ' ' ILE . 21.8 p -78.85 175.21 10.71 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 118.598 0.635 . . . . 0.0 109.513 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.92 60.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.24 1.019 . . . . 0.0 109.477 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.15 -14.36 41.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.283 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 33.5 14.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.801 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 113.29 26.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 66.1 m-85 -82.89 147.6 28.19 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.776 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -169.28 154.28 23.56 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.43 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.505 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 27.8 m-85 -73.31 149.35 42.73 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.84 0.828 . . . . 0.0 111.08 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.898 HG12 ' HE2' ' A' ' 46' ' ' PHE . 59.9 mt -130.05 134.07 63.4 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.875 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 77' ' ' ILE . 47.9 mtmt -67.58 139.47 56.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.6 p -66.92 -12.06 58.26 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.84 0.828 . . . . 0.0 111.742 -175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' THR . 2.8 t -100.88 -18.04 16.56 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.565 1.146 . . . . 0.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -74.1 -13.89 60.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.758 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.98 HG11 HD11 ' A' ' 52' ' ' ILE . 28.2 m -135.76 161.68 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.201 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.83 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 32' ' ' LYS . 31.1 mm-40 -110.21 113.54 26.3 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.2 mp -84.79 140.47 15.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -78.19 154.68 30.9 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 122.009 0.909 . . . . 0.0 112.156 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -98.83 -19.65 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.772 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.03 -39.07 74.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.437 1.095 . . . . 0.0 111.915 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 p -54.81 -27.16 39.79 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.084 0.954 . . . . 0.0 112.535 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD21 ' CE1' ' A' ' 29' ' ' HIS . 27.9 mt -93.48 -63.94 1.15 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -104.98 99.26 8.88 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.54 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.5 tp -78.49 100.03 6.71 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -125.74 136.81 53.59 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.699 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.54 113.7 20.45 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.894 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -91.61 113.52 25.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.86 97.08 7.5 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.26 1.607 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.32 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.684 ' HD2' ' HB2' ' A' ' 6' ' ' LYS . 13.5 tppt? -145.33 49.45 1.25 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -82.38 2.69 31.21 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.735 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -85.24 -3.47 58.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 6.2 tp60 64.96 95.07 0.05 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.514 1.926 . . . . 0.0 112.979 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.684 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . 65.7 mttm -152.64 174.05 14.45 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -87.02 -91.12 0.11 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -159.51 92.71 1.07 Allowed 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 125.119 1.368 . . . . 0.0 107.591 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 38.5 mt-10 -85.72 16.9 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.813 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -56.55 -34.85 67.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.09 -54.86 5.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.448 0.642 . . . . 0.0 109.429 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.689 ' HA ' HG13 ' A' ' 15' ' ' ILE . 14.9 pt-20 -68.47 -28.12 66.75 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -171.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' A' ' 9' ' ' GLU . 94.1 mt-30 -60.21 -32.81 71.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.422 0.556 . . . . 0.0 111.865 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.26 -46.65 11.6 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.689 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.2 pp -61.01 -30.46 47.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.718 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 96.8 mttt -73.75 -29.72 62.39 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.95 -40.31 16.0 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.48 -44.52 64.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.116 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -95.12 -5.16 44.8 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.798 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm 59.5 71.92 0.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.6 tp -107.3 16.65 23.76 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.502 -171.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -49.85 132.41 22.41 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.543 0.737 . . . . 0.0 112.418 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.76 -152.77 17.43 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.97 142.87 17.68 Favored 'Trans proline' 0 CA--C 1.503 -1.037 0 C-N-CA 122.931 2.42 . . . . 0.0 112.84 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.75 109.61 28.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.182 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.26 141.6 39.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.681 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 14.8 m -67.55 152.91 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-O 121.258 0.551 . . . . 0.0 111.356 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 57' ' ' ILE . 21.0 mm -107.65 -31.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 1.051 ' HB2' HD11 ' A' ' 54' ' ' ILE . 47.8 m-70 -153.98 179.57 8.78 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -117.45 128.96 55.52 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -113.6 169.73 8.76 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.234 0.54 . . . . 0.0 110.599 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HE2' ' OD2' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -153.7 111.48 3.53 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 174.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -65.48 138.97 58.44 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.88 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLN . 41.7 t -121.1 148.69 43.83 Favored 'General case' 0 CA--C 1.442 -3.178 0 CA-C-O 121.16 0.505 . . . . 0.0 110.081 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' N ' ' HA ' ' A' ' 48' ' ' GLN . 12.3 m 70.11 176.07 0.28 Allowed 'General case' 0 N--CA 1.401 -2.876 0 O-C-N 126.055 2.097 . . . . 0.0 111.537 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.6 114.37 20.25 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.01 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.831 HG21 ' CE1' ' A' ' 46' ' ' PHE . 13.1 m -115.57 156.48 16.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.671 -174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -47.31 -61.63 1.81 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 124.339 1.025 . . . . 0.0 109.328 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.11 43.67 83.48 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.449 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.79 -171.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 -174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 27.2 mtpp -54.01 -46.07 71.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -174.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.594 HD22 ' HD2' ' A' ' 76' ' ' TYR . 4.0 p-10 -94.46 -4.87 47.46 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.801 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.77 168.28 10.92 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -83.2 126.66 32.87 Favored 'General case' 0 CA--C 1.479 -1.763 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.9 m -85.84 45.89 1.26 Allowed 'General case' 0 C--N 1.256 -3.46 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.974 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.942 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -75.75 179.26 5.55 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.867 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 54.8 mtpt -122.25 -172.61 2.49 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.233 -174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 35' ' ' CYS . 39.1 tt0 -69.17 -17.71 63.84 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 126.482 1.913 . . . . 0.0 115.45 -166.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.63 19.2 2.03 Favored Glycine 1 C--N 1.249 -4.261 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.842 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.2 mm-40 -70.36 132.82 46.23 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.12 97.33 11.08 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 123.211 1.482 . . . . 0.0 108.616 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.809 HD11 HG11 ' A' ' 82' ' ' VAL . 18.9 pt -110.83 159.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.726 0 CA-C-N 111.363 -2.653 . . . . 0.0 112.367 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.8 130.02 31.27 Favored 'General case' 0 C--N 1.27 -2.885 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.619 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -91.72 130.04 41.48 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.405 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -113.78 6.44 7.8 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.535 -175.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 37.3 ttm180 -154.29 119.5 5.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.027 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 28' ' ' ILE . 41.7 mm -87.78 111.26 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 170.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.3 p -91.43 146.18 24.01 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.45 0.643 . . . . 0.0 112.618 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.22 0.98 19.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -53.75 145.97 28.66 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 126.238 1.815 . . . . 0.0 111.874 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.16 -30.69 15.03 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.657 3.571 . . . . 0.0 115.247 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.74 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 12.9 mm-40 -59.82 -37.8 80.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.5 15.83 79.06 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -175.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.74 ' HG2' ' HB3' ' A' ' 62' ' ' GLU . 30.5 mmtp -110.29 142.43 41.92 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.424 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 34.9 m0 -83.93 152.42 24.51 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 123.623 0.577 . . . . 0.0 110.927 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.8 tm? -93.58 107.77 19.58 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.284 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -111.9 174.26 16.3 Favored Glycine 0 N--CA 1.414 -2.814 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.669 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' HG2' HD12 ' A' ' 55' ' ' ILE . 13.4 ptm180 -151.69 146.36 25.72 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 52' ' ' ILE . 71.3 p -82.0 169.66 16.48 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.8 31.02 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.234 0.54 . . . . 0.0 110.536 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.87 4.31 47.46 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.331 0.586 . . . . 0.0 109.852 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.84 17.75 59.24 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.512 -0.767 . . . . 0.0 114.526 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -98.73 109.26 22.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 25.8 m-85 -87.87 146.37 25.61 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.197 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.06 158.21 30.65 Favored Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.813 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.594 ' HD2' HD22 ' A' ' 42' ' ' ASN . 27.2 m-85 -74.28 135.35 42.62 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.699 0.761 . . . . 0.0 110.976 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.942 HG12 ' HE2' ' A' ' 46' ' ' PHE . 87.5 mt -114.83 124.44 71.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.338 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -69.07 128.53 36.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.0 p -60.9 -11.87 9.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.394 0.616 . . . . 0.0 112.656 -173.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 80' ' ' THR . 4.4 t -92.39 -19.83 21.67 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 123.674 0.79 . . . . 0.0 110.329 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -79.43 -10.6 59.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.972 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.849 HG12 ' HA ' ' A' ' 33' ' ' ALA . 31.6 m -133.29 160.77 42.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.298 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -102.21 103.93 14.47 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.611 HD13 ' HB2' ' A' ' 31' ' ' ALA . 30.0 mm -84.35 121.53 36.77 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.949 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 63.0 m-20 -88.48 149.32 23.72 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.676 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 80.5 m-85 -99.52 0.9 43.32 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.725 0.774 . . . . 0.0 109.693 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.42 -29.45 61.59 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.561 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.8 t -63.42 -24.12 67.7 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.169 0.293 . . . . 0.0 110.89 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.37 -29.31 10.82 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.676 ' HE3' ' HB2' ' A' ' 86' ' ' TYR . 97.9 mttt -61.39 -53.65 53.87 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.39 0.614 . . . . 0.0 109.386 176.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.8 tp -124.8 86.95 2.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -78.74 163.14 25.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.274 -171.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -134.74 -82.83 0.43 Allowed 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 46.38 38.51 5.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.195 1.398 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.1 tp -145.53 145.09 30.89 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.344 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -83.02 -43.44 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -89.96 86.0 6.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.138 0.971 . . . . 0.0 111.169 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -84.52 -37.16 21.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.54 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -95.13 86.82 4.69 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.601 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.827 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -88.65 116.24 26.76 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.779 177.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.21 164.16 11.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -173.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 9' ' ' GLU . 7.1 tmtm? -87.92 142.61 27.67 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.583 ' HB2' ' CG ' ' A' ' 12' ' ' GLU . 11.8 pt-20 -72.85 46.13 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 51.6 mtpt -62.8 -35.96 81.57 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 111.545 -177.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -67.04 -41.72 86.06 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 120.99 0.424 . . . . 0.0 109.956 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.845 ' HA ' HG13 ' A' ' 15' ' ' ILE . 11.4 pt-20 -79.91 -27.03 39.99 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 54.1 mt-30 -59.24 -39.6 83.29 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 122.233 1.016 . . . . 0.0 108.532 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -72.61 -46.88 52.0 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.486 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.845 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -65.66 -26.56 39.25 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.801 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 87.9 mttt -74.03 -22.57 59.52 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.434 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -89.54 -39.59 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -65.93 -51.03 62.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.004 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -98.87 3.01 47.17 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.92 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm 51.67 76.21 0.18 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.397 1.094 . . . . 0.0 109.912 -173.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.801 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 6.5 tp -127.51 15.93 7.07 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.783 -173.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 t -57.62 128.66 38.2 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.251 0.548 . . . . 0.0 110.75 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.07 166.97 12.78 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.95 111.71 3.14 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.293 1.995 . . . . 0.0 110.651 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.853 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 pp -98.57 142.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -116.21 142.63 46.58 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.152 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.8 p -71.08 144.65 13.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 120.966 0.412 . . . . 0.0 111.388 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' CD2' ' A' ' 29' ' ' HIS . 51.2 mm -103.76 -36.03 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.191 0.52 . . . . 0.0 110.757 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.811 ' HB2' HD11 ' A' ' 54' ' ' ILE . 75.1 m-70 -147.94 152.58 37.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.409 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.5 mp -92.06 119.71 32.01 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.41 174.88 5.68 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.541 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.35 112.66 3.8 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.832 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.69 137.34 56.61 Favored 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.567 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 35.2 t -127.47 154.22 45.36 Favored 'General case' 0 CA--C 1.444 -3.133 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.777 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.5 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 11.3 m 71.15 175.11 0.29 Allowed 'General case' 0 N--CA 1.4 -2.965 0 O-C-N 125.748 1.905 . . . . 0.0 111.275 163.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.27 110.21 14.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.761 HG21 ' CE1' ' A' ' 46' ' ' PHE . 14.0 m -108.44 155.27 9.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.613 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -56.68 -46.41 81.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.83 43.0 87.15 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.788 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.77 -178.81 0.31 Allowed Glycine 0 CA--C 1.541 1.677 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -29.73 38.13 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -106.76 -6.12 18.0 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.328 0.585 . . . . 0.0 109.945 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -95.78 164.34 12.79 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.523 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -78.8 140.13 38.27 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 t -88.0 43.91 1.15 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.949 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -80.16 -178.98 6.82 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.372 -178.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 57.9 mtpt -130.53 178.87 6.29 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.069 -176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 3.7 tt0 -65.2 -12.77 54.77 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 128.236 2.614 . . . . 0.0 114.241 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -137.39 18.65 3.45 Favored Glycine 0 C--N 1.266 -3.333 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.1 mm-40 -85.22 127.42 34.29 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 112.679 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 97.22 10.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 82' ' ' VAL . 27.6 pt -109.56 157.51 9.94 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.914 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.201 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.892 ' HB3' HG21 ' A' ' 27' ' ' VAL . 43.5 mt-10 -123.71 135.53 53.92 Favored 'General case' 0 C--N 1.281 -2.393 0 O-C-N 121.265 -0.897 . . . . 0.0 109.099 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -101.25 137.03 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 118.571 -1.252 . . . . 0.0 113.011 -179.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.853 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.7 mp -104.13 -49.09 9.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.203 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.863 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 40.6 ttm180 -97.56 113.89 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.661 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG23 ' CE2' ' A' ' 65' ' ' TRP . 43.1 mm -95.57 98.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.876 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 20.7 p -134.76 141.64 46.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.54 -29.08 6.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -73.38 -62.84 1.11 Allowed Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.116 -0.945 . . . . 0.0 112.865 -175.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.876 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.4 Cg_exo -56.6 -78.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.242 1.961 . . . . 0.0 114.37 -173.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 25.9 mm-40 -98.86 -10.01 23.49 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.014 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 22.66 76.68 Favored Glycine 0 CA--C 1.503 -0.677 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 70.4 mmtt -134.28 167.78 20.08 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 42.8 m0 -104.18 140.36 37.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.768 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.4 tm? -87.2 111.93 21.48 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -109.24 -179.64 21.19 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.14 138.88 19.77 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.755 ' HA ' HG22 ' A' ' 52' ' ' ILE . 40.9 p -77.98 171.8 14.46 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -0.18 19.71 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.603 0.716 . . . . 0.0 109.979 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.571 ' HE ' ' HA ' ' A' ' 71' ' ' ARG . 1.8 mmp_? -101.11 -14.56 17.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.815 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.8 21.38 9.72 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.597 -0.811 . . . . 0.0 114.112 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -103.12 113.66 27.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 117.324 0.562 . . . . 0.0 109.787 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB3' HD21 ' A' ' 66' ' ' LEU . 47.5 m-85 -86.96 144.79 26.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.854 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HG ' ' A' ' 44' ' ' LEU . . . -167.73 153.32 22.56 Favored Glycine 0 C--N 1.301 -1.396 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.935 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.531 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 41.4 m-85 -73.04 155.13 40.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.393 0.616 . . . . 0.0 111.324 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.949 HG12 ' HE2' ' A' ' 46' ' ' PHE . 53.1 mt -137.87 136.39 45.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 77' ' ' ILE . 44.0 mtmt -69.16 141.72 54.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 168.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -69.49 -6.82 33.06 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 119.271 0.941 . . . . 0.0 112.372 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.3 t -96.18 -22.11 17.48 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 124.069 0.948 . . . . 0.0 109.71 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -73.21 -15.48 61.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 52' ' ' ILE . 27.3 m -130.69 152.33 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.487 0 CA-C-O 121.17 0.51 . . . . 0.0 112.13 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -92.65 100.68 13.14 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 82' ' ' VAL . 27.8 mm -92.22 125.02 44.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.75 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -102.84 140.31 37.28 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.941 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.448 ' HA ' ' CE1' ' A' ' 29' ' ' HIS . 75.4 m-85 -79.6 -23.76 42.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -51.11 -20.15 1.37 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.379 1.472 . . . . 0.0 114.552 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -62.32 -60.09 4.06 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 117.779 0.263 . . . . 0.0 111.125 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 28' ' ' ILE . 45.8 mt -105.99 -21.18 13.21 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -100.84 94.22 5.94 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.7 113.47 19.71 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.61 -173.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -98.27 -33.23 11.17 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -106.17 101.63 11.1 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.311 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.77 102.08 14.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.4 tp -116.06 91.55 3.63 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--N 1.313 -0.98 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -115.89 -43.1 3.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.725 ' HG3' ' HG3' ' A' ' 5' ' ' GLN . 19.8 ptpt -125.0 20.22 8.31 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.111 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 75.1 -65.81 0.32 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.52 1.128 . . . . 0.0 112.383 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.725 ' HG3' ' HG3' ' A' ' 3' ' ' LYS . 90.3 mt-30 62.78 -59.77 0.14 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -116.04 12.56 15.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -84.69 82.09 8.58 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.518 0.675 . . . . 0.0 110.031 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -79.8 126.59 31.17 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.89 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.23 167.93 19.69 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.148 0.499 . . . . 0.0 110.941 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -80.6 6.8 11.57 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' ILE . 67.1 mttm -74.18 -29.79 61.93 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' CG1' ' A' ' 15' ' ' ILE 0.383 0.0 OUTLIER -69.74 -19.79 63.53 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 -170.893 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -94.36 -12.27 28.28 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.654 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.49 -44.56 12.61 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.542 HD12 ' HG3' ' A' ' 16' ' ' LYS . 2.8 pp -55.87 -28.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.314 1.046 . . . . 0.0 111.916 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' HD12 ' A' ' 15' ' ' ILE . 95.9 mttt -72.5 -22.4 61.05 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -96.97 -45.17 6.7 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 88.1 tttt -59.42 -47.3 85.99 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.149 1.38 . . . . 0.0 111.729 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.45 0.3 19.26 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 33.2 mmtp 56.54 75.24 0.36 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.54 1.162 . . . . 0.0 111.593 -173.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 74' ' ' TYR . 78.8 mt -125.98 16.71 7.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.867 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -72.62 102.46 3.29 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.392 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.63 -155.19 26.37 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -93.32 121.09 0.41 Allowed 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 123.113 2.542 . . . . 0.0 111.65 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 55' ' ' ILE . 2.6 pp -111.79 142.16 25.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.569 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' C ' HG22 ' A' ' 55' ' ' ILE . 54.3 mt-30 -132.47 138.38 47.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 53' ' ' GLU . 14.0 m -59.94 134.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.346 0.593 . . . . 0.0 111.953 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.87 -34.7 5.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 54' ' ' ILE . 76.1 m-70 -155.1 173.59 16.38 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -112.8 139.88 48.05 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -112.58 172.01 7.18 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.163 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -152.71 102.64 2.72 Favored 'General case' 0 C--N 1.264 -3.145 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -69.11 137.36 53.39 Favored 'General case' 0 C--N 1.268 -2.978 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.792 -175.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.0 t -124.78 150.08 46.68 Favored 'General case' 0 CA--C 1.436 -3.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.268 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.3 m 72.74 164.7 0.29 Allowed 'General case' 0 N--CA 1.4 -2.958 0 O-C-N 126.234 2.209 . . . . 0.0 111.15 163.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.64 106.76 1.9 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.775 HG21 ' CE1' ' A' ' 46' ' ' PHE . 19.9 m -98.81 157.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.445 -173.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -42.52 -65.89 0.42 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 125.001 1.438 . . . . 0.0 110.331 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.08 43.53 90.18 Favored Glycine 0 C--N 1.321 -0.259 0 C-N-CA 119.85 -1.167 . . . . 0.0 114.264 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 43' ' ' GLU . . . -57.46 -173.01 0.27 Allowed Glycine 0 CA--C 1.552 2.405 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -64.62 -37.92 89.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -102.2 1.96 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.649 0.737 . . . . 0.0 109.937 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' N ' ' A' ' 40' ' ' GLY . 47.2 mt-10 -92.53 163.26 13.88 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.714 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.73 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -84.73 127.31 34.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -89.93 73.75 7.38 Favored 'General case' 0 C--N 1.253 -3.625 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.791 ' HE2' HG12 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -97.73 -176.76 3.56 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.546 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.596 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 47.7 mtpt -131.44 -173.18 3.04 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.822 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' CB ' ' H ' ' A' ' 35' ' ' CYS . 60.5 tt0 -88.06 114.74 24.98 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 125.089 1.356 . . . . 0.0 107.651 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.89 -1.77 51.96 Favored Glycine 0 C--N 1.29 -2.025 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 12.7 mm-40 -72.32 125.18 26.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.146 0.974 . . . . 0.0 111.548 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -92.95 96.2 9.96 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-O 123.316 1.532 . . . . 0.0 108.154 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 HG11 ' A' ' 82' ' ' VAL . 23.5 pt -106.59 158.61 6.63 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.365 0 CA-C-N 111.912 -2.404 . . . . 0.0 111.004 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG12 ' A' ' 27' ' ' VAL . 4.8 pt-20 -134.67 130.22 36.01 Favored 'General case' 0 C--N 1.249 -3.785 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.623 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -93.69 136.2 26.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 CA-C-O 122.196 0.998 . . . . 0.0 112.158 -178.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.477 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -118.47 7.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.697 -177.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.892 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 42.7 ttm180 -149.44 123.84 9.64 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.182 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.421 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 51.0 mm -109.35 99.71 9.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.6 p -128.15 140.41 51.94 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -108.92 -14.29 14.59 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -46.59 136.03 7.56 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 125.67 1.588 . . . . 0.0 110.209 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -26.1 94.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.481 1 C-N-CA 125.929 4.419 . . . . 0.0 114.81 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 173.58 -51.61 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.64 21.06 67.25 Favored Glycine 0 CA--C 1.491 -1.432 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.162 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.561 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 46.7 mmtm -133.74 161.01 35.85 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.478 ' CZ3' HG13 ' A' ' 84' ' ' ILE . 33.1 m0 -102.7 161.05 14.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 3.1 tm? -106.3 115.42 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.961 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.693 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -116.44 179.39 17.7 Favored Glycine 0 N--CA 1.416 -2.668 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.972 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 31.3 ptt180 -152.22 144.4 23.9 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.806 ' HA ' HG22 ' A' ' 52' ' ' ILE . 27.5 p -74.55 169.89 16.85 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.06 64.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.628 0.728 . . . . 0.0 109.196 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -78.26 -23.86 47.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.653 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.36 26.96 6.68 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.303 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -108.83 111.74 23.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 1.9 m-85 -87.11 148.09 25.37 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.716 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.84 154.19 22.32 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.008 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.445 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 34.6 m-85 -70.44 142.58 51.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.763 0.792 . . . . 0.0 111.626 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.791 HG12 ' HE2' ' A' ' 46' ' ' PHE . 67.2 mt -125.39 136.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.415 -173.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 77' ' ' ILE . 89.5 mttt -72.82 135.98 45.31 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 166.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.8 p -65.23 -10.47 32.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.619 0.723 . . . . 0.0 112.031 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -98.7 -17.66 18.44 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.209 1.004 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.68 -12.77 60.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.584 0.707 . . . . 0.0 109.224 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.943 HG11 HD11 ' A' ' 52' ' ' ILE . 34.9 m -134.97 155.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.511 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -98.87 100.53 11.73 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 31' ' ' ALA . 26.1 mm -79.72 128.46 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -110.21 148.82 31.1 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.993 0.901 . . . . 0.0 110.655 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.738 ' HD1' ' HE1' ' A' ' 29' ' ' HIS . 51.9 t80 -99.06 -27.45 13.83 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.908 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -50.02 -45.62 52.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.307 1.843 . . . . 0.0 114.124 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m -67.68 -14.9 63.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.649 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.866 HD21 ' HA ' ' A' ' 29' ' ' HIS . 2.1 mm? -104.36 -64.22 1.13 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -142.25 174.8 10.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -119.92 152.75 36.92 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.07 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -101.15 -0.99 35.08 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.79 0.805 . . . . 0.0 109.402 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.0 141.9 58.62 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.911 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -68.71 135.31 51.12 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -90.53 -75.75 0.45 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.939 0.4 . . . . 0.0 110.807 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--N 1.308 -1.221 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.135 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -85.13 93.24 8.59 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.379 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -105.29 -41.47 5.53 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.51 111.8 13.65 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.672 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -110.71 84.17 1.88 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.857 0.837 . . . . 0.0 109.817 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -102.12 -61.74 1.35 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 40.33 72.01 0.17 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.793 1.637 . . . . 0.0 111.264 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.79 107.71 0.87 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.047 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 65.0 mm-40 -90.95 144.98 25.11 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.762 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -92.6 -3.63 54.69 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.636 0.731 . . . . 0.0 109.77 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 15' ' ' ILE . 46.8 mmtm -61.5 -38.32 86.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.658 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.785 ' HA ' HG13 ' A' ' 15' ' ' ILE . 10.4 pt-20 -63.79 -30.73 71.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -40.88 90.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -72.97 -54.82 7.64 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.879 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.785 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.0 pp -60.71 -29.34 44.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 98.2 mttt -80.69 -25.67 38.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.878 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -90.5 -42.67 10.71 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.381 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -69.82 -52.73 22.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.433 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.23 -0.46 53.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 54.08 73.41 0.39 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.947 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HG ' HG21 ' A' ' 25' ' ' ILE . 4.5 tp -127.03 16.61 7.3 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.351 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 16' ' ' LYS . 10.3 t -77.39 126.06 30.32 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 119.184 -1.007 . . . . 0.0 110.433 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.76 -155.72 16.2 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.74 137.11 34.75 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 123.395 2.73 . . . . 0.0 110.486 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.878 ' HB ' HG21 ' A' ' 55' ' ' ILE . 17.0 pt -127.07 -70.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.859 ' H ' HG13 ' A' ' 25' ' ' ILE . 30.4 mt-30 70.39 131.37 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.14 1.776 . . . . 0.0 113.638 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 88.3 t -76.26 136.13 25.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 113.199 -1.818 . . . . 0.0 109.871 -178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG22 ' CD2' ' A' ' 29' ' ' HIS . 47.9 mm -99.83 -43.63 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.976 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.93 ' HB2' HD11 ' A' ' 54' ' ' ILE . 65.2 m-70 -140.24 173.88 11.07 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.86 124.77 51.16 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.7 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -104.05 172.49 6.77 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.519 0.676 . . . . 0.0 110.302 177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 4.4 ttmp? -151.88 106.46 3.22 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.876 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.44 120.57 13.58 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.24 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 42.2 t -93.32 155.8 17.19 Favored 'General case' 0 CA--C 1.454 -2.725 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.2 m 62.5 -174.11 0.15 Allowed 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 125.6 1.812 . . . . 0.0 111.127 163.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -91.21 118.27 30.33 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 166.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.904 HG21 ' HE1' ' A' ' 46' ' ' PHE . 20.9 m -97.41 156.89 3.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.614 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -51.43 -47.81 62.9 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.232 0.957 . . . . 0.0 108.703 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.36 95.68 Favored Glycine 0 N--CA 1.438 -1.201 0 O-C-N 124.157 0.911 . . . . 0.0 113.388 173.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.23 178.59 0.13 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 115.466 0.946 . . . . 0.0 115.466 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -49.41 -43.56 44.54 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.843 1.257 . . . . 0.0 113.304 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -94.19 -1.58 53.89 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.573 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.4 167.09 12.21 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.164 0.507 . . . . 0.0 110.961 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -79.75 141.95 35.86 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.103 -177.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.0 p -87.44 84.73 7.13 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.076 175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.904 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.15 176.89 6.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.631 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 57.6 mtpt -128.44 -172.81 2.79 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.748 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 53.5 tt0 -83.2 110.25 17.9 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 125.099 1.359 . . . . 0.0 109.945 -175.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.76 17.4 48.57 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.565 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 27.5 mm-40 -76.33 130.39 38.03 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.626 0.727 . . . . 0.0 110.99 177.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.98 96.9 10.43 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.521 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.854 HD11 HG11 ' A' ' 82' ' ' VAL . 28.7 pt -113.57 157.74 14.16 Favored 'Isoleucine or valine' 1 C--N 1.235 -4.41 0 CA-C-N 111.834 -2.439 . . . . 0.0 111.053 174.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.19 136.94 53.44 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -100.58 138.7 23.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.806 178.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.878 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.6 mp -103.2 -47.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.569 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 57.0 ttt180 -110.17 121.79 46.1 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.325 -172.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.41 HG23 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mm -97.72 95.89 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.2 t -137.15 148.92 46.94 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.19 -0.26 21.08 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.22 -52.99 69.29 Favored Pre-proline 0 C--O 1.212 -0.916 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.61 65.82 6.57 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.087 1.858 . . . . 0.0 111.733 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 56.18 38.64 30.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.945 1.298 . . . . 0.0 112.674 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.07 31.7 34.19 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 114.96 -1.018 . . . . 0.0 115.498 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 45.8 mmtm -121.61 144.33 48.8 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.62 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 35.3 m0 -93.75 162.22 14.01 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.851 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.9 tm? -102.59 117.33 34.44 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.647 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -120.56 176.79 16.3 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HB3' ' CD2' ' A' ' 74' ' ' TYR . 8.6 ptm180 -151.65 142.57 23.0 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 124.536 1.134 . . . . 0.0 108.814 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' ILE . 31.1 p -77.89 168.36 20.04 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.95 -21.37 66.42 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.674 0.273 . . . . 0.0 110.633 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -78.8 -27.04 44.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.8 25.81 3.81 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.14 -1.029 . . . . 0.0 114.188 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.1 m -100.03 113.25 25.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.758 ' HB2' HG21 ' A' ' 15' ' ' ILE . 7.0 m-85 -91.93 144.04 25.88 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.533 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.17 159.64 32.81 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.191 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.621 ' HB3' ' HB3' ' A' ' 64' ' ' LYS . 24.2 m-85 -72.0 151.0 43.52 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.15 0.5 . . . . 0.0 110.119 174.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HE2' ' A' ' 46' ' ' PHE . 60.2 mt -135.18 130.9 51.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.871 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' O ' HG22 ' A' ' 77' ' ' ILE . 56.2 mtmt -64.48 136.74 57.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -67.53 -13.05 61.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.859 0.838 . . . . 0.0 111.936 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 78' ' ' LYS . 11.8 t -96.14 -14.15 23.04 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.287 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.53 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -77.27 -20.27 55.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.876 HG12 ' HA ' ' A' ' 33' ' ' ALA . 34.3 m -128.96 149.64 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-O 121.361 0.601 . . . . 0.0 112.369 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.5 pt-20 -96.97 102.37 14.14 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.447 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -81.72 135.61 24.67 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.672 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.58 154.31 21.81 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.174 0.511 . . . . 0.0 110.303 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -99.67 -27.13 13.82 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.534 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.06 -29.7 45.13 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.82 -35.07 30.37 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 123.903 0.881 . . . . 0.0 112.678 175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.7 mt -81.19 -38.57 26.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.151 -176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp 66.94 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.712 1.205 . . . . 0.0 111.475 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.82 HD21 HD13 ' A' ' 95' ' ' LEU . 61.8 tp 69.37 109.8 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.66 0.784 . . . . 0.0 110.624 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -94.26 25.92 3.59 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -146.33 140.21 26.26 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -84.0 132.38 34.75 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.82 HD13 HD21 ' A' ' 91' ' ' LEU . 10.2 mp -111.28 -37.42 5.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.731 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -105.84 -50.1 3.26 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.11 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 65.52 -177.67 0.18 Allowed 'General case' 0 C--O 1.242 0.689 0 O-C-N 124.263 0.977 . . . . 0.0 109.536 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -81.67 131.76 35.28 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -64.66 -36.4 84.16 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 48.5 mtpt -103.65 94.0 5.22 Favored 'General case' 0 C--O 1.255 1.39 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.503 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.8 85.64 6.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -160.57 88.86 0.8 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.6 tp10 -109.73 137.05 48.09 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.014 -176.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.42 -11.43 59.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.18 0.514 . . . . 0.0 111.285 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 68.6 mttm -59.4 -43.3 92.99 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.92 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HA ' ' CG1' ' A' ' 15' ' ' ILE 0.264 0.0 OUTLIER -71.47 -9.93 58.96 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.613 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -85.66 -47.62 9.64 Favored 'General case' 0 C--O 1.251 1.183 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.19 -45.07 86.3 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.006 -177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.555 ' CG1' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pp -56.33 -29.53 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.427 0.691 . . . . 0.0 112.65 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -74.76 -22.32 58.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.048 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -97.07 -42.83 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.911 0.862 . . . . 0.0 108.744 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -62.65 -50.13 72.41 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.809 1.644 . . . . 0.0 110.732 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -102.05 -2.09 30.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.156 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 58.48 76.42 0.34 Allowed 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 124.096 0.872 . . . . 0.0 108.839 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.62 16.36 9.56 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.865 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -82.46 114.4 20.87 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.889 0.852 . . . . 0.0 110.028 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.96 -170.41 24.55 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.14 117.72 4.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.601 2.2 . . . . 0.0 111.928 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.707 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.9 pp -132.3 139.32 50.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.757 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -131.4 140.29 49.63 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 122.776 0.431 . . . . 0.0 110.448 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.803 HG21 ' HB3' ' A' ' 53' ' ' GLU . 11.0 p -63.4 141.19 18.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 O-C-N 123.603 0.565 . . . . 0.0 111.138 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.675 HD12 HG12 ' A' ' 57' ' ' ILE . 54.6 mt -103.6 -33.08 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.157 0.503 . . . . 0.0 111.937 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.809 ' HB2' HD11 ' A' ' 54' ' ' ILE . 67.8 m-70 -154.95 167.5 30.11 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.589 ' HG ' ' HG2' ' A' ' 53' ' ' GLU . 7.0 mp -106.69 137.64 44.34 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -111.42 171.92 7.2 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.257 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 20.4 ptmt -151.17 106.66 3.36 Favored 'General case' 0 N--CA 1.397 -3.09 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -62.86 109.55 1.48 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.461 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 39.5 t -96.26 150.73 20.22 Favored 'General case' 0 CA--C 1.426 -3.821 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.573 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 9.5 m 66.45 -175.84 0.19 Allowed 'General case' 0 N--CA 1.399 -3.005 0 O-C-N 126.078 2.111 . . . . 0.0 109.385 165.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -72.81 120.63 18.7 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 ' CE1' ' A' ' 46' ' ' PHE . 4.3 m -98.99 154.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -59.38 -69.14 0.22 Allowed 'General case' 0 C--N 1.309 -1.179 0 O-C-N 123.813 0.696 . . . . 0.0 109.29 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.98 42.6 84.93 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.242 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.27 -116.51 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -99.61 -52.97 3.32 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.651 -0.911 . . . . 0.0 112.474 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -90.64 2.84 55.53 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.378 0.609 . . . . 0.0 110.555 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 38.3 mt-10 -90.25 159.16 16.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.145 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.578 HD22 ' HB3' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -64.8 149.09 50.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 124.05 0.844 . . . . 0.0 110.207 -176.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.8 m -88.81 80.14 7.25 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.665 ' HD2' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -134.79 167.61 20.56 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.46 -177.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.9 mmtp -143.67 -172.8 3.8 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.736 0.779 . . . . 0.0 111.263 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 35' ' ' CYS . 49.7 tt0 -67.93 120.7 14.64 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 126.492 1.917 . . . . 0.0 109.346 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.17 4.57 68.6 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.034 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 48.5 mm-40 -76.12 126.77 31.62 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.936 0.874 . . . . 0.0 111.355 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -96.12 96.94 9.18 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.878 HG22 ' HA ' ' A' ' 69' ' ' THR . 33.1 pt -107.75 159.7 7.18 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.105 0 CA-C-N 111.914 -2.403 . . . . 0.0 113.164 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.803 ' HB3' HG21 ' A' ' 27' ' ' VAL . 50.4 mt-10 -121.29 139.73 53.01 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.259 0.2 OUTLIER -105.06 132.17 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.94 175.462 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.707 HG21 ' HB ' ' A' ' 25' ' ' ILE . 2.9 mp -105.42 -34.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.562 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.88 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.8 ttm180 -114.5 119.51 37.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.751 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.675 HG12 HD12 ' A' ' 28' ' ' ILE . 44.0 mm -101.71 98.15 6.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 3.0 p -136.83 141.71 42.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -115.25 -30.64 6.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.998 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 86.5 m-20 -66.2 -55.16 21.82 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 31.5 Cg_exo -58.54 -80.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.796 1.664 . . . . 0.0 113.647 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.79 6.66 13.23 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.797 0.332 . . . . 0.0 111.25 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.89 31.2 78.9 Favored Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.132 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE3' ' HG2' ' A' ' 78' ' ' LYS . 47.4 mmtm -133.49 160.54 37.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' HZ3' HG13 ' A' ' 84' ' ' ILE . 40.5 m0 -101.57 141.87 33.79 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.546 176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.5 tm? -88.75 113.64 24.53 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.669 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -115.58 178.32 17.6 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.843 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 73' ' ' SER . 20.7 ptt180 -151.57 135.74 16.7 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 124.261 1.025 . . . . 0.0 108.396 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.878 ' HA ' HG22 ' A' ' 52' ' ' ILE . 10.8 p -72.67 169.17 17.18 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -17.65 62.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.44 -26.52 60.11 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.99 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.92 12.31 20.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.727 -0.749 . . . . 0.0 114.688 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 21.3 m -91.08 118.93 30.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 118.178 0.989 . . . . 0.0 108.977 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 61.4 m-85 -84.06 144.11 29.29 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.223 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 44' ' ' LEU . . . -166.4 156.64 28.67 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.541 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 43' ' ' GLU . 10.3 m-85 -76.72 134.79 39.1 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.67 0.748 . . . . 0.0 110.018 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.669 HD11 ' HA3' ' A' ' 67' ' ' GLY . 71.6 mt -114.94 138.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.685 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 77' ' ' ILE . 90.5 mttt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 104.829 -2.285 . . . . 0.0 104.829 168.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.6 p -64.62 -18.26 64.76 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-O 121.762 0.791 . . . . 0.0 111.751 -171.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 -19.63 27.19 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.18 -17.84 59.36 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.307 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -129.19 151.81 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -98.27 105.78 17.98 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD13 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mm -83.55 123.69 38.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.682 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 145.43 24.72 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 122.594 1.187 . . . . 0.0 111.806 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.776 ' HB3' HD13 ' A' ' 91' ' ' LEU . 84.5 m-85 -99.6 -13.02 19.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.379 -1.737 . . . . 0.0 108.291 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.53 -47.93 72.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.935 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -69.35 -14.71 63.07 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' ' 29' ' ' HIS . 3.0 mm? -102.07 -17.61 15.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.0 mttp 53.7 80.49 0.11 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 114.557 -1.201 . . . . 0.0 114.099 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 86' ' ' TYR . 6.5 mp -89.06 87.29 7.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 173.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 37.5 mtmt -91.6 -55.03 3.64 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.499 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -174.75 115.03 0.17 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.184 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -98.59 78.68 2.39 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -178.3 102.8 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 C--O 1.259 1.566 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.87 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.666 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -86.99 -60.48 1.97 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -136.82 -50.02 0.65 Allowed 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -100.9 172.76 6.84 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.62 -47.09 8.18 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.732 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 59.16 23.84 12.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.785 0.802 . . . . 0.0 111.147 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -144.47 25.0 1.54 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -80.02 128.36 33.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.3 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.567 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.5 tp10 -136.09 157.06 47.73 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 174.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 38.4 mtmt -92.44 1.85 57.0 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.845 0.831 . . . . 0.0 109.683 -176.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 25.2 ttmm -80.05 -12.95 59.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.95 -172.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' HA ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.37 -19.57 63.83 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.389 -177.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' O ' ' HE2' ' A' ' 17' ' ' LYS . 43.6 tt0 -54.92 -44.3 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.6 0.714 . . . . 0.0 109.476 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -80.97 -43.88 19.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.408 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.603 HG13 ' HA ' ' A' ' 12' ' ' GLU . 2.2 pp -65.13 -26.24 39.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 97.1 mttt -75.27 -18.6 60.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.041 0.448 . . . . 0.0 111.292 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 13' ' ' GLN . 53.0 mtmt -96.9 -41.13 8.57 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -68.07 -46.89 69.82 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.683 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA2' ' A' ' 75' ' ' GLY . 57.1 m-85 -108.01 -3.09 19.08 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.389 -177.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 72.9 mmtt 56.69 69.99 0.69 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.068 0.855 . . . . 0.0 110.369 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.66 16.93 15.4 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.392 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -51.99 117.83 3.03 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.801 0.84 . . . . 0.0 112.791 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.1 179.31 15.91 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.557 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 121.71 6.52 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.364 2.709 . . . . 0.0 110.488 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 55' ' ' ILE . 2.5 pp -120.44 163.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.966 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -126.07 155.49 41.48 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.842 0.829 . . . . 0.0 111.194 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 53' ' ' GLU . 59.8 t -90.43 107.96 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.272 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.408 HD12 HG12 ' A' ' 57' ' ' ILE . 49.9 mt -77.63 -37.56 24.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.871 ' HB2' HD11 ' A' ' 54' ' ' ILE . 69.5 m-70 -150.57 168.47 24.16 Favored 'General case' 0 CA--C 1.483 -1.631 0 CA-C-O 121.04 0.448 . . . . 0.0 110.416 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CD1' ' HG2' ' A' ' 53' ' ' GLU . 3.8 mm? -101.88 119.73 39.26 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 52' ' ' ILE . . . -103.91 164.04 11.96 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -152.46 107.28 3.21 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -60.44 126.27 26.82 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.1 p -103.1 -11.0 18.4 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -167.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.82 175.02 14.12 Favored 'General case' 0 C--N 1.264 -3.137 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.0 -157.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.36 107.83 5.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.826 HG21 ' HE1' ' A' ' 46' ' ' PHE . 14.7 m -103.96 156.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.691 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -57.91 -48.93 78.45 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.8 42.97 60.15 Favored Glycine 0 N--CA 1.44 -1.042 0 O-C-N 124.605 1.19 . . . . 0.0 113.634 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.38 -170.44 0.25 Allowed Glycine 0 CA--C 1.536 1.394 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -52.03 -38.81 58.23 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -100.57 -0.22 38.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.685 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.49 167.23 11.44 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.98 -178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD13 ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -76.08 139.51 41.41 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.933 0.873 . . . . 0.0 111.634 -176.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -82.84 76.03 9.71 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.912 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.826 ' HE1' HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -125.05 -178.99 4.37 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.442 179.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 28.6 mtpp -139.52 -173.09 3.52 Favored 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 123.648 0.593 . . . . 0.0 110.041 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -67.87 -13.14 61.91 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 126.464 1.906 . . . . 0.0 115.619 -168.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.5 15.0 4.73 Favored Glycine 0 C--N 1.254 -3.978 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.459 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 21.0 mm-40 -72.65 123.32 23.0 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 122.282 1.039 . . . . 0.0 112.892 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -93.66 96.17 9.65 Favored 'General case' 0 N--CA 1.397 -3.077 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.866 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 pt -105.11 159.18 5.59 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.08 0 CA-C-N 111.653 -2.521 . . . . 0.0 112.685 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HG2' ' CD1' ' A' ' 30' ' ' LEU . 35.3 mt-10 -124.63 132.04 53.44 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.871 HD11 ' HB2' ' A' ' 29' ' ' HIS 0.277 0.2 OUTLIER -100.47 143.81 13.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 117.503 -1.679 . . . . 0.0 112.284 178.147 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.739 HG12 HD13 ' A' ' 25' ' ' ILE . 2.9 mp -111.6 -21.48 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.613 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.84 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 43.2 ttm180 -127.73 121.36 30.09 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.813 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG12 HD12 ' A' ' 28' ' ' ILE . 39.1 mm -112.51 102.91 14.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 103.842 -2.651 . . . . 0.0 103.842 173.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t -128.08 157.47 40.63 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.614 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -108.93 0.56 20.19 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.53 121.91 56.56 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.74 83.88 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.185 2.59 . . . . 0.0 114.955 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.28 -16.74 5.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.8 9.55 74.32 Favored Glycine 0 CA--C 1.5 -0.856 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.258 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 76' ' ' TYR . 71.3 mmtt -135.31 -177.91 4.87 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.876 0.846 . . . . 0.0 112.372 -174.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 20.1 m0 -120.66 162.27 19.97 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 106.638 166.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.84 ' HB3' ' HB3' ' A' ' 56' ' ' ARG . 2.7 tm? -105.9 120.7 42.42 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.131 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 54' ' ' ILE . . . -124.05 -176.32 14.66 Favored Glycine 0 N--CA 1.422 -2.249 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.206 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 33.5 ptt180 -151.23 146.1 25.84 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 52' ' ' ILE . 12.8 p -85.17 166.78 16.3 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 2.54 25.96 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -91.42 -19.88 22.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.749 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.82 36.9 3.33 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.526 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -128.61 137.53 51.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 29.9 m-85 -106.19 152.14 23.85 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.551 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -169.8 152.6 19.82 Favored Glycine 0 CA--C 1.478 -2.251 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.067 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.521 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 9.3 m-85 -74.53 152.8 39.29 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HE2' ' A' ' 46' ' ' PHE . 40.7 mt -136.67 134.71 48.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' HG22 ' A' ' 77' ' ' ILE . 94.3 mttt -70.7 142.67 51.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 167.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.8 p -65.34 -12.46 52.17 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.757 0.789 . . . . 0.0 112.738 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 78' ' ' LYS . 8.2 t -94.86 -15.04 24.02 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.566 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -78.9 -19.76 51.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 52' ' ' ILE . 35.1 m -134.1 163.95 35.74 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.316 -176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.27 106.82 14.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.659 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' HZ3' ' A' ' 65' ' ' TRP . 1.4 mp -85.02 127.71 39.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.986 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -119.98 154.21 34.85 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.368 0.604 . . . . 0.0 109.997 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.583 ' HA ' HD23 ' A' ' 89' ' ' LEU . 85.3 t80 -98.66 -24.56 15.02 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.989 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.19 -45.04 72.07 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 m -72.79 -1.46 16.67 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 29' ' ' HIS . 4.3 mm? -76.48 -21.16 56.2 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 122.064 -0.397 . . . . 0.0 110.65 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -110.67 133.84 52.97 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -78.01 112.17 14.65 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.628 ' HE2' HD22 ' A' ' 95' ' ' LEU . 60.9 tttm -112.98 90.93 3.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.659 0.742 . . . . 0.0 110.883 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.52 -39.74 3.13 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -112.52 139.47 48.08 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.628 HD22 ' HE2' ' A' ' 92' ' ' LYS . 39.5 tp -137.46 -74.95 0.41 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.615 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 N--CA 1.427 -1.611 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.834 . . . . . . . . 0 0 . 1 stop_ save_